data_2czy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2czy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 t -52.58 -28.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.267 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.02 -41.53 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -38.37 83.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.87 -34.19 66.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -63.48 -53.49 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 40' ' ' TYR . 4.4 t -59.47 -42.37 91.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' N ' HG23 ' A' ' 39' ' ' THR . 39.6 t80 -52.64 -46.87 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.66 -43.39 96.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -29.5 69.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -31.42 56.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.9 t -79.45 -24.76 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.981 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 tttm -77.83 -44.27 27.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -68.73 -51.11 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.34 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -29.21 63.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.137 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -115.69 39.18 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.21 -28.0 71.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.6 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 p -97.32 6.79 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.453 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.17 86.68 12.79 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.672 0.273 . . . . 0.0 110.916 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.83 -25.07 28.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.593 2.195 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.28 86.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -61.1 -45.06 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 45' ' ' LYS . 28.6 t80 -60.83 -50.86 71.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -31.12 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.79 -43.4 84.07 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.05 -44.35 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.45 -37.03 84.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.78 -44.66 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.37 -53.2 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -50.19 70.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -59.34 -39.79 84.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.27 -31.24 71.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.423 ' CZ ' HD12 ' B' ' 46' ' ' LEU . 41.0 t80 -69.98 -40.35 75.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -59.41 -34.74 72.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.6 -16.07 62.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.272 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.38 39.51 0.92 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.833 0.349 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.51 -51.4 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.63 131.09 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.16 172.75 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.403 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.08 -58.41 19.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 83.1 Cg_exo -45.06 -31.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.442 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.44 64.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.461 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.07 -48.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.73 -32.18 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -63.91 -52.49 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -57.09 -47.99 79.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.47 -42.06 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -62.51 -24.84 67.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -96.53 -35.5 11.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 tp -62.83 -44.38 96.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 19.3 m-85 -107.03 51.11 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.74 -30.83 71.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.26 26.64 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -140.11 95.11 8.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.962 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.7 -48.92 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.428 2.085 . . . . 0.0 112.359 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -55.25 -20.62 11.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.4 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 5.0 mt -85.68 -56.59 3.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 110.415 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.01 -28.99 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.291 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.76 -47.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.88 -39.47 68.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.161 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -74.84 -32.59 61.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 -30.06 70.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -8.85 49.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.783 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -99.76 -38.83 8.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.52 138.01 86.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.75 177.04 9.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.537 2.158 . . . . 0.0 112.383 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.15 -29.86 68.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.96 -63.48 5.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.593 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -104.2 88.25 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -87.27 178.77 6.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.771 0.238 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -76.86 -25.51 53.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 110.562 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 2.3 mt -77.49 -33.73 54.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.273 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -73.22 -36.38 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -74.45 -29.96 61.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.703 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.56 -48.36 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.675 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.24 -33.0 74.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -64.58 -46.09 84.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.79 -28.8 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.5 45.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.326 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.909 179.668 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.697 0.284 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.56 -28.48 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.455 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.25 -52.38 65.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -30.57 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.941 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.39 -39.23 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.34 -51.08 67.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.403 HG21 ' N ' ' A' ' 40' ' ' TYR . 3.6 t -59.53 -44.75 93.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' N ' HG21 ' A' ' 39' ' ' THR . 56.6 t80 -54.68 -42.34 71.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.03 -30.21 64.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.46 -31.79 69.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.991 0.424 . . . . 0.0 111.096 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -82.02 -30.98 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.02 -22.8 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -85.05 -47.18 10.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.983 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.9 -53.45 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.246 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -29.64 67.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' CD2' HG23 ' A' ' 54' ' ' THR . 24.2 m-85 -118.36 40.24 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.92 -28.22 63.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -114.92 38.47 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.11 87.72 12.15 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.53 -29.5 24.86 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.557 2.171 . . . . 0.0 112.324 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.77 -49.9 75.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 48' ' ' PHE . 1.7 m -64.75 -52.51 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 5.6 t80 -59.71 -49.07 79.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -60.37 -30.65 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.28 -57.11 7.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.01 -41.21 78.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -45.86 91.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -44.37 87.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -63.27 -31.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -47.41 31.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -66.74 -41.39 87.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.816 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -41.76 98.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 26.8 t80 -59.36 -48.14 82.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.58 76.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -16.69 61.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.9 40.57 0.92 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 p -111.98 -38.23 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.7 tt -98.47 133.28 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.99 178.99 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -64.85 -52.82 47.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.2 Cg_exo -48.43 -38.99 35.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 -29.34 74.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -73.9 -47.86 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.69 -37.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -41.31 60.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -49.06 78.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 83' ' ' PHE . 49.9 t -65.92 -39.13 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -61.66 -25.82 67.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -45.05 13.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.784 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.68 -38.76 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 79' ' ' VAL . 9.0 m-85 -106.55 61.05 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -58.39 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 28.44 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 2.7 m170 -125.11 90.64 50.63 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.788 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.02 -51.94 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.519 2.146 . . . . 0.0 112.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -55.83 -20.37 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 13.0 mt -86.9 -56.65 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.249 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.73 -31.93 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.16 -44.93 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.32 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.36 -32.83 68.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.054 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -73.43 -42.3 62.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 110.707 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -61.57 -24.78 66.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.778 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.83 -9.96 48.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -99.58 -30.7 11.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mt -82.88 146.52 52.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 171.07 13.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.509 2.139 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.04 -27.87 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.07 -45.83 92.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.573 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -108.19 126.34 52.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -127.36 136.55 52.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 CA-C-O 120.827 0.261 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -20.38 54.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 7.6 mt -77.55 -39.99 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.338 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.9 mm -70.44 -38.95 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -26.74 61.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.809 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -68.28 -50.12 55.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.58 81.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -63.25 -39.25 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.739 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 36.2 t -70.9 -30.39 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.93 -35.43 43.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 110.416 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.451 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.091 179.713 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.26 -33.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.53 -43.71 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.19 -39.13 89.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.786 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.61 -33.51 69.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -54.38 34.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 40' ' ' TYR . 4.1 t -58.02 -42.67 85.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' HG21 ' A' ' 39' ' ' THR . 57.7 t80 -52.63 -49.14 65.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.008 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -72.03 -30.0 64.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 110.994 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -76.8 -30.02 56.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.49 -30.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 55' ' ' TYR . 1.6 tppp? -71.77 -47.75 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.05 -48.02 89.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -30.47 69.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CD2' HG22 ' A' ' 54' ' ' THR . 68.3 m-85 -121.79 42.19 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.33 -45.54 92.72 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.533 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -98.18 28.1 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.23 65.98 29.6 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.98 -23.21 20.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.598 2.198 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.55 -39.61 67.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.419 HG22 ' CD2' ' A' ' 48' ' ' PHE . 3.1 m -76.87 -46.43 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 30.4 t80 -62.28 -51.91 65.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.35 -43.32 92.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.21 -48.53 85.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -59.48 -31.35 69.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.2 -46.72 63.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -38.32 83.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -65.59 -51.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 18.2 mmt -67.05 -41.33 86.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -68.67 -31.46 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.92 -34.76 62.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' CE1' HD13 ' B' ' 46' ' ' LEU . 25.9 t80 -64.66 -56.56 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.019 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -36.41 72.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t -67.41 -12.91 61.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.224 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 74.83 45.06 0.17 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -114.46 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.1 tt -81.5 150.1 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.34 -175.3 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -54.61 4.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.2 -32.15 18.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 -38.27 60.23 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -65.53 -33.56 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.6 mt -75.28 -35.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -75.62 -42.74 50.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -56.97 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.421 HG23 ' CE2' ' A' ' 93' ' ' PHE . 47.1 t -58.09 -48.06 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -60.57 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -91.37 -42.68 10.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.755 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.41 -30.79 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.447 ' CD1' ' CD1' ' A' ' 89' ' ' LEU . 19.0 m-85 -110.16 46.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.57 -34.61 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.065 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -108.03 26.12 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.12 94.4 8.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.41 -44.99 2.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.371 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -64.26 -13.78 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.35 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.447 ' CD1' ' CD1' ' A' ' 83' ' ' PHE . 13.3 mt -86.72 -54.57 4.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.37 -29.25 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.151 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.66 -49.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.469 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.74 -38.39 87.96 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.065 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 79' ' ' VAL . 85.1 t80 -71.36 -34.29 70.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.591 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.55 -33.46 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.9 57.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -99.8 29.9 3.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.415 HD12 ' CE2' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -134.54 143.81 48.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.489 2.126 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -19.3 61.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.12 49.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.819 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -128.76 145.57 51.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.63 137.01 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 103' ' ' ILE . 17.3 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.761 0.234 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.48 -25.48 50.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 110.69 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 65' ' ' PHE . 6.9 mt -76.99 -33.97 57.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.374 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -72.43 -39.99 63.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.427 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -29.92 66.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.621 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.58 -50.29 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.419 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -33.45 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -61.62 -44.48 96.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.629 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.95 -29.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.903 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.72 -35.19 52.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.067 0.46 . . . . 0.0 110.204 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 mp . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.872 179.601 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 21.6 p-80 . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.694 0.283 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.68 -52.02 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.762 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 18.2 mt-10 -58.12 -49.07 78.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -58.98 -36.57 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.98 -31.43 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.43 -52.72 43.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 40' ' ' TYR . 3.8 t -59.53 -43.71 93.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' N ' HG22 ' A' ' 39' ' ' THR . 42.6 t80 -52.87 -52.7 56.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.73 -37.27 85.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.23 -32.59 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.005 0.431 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.68 -31.31 36.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.767 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.72 -24.31 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.125 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 16.6 tptt -81.5 -46.76 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -65.09 -47.83 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -29.41 70.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.12 39.34 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.36 -28.75 73.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 m -101.4 18.14 20.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.595 0.236 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.27 86.99 12.37 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.8 -26.33 32.48 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.83 -38.29 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.3 m -76.16 -37.81 57.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 33.9 t80 -71.9 -52.85 15.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.01 -37.65 80.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.78 -42.43 95.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.2 -53.2 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.414 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 3.0 mt -59.8 -35.34 74.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -39.88 92.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -64.55 -54.34 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -62.05 -40.25 95.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -68.12 -31.1 70.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.03 -37.57 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 48.3 t80 -67.84 -38.9 83.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -57.97 -32.12 67.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.793 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -68.25 -12.04 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 65.65 39.54 4.85 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.56 -47.87 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.888 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.7 tt -87.09 158.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.69 -177.68 5.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.431 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -72.74 -51.38 6.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.1 Cg_exo -49.75 -33.59 32.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.78 -30.72 67.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.411 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG22 ' CD1' ' A' ' 65' ' ' PHE . 21.5 t -72.94 -35.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 76' ' ' ILE . 34.9 mm -67.72 -46.29 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -36.45 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -63.26 -53.85 46.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.56 -47.92 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.4 p -58.24 -23.24 55.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -87.11 -41.57 13.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.75 -31.1 71.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.43 ' CD1' HD11 ' A' ' 89' ' ' LEU . 15.3 m-85 -116.31 58.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -71.7 -32.2 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.201 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.6 33.7 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.159 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -140.06 86.16 13.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.054 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.02 -50.53 11.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.25 . . . . 0.0 112.323 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -19.12 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.446 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 83' ' ' PHE . 7.0 mt -87.64 -57.7 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.59 -31.9 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.177 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -77.47 -44.75 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.79 -38.49 96.04 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.96 -34.09 66.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.073 0.464 . . . . 0.0 110.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -69.14 -23.9 64.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.963 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.37 -11.19 57.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.734 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -99.7 -30.21 12.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.71 143.9 63.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 162.91 41.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.42 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -28.55 67.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.57 -27.65 61.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.2 102.09 10.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.75 0.31 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 141.54 39.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.862 0.276 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.04 -22.97 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 15.4 mt -76.9 -35.7 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 mt -72.71 -38.81 59.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.426 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -27.02 61.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.812 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -45.21 65.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.52 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.49 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -64.44 -47.58 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.18 -28.26 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.88 -36.11 42.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.276 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.451 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.953 179.684 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.42 -28.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.27 -39.23 71.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.712 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.89 77.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.22 63.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.52 -49.72 57.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.1 t -59.44 -44.92 92.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.406 ' N ' HG23 ' A' ' 39' ' ' THR . 9.7 t80 -54.54 -51.26 65.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.98 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.51 -31.07 71.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -33.04 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.731 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -79.28 -31.35 43.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.671 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 t -78.38 -29.83 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.751 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 1.2 tttm -72.84 -48.98 33.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.22 -41.64 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -28.33 65.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 54' ' ' THR . 22.1 m-85 -117.61 40.11 3.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.93 50.99 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.552 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.7 17.08 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.661 0.267 . . . . 0.0 111.181 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -140.25 62.74 21.1 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 110.941 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -23.26 23.59 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.533 2.155 . . . . 0.0 112.462 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.47 72.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 48' ' ' PHE . 2.0 m -60.36 -47.42 86.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 13.6 t80 -63.04 -43.34 98.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -44.38 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -43.81 98.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.548 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -58.78 -43.29 90.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 mt -61.7 -37.1 82.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.78 -43.63 97.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -59.93 -59.5 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.3 91.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -64.46 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.02 -32.82 59.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.27 -35.9 81.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -59.21 -32.15 69.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.1 -16.89 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.28 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.46 40.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 p -113.11 -48.77 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.0 tt -78.69 156.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.08 173.56 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -72.06 -51.95 7.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.1 Cg_exo -49.62 -35.33 37.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.536 2.157 . . . . 0.0 112.358 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.83 -30.08 70.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.413 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -71.03 -47.01 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 0.0 111.038 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.06 -32.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -49.78 56.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -45.91 90.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 83' ' ' PHE . 40.2 t -59.47 -46.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -62.12 -24.96 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -78.03 -47.26 18.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.18 -29.0 68.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 79' ' ' VAL . 4.4 m-85 -111.78 54.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.56 -43.34 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.57 26.89 10.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -128.9 93.66 36.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.74 -51.95 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.453 2.102 . . . . 0.0 112.557 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.84 -18.83 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 83' ' ' PHE . 37.9 mt -84.1 -55.49 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.207 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.75 -28.64 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.081 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.71 -46.27 47.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.426 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.47 -35.3 84.81 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -72.59 -35.14 67.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.0 110.775 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -66.95 -27.26 67.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -16.76 55.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.75 -30.07 12.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -68.94 147.64 97.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.26 173.48 11.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.557 2.172 . . . . 0.0 112.349 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -30.88 69.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -68.55 -64.63 2.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.53 84.82 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.55 147.51 27.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.723 0.218 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.99 -24.69 47.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 110.788 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.19 -38.83 56.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.476 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.8 mt -70.49 -39.64 76.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -27.09 62.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.749 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.7 -46.54 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.59 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.35 83.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.051 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -61.89 -45.97 91.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.15 -27.87 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.88 -35.19 51.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.25 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 N--CA 1.45 -0.465 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.826 179.59 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.718 0.294 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.0 -29.11 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.92 76.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -38.49 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.46 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.99 -54.06 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 40' ' ' TYR . 3.4 t -60.5 -44.83 95.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.413 ' N ' HG21 ' A' ' 39' ' ' THR . 45.3 t80 -55.42 -49.9 71.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.053 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.2 mt -65.19 -34.96 79.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -70.91 -27.76 64.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -31.06 34.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.75 -31.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -73.36 -49.25 28.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.02 -45.31 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -62.39 -32.89 73.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -119.14 39.87 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.34 -44.07 52.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.5 m -66.33 -16.39 64.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.661 0.267 . . . . 0.0 111.223 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -132.58 92.68 26.67 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.7 -12.33 35.15 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.516 2.144 . . . . 0.0 112.492 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.8 77.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.5 m -69.0 -36.86 78.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 59' ' ' LEU . 32.5 t80 -65.74 -49.98 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -60.54 -32.74 71.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.69 -51.65 52.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CE1' ' HE3' ' A' ' 62' ' ' MET . 23.2 t80 -59.24 -42.98 92.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.417 HD12 ' CE2' ' A' ' 55' ' ' TYR . 73.1 mt -59.83 -40.61 89.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -42.75 99.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.45 -37.95 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.414 ' HE3' ' CE1' ' A' ' 58' ' ' PHE . 28.5 mmt -68.95 -55.69 10.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -60.35 -31.28 70.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.792 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.22 -40.91 86.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CZ ' HD11 ' B' ' 46' ' ' LEU . 42.1 t80 -66.78 -44.48 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -58.46 -42.43 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.652 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -63.15 -16.63 60.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.26 43.84 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.819 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.94 14.76 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.331 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.1 tt -155.09 145.81 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.042 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.36 178.37 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.53 -53.2 17.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 73.3 Cg_exo -48.99 -38.09 38.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.562 2.175 . . . . 0.0 112.405 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.72 -29.64 71.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.5 t -75.03 -34.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.985 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.9 mt -71.4 -44.31 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.148 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -43.53 94.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -48.06 81.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.76 -34.17 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 t -62.44 -25.43 67.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -32.35 11.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.71 -32.66 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.992 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 89' ' ' LEU . 26.4 m-85 -124.38 47.68 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -9.49 58.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.54 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -103.5 -29.65 11.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.821 0.343 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -100.01 108.25 50.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.25 -42.85 3.52 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.41 2.073 . . . . 0.0 112.229 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.56 -17.64 34.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.288 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 83' ' ' PHE . 18.1 mt -88.2 -56.63 3.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.261 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 tt -60.92 -33.17 54.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.232 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.11 -43.64 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.453 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.27 86.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -73.92 -38.88 64.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.3 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.767 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.74 -9.53 51.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.824 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -99.72 -29.37 12.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mt -86.05 151.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.87 159.24 53.74 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -27.29 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -52.69 47.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.621 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -104.34 68.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -63.99 173.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.976 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 C--O 1.232 0.213 0 N-CA-C 112.606 0.195 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -77.55 -27.33 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.648 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 23.7 mt -75.65 -33.66 60.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mm -73.37 -38.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -27.46 62.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.34 -53.44 19.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.12 67.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.107 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -67.52 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.06 -24.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.91 63.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.17 0.509 . . . . 0.0 109.699 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.008 179.446 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.11 -31.04 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -37.59 65.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -67.05 -43.84 81.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.44 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -62.27 -55.7 25.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.9 t -59.02 -44.63 91.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 39' ' ' THR . 63.3 t80 -53.29 -38.18 62.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.081 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.55 -47.26 49.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -31.62 69.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 110.963 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.2 -46.52 50.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.95 -16.72 21.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.314 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -85.03 -44.06 13.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -66.14 -56.4 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -56.52 -28.38 59.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CE2' HG23 ' A' ' 54' ' ' THR . 33.3 m-85 -117.26 39.77 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.0 70.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -101.96 19.44 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.664 0.269 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.24 74.7 29.53 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.905 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.46 -28.8 65.83 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.384 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.27 89.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 48' ' ' PHE . 2.9 m -59.8 -51.58 69.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -63.16 -50.44 70.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.69 -42.23 92.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.48 -43.92 98.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.93 -49.97 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.075 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.23 76.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.59 -42.89 99.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -61.64 -50.12 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 31.3 mmt -60.15 -49.2 78.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -63.88 -31.61 72.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.74 -46.02 80.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' B' ' 46' ' ' LEU . 34.4 t80 -63.48 -44.0 95.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 t -62.89 -17.25 61.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 70.04 39.82 1.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 -43.09 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.3 tt -97.19 158.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -85.34 176.08 8.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.14 -53.04 27.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.4 Cg_exo -49.2 -28.2 14.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.581 2.187 . . . . 0.0 112.438 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.23 -32.09 60.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 t -72.8 -44.05 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mt -64.31 -47.7 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -39.25 92.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -57.02 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 t -61.62 -22.61 65.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -94.72 -34.29 12.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.2 tp -61.19 -36.57 80.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.449 ' CD1' ' CD1' ' A' ' 89' ' ' LEU . 24.7 m-85 -112.67 52.67 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.86 -25.43 67.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.223 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 25.4 11.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.3 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.429 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -140.14 86.73 12.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.911 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.25 -48.73 14.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.703 2.268 . . . . 0.0 112.422 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.07 -20.91 7.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.598 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 83' ' ' PHE . 44.2 mt -86.84 -59.24 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.436 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -58.31 -30.48 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.38 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.28 -47.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.96 -37.49 85.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.096 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.24 -33.43 63.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.097 0.475 . . . . 0.0 110.673 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.35 -25.17 66.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.8 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.11 26.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.931 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.76 -35.05 9.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.831 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mt -76.08 146.76 79.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.42 176.42 8.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tp -73.47 -24.91 60.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 -26.48 30.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.618 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.93 114.43 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -85.76 139.34 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.157 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.743 0.226 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -75.95 -23.3 55.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.611 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.412 HD12 ' CD2' ' A' ' 65' ' ' PHE . 1.8 mt -77.03 -33.79 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.342 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -72.9 -39.38 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -29.57 65.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.73 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.32 -49.21 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -30.5 71.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -62.45 -49.88 73.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.64 -29.17 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.836 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.54 -34.24 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.203 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.45 -0.432 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.917 179.544 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.907 0.384 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -57.7 -38.99 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.07 -38.49 88.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.431 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -39.68 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.529 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.77 72.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -64.76 -52.77 55.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.2 t -54.64 -42.32 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 39' ' ' THR . 17.1 t80 -54.97 -54.93 36.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.6 mt -63.48 -30.29 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.27 -41.08 94.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.53 -27.16 51.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 t -79.59 -30.97 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.746 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -71.92 -49.64 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.687 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -64.35 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -59.89 -30.99 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 54' ' ' THR . 32.6 m-85 -119.68 40.29 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.26 -38.17 81.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.398 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -81.45 -18.05 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.14 89.9 51.31 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.012 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.32 -8.94 24.8 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.583 2.189 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.61 -39.07 67.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.249 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 48' ' ' PHE . 1.2 m -75.48 -43.04 51.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 59' ' ' LEU . 27.5 t80 -61.27 -48.83 79.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -61.38 -43.41 98.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.97 83.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.375 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -61.13 -35.39 76.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' A' ' 55' ' ' TYR . 1.9 mt -65.1 -46.48 80.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.51 75.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.34 -32.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.8 mmt -75.43 -44.48 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -33.51 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.664 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.32 -41.15 81.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.809 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.45 ' CE2' ' CB ' ' B' ' 46' ' ' LEU . 78.8 t80 -61.99 -46.02 91.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.6 -39.32 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -15.87 60.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 73.87 41.05 0.44 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.25 -42.37 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.804 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.34 147.95 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.12 171.24 13.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.7 -53.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.7 Cg_exo -50.36 -37.86 51.48 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.91 82.42 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.452 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 t -62.33 -49.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.21 -43.64 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -44.65 96.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -59.66 -50.99 71.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.432 HG12 ' CE2' ' A' ' 83' ' ' PHE . 46.9 t -62.34 -42.95 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.96 -23.3 66.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -46.3 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.61 -34.99 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CE2' HG12 ' A' ' 79' ' ' VAL . 9.0 m-85 -106.87 53.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -61.97 -57.45 11.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.42 27.08 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -126.59 89.55 51.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.781 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.05 -51.17 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.605 2.203 . . . . 0.0 112.598 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.9 -21.99 4.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.501 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.0 mt -85.17 -58.35 2.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.346 . . . . 0.0 110.446 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -59.08 -27.85 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.0 t -76.17 -48.87 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.517 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.89 93.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.129 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -72.39 -33.35 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -62.5 -34.54 77.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 -22.4 49.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -100.0 30.32 3.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.823 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.5 126.46 22.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.38 176.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.492 2.128 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -29.05 28.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.75 -27.18 58.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -126.14 95.81 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 139.29 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 tt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.692 0.205 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -79.93 -27.33 39.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.778 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.45 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -79.77 -34.65 39.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.349 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.03 -32.98 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.504 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -30.35 53.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.36 -43.32 67.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.42 72.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -63.97 -49.21 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.744 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.74 -28.76 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.19 -35.41 41.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.451 -0.412 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.887 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 29.9 p-80 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.501 0.191 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.25 -31.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -64.84 -44.55 89.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -65.37 -44.16 88.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.934 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.74 66.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 mt -64.86 -53.99 37.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 40' ' ' TYR . 2.9 t -59.51 -45.55 91.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' N ' HG22 ' A' ' 39' ' ' THR . 53.8 t80 -55.69 -47.2 77.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.067 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.36 -31.42 72.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -32.68 71.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.81 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -26.39 38.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.835 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.45 -29.16 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -46.2 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 mt -66.62 -41.6 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -30.91 68.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -124.82 43.75 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.1 -35.58 84.68 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.469 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 p -107.9 42.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -140.13 92.38 9.63 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.94 -38.84 12.23 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.472 2.114 . . . . 0.0 112.24 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.47 77.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.2 m -71.57 -48.21 49.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -65.35 -58.53 5.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.32 -32.11 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.68 -50.57 41.6 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.66 -44.58 85.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -35.27 80.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.696 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.7 -35.8 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.874 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.8 mt -69.48 -50.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -32.39 73.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -71.87 -31.63 66.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 -30.13 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.405 ' HA ' HG12 ' A' ' 70' ' ' ILE . 40.4 t80 -70.44 -40.35 73.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -56.97 -32.54 66.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -64.94 -16.15 62.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.05 42.5 1.25 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.743 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -113.86 -51.5 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 65' ' ' PHE . 11.2 pt -74.58 178.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -116.62 -177.47 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.42 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.35 -52.76 20.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.6 Cg_exo -47.94 -27.75 9.19 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.642 2.228 . . . . 0.0 112.428 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.8 -29.35 57.57 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.67 -33.89 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -73.59 -45.43 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -46.41 76.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -45.65 87.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.11 -41.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.2 t -58.28 -22.51 52.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.09 -38.77 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.07 -31.57 72.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -119.92 50.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -67.44 -41.09 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -100.74 30.0 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -139.96 85.77 13.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -56.93 -59.31 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.61 2.207 . . . . 0.0 112.225 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -51.33 -22.77 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.556 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -81.79 -55.72 4.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.28 -26.21 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.94 -47.92 46.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.33 -43.56 93.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.31 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.45 -29.53 66.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.921 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.24 -22.49 61.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 -3.32 28.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.4 ' CZ ' ' OD2' ' A' ' 36' ' ' ASP . 79.5 m-85 -99.76 -28.98 12.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.3 mt -89.03 140.07 29.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.63 177.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.443 2.095 . . . . 0.0 112.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.9 -31.69 71.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.32 -34.64 81.34 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.55 75.13 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.89 127.51 33.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.697 0.207 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.61 -21.0 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.386 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -79.38 -38.74 34.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.35 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.02 -35.2 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -27.8 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.75 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.14 -43.46 67.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.425 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -36.46 79.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.997 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.54 -39.98 94.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 t -72.52 -28.03 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.748 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.49 52.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.449 -0.51 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.8 t -53.52 -27.67 14.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.261 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.87 -39.47 69.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -36.28 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.43 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.83 -49.87 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.7 t -59.5 -44.66 93.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 39' ' ' THR . 62.8 t80 -53.08 -49.75 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.042 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.77 -32.63 73.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.21 -33.22 75.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -26.03 36.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 t -76.94 -28.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -80.34 -49.72 11.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.5 mt -60.82 -38.98 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.943 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -67.88 -27.4 66.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -114.99 39.21 2.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.09 -28.35 53.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.78 21.68 16.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -140.2 81.85 17.71 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 -28.1 23.82 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.597 2.198 . . . . 0.0 112.327 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.05 93.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.8 m -60.38 -38.64 84.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -69.89 -47.02 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -59.91 -42.62 94.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.95 94.54 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.551 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.53 -50.45 73.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.28 -36.57 78.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.97 -45.61 92.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mt -59.57 -45.58 93.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -49.9 55.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -59.49 -36.62 76.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.016 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.97 -30.74 67.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' A' ' 75' ' ' VAL . 50.2 t80 -74.19 -35.33 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -57.72 -40.89 80.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.762 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -15.84 61.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 71.93 53.76 0.19 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.985 0.421 . . . . 0.0 110.836 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.59 -39.02 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt -92.34 156.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.215 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.79 170.09 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.413 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -62.16 -54.22 51.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.791 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.9 Cg_exo -48.38 -41.16 36.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.167 . . . . 0.0 112.233 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.73 99.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG23 ' CD2' ' A' ' 65' ' ' PHE . 18.8 t -58.5 -40.0 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.98 -43.26 98.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -67.86 -36.06 79.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -57.27 -65.82 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.435 ' CG1' ' CE2' ' A' ' 83' ' ' PHE . 23.9 t -63.44 -31.31 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -64.85 -23.82 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.66 -37.73 11.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.49 -30.26 70.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.023 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CE2' ' CG1' ' A' ' 79' ' ' VAL . 11.8 m-85 -114.62 55.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -66.78 -33.09 74.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.56 26.35 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -140.05 88.21 11.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.96 -44.46 3.93 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.591 2.194 . . . . 0.0 112.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -50.15 -25.35 3.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 ' CE1' ' A' ' 83' ' ' PHE . 92.9 mt -82.72 -51.0 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.404 HG22 ' CD1' ' A' ' 103' ' ' ILE . 57.0 mt -62.52 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.956 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 -50.41 32.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.465 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.35 80.52 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.323 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 97' ' ' LEU . 64.5 t80 -74.76 -30.74 61.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.92 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -74.89 -27.28 60.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.878 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.25 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.519 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -99.66 -38.38 8.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.06 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.429 HD13 ' CE2' ' A' ' 93' ' ' PHE . 7.1 mt -66.24 148.32 98.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 172.32 12.49 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.53 -22.21 57.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.77 -44.2 70.1 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.693 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.413 ' CE2' ' HB ' ' A' ' 72' ' ' THR . 47.4 m-85 -102.9 99.44 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.829 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -77.97 116.26 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 90' ' ' ILE . 3.6 tt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.024 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.708 0.212 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -79.49 -26.48 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.658 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.409 HD11 ' CE2' ' A' ' 65' ' ' PHE . 20.5 mt -78.92 -36.08 42.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 mt -73.47 -34.7 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.35 -43.35 67.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.67 72.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -50.32 69.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.46 -29.16 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.68 -34.44 58.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.111 0.481 . . . . 0.0 110.091 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.728 179.58 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.449 ' CD2' ' HB2' ' A' ' 35' ' ' GLU . 5.6 p-80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -41.99 -32.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.886 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 5.7 mm-40 -63.46 -47.21 82.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.707 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -64.36 -37.74 88.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.95 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.44 -48.78 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 40' ' ' TYR . 2.6 t -60.21 -45.67 92.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.854 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' HG21 ' A' ' 39' ' ' THR . 69.2 t80 -55.47 -47.89 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.69 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -63.11 -30.2 71.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.59 -28.29 30.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -81.02 -20.29 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.33 -46.43 9.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.724 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 mt -67.04 -50.07 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -59.41 -30.66 68.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -119.62 40.75 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.02 -29.26 64.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.578 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -107.72 30.35 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.17 88.58 11.5 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.62 -28.53 31.2 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.513 2.142 . . . . 0.0 112.329 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.68 69.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -74.04 -56.64 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -59.19 -52.03 67.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -61.27 -34.85 75.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.2 -50.16 23.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.23 -27.41 67.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -53.48 15.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.8 -38.23 69.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.016 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.87 -56.85 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.852 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.09 86.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.777 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -64.59 -52.09 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.82 -30.35 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HA ' HG12 ' A' ' 70' ' ' ILE . 61.8 t80 -66.48 -47.49 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -57.31 -27.37 62.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 m -66.97 -13.03 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.86 47.78 2.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.956 0.407 . . . . 0.0 110.823 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 m -121.82 -39.28 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 65' ' ' PHE . 9.5 pt -91.26 178.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -108.85 172.69 6.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.424 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.17 -51.98 32.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.014 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.3 Cg_exo -50.38 -34.1 39.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.27 90.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.95 -39.36 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.5 mt -69.03 -35.9 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -70.31 -47.3 61.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -58.45 -37.94 76.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.22 -45.54 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 t -58.61 -23.83 59.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -84.02 -40.14 18.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.806 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.88 -31.5 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 6.0 m-85 -121.58 62.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -69.71 -44.12 71.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.654 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HG2' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -99.94 26.63 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.8 m170 -130.83 104.31 15.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -74.6 -47.51 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.091 . . . . 0.0 112.712 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.25 -17.65 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.58 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.68 -55.86 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.208 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.72 -30.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.06 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.17 -45.57 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.289 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 -34.55 82.49 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.998 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -74.15 -37.79 63.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.659 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -61.45 -29.89 70.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -17.94 57.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.496 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.85 29.7 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.333 . . . . 0.0 110.954 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.2 145.32 23.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 158.88 54.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -26.81 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.34 -27.46 53.23 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.615 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 109.03 10.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.97 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.746 0.228 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -77.28 -19.02 57.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -78.99 -38.29 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 110.37 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.49 -37.25 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.448 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -28.46 61.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mt -72.18 -41.29 67.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.39 75.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.867 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.04 -53.48 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.693 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.06 -28.0 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.003 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.1 48.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.096 0.474 . . . . 0.0 110.214 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.888 179.618 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.821 0.343 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.27 -36.81 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.26 -39.71 95.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.66 75.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 -30.78 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mt -66.53 -53.14 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.58 -44.31 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -52.87 -55.74 20.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.06 -33.13 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -28.87 66.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.53 -26.84 37.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.77 -29.7 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.973 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -78.23 -47.2 18.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 mt -63.01 -45.53 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.13 -28.44 68.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CD2' HG21 ' A' ' 54' ' ' THR . 63.8 m-85 -123.79 43.1 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -39.53 85.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.448 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -79.25 -19.49 50.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.224 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -111.0 92.86 15.89 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.01 -23.75 40.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.02 77.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 ' CD2' ' A' ' 48' ' ' PHE . 18.9 m -65.14 -48.41 73.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CD2' HD13 ' A' ' 59' ' ' LEU . 9.2 t80 -62.76 -46.96 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -60.27 -34.93 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.22 -49.54 56.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.78 -53.06 62.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD13 ' CD2' ' A' ' 55' ' ' TYR . 33.2 mt -57.3 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -37.86 73.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.08 -29.07 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -41.45 61.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -71.82 -44.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -58.6 -58.55 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -60.24 -44.14 95.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.138 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -52.57 -37.17 57.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -13.86 61.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.032 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 71.02 49.38 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.0 m -112.44 -33.36 6.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.96 173.37 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -96.21 168.94 10.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.01 -52.32 75.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.8 Cg_exo -48.23 -35.43 26.91 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.288 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.08 81.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.338 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.9 t -74.97 -33.38 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.6 mt -71.8 -47.38 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -64.23 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -55.01 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.409 HG11 ' CE2' ' A' ' 83' ' ' PHE . 37.7 t -69.84 -35.32 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -62.54 -26.99 68.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.92 -32.5 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.81 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.08 -40.14 92.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.803 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 16.9 m-85 -107.26 61.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -92.39 22.47 4.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.403 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -128.37 -44.94 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -103.09 118.25 58.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -33.54 14.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.525 2.15 . . . . 0.0 112.326 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.23 -13.95 33.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.527 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 5.0 mt -87.19 -56.74 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.32 -31.28 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.75 -47.67 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.2 82.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.092 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -73.24 -35.02 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.47 . . . . 0.0 110.717 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -33.27 73.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -18.5 58.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.322 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -99.79 30.03 3.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -144.3 147.12 35.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.88 159.77 51.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.545 2.163 . . . . 0.0 112.212 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.99 -29.76 68.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.49 69.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.8 88.52 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -85.74 -174.58 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.151 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.231 0.174 0 N-CA-C 112.613 0.197 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.52 -25.67 41.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 55.4 mt -79.4 -36.01 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.43 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.6 mm -74.26 -33.62 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.544 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.1 -29.44 54.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.696 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.06 -46.0 65.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -33.46 73.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.965 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.26 -42.55 96.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.82 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 t -70.97 -30.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.726 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.99 43.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.307 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.91 179.623 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.741 0.305 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.47 -30.71 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.206 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -38.8 78.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -39.47 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.37 69.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.66 -54.35 43.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 40' ' ' TYR . 4.0 t -59.83 -44.53 94.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.402 ' N ' HG21 ' A' ' 39' ' ' THR . 75.1 t80 -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.077 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.65 -34.23 73.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -29.49 70.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -81.37 -26.55 35.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.25 -29.93 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.043 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 2.8 tptt -78.15 -47.61 17.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -64.91 -48.39 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -62.09 -31.55 72.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' ' CG2' ' A' ' 54' ' ' THR . 64.4 m-85 -122.14 42.35 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 -35.03 91.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.566 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -97.63 20.83 11.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.288 . . . . 0.0 111.223 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.21 89.15 11.07 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.994 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.15 -26.91 42.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.417 2.078 . . . . 0.0 112.25 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -45.15 93.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.421 ' CG2' ' CD2' ' A' ' 48' ' ' PHE . 28.2 m -61.23 -55.84 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 t80 -60.3 -46.87 88.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.26 -38.15 82.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.45 -46.15 91.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.489 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -60.76 -46.31 90.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.413 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -60.49 -37.71 81.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.22 -41.97 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mt -63.97 -46.79 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.2 mmt -69.37 -43.43 73.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -66.01 -32.75 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -65.54 -47.39 76.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.21 -41.66 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.693 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -64.45 -15.1 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 74.02 40.93 0.43 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.939 0.399 . . . . 0.0 110.798 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.7 t -117.55 14.3 14.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 tt -159.01 146.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -90.52 177.19 6.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.37 -53.85 42.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 77.0 Cg_exo -48.01 -39.14 32.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.572 2.182 . . . . 0.0 112.467 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 -29.21 72.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.41 -43.86 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -61.83 -43.83 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -41.3 84.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -44.16 78.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.5 t -76.13 -32.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -62.46 -25.37 67.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -31.17 13.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.5 tp -62.23 -63.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 89' ' ' LEU . 11.3 m-85 -89.19 53.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.19 -39.4 93.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.02 25.8 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.157 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 1.2 m-70 -140.17 97.15 7.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.94 -46.65 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.59 2.194 . . . . 0.0 112.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -55.83 -20.75 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 1.8 mt -85.67 -57.77 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.8 tt -53.84 -26.43 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.193 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.2 -50.56 20.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.188 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 -32.59 53.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.979 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -78.32 -34.88 48.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.18 0.514 . . . . 0.0 110.494 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -59.96 -29.19 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.633 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.59 -4.5 27.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.881 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -99.7 -50.1 4.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.71 0.291 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.24 142.6 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 176.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.134 . . . . 0.0 112.311 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.15 -28.98 60.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.75 -51.21 58.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.624 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.79 88.79 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -86.36 122.37 30.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.0 tt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.794 0.247 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . 0.425 ' HA ' ' HG2' ' B' ' 48' ' ' MET . 20.3 mp0 -76.12 -26.56 56.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.514 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -76.61 -32.56 58.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.237 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -72.74 -37.98 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' MET . . . . . 0.425 ' HG2' ' HA ' ' B' ' 45' ' ' GLN . 2.7 ptt? -71.05 -32.16 68.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.97 -43.18 79.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.62 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.88 -34.02 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.976 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.54 -44.83 85.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 t -67.62 -29.1 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.68 -35.26 52.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 110.256 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.915 179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 35' ' ' GLU . 29.2 p-80 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.529 0.204 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -44.63 -30.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.813 0.339 . . . . 0.0 111.532 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 33' ' ' HIS . 29.6 tt0 -62.22 -59.41 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -31.15 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.12 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mt -61.94 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -62.02 -44.51 96.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' N ' ' CG2' ' A' ' 39' ' ' THR . 61.9 t80 -54.13 -48.31 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.088 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -63.05 -37.66 88.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.48 -32.14 70.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -30.62 62.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 t -82.87 -37.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -48.11 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.702 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -70.6 -47.97 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -60.73 -36.05 77.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 54' ' ' THR . 19.1 m-85 -115.68 39.06 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.19 -27.83 65.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -97.38 15.21 23.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.693 0.282 . . . . 0.0 111.29 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -140.18 77.49 25.06 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 -24.26 19.86 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.51 -55.28 36.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.228 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.416 HG23 ' CD2' ' A' ' 48' ' ' PHE . 3.3 m -59.85 -38.34 81.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.13 -56.23 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -31.97 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 -49.41 12.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.469 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.042 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -39.64 83.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -62.24 -40.31 95.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -64.47 -51.74 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -41.83 98.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -69.12 -42.52 75.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' B' ' 46' ' ' LEU . 23.3 t80 -62.81 -44.72 95.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -31.63 67.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -66.49 -13.33 60.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.245 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 63.43 42.16 6.96 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.962 0.411 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -116.65 -39.04 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.0 tt -96.16 157.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -84.51 -177.69 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -74.36 -53.29 3.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 71.3 Cg_exo -48.75 -27.95 11.95 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.584 2.189 . . . . 0.0 112.364 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.38 -37.03 48.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.429 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -68.29 -40.16 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.765 0.316 . . . . 0.0 111.029 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.3 mt -68.81 -42.51 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -58.76 -44.67 90.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.9 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 83' ' ' PHE . 45.5 t -64.51 -41.97 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -23.36 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.01 -39.33 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 tp -61.38 -34.15 74.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 79' ' ' VAL . 18.5 m-85 -109.08 42.42 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -29.52 68.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 28.15 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -140.13 96.13 8.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.07 -48.39 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.348 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.62 -18.26 28.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 83' ' ' PHE . 40.9 mt -87.41 -56.11 3.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.328 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 91' ' ' VAL . 17.8 tt -59.22 -28.49 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.278 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.431 ' N ' HG21 ' A' ' 90' ' ' ILE . 66.1 t -78.34 -48.04 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.21 85.67 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.934 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -72.51 -40.3 66.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.508 . . . . 0.0 110.773 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -67.05 -21.18 65.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.004 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.66 -7.26 43.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.87 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -99.72 -30.24 12.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.331 . . . . 0.0 110.951 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -77.85 153.81 80.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 163.95 29.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.283 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -31.1 68.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.0 -43.82 92.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.403 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -93.91 76.02 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.01 162.9 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.735 0.223 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.33 -25.84 51.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.706 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . 57.8 mt -77.16 -33.13 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.297 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.408 HD12 ' CE2' ' A' ' 65' ' ' PHE . 26.2 mm -74.06 -37.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.503 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -28.96 62.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.687 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.18 -47.4 61.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.436 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.19 -30.75 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.943 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -63.52 -50.73 68.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.15 -30.61 50.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.82 53.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.993 179.616 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 35' ' ' GLU . 27.1 p-80 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.602 0.239 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -44.78 -46.66 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.718 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . 21.7 tt0 -58.2 -41.35 83.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.974 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -65.88 -36.42 83.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.85 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -61.96 -54.89 35.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.6 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' ' CG2' ' A' ' 39' ' ' THR . 81.4 t80 -55.21 -51.63 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.39 -32.0 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.96 -27.39 33.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.1 t -80.67 -29.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.53 -48.19 15.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.711 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 mt -64.77 -49.08 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -59.41 -30.25 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 54' ' ' THR . 34.2 m-85 -115.81 39.29 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.03 93.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.24 25.07 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.663 0.268 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -140.19 87.01 12.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.63 -28.34 37.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.574 2.183 . . . . 0.0 112.258 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.01 88.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.415 HG22 ' CE2' ' A' ' 48' ' ' PHE . 8.7 m -66.9 -50.89 60.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 45' ' ' LYS . 12.5 t80 -60.06 -51.68 68.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.793 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.61 -54.01 31.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.437 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.02 -36.65 77.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mt -66.27 -41.17 90.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -59.82 -39.13 83.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.34 -31.82 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -69.17 -43.73 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -70.81 -31.08 67.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -55.28 32.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CZ ' HD12 ' B' ' 46' ' ' LEU . 25.8 t80 -59.66 -42.26 92.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -36.47 74.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.42 -15.7 61.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 72.27 51.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 t -130.77 -54.29 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 tt -73.96 148.52 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.96 175.34 7.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.03 -53.26 56.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.2 Cg_exo -49.87 -36.53 43.37 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.615 2.21 . . . . 0.0 112.305 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.92 77.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.99 -46.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.49 -48.85 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 mtt85 -59.83 -40.09 87.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -49.82 76.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -75.1 -36.09 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.186 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -60.57 -25.12 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.04 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.91 -33.51 11.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.407 HD22 ' CZ ' ' A' ' 83' ' ' PHE . 14.7 tp -62.98 -46.79 86.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 89' ' ' LEU . 23.7 m-85 -104.63 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.68 -4.85 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.609 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -102.49 -35.31 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -105.83 119.76 51.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.18 -42.44 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.447 2.098 . . . . 0.0 112.287 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.61 -18.01 17.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 83' ' ' PHE . 12.9 mt -85.23 -55.79 3.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.303 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -61.4 -27.51 42.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.1 t -76.43 -48.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.16 -35.68 65.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.098 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.76 -36.14 62.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.685 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -63.02 -25.86 68.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.714 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.3 -1.66 21.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -99.75 -30.89 11.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.88 153.58 70.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.38 173.8 9.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.45 -13.89 61.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.266 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.05 -29.99 45.22 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.687 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -131.63 137.56 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -108.52 139.92 42.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.733 0.222 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -79.65 -22.29 43.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.42 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 21.9 mt -81.31 -35.66 30.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.96 -33.61 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.351 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -31.29 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.607 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.55 -49.94 60.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.62 74.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.818 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -71.25 -31.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.59 49.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.49 . . . . 0.0 110.163 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.45 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.796 179.551 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.01 -28.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.536 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.9 -49.3 78.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.767 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.58 -30.88 64.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.86 -39.57 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.47 -51.99 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -58.15 -42.68 86.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -53.65 -50.01 66.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.106 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.17 -34.82 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -33.59 76.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -27.12 38.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.27 -28.52 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.5 -47.23 17.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -63.54 -48.53 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -63.93 -29.97 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 54' ' ' THR . 4.8 m-85 -117.91 40.07 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.02 -28.62 72.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 p -104.89 25.55 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.11 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -140.18 68.11 33.48 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.28 -28.12 33.22 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.568 2.179 . . . . 0.0 112.307 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.64 89.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.424 ' CG2' ' CD2' ' A' ' 48' ' ' PHE . 57.1 m -65.6 -45.03 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 12.4 t80 -59.52 -51.3 70.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -33.52 73.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.46 -50.85 40.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -57.77 -46.07 85.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -44.24 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -54.01 -40.19 66.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.49 -32.1 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 32.8 mmt -69.59 -47.9 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HG2' ' CG ' ' B' ' 54' ' ' LEU . 5.4 mttt -65.45 -38.4 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.716 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.99 -44.59 94.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 16.3 t80 -59.19 -54.7 43.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -59.48 -35.18 73.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -64.0 -16.92 62.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.254 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.81 44.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.13 -41.73 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.68 147.84 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -87.04 172.61 9.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.416 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -61.8 -52.78 66.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.997 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.4 Cg_exo -49.73 -47.57 22.6 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.487 2.125 . . . . 0.0 112.463 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.33 -29.88 66.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.76 -47.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.113 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 mt -64.19 -36.34 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -61.85 -50.23 73.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -57.25 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.1 t -57.74 -47.56 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -59.12 -22.78 61.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.066 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -94.28 -36.46 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.58 -35.33 79.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 89' ' ' LEU . 13.8 m-85 -113.1 56.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.962 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -69.55 -29.91 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.153 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.15 26.21 10.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -140.14 94.62 8.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.54 -45.78 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.443 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.85 -18.87 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 83' ' ' PHE . 8.1 mt -85.17 -56.91 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.62 -26.75 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.259 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.0 t -76.12 -51.63 19.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.39 87.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.126 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.63 -31.99 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -62.87 -32.3 73.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.632 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.22 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.379 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -99.82 29.94 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.9 mt -134.76 141.21 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.949 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.85 164.15 35.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.466 2.111 . . . . 0.0 112.295 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -26.69 68.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.014 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.7 -36.32 71.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.575 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -120.9 96.79 5.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.443 HG23 HD11 ' A' ' 103' ' ' ILE . 25.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 CA-C-O 120.692 0.205 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -79.84 -27.28 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.7 mt -78.98 -37.1 40.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.385 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.85 -34.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -75.5 -30.69 59.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.39 -49.9 65.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.442 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.86 79.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.921 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.12 -40.37 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.704 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.37 -34.07 56.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.802 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.6 -32.93 47.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.352 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.431 ' CG ' ' HG2' ' A' ' 63' ' ' LYS . 8.6 mp . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.291 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.619 0.247 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -45.59 -35.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.444 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.44 -33.31 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -43.71 59.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.36 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.971 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.93 -55.68 15.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.1 t -58.59 -45.07 89.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.402 ' N ' ' CG2' ' A' ' 39' ' ' THR . 58.9 t80 -55.19 -48.06 74.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.07 -39.79 93.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.97 -29.07 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.801 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -79.45 -26.87 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.94 -25.45 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -82.14 -45.99 14.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.24 -51.91 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.207 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -58.13 -30.22 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' HG23 ' A' ' 54' ' ' THR . 32.0 m-85 -116.99 39.82 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 -40.32 92.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.575 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -97.75 24.0 7.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.038 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.17 63.96 24.94 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -51.3 -25.35 17.79 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.548 2.166 . . . . 0.0 112.436 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.51 82.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.414 HG23 ' CE2' ' A' ' 48' ' ' PHE . 4.9 m -68.32 -48.91 63.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 45' ' ' LYS . 16.9 t80 -60.66 -48.49 81.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.21 -40.53 90.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -48.19 80.36 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.405 ' CE1' ' HE1' ' A' ' 62' ' ' MET . 34.6 t80 -58.22 -44.3 88.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 55' ' ' TYR . 17.6 mt -61.07 -40.41 93.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.09 -38.49 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.7 -33.59 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.405 ' HE1' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -69.64 -35.77 75.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -76.62 -33.54 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.761 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -38.47 89.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.0 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 37.7 t80 -76.26 -45.98 30.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -34.59 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 p -67.46 -13.09 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.324 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 43.93 0.29 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.911 0.386 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 m -115.36 -65.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.97 144.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.5 -178.14 6.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.31 -52.9 50.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.4 Cg_exo -48.46 -43.03 33.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.556 2.171 . . . . 0.0 112.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.41 -29.92 76.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.394 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 65' ' ' PHE . 21.6 t -74.55 -45.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mt -61.37 -50.6 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -58.55 -45.72 88.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -59.44 -31.38 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.001 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.75 -47.32 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -22.19 48.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -92.58 -36.58 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.27 -30.57 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.39 40.63 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -68.04 -13.41 62.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.445 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -100.05 -30.29 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 111.072 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -100.14 114.44 65.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 -43.55 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.45 2.1 . . . . 0.0 112.291 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -16.08 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -53.46 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 0.0 110.055 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 tt -61.25 -28.69 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.192 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.56 -51.07 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.26 -35.37 55.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -75.81 -34.33 60.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -62.53 -27.63 69.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.62 -1.63 22.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.012 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -99.88 -30.28 12.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.91 138.43 20.98 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.07 177.02 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.452 2.102 . . . . 0.0 112.227 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp -65.65 -29.94 70.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.57 -72.33 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.566 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.95 65.32 6.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.93 157.89 29.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.154 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.854 0.273 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -79.81 -21.12 44.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 22.6 mt -81.08 -39.07 26.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.367 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 mt -72.59 -34.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.379 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -32.35 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.435 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -44.65 74.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.403 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.43 -34.33 77.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.44 -46.32 90.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.93 -27.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.686 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.71 -36.26 37.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.069 0.461 . . . . 0.0 110.381 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.044 179.612 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.57 -30.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -50.19 18.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.754 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.89 -39.16 64.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.53 -50.99 67.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 40' ' ' TYR . 4.2 t -59.1 -42.78 91.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' HG22 ' A' ' 39' ' ' THR . 75.9 t80 -52.56 -51.32 60.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.998 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.22 -33.27 75.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.77 -30.73 70.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -80.85 -26.02 37.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -78.74 -28.4 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.006 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HE2' ' CE2' ' A' ' 55' ' ' TYR . 1.5 tppp? -80.13 -49.29 11.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.0 mt -63.39 -41.12 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -60.05 -28.07 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CD2' ' CG2' ' A' ' 54' ' ' THR . 31.4 m-85 -131.97 47.63 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.84 77.81 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 19.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.21 87.27 12.28 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.855 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.97 -24.54 39.37 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.595 2.196 . . . . 0.0 112.418 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.34 80.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.425 ' CG2' ' CD2' ' A' ' 48' ' ' PHE . 16.3 m -67.32 -57.98 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.41 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 15.9 t80 -59.97 -43.9 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -60.48 -38.28 83.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.77 56.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -57.97 -48.52 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.92 -49.51 76.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -42.47 61.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 mt -65.02 -31.91 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.82 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -43.84 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -74.14 -38.2 63.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 110.806 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 77.9 t80 -66.84 -45.98 76.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -29.69 58.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -15.32 62.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.305 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 69.33 42.03 1.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.921 0.391 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 p -117.5 -36.52 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 65' ' ' PHE . 1.2 pt -93.32 178.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.86 170.16 8.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.423 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.69 -60.72 9.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.228 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 93.3 Cg_exo -42.99 -30.46 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.602 2.201 . . . . 0.0 112.58 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.74 -34.93 66.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.314 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.67 -48.64 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.358 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.17 -34.74 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -76.0 -39.68 55.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -60.42 -49.47 84.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.074 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.3 t -56.96 -25.5 58.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.78 -42.88 26.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.23 -31.37 72.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 4.7 m-85 -118.22 61.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -73.59 -31.12 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.566 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.85 24.15 12.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.51 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.9 m170 -129.65 90.81 42.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.79 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.403 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 29.5 Cg_endo -64.11 -55.5 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.513 2.142 . . . . 0.0 112.393 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -50.75 -23.7 2.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.476 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.1 mt -81.53 -57.9 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 tt -61.94 -25.4 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.466 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 87' ' ' PRO . 98.3 t -72.98 -50.5 31.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.19 -37.51 80.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.219 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' HD11 ' B' ' 49' ' ' LEU . 54.1 t80 -72.85 -30.71 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.047 0.451 . . . . 0.0 110.837 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -69.02 -27.42 65.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.16 -13.59 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -99.75 -29.18 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.7 149.7 78.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.721 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.98 172.07 12.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.612 2.208 . . . . 0.0 112.301 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -67.67 -42.78 81.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.68 -49.22 79.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.19 54.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -174.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.767 0.236 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.38 -24.62 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 11.8 mt -78.02 -40.23 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.447 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.0 -37.52 72.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.47 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -29.06 62.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 93' ' ' PHE . 11.2 mt -67.43 -43.45 81.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.514 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.84 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.77 -46.35 89.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.628 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.2 -30.22 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.12 43.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.416 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.438 ' CD1' ' HG2' ' A' ' 63' ' ' LYS . 8.4 mp . . . . . 0 N--CA 1.449 -0.49 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.327 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.812 0.339 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.24 -32.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.198 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.71 -34.34 75.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.96 -41.44 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.89 -51.19 60.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 40' ' ' TYR . 3.7 t -60.12 -44.93 94.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.42 ' N ' HG21 ' A' ' 39' ' ' THR . 70.0 t80 -52.79 -51.28 61.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.916 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -60.7 -40.23 91.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.39 -25.29 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.18 -28.21 38.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -79.68 -30.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.977 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 55' ' ' TYR . 1.2 ttpm? -76.92 -47.89 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.02 -44.61 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.12 -29.01 63.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 54' ' ' THR . 87.2 m-85 -122.9 42.8 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -42.39 85.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.83 9.57 26.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.613 0.244 . . . . 0.0 111.296 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -140.32 79.51 21.02 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 -15.6 48.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.54 2.16 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.67 68.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.233 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 48' ' ' PHE . 53.8 m -63.85 -47.54 80.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.414 ' CG ' HD13 ' A' ' 59' ' ' LEU . 17.7 t80 -58.8 -46.9 86.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.996 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.67 -46.66 45.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.615 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -61.81 -49.68 75.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 55' ' ' TYR . 5.6 mt -56.9 -43.61 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.064 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -55.89 -47.1 78.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.163 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.3 -38.56 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.108 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.3 mmt -66.83 -47.84 70.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HD2' ' CD1' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -64.56 -45.02 88.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.684 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -33.63 76.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 38.5 t80 -60.1 -55.02 39.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.85 -30.27 70.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.0 p -71.37 -8.33 53.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.262 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 65.81 43.3 3.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.815 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -119.84 1.92 11.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.323 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.1 tt -145.04 137.82 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.16 172.21 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.997 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -58.5 -58.32 19.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.6 Cg_endo -47.33 -42.36 27.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.549 2.166 . . . . 0.0 112.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 -29.02 67.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.202 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.86 -43.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.849 0.357 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.02 -41.72 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -60.13 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -55.77 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.66 -45.28 90.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.9 p -61.48 -23.42 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.044 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -94.77 -31.36 13.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -60.56 -36.54 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 89' ' ' LEU . 21.3 m-85 -113.71 47.19 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -62.39 -22.58 66.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.182 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -99.9 -32.14 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -102.48 95.13 5.65 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.59 -30.94 22.27 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.41 2.073 . . . . 0.0 112.263 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.85 -19.7 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -85.27 -49.82 7.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.014 0.435 . . . . 0.0 109.87 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 90' ' ' ILE . 53.5 mt -61.57 -27.66 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.915 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.2 -51.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.28 81.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.071 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -70.26 -35.57 73.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.674 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.95 -26.68 66.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.668 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 -11.41 53.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.747 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.6 -37.25 9.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mp -72.32 116.86 53.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.47 177.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.418 2.078 . . . . 0.0 112.275 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.97 -27.29 65.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -31.14 58.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.519 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -133.03 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -111.95 134.94 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 103' ' ' ILE . 24.5 mt . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 CA--C 1.527 0.13 0 CA-C-O 120.807 0.253 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.86 -23.24 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.1 mt -77.92 -37.31 48.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.381 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -71.35 -38.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.453 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -29.59 64.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.82 -43.05 76.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.532 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.86 83.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.947 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -61.85 -42.74 99.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.658 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.12 -29.69 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.741 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.02 -36.85 40.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.31 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.414 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 7.4 mp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.857 0.36 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.2 -29.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.52 -41.62 72.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.5 -33.56 69.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.16 -36.94 64.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.037 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -52.22 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 40' ' ' TYR . 4.7 t -60.08 -42.92 95.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.409 ' N ' HG21 ' A' ' 39' ' ' THR . 55.0 t80 -52.08 -47.69 65.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.16 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.13 -40.42 94.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -68.06 -29.88 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -76.62 -30.19 56.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.797 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.2 t -78.06 -30.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.46 -45.59 58.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.65 -39.62 84.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -29.9 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 54' ' ' THR . 68.7 m-85 -118.46 40.19 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.99 -21.5 79.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.3 p -92.01 -9.16 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -140.03 100.57 7.17 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.575 0.226 . . . . 0.0 111.041 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.46 -14.93 37.84 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.491 2.128 . . . . 0.0 112.598 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.84 -40.36 69.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -68.37 -50.0 56.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -61.75 -49.11 77.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.47 -34.46 74.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -48.55 49.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -56.69 -46.63 81.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.944 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.55 -39.33 87.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -62.03 -38.61 89.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -68.53 -48.81 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.6 mmt -64.23 -37.57 87.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -70.84 -47.77 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.85 -29.88 69.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.418 ' CD1' HG22 ' A' ' 75' ' ' VAL . 54.3 t80 -76.44 -42.11 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm -54.26 -33.8 59.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.006 0.431 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -15.86 60.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.03 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 63.66 43.4 5.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 110.763 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -116.53 -35.63 4.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.6 pt -86.6 178.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.23 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.36 161.44 13.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.511 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -58.47 -59.26 14.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.0 Cg_endo -45.46 -41.28 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.812 2.341 . . . . 0.0 112.179 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.31 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG22 ' CD1' ' A' ' 65' ' ' PHE . 12.5 t -79.27 -46.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 mt -65.68 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -45.63 68.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.756 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -48.01 82.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 83' ' ' PHE . 39.9 t -67.03 -41.15 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -61.39 -23.44 65.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -36.38 11.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.793 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.66 -38.91 89.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 79' ' ' VAL . 21.9 m-85 -104.61 60.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.07 31.25 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -46.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -105.2 103.52 42.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.73 -34.24 97.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.536 2.157 . . . . 0.0 112.292 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.63 -17.79 16.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.606 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 83' ' ' PHE . 4.3 mt -83.06 -55.91 4.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.179 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 90' ' ' ILE . 18.0 tt -60.25 -27.08 38.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.22 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.75 -48.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.524 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -38.56 90.78 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -71.68 -32.26 67.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.967 0.413 . . . . 0.0 110.715 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -66.51 -29.38 69.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.784 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.41 -17.72 55.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.496 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.74 30.07 3.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mt -142.06 143.58 28.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.13 169.44 22.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.286 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.02 -32.53 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.16 89.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.45 93.16 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -103.55 148.9 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.788 0.245 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' B' ' 48' ' ' MET . 14.5 mt-30 -79.09 -22.08 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 17.1 mt -79.13 -37.85 37.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.35 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -72.68 -36.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 45' ' ' GLN . 0.1 OUTLIER -73.9 -29.19 61.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.67 -47.25 67.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.34 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.25 80.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.7 -42.79 99.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.59 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.32 -32.97 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.28 -33.48 49.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.443 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.451 -0.419 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.293 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 CA-C-O 120.729 0.221 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.62 83.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.27 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -125.12 -176.69 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 t -52.58 -28.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.267 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.02 -41.53 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -38.37 83.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.87 -34.19 66.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -63.48 -53.49 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 40' ' ' TYR . 4.4 t -59.47 -42.37 91.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' N ' HG23 ' A' ' 39' ' ' THR . 39.6 t80 -52.64 -46.87 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.66 -43.39 96.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -29.5 69.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -31.42 56.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.9 t -79.45 -24.76 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.981 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 tttm -77.83 -44.27 27.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -68.73 -51.11 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.34 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -29.21 63.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.137 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -115.69 39.18 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.21 -28.0 71.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.6 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 p -97.32 6.79 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.453 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.17 86.68 12.79 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.672 0.273 . . . . 0.0 110.916 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.83 -25.07 28.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.593 2.195 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.28 86.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -61.1 -45.06 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 45' ' ' LYS . 28.6 t80 -60.83 -50.86 71.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -31.12 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.79 -43.4 84.07 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.05 -44.35 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.45 -37.03 84.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.78 -44.66 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.37 -53.2 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -50.19 70.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -59.34 -39.79 84.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.27 -31.24 71.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.423 ' CZ ' HD12 ' B' ' 46' ' ' LEU . 41.0 t80 -69.98 -40.35 75.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -59.41 -34.74 72.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.6 -16.07 62.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.272 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.38 39.51 0.92 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.833 0.349 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.51 -51.4 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.63 131.09 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.16 172.75 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.403 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.08 -58.41 19.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 83.1 Cg_exo -45.06 -31.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.442 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.44 64.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.461 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.5 t -71.07 -48.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.73 -32.18 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -63.91 -52.49 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -57.09 -47.99 79.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.47 -42.06 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -62.51 -24.84 67.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -96.53 -35.5 11.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 tp -62.83 -44.38 96.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 19.3 m-85 -107.03 51.11 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.74 -30.83 71.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.26 26.64 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -140.11 95.11 8.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.962 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.7 -48.92 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.428 2.085 . . . . 0.0 112.359 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -55.25 -20.62 11.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.4 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 5.0 mt -85.68 -56.59 3.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 110.415 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.01 -28.99 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.291 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.76 -47.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.88 -39.47 68.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.161 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -74.84 -32.59 61.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 -30.06 70.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -8.85 49.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.783 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -99.76 -38.83 8.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.52 138.01 86.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.75 177.04 9.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.537 2.158 . . . . 0.0 112.383 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.15 -29.86 68.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.96 -63.48 5.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.593 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -104.2 88.25 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -87.27 178.77 6.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.6 mt -109.2 140.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.26 154.44 23.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.51 78.68 28.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.87 115.27 2.3 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.552 2.168 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.857 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.622 0.249 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -22.92 49.17 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 112.418 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -76.86 -25.51 53.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 110.562 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 2.3 mt -77.49 -33.73 54.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.273 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -73.22 -36.38 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -74.45 -29.96 61.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.703 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.56 -48.36 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.675 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.24 -33.0 74.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -64.58 -46.09 84.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.79 -28.8 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -35.5 45.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.326 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.71 -19.4 29.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.909 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 78.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.799 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.19 50.74 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.929 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.488 1.16 0 CA-C-O 120.795 0.248 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 ' CG1' ' CD2' ' A' ' 96' ' ' PHE . 25.2 t -81.91 78.37 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -106.34 -161.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -47.56 -28.48 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.455 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.25 -52.38 65.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -30.57 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.941 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.39 -39.23 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.34 -51.08 67.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.403 HG21 ' N ' ' A' ' 40' ' ' TYR . 3.6 t -59.53 -44.75 93.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' N ' HG21 ' A' ' 39' ' ' THR . 56.6 t80 -54.68 -42.34 71.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.03 -30.21 64.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.46 -31.79 69.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.991 0.424 . . . . 0.0 111.096 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -82.02 -30.98 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.02 -22.8 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -85.05 -47.18 10.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.983 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.0 mt -62.9 -53.45 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.246 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -29.64 67.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' CD2' HG23 ' A' ' 54' ' ' THR . 24.2 m-85 -118.36 40.24 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.92 -28.22 63.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -114.92 38.47 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.11 87.72 12.15 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.53 -29.5 24.86 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.557 2.171 . . . . 0.0 112.324 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.77 -49.9 75.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 48' ' ' PHE . 1.7 m -64.75 -52.51 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 5.6 t80 -59.71 -49.07 79.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -60.37 -30.65 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.28 -57.11 7.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.01 -41.21 78.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -45.86 91.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -44.37 87.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -63.27 -31.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -47.41 31.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -66.74 -41.39 87.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.816 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -41.76 98.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 26.8 t80 -59.36 -48.14 82.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.58 76.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -16.69 61.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.9 40.57 0.92 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 p -111.98 -38.23 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.7 tt -98.47 133.28 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -75.99 178.99 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -64.85 -52.82 47.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.2 Cg_exo -48.43 -38.99 35.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 -29.34 74.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -73.9 -47.86 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mt -59.69 -37.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -41.31 60.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -49.06 78.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 83' ' ' PHE . 49.9 t -65.92 -39.13 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -61.66 -25.82 67.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -45.05 13.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.784 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.8 tp -60.68 -38.76 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 79' ' ' VAL . 9.0 m-85 -106.55 61.05 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -58.39 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 28.44 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 2.7 m170 -125.11 90.64 50.63 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.788 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.02 -51.94 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.519 2.146 . . . . 0.0 112.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -55.83 -20.37 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 13.0 mt -86.9 -56.65 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.249 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.73 -31.93 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -75.16 -44.93 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.32 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.36 -32.83 68.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.054 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -73.43 -42.3 62.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 110.707 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -61.57 -24.78 66.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.778 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.83 -9.96 48.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.447 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 10.9 m-85 -99.58 -30.7 11.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mt -82.88 146.52 52.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 171.07 13.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.509 2.139 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.04 -27.87 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.07 -45.83 92.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.573 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -108.19 126.34 52.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -127.36 136.55 52.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 20.8 tt -90.79 118.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.58 177.34 4.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.025 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 mp -127.79 94.97 35.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.45 164.19 33.7 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.79 -31.38 10.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.589 2.192 . . . . 0.0 112.368 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -20.38 54.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 7.6 mt -77.55 -39.99 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.338 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 27.9 mm -70.44 -38.95 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.02 -26.74 61.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.809 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -68.28 -50.12 55.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.58 81.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -63.25 -39.25 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.739 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 36.2 t -70.9 -30.39 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.93 -35.43 43.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 110.416 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.39 -19.93 27.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.091 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.9 93.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.03 30.82 7.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.947 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.487 1.134 0 CA-C-O 120.864 0.276 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 3.7 m -63.1 83.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -107.58 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.26 -33.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.53 -43.71 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.19 -39.13 89.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.786 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.61 -33.51 69.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -54.38 34.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 40' ' ' TYR . 4.1 t -58.02 -42.67 85.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' HG21 ' A' ' 39' ' ' THR . 57.7 t80 -52.63 -49.14 65.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.008 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -72.03 -30.0 64.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 110.994 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -76.8 -30.02 56.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.49 -30.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 55' ' ' TYR . 1.6 tppp? -71.77 -47.75 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.05 -48.02 89.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -30.47 69.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CD2' HG22 ' A' ' 54' ' ' THR . 68.3 m-85 -121.79 42.19 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.33 -45.54 92.72 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.533 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -98.18 28.1 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.23 65.98 29.6 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.98 -23.21 20.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.598 2.198 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.55 -39.61 67.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.419 HG22 ' CD2' ' A' ' 48' ' ' PHE . 3.1 m -76.87 -46.43 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 30.4 t80 -62.28 -51.91 65.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.35 -43.32 92.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.21 -48.53 85.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -59.48 -31.35 69.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.2 -46.72 63.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -38.32 83.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -65.59 -51.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 18.2 mmt -67.05 -41.33 86.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -68.67 -31.46 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.92 -34.76 62.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' CE1' HD13 ' B' ' 46' ' ' LEU . 25.9 t80 -64.66 -56.56 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.019 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -36.41 72.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t -67.41 -12.91 61.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.224 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 74.83 45.06 0.17 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -114.46 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.1 tt -81.5 150.1 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.34 -175.3 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -54.61 4.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.2 -32.15 18.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 -38.27 60.23 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -65.53 -33.56 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.6 mt -75.28 -35.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -75.62 -42.74 50.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -56.97 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.421 HG23 ' CE2' ' A' ' 93' ' ' PHE . 47.1 t -58.09 -48.06 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -60.57 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -91.37 -42.68 10.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.755 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.41 -30.79 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.447 ' CD1' ' CD1' ' A' ' 89' ' ' LEU . 19.0 m-85 -110.16 46.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.57 -34.61 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.065 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -108.03 26.12 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -140.12 94.4 8.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.41 -44.99 2.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.371 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -64.26 -13.78 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.35 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.447 ' CD1' ' CD1' ' A' ' 83' ' ' PHE . 13.3 mt -86.72 -54.57 4.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.37 -29.25 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.151 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.66 -49.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.469 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.74 -38.39 87.96 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.065 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 79' ' ' VAL . 85.1 t80 -71.36 -34.29 70.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.591 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.55 -33.46 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.9 57.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.426 ' CD2' ' HB ' ' A' ' 32' ' ' VAL . 75.8 m-85 -99.8 29.9 3.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.415 HD12 ' CE2' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -134.54 143.81 48.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.489 2.126 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -19.3 61.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.12 49.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.819 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -128.76 145.57 51.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.63 137.01 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 103' ' ' ILE . 17.3 mt -91.25 150.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.86 156.85 22.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.53 79.22 67.56 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 136.89 67.85 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.605 2.203 . . . . 0.0 112.253 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.687 0.28 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 -18.89 22.32 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.595 2.197 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.48 -25.48 50.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 110.69 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 65' ' ' PHE . 6.9 mt -76.99 -33.97 57.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.374 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -72.43 -39.99 63.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.427 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -29.92 66.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.621 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.58 -50.29 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.419 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -33.45 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -61.62 -44.48 96.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.629 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.95 -29.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.903 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.72 -35.19 52.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.067 0.46 . . . . 0.0 110.204 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.43 -21.09 30.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.872 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.83 93.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.804 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.39 52.22 4.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.529 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.947 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.237 0 CA-C-O 120.81 0.254 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.3 87.48 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.207 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 21.6 p-80 -135.04 -164.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.68 -52.02 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.762 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 18.2 mt-10 -58.12 -49.07 78.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -58.98 -36.57 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.98 -31.43 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.43 -52.72 43.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 40' ' ' TYR . 3.8 t -59.53 -43.71 93.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' N ' HG22 ' A' ' 39' ' ' THR . 42.6 t80 -52.87 -52.7 56.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.73 -37.27 85.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -66.23 -32.59 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.005 0.431 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.68 -31.31 36.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.767 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.72 -24.31 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.125 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 16.6 tptt -81.5 -46.76 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -65.09 -47.83 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -29.41 70.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -116.12 39.34 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.36 -28.75 73.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 m -101.4 18.14 20.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.595 0.236 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.27 86.99 12.37 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.8 -26.33 32.48 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.83 -38.29 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.3 m -76.16 -37.81 57.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 33.9 t80 -71.9 -52.85 15.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.01 -37.65 80.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.78 -42.43 95.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -59.2 -53.2 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.414 HD12 ' CZ ' ' A' ' 55' ' ' TYR . 3.0 mt -59.8 -35.34 74.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -39.88 92.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -64.55 -54.34 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -62.05 -40.25 95.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -68.12 -31.1 70.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.03 -37.57 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 48.3 t80 -67.84 -38.9 83.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -57.97 -32.12 67.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.793 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -68.25 -12.04 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 65.65 39.54 4.85 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.56 -47.87 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.888 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.7 tt -87.09 158.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.69 -177.68 5.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.431 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -72.74 -51.38 6.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.1 Cg_exo -49.75 -33.59 32.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.78 -30.72 67.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.411 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG22 ' CD1' ' A' ' 65' ' ' PHE . 21.5 t -72.94 -35.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 76' ' ' ILE . 34.9 mm -67.72 -46.29 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -36.45 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -63.26 -53.85 46.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.9 t -66.56 -47.92 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.191 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.4 p -58.24 -23.24 55.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -87.11 -41.57 13.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.75 -31.1 71.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.43 ' CD1' HD11 ' A' ' 89' ' ' LEU . 15.3 m-85 -116.31 58.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -71.7 -32.2 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.201 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.6 33.7 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.159 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -140.06 86.16 13.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.054 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -57.02 -50.53 11.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.25 . . . . 0.0 112.323 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -19.12 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.446 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 83' ' ' PHE . 7.0 mt -87.64 -57.7 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.59 -31.9 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.177 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -77.47 -44.75 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.79 -38.49 96.04 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.96 -34.09 66.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.073 0.464 . . . . 0.0 110.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -69.14 -23.9 64.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.963 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.37 -11.19 57.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.734 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -99.7 -30.21 12.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.71 143.9 63.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 162.91 41.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.42 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -28.55 67.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.57 -27.65 61.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.2 102.09 10.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.75 0.31 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 141.54 39.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.62 111.53 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -110.52 167.45 10.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 pt -127.82 128.61 23.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.26 135.24 22.31 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.433 2.088 . . . . 0.0 112.29 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.1 mttt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.984 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.06 -26.33 26.27 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.04 -22.97 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 15.4 mt -76.9 -35.7 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 mt -72.71 -38.81 59.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.426 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -27.02 61.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.812 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -45.21 65.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.52 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.49 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -64.44 -47.58 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.18 -28.26 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.88 -36.11 42.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.276 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.16 -21.24 31.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.953 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.4 93.82 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.64 44.71 2.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.954 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.897 0.291 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.71 77.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.237 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.47 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.42 -28.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.27 -39.23 71.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.712 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.89 77.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.22 63.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.52 -49.72 57.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.1 t -59.44 -44.92 92.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.406 ' N ' HG23 ' A' ' 39' ' ' THR . 9.7 t80 -54.54 -51.26 65.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.98 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.51 -31.07 71.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -33.04 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.731 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -79.28 -31.35 43.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.671 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.4 t -78.38 -29.83 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.751 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 1.2 tttm -72.84 -48.98 33.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.22 -41.64 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -28.33 65.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 54' ' ' THR . 22.1 m-85 -117.61 40.11 3.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.93 50.99 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.552 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.7 17.08 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.661 0.267 . . . . 0.0 111.181 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -140.25 62.74 21.1 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 110.941 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -23.26 23.59 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.533 2.155 . . . . 0.0 112.462 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.47 72.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 48' ' ' PHE . 2.0 m -60.36 -47.42 86.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 13.6 t80 -63.04 -43.34 98.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -44.38 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -43.81 98.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.548 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -58.78 -43.29 90.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 mt -61.7 -37.1 82.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.78 -43.63 97.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -59.93 -59.5 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.3 91.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -64.46 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.02 -32.82 59.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.27 -35.9 81.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -59.21 -32.15 69.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.1 -16.89 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.28 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.46 40.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 p -113.11 -48.77 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.0 tt -78.69 156.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -87.08 173.56 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -72.06 -51.95 7.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.1 Cg_exo -49.62 -35.33 37.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.536 2.157 . . . . 0.0 112.358 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.83 -30.08 70.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.413 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -71.03 -47.01 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 0.0 111.038 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.06 -32.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -49.78 56.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -45.91 90.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 83' ' ' PHE . 40.2 t -59.47 -46.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -62.12 -24.96 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -78.03 -47.26 18.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.18 -29.0 68.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 79' ' ' VAL . 4.4 m-85 -111.78 54.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.56 -43.34 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.57 26.89 10.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -128.9 93.66 36.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.799 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.74 -51.95 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.453 2.102 . . . . 0.0 112.557 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.84 -18.83 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 83' ' ' PHE . 37.9 mt -84.1 -55.49 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.207 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.75 -28.64 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.081 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.71 -46.27 47.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.426 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.47 -35.3 84.81 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -72.59 -35.14 67.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.0 110.775 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -66.95 -27.26 67.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -16.76 55.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.75 -30.07 12.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -68.94 147.64 97.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.26 173.48 11.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.557 2.172 . . . . 0.0 112.349 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -30.88 69.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -68.55 -64.63 2.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.53 84.82 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.55 147.51 27.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 tt -89.03 129.86 39.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.31 -173.32 3.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 pt -156.91 96.38 2.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.061 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.5 122.82 9.35 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.55 2.167 . . . . 0.0 112.389 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.927 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.12 -19.84 22.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.457 2.104 . . . . 0.0 112.453 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.99 -24.69 47.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 110.788 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.19 -38.83 56.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.476 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.8 mt -70.49 -39.64 76.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -27.09 62.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.749 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.7 -46.54 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.59 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.35 83.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.051 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -61.89 -45.97 91.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 41.7 t -67.15 -27.87 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.88 -35.19 51.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.25 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.25 -22.63 26.76 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.826 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.65 71.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.14 -35.66 2.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.933 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.487 1.131 0 CA-C-O 120.88 0.283 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.0 86.45 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 -169.38 2.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -48.0 -29.11 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.92 76.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -38.49 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.46 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.99 -54.06 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 40' ' ' TYR . 3.4 t -60.5 -44.83 95.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.413 ' N ' HG21 ' A' ' 39' ' ' THR . 45.3 t80 -55.42 -49.9 71.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.053 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.2 mt -65.19 -34.96 79.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -70.91 -27.76 64.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -31.06 34.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.75 -31.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -73.36 -49.25 28.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.02 -45.31 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -62.39 -32.89 73.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -119.14 39.87 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.34 -44.07 52.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.5 m -66.33 -16.39 64.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.661 0.267 . . . . 0.0 111.223 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -132.58 92.68 26.67 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.7 -12.33 35.15 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.516 2.144 . . . . 0.0 112.492 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.8 77.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.5 m -69.0 -36.86 78.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 59' ' ' LEU . 32.5 t80 -65.74 -49.98 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -60.54 -32.74 71.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.69 -51.65 52.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CE1' ' HE3' ' A' ' 62' ' ' MET . 23.2 t80 -59.24 -42.98 92.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.417 HD12 ' CE2' ' A' ' 55' ' ' TYR . 73.1 mt -59.83 -40.61 89.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -42.75 99.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.45 -37.95 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.414 ' HE3' ' CE1' ' A' ' 58' ' ' PHE . 28.5 mmt -68.95 -55.69 10.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -60.35 -31.28 70.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.792 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.22 -40.91 86.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CZ ' HD11 ' B' ' 46' ' ' LEU . 42.1 t80 -66.78 -44.48 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -58.46 -42.43 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.652 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -63.15 -16.63 60.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.26 43.84 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.819 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.94 14.76 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.331 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.1 tt -155.09 145.81 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.042 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -84.36 178.37 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.53 -53.2 17.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 73.3 Cg_exo -48.99 -38.09 38.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.562 2.175 . . . . 0.0 112.405 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.72 -29.64 71.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.5 t -75.03 -34.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.985 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.9 mt -71.4 -44.31 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.148 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -43.53 94.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -48.06 81.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.76 -34.17 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.8 t -62.44 -25.43 67.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -32.35 11.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.71 -32.66 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.992 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 89' ' ' LEU . 26.4 m-85 -124.38 47.68 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -9.49 58.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.54 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -103.5 -29.65 11.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.821 0.343 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -100.01 108.25 50.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.25 -42.85 3.52 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.41 2.073 . . . . 0.0 112.229 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.56 -17.64 34.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.288 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 83' ' ' PHE . 18.1 mt -88.2 -56.63 3.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.261 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 tt -60.92 -33.17 54.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.232 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.11 -43.64 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.453 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.27 86.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -73.92 -38.88 64.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.609 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.3 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.767 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.74 -9.53 51.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.824 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -99.72 -29.37 12.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mt -86.05 151.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.87 159.24 53.74 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -27.29 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -52.69 47.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.621 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -104.34 68.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -63.99 173.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.976 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.67 130.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -77.27 176.04 9.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.68 84.28 3.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.91 126.08 18.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.617 2.211 . . . . 0.0 112.252 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.808 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.67 0.271 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.36 -9.72 26.5 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 112.606 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -77.55 -27.33 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.648 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.416 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 23.7 mt -75.65 -33.66 60.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mm -73.37 -38.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -27.46 62.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.34 -53.44 19.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.12 67.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.107 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -67.52 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.06 -24.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.91 63.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.17 0.509 . . . . 0.0 109.699 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp -98.71 10.14 41.8 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.008 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -170.85 70.04 0.05 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 110.998 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.68 -31.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.93 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.488 1.18 0 CA-C-O 120.979 0.324 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 96' ' ' PHE . 3.7 m -63.2 91.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.26 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.84 -168.47 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.11 -31.04 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -37.59 65.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -67.05 -43.84 81.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.44 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -62.27 -55.7 25.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.9 t -59.02 -44.63 91.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 39' ' ' THR . 63.3 t80 -53.29 -38.18 62.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.081 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.55 -47.26 49.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -31.62 69.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 110.963 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.2 -46.52 50.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.95 -16.72 21.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.314 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -85.03 -44.06 13.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -66.14 -56.4 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -56.52 -28.38 59.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CE2' HG23 ' A' ' 54' ' ' THR . 33.3 m-85 -117.26 39.77 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.0 70.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -101.96 19.44 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.664 0.269 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.24 74.7 29.53 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.905 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.46 -28.8 65.83 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.384 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.27 89.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 48' ' ' PHE . 2.9 m -59.8 -51.58 69.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -63.16 -50.44 70.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.69 -42.23 92.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.48 -43.92 98.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.93 -49.97 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.075 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.23 76.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.59 -42.89 99.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mt -61.64 -50.12 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 31.3 mmt -60.15 -49.2 78.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -63.88 -31.61 72.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.74 -46.02 80.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' B' ' 46' ' ' LEU . 34.4 t80 -63.48 -44.0 95.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 t -62.89 -17.25 61.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 70.04 39.82 1.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 -43.09 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.3 tt -97.19 158.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -85.34 176.08 8.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.14 -53.04 27.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.4 Cg_exo -49.2 -28.2 14.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.581 2.187 . . . . 0.0 112.438 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.23 -32.09 60.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 t -72.8 -44.05 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mt -64.31 -47.7 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -39.25 92.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -57.02 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.19 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 t -61.62 -22.61 65.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -94.72 -34.29 12.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.2 tp -61.19 -36.57 80.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.449 ' CD1' ' CD1' ' A' ' 89' ' ' LEU . 24.7 m-85 -112.67 52.67 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.86 -25.43 67.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.223 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 25.4 11.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.3 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.429 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -140.14 86.73 12.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.911 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.25 -48.73 14.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.703 2.268 . . . . 0.0 112.422 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.07 -20.91 7.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.598 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.449 ' CD1' ' CD1' ' A' ' 83' ' ' PHE . 44.2 mt -86.84 -59.24 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.436 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.4 tt -58.31 -30.48 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.38 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.28 -47.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.96 -37.49 85.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.096 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.24 -33.43 63.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.097 0.475 . . . . 0.0 110.673 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.35 -25.17 66.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.8 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.11 26.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.931 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.416 ' CE2' HG12 ' A' ' 32' ' ' VAL . 87.3 m-85 -99.76 -35.05 9.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.831 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mt -76.08 146.76 79.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.42 176.42 8.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tp -73.47 -24.91 60.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 -26.48 30.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.618 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.93 114.43 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -85.76 139.34 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 tt -78.58 143.9 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.14 137.41 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.23 89.22 9.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.11 122.1 8.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.58 2.187 . . . . 0.0 112.323 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.591 0.234 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.06 -26.56 14.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.523 2.149 . . . . 0.0 112.366 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -75.95 -23.3 55.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.611 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.412 HD12 ' CD2' ' A' ' 65' ' ' PHE . 1.8 mt -77.03 -33.79 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.342 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -72.9 -39.38 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -29.57 65.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.73 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mt -68.32 -49.21 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -30.5 71.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -62.45 -49.88 73.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.64 -29.17 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.836 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.54 -34.24 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.203 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.76 -19.32 29.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.917 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -167.89 84.69 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.5 41.72 2.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.467 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.943 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.487 1.14 0 CA-C-O 120.774 0.239 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 ' CG2' ' CD2' ' A' ' 96' ' ' PHE . 87.8 t -60.22 -81.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.88 146.46 3.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -57.7 -38.99 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.07 -38.49 88.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.431 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -39.68 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.529 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.77 72.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -64.76 -52.77 55.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.2 t -54.64 -42.32 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 39' ' ' THR . 17.1 t80 -54.97 -54.93 36.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.6 mt -63.48 -30.29 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.27 -41.08 94.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.53 -27.16 51.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 t -79.59 -30.97 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.746 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -71.92 -49.64 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.687 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -64.35 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -59.89 -30.99 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 54' ' ' THR . 32.6 m-85 -119.68 40.29 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.26 -38.17 81.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.398 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -81.45 -18.05 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.14 89.9 51.31 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.012 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.32 -8.94 24.8 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.583 2.189 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.61 -39.07 67.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.249 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 48' ' ' PHE . 1.2 m -75.48 -43.04 51.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 59' ' ' LEU . 27.5 t80 -61.27 -48.83 79.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -61.38 -43.41 98.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.97 83.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.375 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -61.13 -35.39 76.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' A' ' 55' ' ' TYR . 1.9 mt -65.1 -46.48 80.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.51 75.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.34 -32.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.8 mmt -75.43 -44.48 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.25 -33.51 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.664 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.32 -41.15 81.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.809 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.45 ' CE2' ' CB ' ' B' ' 46' ' ' LEU . 78.8 t80 -61.99 -46.02 91.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.6 -39.32 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -15.87 60.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 73.87 41.05 0.44 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.25 -42.37 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.804 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.34 147.95 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -84.12 171.24 13.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.7 -53.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.7 Cg_exo -50.36 -37.86 51.48 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.91 82.42 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.452 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 t -62.33 -49.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.21 -43.64 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -44.65 96.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -59.66 -50.99 71.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.432 HG12 ' CE2' ' A' ' 83' ' ' PHE . 46.9 t -62.34 -42.95 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.96 -23.3 66.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -46.3 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.61 -34.99 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CE2' HG12 ' A' ' 79' ' ' VAL . 9.0 m-85 -106.87 53.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -61.97 -57.45 11.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.42 27.08 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -126.59 89.55 51.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.781 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.05 -51.17 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.605 2.203 . . . . 0.0 112.598 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.9 -21.99 4.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.501 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.0 mt -85.17 -58.35 2.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.346 . . . . 0.0 110.446 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 tt -59.08 -27.85 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.0 t -76.17 -48.87 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.517 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.89 93.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.129 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -72.39 -33.35 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -62.5 -34.54 77.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 -22.4 49.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' CD2' ' CG2' ' A' ' 32' ' ' VAL . 47.5 m-85 -100.0 30.32 3.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.823 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.5 126.46 22.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.38 176.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.492 2.128 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -29.05 28.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.75 -27.18 58.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -126.14 95.81 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 139.29 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 tt -65.18 128.4 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.91 115.61 21.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 pt -101.92 145.54 30.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.28 148.45 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.5 2.133 . . . . 0.0 112.318 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.831 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.749 0.309 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.38 -21.22 20.06 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.514 2.143 . . . . 0.0 112.586 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -79.93 -27.33 39.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.778 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.45 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -79.77 -34.65 39.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.349 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.03 -32.98 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.504 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -30.35 53.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.36 -43.32 67.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.42 72.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -63.97 -49.21 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.744 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.74 -28.76 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.19 -35.41 41.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.4 mp -86.08 -20.17 29.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.887 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.51 70.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.61 27.54 6.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.955 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.866 0.278 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG1' ' CE2' ' A' ' 96' ' ' PHE . 25.4 t -77.15 81.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 29.9 p-80 -125.98 -161.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.725 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.25 -31.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -64.84 -44.55 89.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -65.37 -44.16 88.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.934 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.74 66.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 mt -64.86 -53.99 37.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 40' ' ' TYR . 2.9 t -59.51 -45.55 91.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' N ' HG22 ' A' ' 39' ' ' THR . 53.8 t80 -55.69 -47.2 77.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.067 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.36 -31.42 72.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.79 -32.68 71.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.81 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -26.39 38.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.835 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.45 -29.16 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -46.2 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 mt -66.62 -41.6 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -30.91 68.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -124.82 43.75 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.1 -35.58 84.68 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.469 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 p -107.9 42.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -140.13 92.38 9.63 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.94 -38.84 12.23 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.472 2.114 . . . . 0.0 112.24 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.47 77.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.2 m -71.57 -48.21 49.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -65.35 -58.53 5.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.32 -32.11 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.68 -50.57 41.6 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -57.66 -44.58 85.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -35.27 80.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.696 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.7 -35.8 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.874 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.8 mt -69.48 -50.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -32.39 73.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -71.87 -31.63 66.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 -30.13 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.405 ' HA ' HG12 ' A' ' 70' ' ' ILE . 40.4 t80 -70.44 -40.35 73.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -56.97 -32.54 66.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -64.94 -16.15 62.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.05 42.5 1.25 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.743 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -113.86 -51.5 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 65' ' ' PHE . 11.2 pt -74.58 178.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -116.62 -177.47 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.42 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.35 -52.76 20.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.6 Cg_exo -47.94 -27.75 9.19 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.642 2.228 . . . . 0.0 112.428 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.8 -29.35 57.57 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -76.67 -33.89 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.4 mt -73.59 -45.43 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.175 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -46.41 76.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -45.65 87.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.11 -41.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.2 t -58.28 -22.51 52.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.09 -38.77 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.07 -31.57 72.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -119.92 50.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -67.44 -41.09 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -100.74 30.0 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -139.96 85.77 13.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -56.93 -59.31 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.61 2.207 . . . . 0.0 112.225 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -51.33 -22.77 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.556 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -81.79 -55.72 4.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.3 tt -63.28 -26.21 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.6 t -72.94 -47.92 46.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.33 -43.56 93.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.31 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.45 -29.53 66.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.921 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.24 -22.49 61.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 -3.32 28.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.413 ' CE2' ' CG1' ' A' ' 32' ' ' VAL . 79.5 m-85 -99.76 -28.98 12.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.3 mt -89.03 140.07 29.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.63 177.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.443 2.095 . . . . 0.0 112.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.9 -31.69 71.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.32 -34.64 81.34 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.55 75.13 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.89 127.51 33.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.66 122.64 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.77 137.82 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -128.16 89.86 48.9 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.75 139.16 87.22 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.244 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.716 0.294 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.66 -22.19 38.08 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.521 2.147 . . . . 0.0 112.385 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.61 -21.0 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.386 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -79.38 -38.74 34.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.35 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.02 -35.2 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 -27.8 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.75 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.14 -43.46 67.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.425 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -36.46 79.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.997 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.54 -39.98 94.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 t -72.52 -28.03 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.748 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.49 52.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mp -90.67 -23.24 20.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.36 79.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.55 -40.13 6.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.5 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.843 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 120.774 0.239 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 m -62.8 82.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.81 -164.51 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.759 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.8 t -53.52 -27.67 14.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.261 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.87 -39.47 69.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -36.28 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.43 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.83 -49.87 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 40' ' ' TYR . 3.7 t -59.5 -44.66 93.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 39' ' ' THR . 62.8 t80 -53.08 -49.75 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.042 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.77 -32.63 73.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.21 -33.22 75.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -26.03 36.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 t -76.94 -28.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.932 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -80.34 -49.72 11.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.5 mt -60.82 -38.98 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.943 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -67.88 -27.4 66.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -114.99 39.21 2.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.09 -28.35 53.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.78 21.68 16.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -140.2 81.85 17.71 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 -28.1 23.82 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.597 2.198 . . . . 0.0 112.327 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.05 93.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.8 m -60.38 -38.64 84.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -69.89 -47.02 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -59.91 -42.62 94.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.95 94.54 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.551 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.53 -50.45 73.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.28 -36.57 78.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.97 -45.61 92.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mt -59.57 -45.58 93.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -49.9 55.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -59.49 -36.62 76.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.016 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.97 -30.74 67.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' A' ' 75' ' ' VAL . 50.2 t80 -74.19 -35.33 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -57.72 -40.89 80.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.762 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -15.84 61.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 71.93 53.76 0.19 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.985 0.421 . . . . 0.0 110.836 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.59 -39.02 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt -92.34 156.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.215 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.79 170.09 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.413 ' HB ' ' CE2' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -62.16 -54.22 51.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.791 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.9 Cg_exo -48.38 -41.16 36.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.167 . . . . 0.0 112.233 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.73 99.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG23 ' CD2' ' A' ' 65' ' ' PHE . 18.8 t -58.5 -40.0 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.98 -43.26 98.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -67.86 -36.06 79.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -57.27 -65.82 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.435 ' CG1' ' CE2' ' A' ' 83' ' ' PHE . 23.9 t -63.44 -31.31 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -64.85 -23.82 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.66 -37.73 11.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.49 -30.26 70.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.023 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CE2' ' CG1' ' A' ' 79' ' ' VAL . 11.8 m-85 -114.62 55.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -66.78 -33.09 74.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.56 26.35 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -140.05 88.21 11.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.96 -44.46 3.93 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.591 2.194 . . . . 0.0 112.282 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -50.15 -25.35 3.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 ' CE1' ' A' ' 83' ' ' PHE . 92.9 mt -82.72 -51.0 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.404 HG22 ' CD1' ' A' ' 103' ' ' ILE . 57.0 mt -62.52 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.956 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 -50.41 32.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.465 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.35 80.52 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.323 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE2' HD13 ' A' ' 97' ' ' LEU . 64.5 t80 -74.76 -30.74 61.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.92 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -74.89 -27.28 60.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.878 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.25 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.519 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -99.66 -38.38 8.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.06 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.429 HD13 ' CE2' ' A' ' 93' ' ' PHE . 7.1 mt -66.24 148.32 98.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 172.32 12.49 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.53 -22.21 57.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.77 -44.2 70.1 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.693 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.413 ' CE2' ' HB ' ' A' ' 72' ' ' THR . 47.4 m-85 -102.9 99.44 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.829 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -77.97 116.26 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 90' ' ' ILE . 3.6 tt -76.53 145.86 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -96.59 173.3 7.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.0 111.143 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.0 tp -162.07 80.11 1.91 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.4 112.78 1.03 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.519 2.146 . . . . 0.0 112.227 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.627 0.251 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.64 -11.97 33.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.438 2.092 . . . . 0.0 112.52 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -79.49 -26.48 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.658 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.409 HD11 ' CE2' ' A' ' 65' ' ' PHE . 20.5 mt -78.92 -36.08 42.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.4 mt -73.47 -34.7 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.35 -43.35 67.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.67 72.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -50.32 69.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.46 -29.16 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.68 -34.44 58.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.111 0.481 . . . . 0.0 110.091 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.99 -20.74 32.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.728 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.06 84.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.775 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.2 46.45 2.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.536 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.883 -179.935 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.926 0.303 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.04 82.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.169 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.449 ' CD2' ' HB2' ' A' ' 35' ' ' GLU . 5.6 p-80 -110.28 -170.58 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -41.99 -32.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.886 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 5.7 mm-40 -63.46 -47.21 82.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.707 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -64.36 -37.74 88.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.95 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.44 -48.78 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 40' ' ' TYR . 2.6 t -60.21 -45.67 92.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.854 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' HG21 ' A' ' 39' ' ' THR . 69.2 t80 -55.47 -47.89 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.69 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -63.11 -30.2 71.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.59 -28.29 30.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -81.02 -20.29 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.11 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.33 -46.43 9.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.724 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.9 mt -67.04 -50.07 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -59.41 -30.66 68.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -119.62 40.75 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.02 -29.26 64.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.578 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -107.72 30.35 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.17 88.58 11.5 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.62 -28.53 31.2 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.513 2.142 . . . . 0.0 112.329 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.68 69.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -74.04 -56.64 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -59.19 -52.03 67.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -61.27 -34.85 75.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.2 -50.16 23.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.23 -27.41 67.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -53.48 15.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.8 -38.23 69.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.016 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.87 -56.85 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.852 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.09 86.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.777 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -64.59 -52.09 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.82 -30.35 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HA ' HG12 ' A' ' 70' ' ' ILE . 61.8 t80 -66.48 -47.49 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -57.31 -27.37 62.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 m -66.97 -13.03 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.86 47.78 2.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.956 0.407 . . . . 0.0 110.823 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 m -121.82 -39.28 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.433 HG12 ' HA ' ' A' ' 65' ' ' PHE . 9.5 pt -91.26 178.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -108.85 172.69 6.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.424 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.17 -51.98 32.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.014 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.3 Cg_exo -50.38 -34.1 39.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.27 90.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.0 t -61.95 -39.36 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.5 mt -69.03 -35.9 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -70.31 -47.3 61.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -58.45 -37.94 76.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.22 -45.54 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 t -58.61 -23.83 59.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -84.02 -40.14 18.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.806 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.88 -31.5 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 6.0 m-85 -121.58 62.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.424 ' CE1' ' HG3' ' A' ' 106' ' ' PRO . 6.7 t60 -69.71 -44.12 71.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.654 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HG2' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -99.94 26.63 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.8 m170 -130.83 104.31 15.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -74.6 -47.51 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.091 . . . . 0.0 112.712 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.25 -17.65 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.58 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.68 -55.86 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.208 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.72 -30.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.06 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.17 -45.57 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.289 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 -34.55 82.49 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.998 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -74.15 -37.79 63.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.659 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -61.45 -29.89 70.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -17.94 57.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.496 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.85 29.7 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.333 . . . . 0.0 110.954 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.2 145.32 23.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 158.88 54.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -26.81 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.34 -27.46 53.23 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.615 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 109.03 10.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 tt -95.31 124.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.21 169.69 14.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.013 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 13.5 pt -152.04 146.41 18.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 60.7 Cg_endo -72.88 126.87 11.68 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.59 2.194 . . . . 0.0 112.271 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.908 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 -22.28 26.89 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.586 2.191 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -77.28 -19.02 57.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -78.99 -38.29 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 110.37 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.49 -37.25 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.448 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -28.46 61.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mt -72.18 -41.29 67.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.39 75.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.867 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.04 -53.48 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.693 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.06 -28.0 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.003 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.1 48.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.096 0.474 . . . . 0.0 110.214 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.4 mp -84.01 -20.41 32.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.41 78.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.23 28.54 15.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.517 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.02 -179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.092 0 CA-C-O 120.861 0.276 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.425 HG12 ' CD2' ' A' ' 96' ' ' PHE . 4.4 m -66.93 75.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -165.7 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.27 -36.81 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.26 -39.71 95.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.66 75.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 -30.78 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mt -66.53 -53.14 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.58 -44.31 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -52.87 -55.74 20.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.06 -33.13 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.6 -28.87 66.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.53 -26.84 37.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.77 -29.7 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.973 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -78.23 -47.2 18.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 mt -63.01 -45.53 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.13 -28.44 68.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CD2' HG21 ' A' ' 54' ' ' THR . 63.8 m-85 -123.79 43.1 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -39.53 85.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.448 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -79.25 -19.49 50.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.224 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -111.0 92.86 15.89 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.01 -23.75 40.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.02 77.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 ' CD2' ' A' ' 48' ' ' PHE . 18.9 m -65.14 -48.41 73.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CD2' HD13 ' A' ' 59' ' ' LEU . 9.2 t80 -62.76 -46.96 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -60.27 -34.93 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.22 -49.54 56.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.78 -53.06 62.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD13 ' CD2' ' A' ' 55' ' ' TYR . 33.2 mt -57.3 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -37.86 73.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.4 mt -73.08 -29.07 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -41.45 61.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -71.82 -44.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -58.6 -58.55 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -60.24 -44.14 95.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.138 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -52.57 -37.17 57.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -13.86 61.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.032 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 71.02 49.38 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.0 m -112.44 -33.36 6.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.96 173.37 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -96.21 168.94 10.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.01 -52.32 75.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.8 Cg_exo -48.23 -35.43 26.91 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.288 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.08 81.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.338 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.9 t -74.97 -33.38 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.6 mt -71.8 -47.38 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -64.23 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -55.01 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.409 HG11 ' CE2' ' A' ' 83' ' ' PHE . 37.7 t -69.84 -35.32 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -62.54 -26.99 68.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.92 -32.5 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.81 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.08 -40.14 92.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.803 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 89' ' ' LEU . 16.9 m-85 -107.26 61.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -92.39 22.47 4.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.403 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -128.37 -44.94 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -103.09 118.25 58.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -33.54 14.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.525 2.15 . . . . 0.0 112.326 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.23 -13.95 33.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.527 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 5.0 mt -87.19 -56.74 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.32 -31.28 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.75 -47.67 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.2 82.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.092 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -73.24 -35.02 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.47 . . . . 0.0 110.717 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -33.27 73.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -18.5 58.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.322 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' CD2' HG12 ' A' ' 32' ' ' VAL . 95.3 m-85 -99.79 30.03 3.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -144.3 147.12 35.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.88 159.77 51.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.545 2.163 . . . . 0.0 112.212 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.99 -29.76 68.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.49 69.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.8 88.52 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -85.74 -174.58 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 27.8 mt -122.26 140.13 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.151 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.95 132.82 34.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.49 125.47 59.61 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.22 157.69 49.84 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.478 2.119 . . . . 0.0 112.217 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 tptm . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.904 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.69 0.281 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -12.47 31.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.593 2.195 . . . . 0.0 112.613 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.52 -25.67 41.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 55.4 mt -79.4 -36.01 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.43 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.6 mm -74.26 -33.62 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.544 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.1 -29.44 54.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.696 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.06 -46.0 65.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -33.46 73.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.965 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.26 -42.55 96.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.82 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 t -70.97 -30.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.726 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.99 43.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.307 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -88.78 -18.39 27.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.91 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.47 76.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.781 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.15 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.911 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.488 1.159 0 CA-C-O 120.823 0.26 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 96' ' ' PHE . 3.5 m -62.62 83.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -165.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.47 -30.71 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.206 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -38.8 78.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -39.47 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.37 69.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.66 -54.35 43.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 40' ' ' TYR . 4.0 t -59.83 -44.53 94.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.402 ' N ' HG21 ' A' ' 39' ' ' THR . 75.1 t80 -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.077 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.65 -34.23 73.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -29.49 70.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -81.37 -26.55 35.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.25 -29.93 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.043 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 2.8 tptt -78.15 -47.61 17.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 mt -64.91 -48.39 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -62.09 -31.55 72.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' ' CG2' ' A' ' 54' ' ' THR . 64.4 m-85 -122.14 42.35 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 -35.03 91.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.566 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -97.63 20.83 11.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.288 . . . . 0.0 111.223 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.21 89.15 11.07 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.994 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.15 -26.91 42.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.417 2.078 . . . . 0.0 112.25 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -45.15 93.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.421 ' CG2' ' CD2' ' A' ' 48' ' ' PHE . 28.2 m -61.23 -55.84 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 t80 -60.3 -46.87 88.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.26 -38.15 82.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.45 -46.15 91.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.489 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -60.76 -46.31 90.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.413 HD12 ' CE2' ' A' ' 55' ' ' TYR . 0.9 OUTLIER -60.49 -37.71 81.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.22 -41.97 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mt -63.97 -46.79 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.2 mmt -69.37 -43.43 73.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -66.01 -32.75 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -65.54 -47.39 76.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.21 -41.66 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.693 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -64.45 -15.1 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 74.02 40.93 0.43 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.939 0.399 . . . . 0.0 110.798 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.7 t -117.55 14.3 14.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 tt -159.01 146.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -90.52 177.19 6.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.37 -53.85 42.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 77.0 Cg_exo -48.01 -39.14 32.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.572 2.182 . . . . 0.0 112.467 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 -29.21 72.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.4 t -72.41 -43.86 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 mt -61.83 -43.83 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -41.3 84.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -44.16 78.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.5 t -76.13 -32.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -62.46 -25.37 67.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -31.17 13.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.5 tp -62.23 -63.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 89' ' ' LEU . 11.3 m-85 -89.19 53.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.19 -39.4 93.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.02 25.8 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.157 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 1.2 m-70 -140.17 97.15 7.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.94 -46.65 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.59 2.194 . . . . 0.0 112.891 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -55.83 -20.75 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 86' ' ' HIS . 1.8 mt -85.67 -57.77 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.8 tt -53.84 -26.43 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.193 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.2 -50.56 20.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.188 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 -32.59 53.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.979 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -78.32 -34.88 48.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.18 0.514 . . . . 0.0 110.494 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -59.96 -29.19 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.633 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.59 -4.5 27.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.881 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.419 ' CD2' HG13 ' A' ' 32' ' ' VAL . 69.3 m-85 -99.7 -50.1 4.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.71 0.291 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.24 142.6 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 176.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.134 . . . . 0.0 112.311 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.15 -28.98 60.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.75 -51.21 58.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.624 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.79 88.79 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -86.36 122.37 30.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.0 tt -65.19 121.44 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.49 157.26 16.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.52 103.01 54.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.982 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.72 108.8 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.358 2.039 . . . . 0.0 112.286 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.69 0.281 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.72 -23.69 41.89 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.499 2.132 . . . . 0.0 112.36 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . 0.425 ' HA ' ' HG2' ' B' ' 48' ' ' MET . 20.3 mp0 -76.12 -26.56 56.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.514 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -76.61 -32.56 58.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.237 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -72.74 -37.98 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' MET . . . . . 0.425 ' HG2' ' HA ' ' B' ' 45' ' ' GLN . 2.7 ptt? -71.05 -32.16 68.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.97 -43.18 79.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.62 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.88 -34.02 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.976 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.54 -44.83 85.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 25.4 t -67.62 -29.1 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.68 -35.26 52.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 110.256 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.0 mp -86.81 -19.53 28.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.915 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -167.37 87.4 0.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.33 47.2 2.61 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.938 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 120.79 0.246 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.1 77.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 35' ' ' GLU . 29.2 p-80 -129.23 -160.39 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.714 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -44.63 -30.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.813 0.339 . . . . 0.0 111.532 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 33' ' ' HIS . 29.6 tt0 -62.22 -59.41 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -31.15 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.12 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mt -61.94 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -62.02 -44.51 96.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' N ' ' CG2' ' A' ' 39' ' ' THR . 61.9 t80 -54.13 -48.31 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.088 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -63.05 -37.66 88.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.48 -32.14 70.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -30.62 62.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 t -82.87 -37.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.807 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -48.11 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.702 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -70.6 -47.97 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -60.73 -36.05 77.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 54' ' ' THR . 19.1 m-85 -115.68 39.06 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.19 -27.83 65.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -97.38 15.21 23.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.693 0.282 . . . . 0.0 111.29 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -140.18 77.49 25.06 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 -24.26 19.86 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.51 -55.28 36.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.228 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.416 HG23 ' CD2' ' A' ' 48' ' ' PHE . 3.3 m -59.85 -38.34 81.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.13 -56.23 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -31.97 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 -49.41 12.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.469 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.042 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -39.64 83.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -62.24 -40.31 95.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -64.47 -51.74 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -41.83 98.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.61 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -69.12 -42.52 75.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' B' ' 46' ' ' LEU . 23.3 t80 -62.81 -44.72 95.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -31.63 67.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -66.49 -13.33 60.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.245 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 63.43 42.16 6.96 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.962 0.411 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -116.65 -39.04 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.0 tt -96.16 157.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -84.51 -177.69 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -74.36 -53.29 3.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 71.3 Cg_exo -48.75 -27.95 11.95 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.584 2.189 . . . . 0.0 112.364 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.38 -37.03 48.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.429 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.8 t -68.29 -40.16 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.765 0.316 . . . . 0.0 111.029 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.3 mt -68.81 -42.51 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -58.76 -44.67 90.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.9 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 83' ' ' PHE . 45.5 t -64.51 -41.97 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -23.36 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.01 -39.33 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 tp -61.38 -34.15 74.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 79' ' ' VAL . 18.5 m-85 -109.08 42.42 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -29.52 68.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 28.15 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -140.13 96.13 8.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.07 -48.39 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.348 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.62 -18.26 28.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 83' ' ' PHE . 40.9 mt -87.41 -56.11 3.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.328 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 91' ' ' VAL . 17.8 tt -59.22 -28.49 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.278 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.431 ' N ' HG21 ' A' ' 90' ' ' ILE . 66.1 t -78.34 -48.04 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.21 85.67 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.934 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -72.51 -40.3 66.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.508 . . . . 0.0 110.773 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -67.05 -21.18 65.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.004 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.66 -7.26 43.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.87 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -99.72 -30.24 12.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.331 . . . . 0.0 110.951 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -77.85 153.81 80.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 163.95 29.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.283 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -31.1 68.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.0 -43.82 92.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.403 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -93.91 76.02 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.01 162.9 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.53 138.08 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.63 144.14 39.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 tp -159.01 122.28 2.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 154.87 65.59 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.405 2.07 . . . . 0.0 112.369 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.71 0.29 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 -21.76 20.23 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.33 -25.84 51.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.706 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . 57.8 mt -77.16 -33.13 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.297 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.408 HD12 ' CE2' ' A' ' 65' ' ' PHE . 26.2 mm -74.06 -37.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.503 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -28.96 62.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.687 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.18 -47.4 61.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.436 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.19 -30.75 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.943 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -63.52 -50.73 68.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.5 t -64.15 -30.61 50.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.82 53.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.47 -9.72 58.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.993 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 13.5 t 45.37 43.88 8.87 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.932 0.396 . . . . 0.0 111.324 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.89 -27.55 66.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.423 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.934 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 CA-C-O 120.744 0.227 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 3.1 m -68.98 82.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.25 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 35' ' ' GLU . 27.1 p-80 -122.53 -162.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -44.78 -46.66 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.718 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . 21.7 tt0 -58.2 -41.35 83.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.974 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -65.88 -36.42 83.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.85 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -61.96 -54.89 35.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.6 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' ' CG2' ' A' ' 39' ' ' THR . 81.4 t80 -55.21 -51.63 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.39 -32.0 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.96 -27.39 33.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.1 t -80.67 -29.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.53 -48.19 15.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.711 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.5 mt -64.77 -49.08 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -59.41 -30.25 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 54' ' ' THR . 34.2 m-85 -115.81 39.29 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.03 93.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.24 25.07 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.663 0.268 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -140.19 87.01 12.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.63 -28.34 37.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.574 2.183 . . . . 0.0 112.258 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.01 88.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.415 HG22 ' CE2' ' A' ' 48' ' ' PHE . 8.7 m -66.9 -50.89 60.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 45' ' ' LYS . 12.5 t80 -60.06 -51.68 68.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.793 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.61 -54.01 31.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.437 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.02 -36.65 77.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mt -66.27 -41.17 90.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.798 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -59.82 -39.13 83.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.34 -31.82 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -69.17 -43.73 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -70.81 -31.08 67.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -55.28 32.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CZ ' HD12 ' B' ' 46' ' ' LEU . 25.8 t80 -59.66 -42.26 92.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -36.47 74.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.42 -15.7 61.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 72.27 51.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 t -130.77 -54.29 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 tt -73.96 148.52 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.96 175.34 7.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.03 -53.26 56.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.2 Cg_exo -49.87 -36.53 43.37 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.615 2.21 . . . . 0.0 112.305 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.92 77.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.99 -46.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mt -59.49 -48.85 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 mtt85 -59.83 -40.09 87.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -49.82 76.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -75.1 -36.09 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.186 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -60.57 -25.12 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.04 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.91 -33.51 11.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.407 HD22 ' CZ ' ' A' ' 83' ' ' PHE . 14.7 tp -62.98 -46.79 86.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 89' ' ' LEU . 23.7 m-85 -104.63 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.68 -4.85 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.609 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -102.49 -35.31 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -105.83 119.76 51.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.18 -42.44 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.447 2.098 . . . . 0.0 112.287 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.61 -18.01 17.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 83' ' ' PHE . 12.9 mt -85.23 -55.79 3.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.303 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.7 tt -61.4 -27.51 42.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.1 t -76.43 -48.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.16 -35.68 65.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.098 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.76 -36.14 62.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.685 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -63.02 -25.86 68.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.714 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.3 -1.66 21.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 32' ' ' VAL . 76.2 m-85 -99.75 -30.89 11.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.88 153.58 70.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.38 173.8 9.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.45 -13.89 61.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.266 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.05 -29.99 45.22 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.687 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -131.63 137.56 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -108.52 139.92 42.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.1 141.27 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -98.61 140.09 33.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.799 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.7 mp -140.97 103.59 6.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.47 142.47 59.55 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.762 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.692 0.282 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.95 -21.51 37.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 112.425 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -79.65 -22.29 43.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.42 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 21.9 mt -81.31 -35.66 30.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.96 -33.61 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.351 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -31.29 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.607 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.55 -49.94 60.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.62 74.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.818 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -71.25 -31.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.59 49.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.49 . . . . 0.0 110.163 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.78 -20.13 28.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.796 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.54 73.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.87 42.5 1.92 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.487 1.116 0 CA-C-O 120.89 0.288 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.415 HG23 ' CE2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -90.04 12.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.713 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.01 -28.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.536 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.9 -49.3 78.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.767 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.58 -30.88 64.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.86 -39.57 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.47 -51.99 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -58.15 -42.68 86.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -53.65 -50.01 66.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.106 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.17 -34.82 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -33.59 76.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -27.12 38.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.27 -28.52 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.5 -47.23 17.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -63.54 -48.53 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -63.93 -29.97 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 54' ' ' THR . 4.8 m-85 -117.91 40.07 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.02 -28.62 72.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 p -104.89 25.55 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.11 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -140.18 68.11 33.48 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.28 -28.12 33.22 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.568 2.179 . . . . 0.0 112.307 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.64 89.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.424 ' CG2' ' CD2' ' A' ' 48' ' ' PHE . 57.1 m -65.6 -45.03 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 12.4 t80 -59.52 -51.3 70.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -33.52 73.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.46 -50.85 40.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -57.77 -46.07 85.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -44.24 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -54.01 -40.19 66.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.49 -32.1 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 32.8 mmt -69.59 -47.9 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HG2' ' CG ' ' B' ' 54' ' ' LEU . 5.4 mttt -65.45 -38.4 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.716 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.99 -44.59 94.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 16.3 t80 -59.19 -54.7 43.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -59.48 -35.18 73.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -64.0 -16.92 62.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.254 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.81 44.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.13 -41.73 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.68 147.84 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -87.04 172.61 9.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.416 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -61.8 -52.78 66.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.997 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.4 Cg_exo -49.73 -47.57 22.6 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.487 2.125 . . . . 0.0 112.463 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.33 -29.88 66.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.76 -47.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.113 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 mt -64.19 -36.34 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -61.85 -50.23 73.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -57.25 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.1 t -57.74 -47.56 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -59.12 -22.78 61.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.066 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -94.28 -36.46 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.58 -35.33 79.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.426 ' CD1' HD12 ' A' ' 89' ' ' LEU . 13.8 m-85 -113.1 56.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.962 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -69.55 -29.91 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.153 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.15 26.21 10.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -140.14 94.62 8.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.54 -45.78 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.443 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.85 -18.87 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 83' ' ' PHE . 8.1 mt -85.17 -56.91 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.62 -26.75 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.259 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.0 t -76.12 -51.63 19.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.39 87.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.126 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.63 -31.99 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -62.87 -32.3 73.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.632 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.22 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.379 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 32' ' ' VAL . 29.8 m-85 -99.82 29.94 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.9 mt -134.76 141.21 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.949 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.85 164.15 35.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.466 2.111 . . . . 0.0 112.295 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -26.69 68.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.014 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.7 -36.32 71.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.575 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -120.9 96.79 5.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.443 HG23 HD11 ' A' ' 103' ' ' ILE . 25.5 mt -75.17 153.25 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.67 171.43 9.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 pt -155.51 137.13 9.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.61 145.6 47.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.072 . . . . 0.0 112.173 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.527 0.203 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.69 -11.94 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.508 2.138 . . . . 0.0 112.603 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -79.84 -27.28 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.421 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.7 mt -78.98 -37.1 40.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.385 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.85 -34.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -75.5 -30.69 59.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.39 -49.9 65.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.442 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.86 79.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.921 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.12 -40.37 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.704 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.37 -34.07 56.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.802 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.6 -32.93 47.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.352 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.431 ' CG ' ' HG2' ' A' ' 63' ' ' LYS . 8.6 mp -88.41 -9.14 53.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.291 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 14.7 t 45.97 37.84 4.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.958 0.408 . . . . 0.0 111.357 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.87 -26.16 54.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.391 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.926 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 5.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 CA-C-O 120.844 0.269 . . . . 0.0 111.768 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.34 80.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.346 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.409 ' CE1' ' HB2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -121.07 -171.48 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -45.59 -35.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.444 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.44 -33.31 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -43.71 59.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.36 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.971 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.93 -55.68 15.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.1 t -58.59 -45.07 89.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.402 ' N ' ' CG2' ' A' ' 39' ' ' THR . 58.9 t80 -55.19 -48.06 74.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.07 -39.79 93.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.97 -29.07 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.801 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -79.45 -26.87 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.94 -25.45 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -82.14 -45.99 14.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.24 -51.91 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.207 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -58.13 -30.22 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CE2' HG23 ' A' ' 54' ' ' THR . 32.0 m-85 -116.99 39.82 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 -40.32 92.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.575 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -97.75 24.0 7.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.038 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.17 63.96 24.94 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -51.3 -25.35 17.79 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.548 2.166 . . . . 0.0 112.436 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.51 82.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.414 HG23 ' CE2' ' A' ' 48' ' ' PHE . 4.9 m -68.32 -48.91 63.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 45' ' ' LYS . 16.9 t80 -60.66 -48.49 81.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.21 -40.53 90.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -48.19 80.36 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.405 ' CE1' ' HE1' ' A' ' 62' ' ' MET . 34.6 t80 -58.22 -44.3 88.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 55' ' ' TYR . 17.6 mt -61.07 -40.41 93.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.09 -38.49 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.7 -33.59 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.405 ' HE1' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -69.64 -35.77 75.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -76.62 -33.54 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.761 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -38.47 89.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.0 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 37.7 t80 -76.26 -45.98 30.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -34.59 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 p -67.46 -13.09 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.324 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 43.93 0.29 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.911 0.386 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 m -115.36 -65.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.97 144.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -82.5 -178.14 6.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.31 -52.9 50.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.4 Cg_exo -48.46 -43.03 33.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.556 2.171 . . . . 0.0 112.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.41 -29.92 76.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.394 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 65' ' ' PHE . 21.6 t -74.55 -45.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.6 mt -61.37 -50.6 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -58.55 -45.72 88.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -59.44 -31.38 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.001 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.5 t -80.75 -47.32 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -22.19 48.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -92.58 -36.58 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.27 -30.57 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.39 40.63 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -68.04 -13.41 62.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.445 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -100.05 -30.29 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 111.072 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -100.14 114.44 65.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 -43.55 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.45 2.1 . . . . 0.0 112.291 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -16.08 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -53.46 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 0.0 110.055 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 tt -61.25 -28.69 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.192 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.56 -51.07 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.26 -35.37 55.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -75.81 -34.33 60.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -62.53 -27.63 69.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.62 -1.63 22.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.012 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -99.88 -30.28 12.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.91 138.43 20.98 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.07 177.02 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.452 2.102 . . . . 0.0 112.227 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp -65.65 -29.94 70.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.57 -72.33 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.566 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.95 65.32 6.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.93 157.89 29.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.4 tt -89.63 136.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.154 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.25 -177.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pp -146.58 129.96 8.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.05 162.29 37.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.461 2.107 . . . . 0.0 112.415 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.756 0.312 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.65 -30.33 34.94 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.47 2.113 . . . . 0.0 112.326 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -79.81 -21.12 44.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 22.6 mt -81.08 -39.07 26.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.367 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 mt -72.59 -34.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.379 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -32.35 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.435 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.42 -44.65 74.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.403 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.43 -34.33 77.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.44 -46.32 90.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.93 -27.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.686 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.71 -36.26 37.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.069 0.461 . . . . 0.0 110.381 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 9.0 mp -87.91 -17.4 31.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.044 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -169.79 70.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.97 49.48 0.85 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.488 1.147 0 CA-C-O 120.813 0.255 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -86.18 -31.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.9 100.09 0.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.971 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.57 -30.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -50.19 18.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.754 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.89 -39.16 64.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.53 -50.99 67.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 40' ' ' TYR . 4.2 t -59.1 -42.78 91.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.415 ' N ' HG22 ' A' ' 39' ' ' THR . 75.9 t80 -52.56 -51.32 60.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.998 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.22 -33.27 75.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.77 -30.73 70.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -80.85 -26.02 37.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -78.74 -28.4 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.006 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HE2' ' CE2' ' A' ' 55' ' ' TYR . 1.5 tppp? -80.13 -49.29 11.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.0 mt -63.39 -41.12 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -60.05 -28.07 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CD2' ' CG2' ' A' ' 54' ' ' THR . 31.4 m-85 -131.97 47.63 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.84 77.81 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 19.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.21 87.27 12.28 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.855 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.97 -24.54 39.37 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.595 2.196 . . . . 0.0 112.418 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.34 80.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.425 ' CG2' ' CD2' ' A' ' 48' ' ' PHE . 16.3 m -67.32 -57.98 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.41 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 15.9 t80 -59.97 -43.9 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -60.48 -38.28 83.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.77 56.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -57.97 -48.52 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.92 -49.51 76.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -42.47 61.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.4 mt -65.02 -31.91 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.82 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -43.84 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -74.14 -38.2 63.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 110.806 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 77.9 t80 -66.84 -45.98 76.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -29.69 58.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -15.32 62.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.305 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 69.33 42.03 1.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.921 0.391 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 p -117.5 -36.52 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 65' ' ' PHE . 1.2 pt -93.32 178.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.86 170.16 8.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.423 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.69 -60.72 9.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.228 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 93.3 Cg_exo -42.99 -30.46 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.602 2.201 . . . . 0.0 112.58 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.74 -34.93 66.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.314 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -70.67 -48.64 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.358 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.17 -34.74 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -76.0 -39.68 55.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -60.42 -49.47 84.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.074 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.3 t -56.96 -25.5 58.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.78 -42.88 26.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.23 -31.37 72.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 86' ' ' HIS . 4.7 m-85 -118.22 61.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -73.59 -31.12 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.566 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.85 24.15 12.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.51 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.9 m170 -129.65 90.81 42.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.79 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 29.5 Cg_endo -64.11 -55.5 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.513 2.142 . . . . 0.0 112.393 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -50.75 -23.7 2.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.476 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.1 mt -81.53 -57.9 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 tt -61.94 -25.4 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.466 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 87' ' ' PRO . 98.3 t -72.98 -50.5 31.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.19 -37.51 80.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.219 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' CE1' HD11 ' B' ' 49' ' ' LEU . 54.1 t80 -72.85 -30.71 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.047 0.451 . . . . 0.0 110.837 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -69.02 -27.42 65.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.16 -13.59 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -99.75 -29.18 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.7 149.7 78.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.721 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.98 172.07 12.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.612 2.208 . . . . 0.0 112.301 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -67.67 -42.78 81.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.68 -49.22 79.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.19 54.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.849 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -174.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.5 mt -117.87 156.95 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -126.5 130.47 50.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.66 89.83 7.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.61 108.75 2.31 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.498 2.132 . . . . 0.0 112.276 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.673 0.273 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.72 -25.59 46.3 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.59 2.193 . . . . 0.0 112.435 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.38 -24.62 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 11.8 mt -78.02 -40.23 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.447 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.0 -37.52 72.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.47 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -29.06 62.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.628 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 93' ' ' PHE . 11.2 mt -67.43 -43.45 81.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.514 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.84 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.77 -46.35 89.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.628 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.2 -30.22 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.12 43.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.416 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.438 ' CD1' ' HG2' ' A' ' 63' ' ' LYS . 8.4 mp -91.08 -4.2 56.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.327 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' B' ' 54' ' ' LEU . 11.6 t 44.97 47.0 9.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.61 65.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.373 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.959 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.115 0 CA-C-O 120.87 0.279 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 HG13 ' CE2' ' A' ' 96' ' ' PHE . 3.7 m -63.72 81.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.59 -171.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.24 -32.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.198 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.71 -34.34 75.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.96 -41.44 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.89 -51.19 60.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 40' ' ' TYR . 3.7 t -60.12 -44.93 94.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.42 ' N ' HG21 ' A' ' 39' ' ' THR . 70.0 t80 -52.79 -51.28 61.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.916 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -60.7 -40.23 91.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.39 -25.29 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.18 -28.21 38.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.3 t -79.68 -30.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.977 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 55' ' ' TYR . 1.2 ttpm? -76.92 -47.89 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.02 -44.61 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.12 -29.01 63.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 54' ' ' THR . 87.2 m-85 -122.9 42.8 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -42.39 85.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.83 9.57 26.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.613 0.244 . . . . 0.0 111.296 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -140.32 79.51 21.02 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 -15.6 48.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.54 2.16 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.67 68.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.233 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 48' ' ' PHE . 53.8 m -63.85 -47.54 80.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.414 ' CG ' HD13 ' A' ' 59' ' ' LEU . 17.7 t80 -58.8 -46.9 86.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.996 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.67 -46.66 45.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.615 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -61.81 -49.68 75.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 55' ' ' TYR . 5.6 mt -56.9 -43.61 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.064 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -55.89 -47.1 78.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.163 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.3 -38.56 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.108 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.3 mmt -66.83 -47.84 70.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HD2' ' CD1' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -64.56 -45.02 88.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.684 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -33.63 76.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' B' ' 46' ' ' LEU . 38.5 t80 -60.1 -55.02 39.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.85 -30.27 70.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.0 p -71.37 -8.33 53.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.262 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 65.81 43.3 3.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.815 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -119.84 1.92 11.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.323 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.1 tt -145.04 137.82 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.16 172.21 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.997 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.525 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -58.5 -58.32 19.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.6 Cg_endo -47.33 -42.36 27.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.549 2.166 . . . . 0.0 112.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 -29.02 67.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.202 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.86 -43.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.849 0.357 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -69.02 -41.72 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -60.13 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -55.77 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.3 t -58.66 -45.28 90.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.9 p -61.48 -23.42 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.044 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -94.77 -31.36 13.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -60.56 -36.54 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 89' ' ' LEU . 21.3 m-85 -113.71 47.19 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -62.39 -22.58 66.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.182 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -99.9 -32.14 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -102.48 95.13 5.65 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.59 -30.94 22.27 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.41 2.073 . . . . 0.0 112.263 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.85 -19.7 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -85.27 -49.82 7.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.014 0.435 . . . . 0.0 109.87 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 90' ' ' ILE . 53.5 mt -61.57 -27.66 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.915 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.2 -51.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.28 81.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.071 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -70.26 -35.57 73.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.674 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.95 -26.68 66.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.668 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 -11.41 53.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.747 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CE2' HG13 ' A' ' 32' ' ' VAL . 90.3 m-85 -99.6 -37.25 9.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mp -72.32 116.86 53.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.47 177.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.418 2.078 . . . . 0.0 112.275 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.97 -27.29 65.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -31.14 58.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.519 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -133.03 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -111.95 134.94 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 103' ' ' ILE . 24.5 mt -92.38 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -73.58 128.9 36.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -136.71 153.0 75.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.96 142.53 57.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.586 2.191 . . . . 0.0 112.299 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 tttt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.895 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.91 -22.52 36.01 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.577 2.184 . . . . 0.0 112.435 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -77.86 -23.24 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.1 mt -77.92 -37.31 48.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.381 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -71.35 -38.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.453 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -29.59 64.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.82 -43.05 76.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.532 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.86 83.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.947 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -61.85 -42.74 99.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.658 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.12 -29.69 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.741 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.02 -36.85 40.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.31 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.414 ' CD1' ' HD2' ' A' ' 63' ' ' LYS . 7.4 mp -83.44 -25.11 31.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.835 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.67 71.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.628 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.53 -48.34 3.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.54 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.846 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 CA-C-O 120.83 0.262 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.04 79.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -131.26 -175.95 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.2 -29.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.52 -41.62 72.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.5 -33.56 69.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.16 -36.94 64.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.037 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -52.22 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 40' ' ' TYR . 4.7 t -60.08 -42.92 95.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.409 ' N ' HG21 ' A' ' 39' ' ' THR . 55.0 t80 -52.08 -47.69 65.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.16 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.13 -40.42 94.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -68.06 -29.88 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -76.62 -30.19 56.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.797 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.2 t -78.06 -30.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.46 -45.59 58.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.65 -39.62 84.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -29.9 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 54' ' ' THR . 68.7 m-85 -118.46 40.19 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.99 -21.5 79.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.3 p -92.01 -9.16 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -140.03 100.57 7.17 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.575 0.226 . . . . 0.0 111.041 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.46 -14.93 37.84 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.491 2.128 . . . . 0.0 112.598 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.84 -40.36 69.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -68.37 -50.0 56.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -61.75 -49.11 77.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.47 -34.46 74.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -48.55 49.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -56.69 -46.63 81.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.944 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.55 -39.33 87.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -62.03 -38.61 89.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -68.53 -48.81 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.6 mmt -64.23 -37.57 87.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -70.84 -47.77 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.85 -29.88 69.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.418 ' CD1' HG22 ' A' ' 75' ' ' VAL . 54.3 t80 -76.44 -42.11 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm -54.26 -33.8 59.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.006 0.431 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -15.86 60.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.03 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 63.66 43.4 5.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 110.763 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -116.53 -35.63 4.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.6 pt -86.6 178.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.23 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.36 161.44 13.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.511 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -58.47 -59.26 14.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.0 Cg_endo -45.46 -41.28 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.812 2.341 . . . . 0.0 112.179 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.31 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG22 ' CD1' ' A' ' 65' ' ' PHE . 12.5 t -79.27 -46.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 mt -65.68 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -45.63 68.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.756 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -48.01 82.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG12 ' CE2' ' A' ' 83' ' ' PHE . 39.9 t -67.03 -41.15 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -61.39 -23.44 65.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -36.38 11.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.793 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.66 -38.91 89.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 79' ' ' VAL . 21.9 m-85 -104.61 60.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.07 31.25 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -46.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -105.2 103.52 42.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.73 -34.24 97.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.536 2.157 . . . . 0.0 112.292 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.63 -17.79 16.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.606 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 83' ' ' PHE . 4.3 mt -83.06 -55.91 4.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.179 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 90' ' ' ILE . 18.0 tt -60.25 -27.08 38.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.22 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 67.7 t -73.75 -48.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.524 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -38.56 90.78 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -71.68 -32.26 67.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.967 0.413 . . . . 0.0 110.715 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -66.51 -29.38 69.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.784 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.41 -17.72 55.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.496 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.74 30.07 3.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.1 mt -142.06 143.58 28.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.13 169.44 22.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.286 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.02 -32.53 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.16 89.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.45 93.16 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -103.55 148.9 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.8 tt -79.09 138.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -72.8 129.08 37.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.2 mt -110.17 78.38 1.35 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 140.5 38.9 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.58 2.186 . . . . 0.0 112.253 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.852 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.719 0.295 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 -25.51 22.08 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.545 2.163 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' B' ' 48' ' ' MET . 14.5 mt-30 -79.09 -22.08 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 17.1 mt -79.13 -37.85 37.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.35 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -72.68 -36.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 45' ' ' GLN . 0.1 OUTLIER -73.9 -29.19 61.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.67 -47.25 67.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.34 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.25 80.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.7 -42.79 99.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.59 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.32 -32.97 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.873 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.28 -33.48 49.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.443 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.405 ' O ' ' CG2' ' B' ' 55' ' ' THR . 6.1 mp -91.75 -3.91 55.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.293 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' B' ' 54' ' ' LEU . 15.2 t 45.5 42.17 7.59 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.368 . . . . 0.0 111.504 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.76 28.52 5.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.398 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.944 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 t -52.58 -28.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.267 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.02 -41.53 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -38.37 83.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.87 -34.19 66.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -63.48 -53.49 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 t -59.47 -42.37 91.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.905 ' O ' HG23 ' A' ' 44' ' ' VAL . 39.6 t80 -52.64 -46.87 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.66 -43.39 96.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -29.5 69.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -31.42 56.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 40' ' ' TYR . 32.9 t -79.45 -24.76 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 tttm -77.83 -44.27 27.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -68.73 -51.11 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.34 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -29.21 63.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.137 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 54' ' ' THR . 11.5 m-85 -115.69 39.18 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.21 -28.0 71.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.6 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 p -97.32 6.79 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.453 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.17 86.68 12.79 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.672 0.273 . . . . 0.0 110.916 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.83 -25.07 28.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.593 2.195 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.28 86.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.763 HG21 ' CE2' ' A' ' 48' ' ' PHE . 19.6 m -61.1 -45.06 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.452 ' CE2' HD11 ' A' ' 59' ' ' LEU . 28.6 t80 -60.83 -50.86 71.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -31.12 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.79 -43.4 84.07 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.842 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.9 t80 -61.05 -44.35 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.828 HD23 ' HB1' ' B' ' 53' ' ' ALA . 6.6 mt -62.45 -37.03 84.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.78 -44.66 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 58' ' ' PHE . 4.9 mt -59.37 -53.2 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -50.19 70.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HG3' HD21 ' B' ' 54' ' ' LEU . 21.6 tttm -59.34 -39.79 84.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.27 -31.24 71.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CZ ' HD13 ' B' ' 46' ' ' LEU . 41.0 t80 -69.98 -40.35 75.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -59.41 -34.74 72.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.6 -16.07 62.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.272 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.38 39.51 0.92 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.833 0.349 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.51 -51.4 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.63 131.09 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.16 172.75 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -60.08 -58.41 19.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 83.1 Cg_exo -45.06 -31.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.442 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.44 64.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.461 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 61' ' ' ILE . 33.5 t -71.07 -48.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 72' ' ' THR . 3.1 mp -67.73 -32.18 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -63.91 -52.49 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -57.09 -47.99 79.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 75' ' ' VAL . 44.0 t -61.47 -42.06 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.967 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -62.51 -24.84 67.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -96.53 -35.5 11.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' CE1' ' A' ' 83' ' ' PHE . 1.9 tp -62.83 -44.38 96.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.3 m-85 -107.03 51.11 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.74 -30.83 71.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.26 26.64 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.785 ' HB3' HD12 ' A' ' 89' ' ' LEU . 14.8 m170 -140.11 95.11 8.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.1 Cg_endo -67.7 -48.92 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.428 2.085 . . . . 0.0 112.359 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -55.25 -20.62 11.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.4 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -85.68 -56.59 3.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 110.415 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 87' ' ' PRO . 16.2 tt -61.01 -28.99 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.8 t -75.76 -47.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.88 -39.47 68.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.161 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -74.84 -32.59 61.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 -30.06 70.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -8.85 49.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.783 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -99.76 -38.83 8.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 76' ' ' ILE . 68.9 mt -70.52 138.01 86.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.75 177.04 9.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.537 2.158 . . . . 0.0 112.383 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.15 -29.86 68.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.96 -63.48 5.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.593 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -104.2 88.25 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -87.27 178.77 6.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 76' ' ' ILE . 17.6 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.771 0.238 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.612 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.4 mm-40 -76.86 -25.51 53.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 110.562 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.68 HD21 HG11 ' A' ' 75' ' ' VAL . 2.3 mt -77.49 -33.73 54.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.273 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -73.22 -36.38 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.747 ' O ' HG23 ' B' ' 52' ' ' VAL . 10.0 ptt? -74.45 -29.96 61.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.703 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.612 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.3 mt -67.56 -48.36 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.675 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.24 -33.0 74.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -64.58 -46.09 84.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.747 HG23 ' O ' ' B' ' 48' ' ' MET . 26.1 t -67.79 -28.8 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.828 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.62 -35.5 45.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.326 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.639 HD21 ' HG3' ' A' ' 63' ' ' LYS . 4.2 mp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.909 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.697 0.284 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 38' ' ' LEU . 21.8 t -47.56 -28.48 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.455 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.25 -52.38 65.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -30.57 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.941 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB2' ' HE3' ' B' ' 48' ' ' MET . . . -74.39 -39.23 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 34' ' ' VAL . 4.9 mt -63.34 -51.08 67.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.53 -44.75 93.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 44' ' ' VAL . 56.6 t80 -54.68 -42.34 71.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.03 -30.21 64.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HD12 ' A' ' 46' ' ' ILE . 34.4 t70 -70.46 -31.79 69.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.991 0.424 . . . . 0.0 111.096 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -82.02 -30.98 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 40' ' ' TYR . 41.7 t -77.02 -22.8 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.071 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -85.05 -47.18 10.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.983 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 42' ' ' ASP . 23.0 mt -62.9 -53.45 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -29.64 67.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 54' ' ' THR . 24.2 m-85 -118.36 40.24 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.92 -28.22 63.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -114.92 38.47 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.11 87.72 12.15 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.53 -29.5 24.86 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.557 2.171 . . . . 0.0 112.324 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.77 -49.9 75.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.799 ' HA ' HD11 ' A' ' 82' ' ' LEU . 1.7 m -64.75 -52.51 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.432 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 5.6 t80 -59.71 -49.07 79.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -60.37 -30.65 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.28 -57.11 7.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.712 ' HA ' HD12 ' A' ' 61' ' ' ILE . 8.4 t80 -57.01 -41.21 78.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -45.86 91.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -44.37 87.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.7 mt -63.27 -31.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -47.41 31.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.859 ' HG2' HD11 ' B' ' 54' ' ' LEU . 2.1 mttp -66.74 -41.39 87.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.816 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -41.76 98.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CE2' HD13 ' B' ' 47' ' ' ILE . 26.8 t80 -59.36 -48.14 82.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HZ3' ' HB3' ' B' ' 50' ' ' ALA . 0.0 OUTLIER -59.4 -36.58 76.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -16.69 61.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.9 40.57 0.92 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 p -111.98 -38.23 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.7 tt -98.47 133.28 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 18.0 m-20 -75.99 178.99 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -64.85 -52.82 47.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.2 Cg_exo -48.43 -38.99 35.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 -29.34 74.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.5 t -73.9 -47.86 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.078 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.9 mt -59.69 -37.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -41.31 60.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -49.06 78.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 83' ' ' PHE . 49.9 t -65.92 -39.13 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -61.66 -25.82 67.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -45.05 13.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.784 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 54' ' ' THR . 12.8 tp -60.68 -38.76 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.64 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.55 61.05 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -58.39 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 28.44 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 2.7 m170 -125.11 90.64 50.63 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.788 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.6 Cg_endo -65.02 -51.94 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.519 2.146 . . . . 0.0 112.43 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -55.83 -20.37 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.64 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.0 mt -86.9 -56.65 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.249 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 103' ' ' ILE . 16.5 tt -59.73 -31.93 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 87' ' ' PRO . 70.2 t -75.16 -44.93 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.32 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.36 -32.83 68.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.054 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -73.43 -42.3 62.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 110.707 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 103' ' ' ILE . 1.1 t30 -61.57 -24.78 66.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.778 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.83 -9.96 48.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -99.58 -30.7 11.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 94' ' ' ASN . 3.4 mt -82.88 146.52 52.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 171.07 13.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.509 2.139 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.04 -27.87 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.07 -45.83 92.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.573 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -108.19 126.34 52.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -127.36 136.55 52.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 HG13 ' A' ' 90' ' ' ILE . 20.8 tt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 CA-C-O 120.827 0.261 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -20.38 54.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 7.6 mt -77.55 -39.99 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.338 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.483 HD13 ' CE2' ' A' ' 65' ' ' PHE . 27.9 mm -70.44 -38.95 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.885 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.02 -26.74 61.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.809 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -68.28 -50.12 55.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' HZ3' ' A' ' 66' ' ' LYS . . . -64.1 -35.58 81.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -63.25 -39.25 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.739 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.885 HG23 ' O ' ' B' ' 48' ' ' MET . 36.2 t -70.9 -30.39 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.93 -35.43 43.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 110.416 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.4 mp . . . . . 0 N--CA 1.451 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.091 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.26 -33.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.53 -43.71 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 39' ' ' THR . 6.5 m-20 -66.19 -39.13 89.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.61 -33.51 69.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -54.38 34.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.1 t -58.02 -42.67 85.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.894 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.7 t80 -52.63 -49.14 65.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.008 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -72.03 -30.0 64.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 110.994 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -76.8 -30.02 56.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.5 t -78.49 -30.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.802 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 55' ' ' TYR . 1.6 tppp? -71.77 -47.75 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.05 -48.02 89.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -30.47 69.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.3 m-85 -121.79 42.19 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.33 -45.54 92.72 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.533 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -98.18 28.1 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.23 65.98 29.6 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.98 -23.21 20.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.598 2.198 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.55 -39.61 67.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.514 HG21 ' CE2' ' A' ' 48' ' ' PHE . 3.1 m -76.87 -46.43 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 30.4 t80 -62.28 -51.91 65.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.35 -43.32 92.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.21 -48.53 85.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 61' ' ' ILE . 13.2 t80 -59.48 -31.35 69.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' B' ' 53' ' ' ALA . 14.8 mt -70.2 -46.72 63.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -38.32 83.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 58' ' ' PHE . 13.1 mt -65.59 -51.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 18.2 mmt -67.05 -41.33 86.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.2 ttmm -68.67 -31.46 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.92 -34.76 62.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' HG21 ' A' ' 75' ' ' VAL . 25.9 t80 -64.66 -56.56 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.019 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.0 OUTLIER -57.94 -36.41 72.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.895 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t -67.41 -12.91 61.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.224 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 74.83 45.06 0.17 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -114.46 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.1 tt -81.5 150.1 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 t0 -88.34 -175.3 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -54.61 4.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.2 -32.15 18.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 -38.27 60.23 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 79' ' ' VAL . 26.3 t -65.53 -33.56 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 103' ' ' ILE . 20.6 mt -75.28 -35.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -75.62 -42.74 50.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -62.24 -56.97 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 93' ' ' PHE . 47.1 t -58.09 -48.06 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -60.57 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -91.37 -42.68 10.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.755 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HG ' HG23 ' A' ' 54' ' ' THR . 2.6 tp -60.41 -30.79 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.868 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.0 m-85 -110.16 46.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.57 -34.61 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.065 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -108.03 26.12 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.689 ' CB ' HD12 ' A' ' 89' ' ' LEU . 29.8 m-70 -140.12 94.4 8.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.819 ' O ' HG23 ' A' ' 91' ' ' VAL . 44.7 Cg_endo -68.41 -44.99 2.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -64.26 -13.78 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.35 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.3 mt -86.72 -54.57 4.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.37 -29.25 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.151 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.6 t -75.66 -49.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.469 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.74 -38.39 87.96 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.065 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 79' ' ' VAL . 85.1 t80 -71.36 -34.29 70.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.591 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.55 -33.46 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.9 57.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CB ' HD11 ' B' ' 49' ' ' LEU . 75.8 m-85 -99.8 29.9 3.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.54 143.81 48.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.489 2.126 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -19.3 61.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.12 49.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.819 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -128.76 145.57 51.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.63 137.01 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.767 HG12 HG23 ' A' ' 76' ' ' ILE . 17.3 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.761 0.234 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.48 -25.48 50.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 110.69 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 65' ' ' PHE . 6.9 mt -76.99 -33.97 57.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.374 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -72.43 -39.99 63.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.427 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.548 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -70.47 -29.92 66.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.621 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' A' ' 96' ' ' PHE . 3.9 mt -66.58 -50.29 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.419 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.03 -33.45 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -61.62 -44.48 96.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.629 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 48' ' ' MET . 39.8 t -67.95 -29.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.903 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -77.72 -35.19 52.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.067 0.46 . . . . 0.0 110.204 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 66' ' ' LYS . 8.3 mp . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.872 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 21.6 p-80 . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.694 0.283 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.68 -52.02 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.762 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 18.2 mt-10 -58.12 -49.07 78.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -58.98 -36.57 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.98 -31.43 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.43 -52.72 43.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 t -59.53 -43.71 93.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.6 t80 -52.87 -52.7 56.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.73 -37.27 85.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 46' ' ' ILE . 6.5 t70 -66.23 -32.59 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.005 0.431 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.68 -31.31 36.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.767 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 33.0 t -78.72 -24.31 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.125 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 16.6 tptt -81.5 -46.76 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 42' ' ' ASP . 19.7 mt -65.09 -47.83 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -29.41 70.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 54' ' ' THR . 25.8 m-85 -116.12 39.34 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.36 -28.75 73.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 m -101.4 18.14 20.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.595 0.236 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.27 86.99 12.37 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.8 -26.33 32.48 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.83 -38.29 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.3 m -76.16 -37.81 57.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 33.9 t80 -71.9 -52.85 15.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.01 -37.65 80.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.78 -42.43 95.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 61' ' ' ILE . 28.0 t80 -59.2 -53.2 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' HB1' ' B' ' 53' ' ' ALA . 3.0 mt -59.8 -35.34 74.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -39.88 92.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -64.55 -54.34 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 28.8 mmt -62.05 -40.25 95.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.869 ' HG3' HD21 ' B' ' 54' ' ' LEU . 14.2 tttt -68.12 -31.1 70.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.03 -37.57 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD1' HG21 ' A' ' 75' ' ' VAL . 48.3 t80 -67.84 -38.9 83.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -57.97 -32.12 67.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.793 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -68.25 -12.04 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 65.65 39.54 4.85 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.56 -47.87 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.888 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.7 tt -87.09 158.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -89.69 -177.68 5.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.546 HG21 ' CE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -72.74 -51.38 6.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.1 Cg_exo -49.75 -33.59 32.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.78 -30.72 67.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.411 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 65' ' ' PHE . 21.5 t -72.94 -35.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.9 mm -67.72 -46.29 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -36.45 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -63.26 -53.85 46.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.9 t -66.56 -47.92 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.191 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.4 p -58.24 -23.24 55.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -87.11 -41.57 13.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 54' ' ' THR . 2.2 tp -62.75 -31.1 71.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.893 ' CD1' HD13 ' A' ' 89' ' ' LEU . 15.3 m-85 -116.31 58.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -71.7 -32.2 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.201 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.6 33.7 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.159 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.8 ' CB ' HD12 ' A' ' 89' ' ' LEU . 59.7 m-70 -140.06 86.16 13.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.054 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.723 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.9 Cg_exo -57.02 -50.53 11.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.25 . . . . 0.0 112.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -19.12 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.446 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.893 HD13 ' CD1' ' A' ' 83' ' ' PHE . 7.0 mt -87.64 -57.7 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 87' ' ' PRO . 11.7 tt -59.59 -31.9 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.177 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.7 t -77.47 -44.75 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.79 -38.49 96.04 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 79' ' ' VAL . 71.2 t80 -72.96 -34.09 66.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.073 0.464 . . . . 0.0 110.788 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -69.14 -23.9 64.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.963 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.37 -11.19 57.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.734 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -99.7 -30.21 12.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.71 143.9 63.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 162.91 41.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.42 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -28.55 67.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.57 -27.65 61.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CE2' HG21 ' A' ' 72' ' ' THR . 24.2 m-85 -111.2 102.09 10.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.75 0.31 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 141.54 39.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 103' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.862 0.276 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.642 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.5 OUTLIER -77.04 -22.97 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' B' ' 46' ' ' LEU . 15.4 mt -76.9 -35.7 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 mt -72.71 -38.81 59.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.426 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.697 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.89 -27.02 61.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.812 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.642 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.7 OUTLIER -70.65 -45.21 65.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.52 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 62' ' ' MET . . . -67.0 -34.49 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -64.44 -47.58 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.697 HG23 ' O ' ' B' ' 48' ' ' MET . 37.2 t -66.18 -28.26 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.88 -36.11 42.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.276 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.869 HD21 ' HG3' ' A' ' 63' ' ' LYS . 7.1 mp . . . . . 0 N--CA 1.451 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.953 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.42 -28.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.27 -39.23 71.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.712 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.89 77.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.22 63.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.52 -49.72 57.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -59.44 -44.92 92.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.7 t80 -54.54 -51.26 65.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.98 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.51 -31.07 71.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -33.04 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.731 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -79.28 -31.35 43.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.671 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.4 t -78.38 -29.83 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.751 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 1.2 tttm -72.84 -48.98 33.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.22 -41.64 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -28.33 65.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -117.61 40.11 3.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.93 50.99 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.552 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.7 17.08 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.661 0.267 . . . . 0.0 111.181 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.3 t0 -140.25 62.74 21.1 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 110.941 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 51' ' ' ASP . 50.2 Cg_exo -53.4 -23.26 23.59 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.533 2.155 . . . . 0.0 112.462 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.47 72.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG23 ' HG ' ' A' ' 82' ' ' LEU . 2.0 m -60.36 -47.42 86.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 13.6 t80 -63.04 -43.34 98.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -44.38 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -43.81 98.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.548 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HA ' HD12 ' A' ' 61' ' ' ILE . 67.3 t80 -58.78 -43.29 90.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 mt -61.7 -37.1 82.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.78 -43.63 97.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.7 mt -59.93 -59.5 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.3 91.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HD3' HD21 ' B' ' 54' ' ' LEU . 1.3 ttpp -64.46 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.02 -32.82 59.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 75' ' ' VAL . 66.9 t80 -66.27 -35.9 81.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -59.21 -32.15 69.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.1 -16.89 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.28 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.46 40.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 p -113.11 -48.77 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 65' ' ' PHE . 13.0 tt -78.69 156.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.1 t0 -87.08 173.56 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -72.06 -51.95 7.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.1 Cg_exo -49.62 -35.33 37.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.536 2.157 . . . . 0.0 112.358 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.83 -30.08 70.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.413 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 79' ' ' VAL . 32.4 t -71.03 -47.01 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 0.0 111.038 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 103' ' ' ILE . 6.7 mt -66.06 -32.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -49.78 56.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -45.91 90.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 75' ' ' VAL . 40.2 t -59.47 -46.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -62.12 -24.96 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -78.03 -47.26 18.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 mp -60.18 -29.0 68.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 89' ' ' LEU . 4.4 m-85 -111.78 54.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.56 -43.34 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.57 26.89 10.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.822 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.9 m170 -128.9 93.66 36.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.799 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 37.3 Cg_endo -66.74 -51.95 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.453 2.102 . . . . 0.0 112.557 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.84 -18.83 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.822 HD12 ' CB ' ' A' ' 86' ' ' HIS . 37.9 mt -84.1 -55.49 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.207 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.75 -28.64 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.081 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' PRO . 58.8 t -73.71 -46.27 47.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.426 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.47 -35.3 84.81 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.8 t80 -72.59 -35.14 67.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.0 110.775 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -66.95 -27.26 67.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -16.76 55.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.75 -30.07 12.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -68.94 147.64 97.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.26 173.48 11.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.557 2.172 . . . . 0.0 112.349 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -30.88 69.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -68.55 -64.63 2.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.53 84.82 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.55 147.51 27.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 76' ' ' ILE . 8.7 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.723 0.218 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.99 -24.69 47.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 110.788 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 46' ' ' LEU . 17.5 mt -76.19 -38.83 56.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.476 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.8 mt -70.49 -39.64 76.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.665 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.5 -27.09 62.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.749 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' HE3' ' B' ' 48' ' ' MET . 4.6 mt -68.7 -46.54 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.59 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.462 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -65.27 -36.35 83.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.051 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -61.89 -45.97 91.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 48' ' ' MET . 41.7 t -67.15 -27.87 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.88 -35.19 51.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.25 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 63' ' ' LYS . 9.5 mp . . . . . 0 N--CA 1.45 -0.465 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.826 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.718 0.294 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.577 ' HA ' HG21 ' B' ' 52' ' ' VAL . 21.4 t -48.0 -29.11 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.37 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.92 76.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -38.49 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.46 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.99 -54.06 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.4 t -60.5 -44.83 95.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.3 t80 -55.42 -49.9 71.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.053 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.2 mt -65.19 -34.96 79.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 46' ' ' ILE . 24.4 m-20 -70.91 -27.76 64.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -31.06 34.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 40' ' ' TYR . 30.0 t -81.75 -31.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.861 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -73.36 -49.25 28.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 42' ' ' ASP . 27.6 mt -66.02 -45.31 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -62.39 -32.89 73.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 54' ' ' THR . 41.4 m-85 -119.14 39.87 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.34 -44.07 52.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.5 m -66.33 -16.39 64.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.661 0.267 . . . . 0.0 111.223 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -132.58 92.68 26.67 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.7 -12.33 35.15 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.516 2.144 . . . . 0.0 112.492 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.8 77.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 64.5 m -69.0 -36.86 78.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 59' ' ' LEU . 32.5 t80 -65.74 -49.98 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -60.54 -32.74 71.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.69 -51.65 52.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.778 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.2 t80 -59.24 -42.98 92.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 55' ' ' TYR . 73.1 mt -59.83 -40.61 89.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -42.75 99.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.3 mt -65.45 -37.95 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.5 mmt -68.95 -55.69 10.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.68 ' HG3' HD21 ' B' ' 54' ' ' LEU . 18.9 tttt -60.35 -31.28 70.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.792 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.22 -40.91 86.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 75' ' ' VAL . 42.1 t80 -66.78 -44.48 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -58.46 -42.43 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.652 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -63.15 -16.63 60.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.26 43.84 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.819 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.94 14.76 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.331 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 65' ' ' PHE . 19.1 tt -155.09 145.81 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.042 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 t70 -84.36 178.37 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.53 -53.2 17.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 73.3 Cg_exo -48.99 -38.09 38.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.562 2.175 . . . . 0.0 112.405 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.72 -29.64 71.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.5 t -75.03 -34.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.9 mt -71.4 -44.31 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.148 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -43.53 94.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -48.06 81.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 75' ' ' VAL . 34.9 t -72.76 -34.17 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.512 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.8 t -62.44 -25.43 67.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -32.35 11.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.528 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -61.71 -32.66 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.562 ' CD1' HD13 ' A' ' 89' ' ' LEU . 26.4 m-85 -124.38 47.68 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -9.49 58.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.54 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -103.5 -29.65 11.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.821 0.343 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -100.01 108.25 50.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.67 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.25 -42.85 3.52 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.41 2.073 . . . . 0.0 112.229 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.56 -17.64 34.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.288 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 83' ' ' PHE . 18.1 mt -88.2 -56.63 3.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.261 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.584 HD11 HG12 ' A' ' 103' ' ' ILE . 11.3 tt -60.92 -33.17 54.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.232 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.3 t -77.11 -43.64 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.453 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.27 86.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 97' ' ' LEU . 70.8 t80 -73.92 -38.88 64.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.609 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.3 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.767 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.74 -9.53 51.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.824 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -99.72 -29.37 12.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 93' ' ' PHE . 3.4 mt -86.05 151.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.87 159.24 53.74 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -27.29 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -52.69 47.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.621 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -104.34 68.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -63.99 173.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.976 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 90' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 C--O 1.232 0.213 0 N-CA-C 112.606 0.195 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -77.55 -27.33 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.648 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.65 -33.66 60.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.367 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mm -73.37 -38.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.67 -27.46 62.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.34 -53.44 19.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.12 67.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.107 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -67.52 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 34' ' ' VAL . 38.1 t -59.06 -24.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.91 63.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.17 0.509 . . . . 0.0 109.699 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.68 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.9 mp . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.008 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.11 -31.04 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -37.59 65.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -67.05 -43.84 81.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.44 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -62.27 -55.7 25.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -59.02 -44.63 91.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 44' ' ' VAL . 63.3 t80 -53.29 -38.18 62.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.081 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.55 -47.26 49.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -31.62 69.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 110.963 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.2 -46.52 50.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.0 t -65.95 -16.72 21.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.314 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -85.03 -44.06 13.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -66.14 -56.4 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -56.52 -28.38 59.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 54' ' ' THR . 33.3 m-85 -117.26 39.77 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.0 70.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -101.96 19.44 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.664 0.269 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.24 74.7 29.53 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.905 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.46 -28.8 65.83 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.384 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.27 89.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' HD21 ' A' ' 82' ' ' LEU . 2.9 m -59.8 -51.58 69.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -63.16 -50.44 70.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.69 -42.23 92.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.48 -43.92 98.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.0 t80 -58.93 -49.97 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.075 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.23 76.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.59 -42.89 99.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -61.64 -50.12 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 31.3 mmt -60.15 -49.2 78.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.644 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.7 ttpt -63.88 -31.61 72.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.74 -46.02 80.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' CE2' HD13 ' B' ' 46' ' ' LEU . 34.4 t80 -63.48 -44.0 95.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 t -62.89 -17.25 61.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 70.04 39.82 1.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 -43.09 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.3 tt -97.19 158.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -85.34 176.08 8.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.14 -53.04 27.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' ILE . 74.4 Cg_exo -49.2 -28.2 14.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.581 2.187 . . . . 0.0 112.438 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.23 -32.09 60.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 61' ' ' ILE . 32.6 t -72.8 -44.05 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 97' ' ' LEU . 3.7 mt -64.31 -47.7 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -39.25 92.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -57.02 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.0 t -64.19 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 t -61.62 -22.61 65.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -94.72 -34.29 12.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 54' ' ' THR . 7.2 tp -61.19 -36.57 80.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.909 ' CD1' HD13 ' A' ' 89' ' ' LEU . 24.7 m-85 -112.67 52.67 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -61.86 -25.43 67.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.223 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 25.4 11.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.3 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.809 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.14 86.73 12.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.911 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.702 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 Cg_exo -58.25 -48.73 14.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.703 2.268 . . . . 0.0 112.422 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.07 -20.91 7.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.598 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.909 HD13 ' CD1' ' A' ' 83' ' ' PHE . 44.2 mt -86.84 -59.24 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.436 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.4 tt -58.31 -30.48 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.38 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 87' ' ' PRO . 88.9 t -76.28 -47.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.96 -37.49 85.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.096 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' HE1' HD11 ' A' ' 97' ' ' LEU . 41.8 t80 -74.24 -33.43 63.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.097 0.475 . . . . 0.0 110.673 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.35 -25.17 66.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.8 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.11 26.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.931 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.76 -35.05 9.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.831 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.542 HD13 HG12 ' A' ' 76' ' ' ILE . 2.4 mt -76.08 146.76 79.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.42 176.42 8.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tp -73.47 -24.91 60.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 -26.48 30.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.618 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.93 114.43 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -85.76 139.34 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.157 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.743 0.226 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.448 ' O ' HD12 ' B' ' 49' ' ' LEU . 3.2 mm-40 -75.95 -23.3 55.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.611 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 65' ' ' PHE . 1.8 mt -77.03 -33.79 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.342 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -72.9 -39.38 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.442 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.44 -29.57 65.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.73 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.448 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.4 mt -68.32 -49.21 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -30.5 71.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -62.45 -49.88 73.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 48' ' ' MET . 39.4 t -65.64 -29.17 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.836 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.54 -34.24 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.203 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.8 mp . . . . . 0 N--CA 1.45 -0.432 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.917 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.907 0.384 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 38' ' ' LEU . 33.8 t -57.7 -38.99 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.69 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.07 -38.49 88.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.431 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -71.37 -39.68 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.529 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.77 72.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.52 HD12 HG12 ' A' ' 34' ' ' VAL . 3.2 mt -64.76 -52.77 55.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 36' ' ' ASP . 3.2 t -54.64 -42.32 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.1 t80 -54.97 -54.93 36.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.6 mt -63.48 -30.29 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.27 -41.08 94.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.53 -27.16 51.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 35.9 t -79.59 -30.97 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.746 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -71.92 -49.64 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.687 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -64.35 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -59.89 -30.99 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -119.68 40.29 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.26 -38.17 81.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.398 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -81.45 -18.05 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.14 89.9 51.31 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.012 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.32 -8.94 24.8 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.583 2.189 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.61 -39.07 67.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.249 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.474 HG23 ' HG ' ' A' ' 82' ' ' LEU . 1.2 m -75.48 -43.04 51.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -61.27 -48.83 79.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -61.38 -43.41 98.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.97 83.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.375 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.822 ' HA ' HD12 ' A' ' 61' ' ' ILE . 19.3 t80 -61.13 -35.39 76.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mt -65.1 -46.48 80.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.51 75.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 58' ' ' PHE . 9.4 mt -69.34 -32.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.8 mmt -75.43 -44.48 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.842 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.8 OUTLIER -69.25 -33.51 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.32 -41.15 81.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.809 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CD1' HG21 ' A' ' 75' ' ' VAL . 78.8 t80 -61.99 -46.02 91.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.6 -39.32 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -15.87 60.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 73.87 41.05 0.44 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.25 -42.37 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.804 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.34 147.95 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.8 t0 -84.12 171.24 13.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.7 -53.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.7 Cg_exo -50.36 -37.86 51.48 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.91 82.42 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.452 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.2 t -62.33 -49.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.21 -43.64 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -44.65 96.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -59.66 -50.99 71.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 75' ' ' VAL . 46.9 t -62.34 -42.95 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.96 -23.3 66.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -46.3 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 tp -60.61 -34.99 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.87 53.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -61.97 -57.45 11.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.42 27.08 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.604 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.2 m170 -126.59 89.55 51.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.781 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.755 ' O ' HG23 ' A' ' 91' ' ' VAL . 34.7 Cg_endo -65.05 -51.17 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.605 2.203 . . . . 0.0 112.598 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.9 -21.99 4.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.501 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 86' ' ' HIS . 73.0 mt -85.17 -58.35 2.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.346 . . . . 0.0 110.446 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.5 tt -59.08 -27.85 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.0 t -76.17 -48.87 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.517 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.89 93.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.129 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -72.39 -33.35 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -62.5 -34.54 77.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 -22.4 49.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -100.0 30.32 3.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.823 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.5 126.46 22.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.38 176.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.492 2.128 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -29.05 28.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.75 -27.18 58.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -126.14 95.81 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 139.29 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 90' ' ' ILE . 3.9 tt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.692 0.205 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.542 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.5 mp0 -79.93 -27.33 39.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.45 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -79.77 -34.65 39.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.349 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.03 -32.98 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.504 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.593 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -77.33 -30.35 53.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.542 HD12 ' O ' ' B' ' 45' ' ' GLN . 15.3 mt -71.36 -43.32 67.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.42 72.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -63.97 -49.21 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.744 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -66.74 -28.76 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.19 -35.41 41.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.842 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.4 mp . . . . . 0 N--CA 1.451 -0.412 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.887 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 29.9 p-80 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.501 0.191 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.25 -31.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -64.84 -44.55 89.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -65.37 -44.16 88.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.934 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.74 66.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 mt -64.86 -53.99 37.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 2.9 t -59.51 -45.55 91.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.813 ' O ' HG23 ' A' ' 44' ' ' VAL . 53.8 t80 -55.69 -47.2 77.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.067 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.36 -31.42 72.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -69.79 -32.68 71.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.81 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -26.39 38.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.835 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.8 t -80.45 -29.16 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -46.2 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.0 mt -66.62 -41.6 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -30.91 68.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' A' ' 54' ' ' THR . 56.0 m-85 -124.82 43.75 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.1 -35.58 84.68 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.469 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 p -107.9 42.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -140.13 92.38 9.63 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.94 -38.84 12.23 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.472 2.114 . . . . 0.0 112.24 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.47 77.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.604 HG21 ' CD2' ' A' ' 48' ' ' PHE . 6.2 m -71.57 -48.21 49.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.735 ' O ' HD12 ' A' ' 59' ' ' LEU . 15.4 t80 -65.35 -58.53 5.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.32 -32.11 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.68 -50.57 41.6 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' HD12 ' A' ' 61' ' ' ILE . 31.6 t80 -57.66 -44.58 85.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 55' ' ' TYR . 0.5 OUTLIER -64.65 -35.27 80.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.696 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.7 -35.8 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.874 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 58' ' ' PHE . 21.8 mt -69.48 -50.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -32.39 73.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HE2' HD21 ' B' ' 54' ' ' LEU . 7.0 tttm -71.87 -31.63 66.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 -30.13 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HA ' HG12 ' A' ' 70' ' ' ILE . 40.4 t80 -70.44 -40.35 73.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -56.97 -32.54 66.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -64.94 -16.15 62.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.05 42.5 1.25 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.743 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -113.86 -51.5 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 65' ' ' PHE . 11.2 pt -74.58 178.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -116.62 -177.47 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.42 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.35 -52.76 20.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.6 Cg_exo -47.94 -27.75 9.19 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.642 2.228 . . . . 0.0 112.428 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.8 -29.35 57.57 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 79' ' ' VAL . 18.5 t -76.67 -33.89 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 103' ' ' ILE . 39.4 mt -73.59 -45.43 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -46.41 76.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -45.65 87.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 75' ' ' VAL . 38.8 t -76.11 -41.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.066 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.2 t -58.28 -22.51 52.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.09 -38.77 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.07 -31.57 72.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 89' ' ' LEU . 17.7 m-85 -119.92 50.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -67.44 -41.09 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -100.74 30.0 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.646 ' CB ' HD12 ' A' ' 89' ' ' LEU . 83.8 m-70 -139.96 85.77 13.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.7 Cg_exo -56.93 -59.31 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.61 2.207 . . . . 0.0 112.225 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -51.33 -22.77 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.556 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 86' ' ' HIS . 14.9 mt -81.79 -55.72 4.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 110.224 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 103' ' ' ILE . 12.3 tt -63.28 -26.21 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 87' ' ' PRO . 95.6 t -72.94 -47.92 46.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.33 -43.56 93.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.31 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.45 -29.53 66.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.921 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.499 ' HB2' HD12 ' A' ' 103' ' ' ILE . 1.4 t30 -72.24 -22.49 61.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 -3.32 28.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.4 ' CZ ' ' OD2' ' A' ' 36' ' ' ASP . 79.5 m-85 -99.76 -28.98 12.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.3 mt -89.03 140.07 29.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.63 177.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.443 2.095 . . . . 0.0 112.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.9 -31.69 71.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.32 -34.64 81.34 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.55 75.13 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.89 127.51 33.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 90' ' ' ILE . 33.2 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.697 0.207 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.437 ' O ' HD12 ' B' ' 49' ' ' LEU . 5.8 mt-30 -78.61 -21.0 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.386 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -79.38 -38.74 34.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.35 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.02 -35.2 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.789 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -75.98 -27.8 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.75 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.437 HD12 ' O ' ' B' ' 45' ' ' GLN . 5.2 mt -71.14 -43.46 67.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.425 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -36.46 79.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.997 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.54 -39.98 94.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 48' ' ' MET . 35.4 t -72.52 -28.03 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.748 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.49 52.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.514 HD21 ' HE2' ' A' ' 63' ' ' LYS . 7.2 mp . . . . . 0 N--CA 1.449 -0.51 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.8 t -53.52 -27.67 14.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.261 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.87 -39.47 69.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -36.28 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.43 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.83 -49.87 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 t -59.5 -44.66 93.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 62.8 t80 -53.08 -49.75 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.042 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.77 -32.63 73.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.409 ' OD1' HD11 ' A' ' 46' ' ' ILE . 7.7 t0 -66.21 -33.22 75.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -26.03 36.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.3 t -76.94 -28.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.932 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -80.34 -49.72 11.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' OD1' ' A' ' 42' ' ' ASP . 47.5 mt -60.82 -38.98 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -67.88 -27.4 66.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.643 ' CE2' HG21 ' A' ' 54' ' ' THR . 31.8 m-85 -114.99 39.21 2.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.09 -28.35 53.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.78 21.68 16.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -140.2 81.85 17.71 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 -28.1 23.82 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.597 2.198 . . . . 0.0 112.327 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.05 93.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.643 HG21 ' CE2' ' A' ' 48' ' ' PHE . 9.8 m -60.38 -38.64 84.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -69.89 -47.02 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -59.91 -42.62 94.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.95 94.54 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.551 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.53 -50.45 73.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.28 -36.57 78.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.97 -45.61 92.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 78' ' ' ARG . 28.5 mt -59.57 -45.58 93.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -49.9 55.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.765 ' HG3' HD21 ' B' ' 54' ' ' LEU . 7.8 ttmt -59.49 -36.62 76.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.97 -30.74 67.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 70' ' ' ILE . 50.2 t80 -74.19 -35.33 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -57.72 -40.89 80.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.762 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -15.84 61.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 71.93 53.76 0.19 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.985 0.421 . . . . 0.0 110.836 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.59 -39.02 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 65' ' ' PHE . 13.5 pt -92.34 156.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.215 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -90.79 170.09 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.4 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -62.16 -54.22 51.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.791 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.9 Cg_exo -48.38 -41.16 36.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.167 . . . . 0.0 112.233 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.73 99.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 71' ' ' ASP . 18.8 t -58.5 -40.0 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.98 -43.26 98.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -67.86 -36.06 79.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.569 ' HB3' HD13 ' A' ' 61' ' ' ILE . 26.6 mmt180 -57.27 -65.82 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.9 t -63.44 -31.31 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -64.85 -23.82 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.66 -37.73 11.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.49 -30.26 70.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.023 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' HD13 ' A' ' 89' ' ' LEU . 11.8 m-85 -114.62 55.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -66.78 -33.09 74.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.56 26.35 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.408 ' CB ' HD12 ' A' ' 89' ' ' LEU . 94.9 m-70 -140.05 88.21 11.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.971 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.878 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.3 Cg_endo -67.96 -44.46 3.93 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.591 2.194 . . . . 0.0 112.282 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -50.15 -25.35 3.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 83' ' ' PHE . 92.9 mt -82.72 -51.0 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 83' ' ' PHE . 57.0 mt -62.52 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.956 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.4 t -73.01 -50.41 32.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.465 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.35 80.52 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.323 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 97' ' ' LEU . 64.5 t80 -74.76 -30.74 61.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.92 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 97' ' ' LEU . 47.2 t30 -74.89 -27.28 60.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.878 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.25 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.519 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -99.66 -38.38 8.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.06 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 93' ' ' PHE . 7.1 mt -66.24 148.32 98.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 172.32 12.49 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.53 -22.21 57.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.77 -44.2 70.1 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.693 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -102.9 99.44 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.829 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -77.97 116.26 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.405 HG22 ' ND2' ' A' ' 94' ' ' ASN . 3.6 tt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.024 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HD12 ' B' ' 47' ' ' ILE . 42.6 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.708 0.212 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -79.49 -26.48 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.658 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 46' ' ' LEU . 20.5 mt -78.92 -36.08 42.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' B' ' 44' ' ' PRO . 7.4 mt -73.47 -34.7 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.508 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.5 OUTLIER -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.35 -43.35 67.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.67 72.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -50.32 69.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 48' ' ' MET . 38.7 t -65.46 -29.16 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.68 -34.44 58.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.111 0.481 . . . . 0.0 110.091 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.765 HD21 ' HG3' ' A' ' 63' ' ' LYS . 6.6 mp . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.728 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.454 ' CD2' ' HB2' ' A' ' 35' ' ' GLU . 5.6 p-80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -41.99 -32.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.886 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 5.7 mm-40 -63.46 -47.21 82.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.707 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -64.36 -37.74 88.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.95 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.44 -48.78 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -60.21 -45.67 92.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 69.2 t80 -55.47 -47.89 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.69 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.438 ' O ' HD12 ' A' ' 46' ' ' ILE . 60.6 m-20 -63.11 -30.2 71.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.59 -28.29 30.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 12.9 t -81.02 -20.29 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.11 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.33 -46.43 9.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.724 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.9 mt -67.04 -50.07 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -59.41 -30.66 68.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.65 ' HE1' HD11 ' A' ' 89' ' ' LEU . 69.3 m-85 -119.62 40.75 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.02 -29.26 64.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.578 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -107.72 30.35 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.17 88.58 11.5 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.62 -28.53 31.2 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.513 2.142 . . . . 0.0 112.329 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.68 69.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -74.04 -56.64 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -59.19 -52.03 67.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -61.27 -34.85 75.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.2 -50.16 23.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.902 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.7 t80 -60.23 -27.41 67.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -53.48 15.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.8 -38.23 69.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.016 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -60.87 -56.85 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.852 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.09 86.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.777 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' B' ' 54' ' ' LEU . 12.5 ttpt -64.59 -52.09 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.82 -30.35 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 61.8 t80 -66.48 -47.49 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -57.31 -27.37 62.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 m -66.97 -13.03 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.86 47.78 2.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.956 0.407 . . . . 0.0 110.823 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 m -121.82 -39.28 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 65' ' ' PHE . 9.5 pt -91.26 178.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -108.85 172.69 6.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.424 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.17 -51.98 32.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.014 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.3 Cg_exo -50.38 -34.1 39.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.27 90.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 79' ' ' VAL . 19.0 t -61.95 -39.36 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 103' ' ' ILE . 40.5 mt -69.03 -35.9 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.173 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -70.31 -47.3 61.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 61' ' ' ILE . 18.8 mtp85 -58.45 -37.94 76.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -73.22 -45.54 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 t -58.61 -23.83 59.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -84.02 -40.14 18.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.806 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.88 -31.5 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 89' ' ' LEU . 6.0 m-85 -121.58 62.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -69.71 -44.12 71.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.654 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -99.94 26.63 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.8 m170 -130.83 104.31 15.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 91' ' ' VAL . 62.5 Cg_endo -74.6 -47.51 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.091 . . . . 0.0 112.712 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.25 -17.65 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.58 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.65 HD11 ' HE1' ' A' ' 48' ' ' PHE . 11.2 mt -87.68 -55.86 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.208 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.658 HG13 HD13 ' A' ' 103' ' ' ILE . 11.5 tt -56.72 -30.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.06 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.7 t -77.17 -45.57 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.289 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 -34.55 82.49 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.998 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.741 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 62.8 t80 -74.15 -37.79 63.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.659 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -61.45 -29.89 70.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -17.94 57.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.496 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.85 29.7 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.333 . . . . 0.0 110.954 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.2 145.32 23.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 158.88 54.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -26.81 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.34 -27.46 53.23 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.615 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 109.03 10.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.658 HD13 HG13 ' A' ' 90' ' ' ILE . 4.4 tt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.746 0.228 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.545 ' O ' HD12 ' B' ' 49' ' ' LEU . 15.1 mp0 -77.28 -19.02 57.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -78.99 -38.29 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 110.37 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.49 -37.25 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.448 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.415 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.8 -28.46 61.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.545 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.6 mt -72.18 -41.29 67.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.39 75.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.867 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.04 -53.48 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.693 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 48' ' ' MET . 43.7 t -63.06 -28.0 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.003 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.1 48.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.096 0.474 . . . . 0.0 110.214 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.4 mp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.821 0.343 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.27 -36.81 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.26 -39.71 95.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.66 75.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 -30.78 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mt -66.53 -53.14 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.58 -44.31 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 44' ' ' VAL . 60.5 t80 -52.87 -55.74 20.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.06 -33.13 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -69.6 -28.87 66.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.53 -26.84 37.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 40' ' ' TYR . 19.0 t -78.77 -29.7 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.973 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -78.23 -47.2 18.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 42' ' ' ASP . 20.7 mt -63.01 -45.53 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.13 -28.44 68.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 54' ' ' THR . 63.8 m-85 -123.79 43.1 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -39.53 85.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.448 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -79.25 -19.49 50.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.224 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -111.0 92.86 15.89 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.01 -23.75 40.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.02 77.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.76 HG21 ' CD2' ' A' ' 48' ' ' PHE . 18.9 m -65.14 -48.41 73.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.612 ' CE2' HD11 ' A' ' 59' ' ' LEU . 9.2 t80 -62.76 -46.96 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -60.27 -34.93 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.22 -49.54 56.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 61' ' ' ILE . 50.7 t80 -58.78 -53.06 62.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 55' ' ' TYR . 33.2 mt -57.3 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -37.86 73.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.4 mt -73.08 -29.07 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.052 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -41.45 61.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.822 ' CG ' HD11 ' B' ' 54' ' ' LEU . 12.8 mttt -71.82 -44.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -58.6 -58.55 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 20.2 t80 -60.24 -44.14 95.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.138 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HD2' HD22 ' B' ' 54' ' ' LEU . 33.2 tttm -52.57 -37.17 57.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -13.86 61.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.032 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 71.02 49.38 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.0 m -112.44 -33.36 6.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 65' ' ' PHE . 11.0 pt -104.96 173.37 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -96.21 168.94 10.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.01 -52.32 75.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.8 Cg_exo -48.23 -35.43 26.91 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.288 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.08 81.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.338 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 65' ' ' PHE . 24.9 t -74.97 -33.38 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.9 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.607 HG23 HG12 ' A' ' 103' ' ' ILE . 39.6 mt -71.8 -47.38 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -64.23 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -55.01 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.506 HG13 ' CE2' ' A' ' 83' ' ' PHE . 37.7 t -69.84 -35.32 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -62.54 -26.99 68.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.92 -32.5 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.81 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 16.9 tp -61.08 -40.14 92.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.676 ' CD1' HD13 ' A' ' 89' ' ' LEU . 16.9 m-85 -107.26 61.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -92.39 22.47 4.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.403 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -128.37 -44.94 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.541 ' HB2' HD12 ' A' ' 89' ' ' LEU . 11.7 m80 -103.09 118.25 58.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 91' ' ' VAL . 56.3 Cg_endo -70.19 -33.54 14.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.525 2.15 . . . . 0.0 112.326 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.23 -13.95 33.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.527 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 83' ' ' PHE . 5.0 mt -87.19 -56.74 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.32 -31.28 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.0 t -75.75 -47.67 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.529 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.2 82.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.092 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -73.24 -35.02 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.47 . . . . 0.0 110.717 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -33.27 73.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -18.5 58.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.322 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -99.79 30.03 3.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -144.3 147.12 35.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.88 159.77 51.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.545 2.163 . . . . 0.0 112.212 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.622 HD11 ' NH2' ' A' ' 102' ' ' ARG . 1.6 tp -59.99 -29.76 68.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.49 69.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.8 88.52 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.622 ' NH2' HD11 ' A' ' 99' ' ' LEU . 3.5 mtt180 -85.74 -174.58 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.607 HG12 HG23 ' A' ' 76' ' ' ILE . 27.8 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.151 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.231 0.174 0 N-CA-C 112.613 0.197 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.52 -25.67 41.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 65' ' ' PHE . 55.4 mt -79.4 -36.01 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.43 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.6 mm -74.26 -33.62 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.544 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.737 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -77.1 -29.44 54.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.696 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.06 -46.0 65.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -33.46 73.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.965 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -64.26 -42.55 96.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.82 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 48' ' ' MET . 35.2 t -70.97 -30.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.726 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.99 43.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.307 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.2 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.91 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.741 0.305 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.47 -30.71 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.206 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -38.8 78.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -39.47 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.37 69.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.66 -54.35 43.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 t -59.83 -44.53 94.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.1 t80 -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.077 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.65 -34.23 73.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -65.69 -29.49 70.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -81.37 -26.55 35.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.92 HG22 HD21 ' A' ' 89' ' ' LEU . 15.8 t -80.25 -29.93 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.043 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 2.8 tptt -78.15 -47.61 17.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 42' ' ' ASP . 24.2 mt -64.91 -48.39 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -62.09 -31.55 72.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.81 ' CD2' HG21 ' A' ' 54' ' ' THR . 64.4 m-85 -122.14 42.35 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 -35.03 91.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.566 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -97.63 20.83 11.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.288 . . . . 0.0 111.223 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.21 89.15 11.07 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.994 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.15 -26.91 42.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.417 2.078 . . . . 0.0 112.25 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -45.15 93.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CD2' ' A' ' 48' ' ' PHE . 28.2 m -61.23 -55.84 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 t80 -60.3 -46.87 88.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.26 -38.15 82.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.45 -46.15 91.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.489 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.7 t80 -60.76 -46.31 90.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HG ' ' HB1' ' B' ' 53' ' ' ALA . 0.9 OUTLIER -60.49 -37.71 81.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.22 -41.97 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.0 mt -63.97 -46.79 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.566 ' HB3' ' HB2' ' B' ' 50' ' ' ALA . 27.2 mmt -69.37 -43.43 73.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.4 ttmt -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -66.01 -32.75 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.1 t80 -65.54 -47.39 76.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.21 -41.66 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.693 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -64.45 -15.1 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 74.02 40.93 0.43 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.939 0.399 . . . . 0.0 110.798 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.7 t -117.55 14.3 14.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 tt -159.01 146.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 t70 -90.52 177.19 6.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.37 -53.85 42.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 76' ' ' ILE . 77.0 Cg_exo -48.01 -39.14 32.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.572 2.182 . . . . 0.0 112.467 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 -29.21 72.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 61' ' ' ILE . 38.4 t -72.41 -43.86 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 73' ' ' PRO . 5.1 mt -61.83 -43.83 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -41.3 84.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -44.16 78.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 75' ' ' VAL . 29.5 t -76.13 -32.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -62.46 -25.37 67.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -31.17 13.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.41 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 12.5 tp -62.23 -63.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.699 ' CD1' HD13 ' A' ' 89' ' ' LEU . 11.3 m-85 -89.19 53.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.19 -39.4 93.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.02 25.8 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.157 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 1.2 m-70 -140.17 97.15 7.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.839 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.4 Cg_endo -72.94 -46.65 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.59 2.194 . . . . 0.0 112.891 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -55.83 -20.75 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.92 HD21 HG22 ' A' ' 44' ' ' VAL . 1.8 mt -85.67 -57.77 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -53.84 -26.43 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.193 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.6 t -77.2 -50.56 20.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.188 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 -32.59 53.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.979 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' CE2' HD11 ' A' ' 97' ' ' LEU . 39.9 t80 -78.32 -34.88 48.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.18 0.514 . . . . 0.0 110.494 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -59.96 -29.19 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.633 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.59 -4.5 27.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.881 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -99.7 -50.1 4.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.71 0.291 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD13 HG12 ' A' ' 76' ' ' ILE . 7.6 mt -66.24 142.6 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 176.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.134 . . . . 0.0 112.311 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.15 -28.98 60.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.75 -51.21 58.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.624 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.79 88.79 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -86.36 122.37 30.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.577 HG12 HD11 ' A' ' 90' ' ' ILE . 8.0 tt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.794 0.247 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.648 ' O ' HD12 ' B' ' 49' ' ' LEU . 20.3 mp0 -76.12 -26.56 56.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.514 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 75' ' ' VAL . 6.0 mt -76.61 -32.56 58.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.237 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -72.74 -37.98 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.646 ' O ' HG23 ' B' ' 52' ' ' VAL . 2.7 ptt? -71.05 -32.16 68.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.648 HD12 ' O ' ' B' ' 45' ' ' GLN . 1.1 mt -67.97 -43.18 79.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.62 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' MET . . . -66.88 -34.02 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -65.54 -44.83 85.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.646 HG23 ' O ' ' B' ' 48' ' ' MET . 25.4 t -67.62 -29.1 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -77.68 -35.26 52.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 110.256 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.506 HD21 ' HG3' ' A' ' 63' ' ' LYS . 9.0 mp . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.915 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.602 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 6.2 p80 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.529 0.204 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -44.63 -30.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.813 0.339 . . . . 0.0 111.532 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.602 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 29.6 tt0 -62.22 -59.41 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -31.15 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.12 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mt -61.94 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -62.02 -44.51 96.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 44' ' ' VAL . 61.9 t80 -54.13 -48.31 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.088 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -63.05 -37.66 88.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.48 -32.14 70.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -30.62 62.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.6 t -82.87 -37.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.807 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -48.11 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.702 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -70.6 -47.97 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -60.73 -36.05 77.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 54' ' ' THR . 19.1 m-85 -115.68 39.06 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.19 -27.83 65.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -97.38 15.21 23.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.693 0.282 . . . . 0.0 111.29 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -140.18 77.49 25.06 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 -24.26 19.86 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.51 -55.28 36.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.228 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.743 HG23 ' HG ' ' A' ' 82' ' ' LEU . 3.3 m -59.85 -38.34 81.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.13 -56.23 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -31.97 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 -49.41 12.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.469 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 61' ' ' ILE . 61.1 t80 -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.042 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -39.64 83.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -62.24 -40.31 95.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 58' ' ' PHE . 7.5 mt -64.47 -51.74 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -41.83 98.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.787 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.0 OUTLIER -64.61 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -69.12 -42.52 75.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 75' ' ' VAL . 23.3 t80 -62.81 -44.72 95.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -31.63 67.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -66.49 -13.33 60.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.245 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 63.43 42.16 6.96 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.962 0.411 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -116.65 -39.04 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.0 tt -96.16 157.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -84.51 -177.69 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -74.36 -53.29 3.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 71.3 Cg_exo -48.75 -27.95 11.95 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.584 2.189 . . . . 0.0 112.364 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.38 -37.03 48.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.429 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.57 HG21 ' CD1' ' A' ' 65' ' ' PHE . 16.8 t -68.29 -40.16 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.765 0.316 . . . . 0.0 111.029 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 103' ' ' ILE . 16.3 mt -68.81 -42.51 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -58.76 -44.67 90.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.9 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' CZ ' ' A' ' 93' ' ' PHE . 45.5 t -64.51 -41.97 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -23.36 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.01 -39.33 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HG ' HG23 ' A' ' 54' ' ' THR . 9.2 tp -61.38 -34.15 74.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.736 ' CD1' HD13 ' A' ' 89' ' ' LEU . 18.5 m-85 -109.08 42.42 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -60.11 -29.52 68.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 28.15 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.697 ' CB ' HD12 ' A' ' 89' ' ' LEU . 29.3 m80 -140.13 96.13 8.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.6 Cg_endo -68.07 -48.39 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.348 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.62 -18.26 28.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' A' ' 83' ' ' PHE . 40.9 mt -87.41 -56.11 3.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.328 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.529 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -59.22 -28.49 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.278 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 87' ' ' PRO . 66.1 t -78.34 -48.04 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.21 85.67 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.934 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 40.9 t80 -72.51 -40.3 66.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.508 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -67.05 -21.18 65.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.004 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.66 -7.26 43.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.87 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -99.72 -30.24 12.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.331 . . . . 0.0 110.951 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -77.85 153.81 80.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 163.95 29.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.283 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.09 -31.1 68.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.0 -43.82 92.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.403 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -93.91 76.02 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.01 162.9 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.529 HG12 HD11 ' A' ' 90' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.735 0.223 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.33 -25.84 51.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.706 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . 57.8 mt -77.16 -33.13 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.297 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.2 mm -74.06 -37.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.491 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.51 -28.96 62.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.687 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.18 -47.4 61.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.436 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.547 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -66.19 -30.75 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.943 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -63.52 -50.73 68.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -64.15 -30.61 50.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.82 53.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.787 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.7 mp . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.993 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 35' ' ' GLU . 27.1 p-80 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.602 0.239 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -44.78 -46.66 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.718 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . 21.7 tt0 -58.2 -41.35 83.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.974 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -65.88 -36.42 83.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.85 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -61.96 -54.89 35.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.6 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 81.4 t80 -55.21 -51.63 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' B' ' 53' ' ' ALA . 24.0 mt -65.39 -32.0 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.3 m-20 -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.96 -27.39 33.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 27.1 t -80.67 -29.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.53 -48.19 15.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.711 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 42' ' ' ASP . 26.5 mt -64.77 -49.08 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -59.41 -30.25 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CE2' HG21 ' A' ' 54' ' ' THR . 34.2 m-85 -115.81 39.29 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.03 93.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.24 25.07 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.663 0.268 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -140.19 87.01 12.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.63 -28.34 37.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.574 2.183 . . . . 0.0 112.258 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.01 88.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 48' ' ' PHE . 8.7 m -66.9 -50.89 60.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 45' ' ' LYS . 12.5 t80 -60.06 -51.68 68.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.793 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.61 -54.01 31.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.437 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 61' ' ' ILE . 9.4 t80 -60.02 -36.65 77.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.431 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.3 mt -66.27 -41.17 90.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -59.82 -39.13 83.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.3 mt -72.34 -31.82 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -69.17 -43.73 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.866 ' HG3' HD11 ' B' ' 54' ' ' LEU . 5.0 mttm -70.81 -31.08 67.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -55.28 32.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.8 t80 -59.66 -42.26 92.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -36.47 74.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.42 -15.7 61.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 72.27 51.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 t -130.77 -54.29 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 65' ' ' PHE . 4.3 tt -73.96 148.52 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t70 -89.96 175.34 7.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.03 -53.26 56.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' A' ' 76' ' ' ILE . 76.2 Cg_exo -49.87 -36.53 43.37 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.615 2.21 . . . . 0.0 112.305 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.92 77.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 71' ' ' ASP . 21.6 t -65.99 -46.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.0 mt -59.49 -48.85 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 mtt85 -59.83 -40.09 87.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -49.82 76.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -75.1 -36.09 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.186 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 90' ' ' ILE . 8.6 t -60.57 -25.12 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.91 -33.51 11.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.7 tp -62.98 -46.79 86.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 89' ' ' LEU . 23.7 m-85 -104.63 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 -4.85 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.609 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -102.49 -35.31 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.629 ' HB2' HD12 ' A' ' 89' ' ' LEU . 71.3 m-70 -105.83 119.76 51.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 91' ' ' VAL . 73.2 Cg_endo -76.18 -42.44 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.447 2.098 . . . . 0.0 112.287 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.61 -18.01 17.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.629 HD12 ' HB2' ' A' ' 86' ' ' HIS . 12.9 mt -85.23 -55.79 3.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.303 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.55 HG13 HD11 ' A' ' 103' ' ' ILE . 17.7 tt -61.4 -27.51 42.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 87' ' ' PRO . 65.1 t -76.43 -48.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.16 -35.68 65.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.098 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.76 -36.14 62.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.685 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -63.02 -25.86 68.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.714 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.3 -1.66 21.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -99.75 -30.89 11.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.88 153.58 70.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.38 173.8 9.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.45 -13.89 61.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.266 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.05 -29.99 45.22 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.687 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -131.63 137.56 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -108.52 139.92 42.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.55 HD11 HG13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.733 0.222 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -79.65 -22.29 43.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 21.9 mt -81.31 -35.66 30.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.96 -33.61 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.351 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.655 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -76.68 -31.29 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.607 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.55 -49.94 60.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.62 74.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.818 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.655 HG23 ' O ' ' B' ' 48' ' ' MET . 39.0 t -71.25 -31.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 41' ' ' LEU . . . -78.11 -34.59 49.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.49 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.866 HD11 ' HG3' ' A' ' 63' ' ' LYS . 9.8 mp . . . . . 0 N--CA 1.45 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.796 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 38' ' ' LEU . 21.7 t -47.01 -28.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.536 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.9 -49.3 78.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.767 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.58 -30.88 64.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.86 -39.57 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 34' ' ' VAL . 23.3 mt -63.47 -51.99 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -58.15 -42.68 86.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.3 t80 -53.65 -50.01 66.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.17 -34.82 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -66.54 -33.59 76.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -27.12 38.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 23.6 t -79.27 -28.52 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.938 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.5 -47.23 17.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.3 mt -63.54 -48.53 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -63.93 -29.97 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.843 ' CD2' HG21 ' A' ' 54' ' ' THR . 4.8 m-85 -117.91 40.07 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.02 -28.62 72.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 p -104.89 25.55 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.11 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -140.18 68.11 33.48 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.28 -28.12 33.22 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.568 2.179 . . . . 0.0 112.307 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.64 89.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 48' ' ' PHE . 57.1 m -65.6 -45.03 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 12.4 t80 -59.52 -51.3 70.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -33.52 73.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.46 -50.85 40.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 61' ' ' ILE . 39.5 t80 -57.77 -46.07 85.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 110.779 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -44.24 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -54.01 -40.19 66.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 58' ' ' PHE . 12.7 mt -69.49 -32.1 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 32.8 mmt -69.59 -47.9 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HG2' HD11 ' B' ' 54' ' ' LEU . 5.4 mttt -65.45 -38.4 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.716 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.99 -44.59 94.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CD1' HG21 ' A' ' 75' ' ' VAL . 16.3 t80 -59.19 -54.7 43.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -59.48 -35.18 73.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -64.0 -16.92 62.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.254 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.81 44.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.13 -41.73 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.68 147.84 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t0 -87.04 172.61 9.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.416 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -61.8 -52.78 66.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.997 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.4 Cg_exo -49.73 -47.57 22.6 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.487 2.125 . . . . 0.0 112.463 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.33 -29.88 66.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.2 t -68.76 -47.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 mt -64.19 -36.34 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -61.85 -50.23 73.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -57.25 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.1 t -57.74 -47.56 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -59.12 -22.78 61.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.066 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -94.28 -36.46 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.58 -35.33 79.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 89' ' ' LEU . 13.8 m-85 -113.1 56.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.962 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -69.55 -29.91 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.153 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.15 26.21 10.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CB ' HD12 ' A' ' 89' ' ' LEU . 34.7 m-70 -140.14 94.62 8.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.835 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.54 -45.78 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.85 -18.87 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 48' ' ' PHE . 8.1 mt -85.17 -56.91 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 103' ' ' ILE . 13.1 tt -57.62 -26.75 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.259 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 87' ' ' PRO . 63.0 t -76.12 -51.63 19.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.39 87.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.126 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.63 -31.99 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 97' ' ' LEU . 34.4 t30 -62.87 -32.3 73.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.632 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.22 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.379 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CB ' HD11 ' B' ' 49' ' ' LEU . 29.8 m-85 -99.82 29.94 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 103' ' ' ILE . 20.9 mt -134.76 141.21 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.949 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.85 164.15 35.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.466 2.111 . . . . 0.0 112.295 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -26.69 68.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.014 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.7 -36.32 71.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.575 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -120.9 96.79 5.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.644 HD11 ' CD1' ' A' ' 97' ' ' LEU . 25.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 CA-C-O 120.692 0.205 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -79.84 -27.28 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.7 mt -78.98 -37.1 40.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.385 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.85 -34.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.719 ' O ' HG23 ' B' ' 52' ' ' VAL . 5.1 ptt? -75.5 -30.69 59.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 96' ' ' PHE . 11.8 mt -66.39 -49.9 65.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.86 79.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.921 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.12 -40.37 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.704 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.719 HG23 ' O ' ' B' ' 48' ' ' MET . 42.9 t -70.37 -34.07 56.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.802 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.6 -32.93 47.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.352 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.58 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.6 mp . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.291 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.619 0.247 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -45.59 -35.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.444 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.44 -33.31 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -43.71 59.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.36 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.971 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.93 -55.68 15.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.1 t -58.59 -45.07 89.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 44' ' ' VAL . 58.9 t80 -55.19 -48.06 74.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.07 -39.79 93.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.97 -29.07 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.801 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -79.45 -26.87 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 40' ' ' TYR . 21.6 t -78.94 -25.45 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -82.14 -45.99 14.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.24 -51.91 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.207 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -58.13 -30.22 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 54' ' ' THR . 32.0 m-85 -116.99 39.82 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 -40.32 92.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.575 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -97.75 24.0 7.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.038 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.17 63.96 24.94 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -51.3 -25.35 17.79 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.548 2.166 . . . . 0.0 112.436 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.51 82.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.869 HG21 ' CE2' ' A' ' 48' ' ' PHE . 4.9 m -68.32 -48.91 63.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CE2' HD11 ' A' ' 59' ' ' LEU . 16.9 t80 -60.66 -48.49 81.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.21 -40.53 90.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -48.19 80.36 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.22 -44.3 88.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.454 HD11 ' CE2' ' A' ' 55' ' ' TYR . 17.6 mt -61.07 -40.41 93.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.09 -38.49 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.43 HD13 ' HB3' ' A' ' 78' ' ' ARG . 27.8 mt -69.7 -33.59 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.412 ' O ' ' HB1' ' B' ' 50' ' ' ALA . 0.1 OUTLIER -69.64 -35.77 75.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HG2' HD11 ' B' ' 54' ' ' LEU . 4.4 mttt -76.62 -33.54 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.761 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -38.47 89.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.0 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 75' ' ' VAL . 37.7 t80 -76.26 -45.98 30.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.2 OUTLIER -57.76 -34.59 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 p -67.46 -13.09 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.324 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 43.93 0.29 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.911 0.386 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 m -115.36 -65.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.97 144.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.3 m-20 -82.5 -178.14 6.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.31 -52.9 50.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.4 Cg_exo -48.46 -43.03 33.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.556 2.171 . . . . 0.0 112.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.41 -29.92 76.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.394 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -74.55 -45.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 73' ' ' PRO . 3.6 mt -61.37 -50.6 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -58.55 -45.72 88.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HB3' HD13 ' A' ' 61' ' ' ILE . 33.7 mtt-85 -59.44 -31.38 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.001 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 75' ' ' VAL . 37.5 t -80.75 -47.32 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.165 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -22.19 48.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -92.58 -36.58 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.27 -30.57 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.39 40.63 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -68.04 -13.41 62.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.445 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -100.05 -30.29 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 111.072 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.637 ' CB ' HD12 ' A' ' 89' ' ' LEU . 8.3 m-70 -100.14 114.44 65.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.855 ' O ' HG23 ' A' ' 91' ' ' VAL . 68.8 Cg_endo -74.2 -43.55 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.45 2.1 . . . . 0.0 112.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -16.08 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.7 HD21 HG22 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -86.27 -53.46 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 0.0 110.055 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 tt -61.25 -28.69 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.192 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 87' ' ' PRO . 54.7 t -75.56 -51.07 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.26 -35.37 55.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -75.81 -34.33 60.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -62.53 -27.63 69.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.62 -1.63 22.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.012 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -99.88 -30.28 12.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.91 138.43 20.98 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.07 177.02 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.452 2.102 . . . . 0.0 112.227 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp -65.65 -29.94 70.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.57 -72.33 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.566 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.95 65.32 6.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.93 157.89 29.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.154 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.854 0.273 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.547 ' O ' HD12 ' B' ' 49' ' ' LEU . 17.8 mt-30 -79.81 -21.12 44.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 22.6 mt -81.08 -39.07 26.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.367 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 mt -72.59 -34.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.379 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.451 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -74.85 -32.35 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.435 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.547 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.8 OUTLIER -68.42 -44.65 74.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.403 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 62' ' ' MET . . . -66.43 -34.33 77.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.44 -46.32 90.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 48' ' ' MET . 43.5 t -68.93 -27.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.686 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.44 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -79.71 -36.26 37.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.069 0.461 . . . . 0.0 110.381 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.881 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.0 mp . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.044 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.57 -30.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -50.19 18.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' THR . 3.4 t0 -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.89 -39.16 64.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.53 -50.99 67.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.2 t -59.1 -42.78 91.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.851 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.9 t80 -52.56 -51.32 60.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.998 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.22 -33.27 75.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.586 ' OD1' HD11 ' A' ' 46' ' ' ILE . 14.6 t0 -67.77 -30.73 70.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -80.85 -26.02 37.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.2 t -78.74 -28.4 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 55' ' ' TYR . 1.5 tppp? -80.13 -49.29 11.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.586 HD11 ' OD1' ' A' ' 42' ' ' ASP . 34.0 mt -63.39 -41.12 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -60.05 -28.07 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 54' ' ' THR . 31.4 m-85 -131.97 47.63 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.84 77.81 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 19.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.21 87.27 12.28 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.855 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.97 -24.54 39.37 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.595 2.196 . . . . 0.0 112.418 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.34 80.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 48' ' ' PHE . 16.3 m -67.32 -57.98 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.758 ' CE2' HD11 ' A' ' 59' ' ' LEU . 15.9 t80 -59.97 -43.9 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -60.48 -38.28 83.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.77 56.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.664 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.0 t80 -57.97 -48.52 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.758 HD11 ' CE2' ' A' ' 55' ' ' TYR . 96.5 mt -57.92 -49.51 76.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -42.47 61.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 58' ' ' PHE . 11.4 mt -65.02 -31.91 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -43.84 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -74.14 -38.2 63.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 110.806 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB2' HD11 ' A' ' 70' ' ' ILE . 77.9 t80 -66.84 -45.98 76.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -55.14 -29.69 58.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -15.32 62.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.305 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 69.33 42.03 1.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.921 0.391 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 p -117.5 -36.52 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 65' ' ' PHE . 1.2 pt -93.32 178.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -114.86 170.16 8.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.443 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.69 -60.72 9.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.228 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 93.3 Cg_exo -42.99 -30.46 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.602 2.201 . . . . 0.0 112.58 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.74 -34.93 66.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.314 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 79' ' ' VAL . 25.0 t -70.67 -48.64 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.358 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.478 HG23 HG12 ' A' ' 103' ' ' ILE . 48.9 mt -60.17 -34.74 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -76.0 -39.68 55.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -61.31 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.4 t -60.42 -49.47 84.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.074 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.777 ' HA ' HD12 ' A' ' 90' ' ' ILE . 28.3 t -56.96 -25.5 58.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.104 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.78 -42.88 26.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 54' ' ' THR . 3.2 tp -64.23 -31.37 72.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE1' HD23 ' A' ' 82' ' ' LEU . 4.7 m-85 -118.22 61.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -73.59 -31.12 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.566 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.85 24.15 12.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.51 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CB ' HD12 ' A' ' 89' ' ' LEU . 1.9 m170 -129.65 90.81 42.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.79 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.811 ' O ' HG23 ' A' ' 91' ' ' VAL . 29.5 Cg_endo -64.11 -55.5 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.513 2.142 . . . . 0.0 112.393 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -50.75 -23.7 2.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.476 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD12 ' CB ' ' A' ' 86' ' ' HIS . 9.1 mt -81.53 -57.9 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.24 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 103' ' ' ILE . 1.6 tt -61.94 -25.4 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.466 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 87' ' ' PRO . 98.3 t -72.98 -50.5 31.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.19 -37.51 80.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.219 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -72.85 -30.71 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.047 0.451 . . . . 0.0 110.837 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 103' ' ' ILE . 65.2 t30 -69.02 -27.42 65.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.16 -13.59 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -99.75 -29.18 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.7 149.7 78.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.721 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.98 172.07 12.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.612 2.208 . . . . 0.0 112.301 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -67.67 -42.78 81.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.68 -49.22 79.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.406 ' HB3' HD11 ' A' ' 76' ' ' ILE . 6.8 m-85 -94.19 54.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.849 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -174.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 90' ' ' ILE . 22.5 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.767 0.236 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.38 -24.62 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 46' ' ' LEU . 11.8 mt -78.02 -40.23 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.447 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 65' ' ' PHE . 32.1 mm -70.0 -37.52 72.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.47 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.731 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.22 -29.06 62.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.628 179.685 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.43 -43.45 81.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.514 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' HG3' ' A' ' 66' ' ' LYS . . . -67.19 -39.84 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.77 -46.35 89.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.628 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 48' ' ' MET . 40.6 t -68.2 -30.22 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.12 43.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.416 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.686 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.4 mp . . . . . 0 N--CA 1.449 -0.49 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.327 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.812 0.339 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.24 -32.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.198 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.71 -34.34 75.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.96 -41.44 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.89 -51.19 60.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.7 t -60.12 -44.93 94.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.802 ' O ' HG23 ' A' ' 44' ' ' VAL . 70.0 t80 -52.79 -51.28 61.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.916 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -60.7 -40.23 91.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.454 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m-20 -71.39 -25.29 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.18 -28.21 38.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.3 t -79.68 -30.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.977 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 55' ' ' TYR . 1.2 ttpm? -76.92 -47.89 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 42' ' ' ASP . 22.6 mt -64.02 -44.61 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.12 -29.01 63.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.9 42.8 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -42.39 85.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.83 9.57 26.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.613 0.244 . . . . 0.0 111.296 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -140.32 79.51 21.02 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 -15.6 48.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.54 2.16 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.67 68.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.233 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.544 ' O ' HD21 ' A' ' 82' ' ' LEU . 53.8 m -63.85 -47.54 80.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 59' ' ' LEU . 17.7 t80 -58.8 -46.9 86.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.996 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.67 -46.66 45.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.615 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 61' ' ' ILE . 79.2 t80 -61.81 -49.68 75.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.6 mt -56.9 -43.61 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.064 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -55.89 -47.1 78.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.163 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -61.3 -38.56 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.108 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.3 mmt -66.83 -47.84 70.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -64.56 -45.02 88.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.684 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -33.63 76.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 75' ' ' VAL . 38.5 t80 -60.1 -55.02 39.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.85 -30.27 70.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.0 p -71.37 -8.33 53.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.262 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 65.81 43.3 3.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.815 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -119.84 1.92 11.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.323 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.1 tt -145.04 137.82 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -80.16 172.21 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.997 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -58.5 -58.32 19.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.6 Cg_endo -47.33 -42.36 27.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.549 2.166 . . . . 0.0 112.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 -29.02 67.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.202 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 79' ' ' VAL . 23.8 t -74.86 -43.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.849 0.357 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 103' ' ' ILE . 41.3 mt -69.02 -41.72 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -60.13 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -55.77 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 75' ' ' VAL . 42.3 t -58.66 -45.28 90.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.9 p -61.48 -23.42 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.044 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -94.77 -31.36 13.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 54' ' ' THR . 4.1 tp -60.56 -36.54 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.762 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.3 m-85 -113.71 47.19 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -62.39 -22.58 66.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.182 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -99.9 -32.14 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.581 ' CB ' HD12 ' A' ' 89' ' ' LEU . 81.7 m-70 -102.48 95.13 5.65 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.59 -30.94 22.27 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.41 2.073 . . . . 0.0 112.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.85 -19.7 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -85.27 -49.82 7.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.014 0.435 . . . . 0.0 109.87 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.524 HG23 HG21 ' A' ' 103' ' ' ILE . 53.5 mt -61.57 -27.66 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.915 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 87' ' ' PRO . 47.7 t -74.2 -51.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.28 81.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.071 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CD2' HG11 ' A' ' 79' ' ' VAL . 18.1 t80 -70.26 -35.57 73.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.95 -26.68 66.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.668 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 -11.41 53.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.747 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.6 -37.25 9.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.613 HD13 HD11 ' A' ' 103' ' ' ILE . 3.9 mp -72.32 116.86 53.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.47 177.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.418 2.078 . . . . 0.0 112.275 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.97 -27.29 65.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -31.14 58.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.519 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -133.03 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -111.95 134.94 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 97' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 CA--C 1.527 0.13 0 CA-C-O 120.807 0.253 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.3 mp0 -77.86 -23.24 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.1 mt -77.92 -37.31 48.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.381 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -71.35 -38.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.453 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.659 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.99 -29.59 64.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.434 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.9 mt -68.82 -43.05 76.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.86 83.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.947 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -61.85 -42.74 99.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.658 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.659 HG23 ' O ' ' B' ' 48' ' ' MET . 38.3 t -69.12 -29.69 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.02 -36.85 40.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.31 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.547 HD11 ' CG ' ' A' ' 63' ' ' LYS . 7.4 mp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.857 0.36 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.2 -29.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.52 -41.62 72.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.5 -33.56 69.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.16 -36.94 64.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.037 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -52.22 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -60.08 -42.92 95.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.901 ' O ' HG23 ' A' ' 44' ' ' VAL . 55.0 t80 -52.08 -47.69 65.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.16 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.13 -40.42 94.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -68.06 -29.88 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -76.62 -30.19 56.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.797 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.2 t -78.06 -30.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.46 -45.59 58.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.65 -39.62 84.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -29.9 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.7 m-85 -118.46 40.19 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.99 -21.5 79.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.3 p -92.01 -9.16 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -140.03 100.57 7.17 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.575 0.226 . . . . 0.0 111.041 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.46 -14.93 37.84 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.491 2.128 . . . . 0.0 112.598 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.84 -40.36 69.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CE2' ' A' ' 48' ' ' PHE . 22.8 m -68.37 -50.0 56.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -61.75 -49.11 77.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.47 -34.46 74.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -48.55 49.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.5 t80 -56.69 -46.63 81.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.944 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.55 -39.33 87.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -62.03 -38.61 89.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.8 mt -68.53 -48.81 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.6 mmt -64.23 -37.57 87.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -70.84 -47.77 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.85 -29.88 69.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 54.3 t80 -76.44 -42.11 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm -54.26 -33.8 59.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.006 0.431 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -15.86 60.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.03 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 63.66 43.4 5.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 110.763 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -116.53 -35.63 4.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.6 pt -86.6 178.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.23 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.36 161.44 13.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -58.47 -59.26 14.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.0 Cg_endo -45.46 -41.28 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.812 2.341 . . . . 0.0 112.179 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.31 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.613 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.5 t -79.27 -46.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 mt -65.68 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -45.63 68.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.756 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -48.01 82.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -67.03 -41.15 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -61.39 -23.44 65.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -36.38 11.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.793 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 54' ' ' THR . 5.0 tp -61.66 -38.91 89.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.8 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.9 m-85 -104.61 60.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.07 31.25 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -46.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.677 ' HB2' HD12 ' A' ' 89' ' ' LEU . 50.6 m-70 -105.2 103.52 42.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.854 ' O ' HG23 ' A' ' 91' ' ' VAL . 36.8 Cg_exo -57.73 -34.24 97.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.536 2.157 . . . . 0.0 112.292 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.63 -17.79 16.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.606 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.8 HD13 ' CD1' ' A' ' 83' ' ' PHE . 4.3 mt -83.06 -55.91 4.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.179 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 103' ' ' ILE . 18.0 tt -60.25 -27.08 38.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.22 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 87' ' ' PRO . 67.7 t -73.75 -48.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.524 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -38.56 90.78 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -71.68 -32.26 67.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.967 0.413 . . . . 0.0 110.715 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 97' ' ' LEU . 50.2 t30 -66.51 -29.38 69.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.784 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.41 -17.72 55.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.496 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.74 30.07 3.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 94' ' ' ASN . 6.1 mt -142.06 143.58 28.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.13 169.44 22.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.286 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.02 -32.53 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.16 89.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.45 93.16 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -103.55 148.9 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 90' ' ' ILE . 5.8 tt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.788 0.245 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 45' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 48' ' ' MET . 14.5 mt-30 -79.09 -22.08 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.1 mt -79.13 -37.85 37.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.35 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -72.68 -36.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' MET . . . . . 0.698 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.1 OUTLIER -73.9 -29.19 61.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.67 -47.25 67.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.34 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.25 80.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.7 -42.79 99.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.59 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.698 HG23 ' O ' ' B' ' 48' ' ' MET . 39.3 t -67.32 -32.97 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.873 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.28 -33.48 49.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.443 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.451 -0.419 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.293 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 CA-C-O 120.729 0.221 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.62 83.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.27 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -125.12 -176.69 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 t -52.58 -28.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.267 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.02 -41.53 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -38.37 83.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.87 -34.19 66.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -63.48 -53.49 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 t -59.47 -42.37 91.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.905 ' O ' HG23 ' A' ' 44' ' ' VAL . 39.6 t80 -52.64 -46.87 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.66 -43.39 96.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -29.5 69.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -31.42 56.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 40' ' ' TYR . 32.9 t -79.45 -24.76 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 tttm -77.83 -44.27 27.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -68.73 -51.11 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.34 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -29.21 63.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.137 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 54' ' ' THR . 11.5 m-85 -115.69 39.18 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.21 -28.0 71.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.6 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 p -97.32 6.79 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.453 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.17 86.68 12.79 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.672 0.273 . . . . 0.0 110.916 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.83 -25.07 28.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.593 2.195 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.28 86.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.763 HG21 ' CE2' ' A' ' 48' ' ' PHE . 19.6 m -61.1 -45.06 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.452 ' CE2' HD11 ' A' ' 59' ' ' LEU . 28.6 t80 -60.83 -50.86 71.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -31.12 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.79 -43.4 84.07 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.842 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.9 t80 -61.05 -44.35 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.828 HD23 ' HB1' ' B' ' 53' ' ' ALA . 6.6 mt -62.45 -37.03 84.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.78 -44.66 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 58' ' ' PHE . 4.9 mt -59.37 -53.2 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -50.19 70.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HG3' HD21 ' B' ' 54' ' ' LEU . 21.6 tttm -59.34 -39.79 84.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.27 -31.24 71.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CZ ' HD13 ' B' ' 46' ' ' LEU . 41.0 t80 -69.98 -40.35 75.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -59.41 -34.74 72.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.6 -16.07 62.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.272 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.38 39.51 0.92 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.833 0.349 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.51 -51.4 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.63 131.09 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.16 172.75 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -60.08 -58.41 19.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 83.1 Cg_exo -45.06 -31.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.442 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.44 64.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.461 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 61' ' ' ILE . 33.5 t -71.07 -48.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 72' ' ' THR . 3.1 mp -67.73 -32.18 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -63.91 -52.49 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -57.09 -47.99 79.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 75' ' ' VAL . 44.0 t -61.47 -42.06 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.967 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -62.51 -24.84 67.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -96.53 -35.5 11.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' CE1' ' A' ' 83' ' ' PHE . 1.9 tp -62.83 -44.38 96.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.3 m-85 -107.03 51.11 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.74 -30.83 71.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.26 26.64 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.785 ' HB3' HD12 ' A' ' 89' ' ' LEU . 14.8 m170 -140.11 95.11 8.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.1 Cg_endo -67.7 -48.92 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.428 2.085 . . . . 0.0 112.359 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -55.25 -20.62 11.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.4 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -85.68 -56.59 3.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 110.415 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 87' ' ' PRO . 16.2 tt -61.01 -28.99 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.8 t -75.76 -47.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.88 -39.47 68.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.161 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -74.84 -32.59 61.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 -30.06 70.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -8.85 49.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.783 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -99.76 -38.83 8.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 76' ' ' ILE . 68.9 mt -70.52 138.01 86.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.75 177.04 9.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.537 2.158 . . . . 0.0 112.383 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.15 -29.86 68.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.96 -63.48 5.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.593 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -104.2 88.25 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -87.27 178.77 6.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 76' ' ' ILE . 17.6 mt -109.2 140.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.26 154.44 23.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.51 78.68 28.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.87 115.27 2.3 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.552 2.168 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.857 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.622 0.249 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -22.92 49.17 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 112.418 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.612 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.4 mm-40 -76.86 -25.51 53.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 110.562 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.68 HD21 HG11 ' A' ' 75' ' ' VAL . 2.3 mt -77.49 -33.73 54.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.273 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -73.22 -36.38 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.747 ' O ' HG23 ' B' ' 52' ' ' VAL . 10.0 ptt? -74.45 -29.96 61.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.703 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.612 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.3 mt -67.56 -48.36 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.675 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.24 -33.0 74.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -64.58 -46.09 84.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.747 HG23 ' O ' ' B' ' 48' ' ' MET . 26.1 t -67.79 -28.8 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.828 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.62 -35.5 45.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.326 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.639 HD21 ' HG3' ' A' ' 63' ' ' LYS . 4.2 mp -86.71 -19.4 29.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.909 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 78.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.799 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.19 50.74 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.929 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.488 1.16 0 CA-C-O 120.795 0.248 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG11 ' CD2' ' A' ' 96' ' ' PHE . 25.2 t -81.91 78.37 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -106.34 -161.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 38' ' ' LEU . 21.8 t -47.56 -28.48 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.455 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.25 -52.38 65.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -30.57 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.941 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.39 -39.23 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 34' ' ' VAL . 4.9 mt -63.34 -51.08 67.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.53 -44.75 93.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 44' ' ' VAL . 56.6 t80 -54.68 -42.34 71.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.03 -30.21 64.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HD12 ' A' ' 46' ' ' ILE . 34.4 t70 -70.46 -31.79 69.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.991 0.424 . . . . 0.0 111.096 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -82.02 -30.98 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 40' ' ' TYR . 41.7 t -77.02 -22.8 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.071 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -85.05 -47.18 10.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.983 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 42' ' ' ASP . 23.0 mt -62.9 -53.45 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -29.64 67.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 54' ' ' THR . 24.2 m-85 -118.36 40.24 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.92 -28.22 63.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -114.92 38.47 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.11 87.72 12.15 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.53 -29.5 24.86 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.557 2.171 . . . . 0.0 112.324 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.77 -49.9 75.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.799 ' HA ' HD11 ' A' ' 82' ' ' LEU . 1.7 m -64.75 -52.51 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.432 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 5.6 t80 -59.71 -49.07 79.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -60.37 -30.65 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.28 -57.11 7.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.712 ' HA ' HD12 ' A' ' 61' ' ' ILE . 8.4 t80 -57.01 -41.21 78.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -45.86 91.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -44.37 87.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.7 mt -63.27 -31.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -47.41 31.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.859 ' HG2' HD11 ' B' ' 54' ' ' LEU . 2.1 mttp -66.74 -41.39 87.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.816 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -41.76 98.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CE2' HD13 ' B' ' 47' ' ' ILE . 26.8 t80 -59.36 -48.14 82.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HZ3' ' HB3' ' B' ' 50' ' ' ALA . 0.0 OUTLIER -59.4 -36.58 76.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -16.69 61.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.9 40.57 0.92 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 p -111.98 -38.23 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.7 tt -98.47 133.28 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 18.0 m-20 -75.99 178.99 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -64.85 -52.82 47.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.2 Cg_exo -48.43 -38.99 35.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 -29.34 74.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.5 t -73.9 -47.86 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.078 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.9 mt -59.69 -37.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -41.31 60.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -49.06 78.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 83' ' ' PHE . 49.9 t -65.92 -39.13 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -61.66 -25.82 67.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -45.05 13.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.784 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 54' ' ' THR . 12.8 tp -60.68 -38.76 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.64 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.55 61.05 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -58.39 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 28.44 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 2.7 m170 -125.11 90.64 50.63 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.788 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.6 Cg_endo -65.02 -51.94 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.519 2.146 . . . . 0.0 112.43 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -55.83 -20.37 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.64 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.0 mt -86.9 -56.65 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.249 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 103' ' ' ILE . 16.5 tt -59.73 -31.93 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 87' ' ' PRO . 70.2 t -75.16 -44.93 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.32 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.36 -32.83 68.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.054 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -73.43 -42.3 62.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 110.707 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 103' ' ' ILE . 1.1 t30 -61.57 -24.78 66.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.778 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.83 -9.96 48.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.484 ' CD2' HG11 ' A' ' 32' ' ' VAL . 10.9 m-85 -99.58 -30.7 11.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 94' ' ' ASN . 3.4 mt -82.88 146.52 52.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 171.07 13.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.509 2.139 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.04 -27.87 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.07 -45.83 92.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.573 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -108.19 126.34 52.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -127.36 136.55 52.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 HG13 ' A' ' 90' ' ' ILE . 20.8 tt -90.79 118.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.58 177.34 4.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.025 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.41 ' CG1' HD13 ' A' ' 90' ' ' ILE . 1.4 mp -127.79 94.97 35.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.45 164.19 33.7 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.79 -31.38 10.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.589 2.192 . . . . 0.0 112.368 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -20.38 54.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 7.6 mt -77.55 -39.99 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.338 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.483 HD13 ' CE2' ' A' ' 65' ' ' PHE . 27.9 mm -70.44 -38.95 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.885 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.02 -26.74 61.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.809 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.468 ' HG ' ' HE3' ' B' ' 48' ' ' MET . 10.0 mt -68.28 -50.12 55.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' HZ3' ' A' ' 66' ' ' LYS . . . -64.1 -35.58 81.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -63.25 -39.25 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.739 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.885 HG23 ' O ' ' B' ' 48' ' ' MET . 36.2 t -70.9 -30.39 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.93 -35.43 43.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 110.416 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.4 mp -87.39 -19.93 27.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.091 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.9 93.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.03 30.82 7.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.947 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.487 1.134 0 CA-C-O 120.864 0.276 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 3.7 m -63.1 83.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -107.58 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.26 -33.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.53 -43.71 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 39' ' ' THR . 6.5 m-20 -66.19 -39.13 89.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.61 -33.51 69.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -54.38 34.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.1 t -58.02 -42.67 85.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.894 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.7 t80 -52.63 -49.14 65.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.008 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -72.03 -30.0 64.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 110.994 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -76.8 -30.02 56.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.5 t -78.49 -30.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.802 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 55' ' ' TYR . 1.6 tppp? -71.77 -47.75 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.05 -48.02 89.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -30.47 69.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.3 m-85 -121.79 42.19 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.33 -45.54 92.72 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.533 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -98.18 28.1 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.23 65.98 29.6 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.98 -23.21 20.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.598 2.198 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.55 -39.61 67.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.514 HG21 ' CE2' ' A' ' 48' ' ' PHE . 3.1 m -76.87 -46.43 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 30.4 t80 -62.28 -51.91 65.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.35 -43.32 92.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.21 -48.53 85.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 61' ' ' ILE . 13.2 t80 -59.48 -31.35 69.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' B' ' 53' ' ' ALA . 14.8 mt -70.2 -46.72 63.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -38.32 83.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 58' ' ' PHE . 13.1 mt -65.59 -51.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 18.2 mmt -67.05 -41.33 86.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.2 ttmm -68.67 -31.46 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.92 -34.76 62.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' HG21 ' A' ' 75' ' ' VAL . 25.9 t80 -64.66 -56.56 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.019 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.0 OUTLIER -57.94 -36.41 72.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.895 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t -67.41 -12.91 61.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.224 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 74.83 45.06 0.17 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -114.46 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.1 tt -81.5 150.1 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 t0 -88.34 -175.3 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -54.61 4.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.2 -32.15 18.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 -38.27 60.23 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 79' ' ' VAL . 26.3 t -65.53 -33.56 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 103' ' ' ILE . 20.6 mt -75.28 -35.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -75.62 -42.74 50.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -62.24 -56.97 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 93' ' ' PHE . 47.1 t -58.09 -48.06 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -60.57 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -91.37 -42.68 10.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.755 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HG ' HG23 ' A' ' 54' ' ' THR . 2.6 tp -60.41 -30.79 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.868 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.0 m-85 -110.16 46.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.57 -34.61 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.065 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -108.03 26.12 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.689 ' CB ' HD12 ' A' ' 89' ' ' LEU . 29.8 m-70 -140.12 94.4 8.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.819 ' O ' HG23 ' A' ' 91' ' ' VAL . 44.7 Cg_endo -68.41 -44.99 2.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -64.26 -13.78 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.35 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.3 mt -86.72 -54.57 4.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.37 -29.25 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.151 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.6 t -75.66 -49.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.469 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.74 -38.39 87.96 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.065 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 79' ' ' VAL . 85.1 t80 -71.36 -34.29 70.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.591 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.55 -33.46 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.9 57.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CB ' HD11 ' B' ' 49' ' ' LEU . 75.8 m-85 -99.8 29.9 3.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.54 143.81 48.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.489 2.126 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -19.3 61.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.12 49.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.819 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -128.76 145.57 51.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.63 137.01 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.767 HG12 HG23 ' A' ' 76' ' ' ILE . 17.3 mt -91.25 150.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.86 156.85 22.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.53 79.22 67.56 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 136.89 67.85 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.605 2.203 . . . . 0.0 112.253 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.687 0.28 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 -18.89 22.32 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.595 2.197 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.48 -25.48 50.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 110.69 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 65' ' ' PHE . 6.9 mt -76.99 -33.97 57.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.374 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -72.43 -39.99 63.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.427 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.548 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -70.47 -29.92 66.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.621 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' A' ' 96' ' ' PHE . 3.9 mt -66.58 -50.29 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.419 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.03 -33.45 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -61.62 -44.48 96.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.629 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 48' ' ' MET . 39.8 t -67.95 -29.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.903 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -77.72 -35.19 52.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.067 0.46 . . . . 0.0 110.204 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 66' ' ' LYS . 8.3 mp -84.43 -21.09 30.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.872 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.83 93.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.804 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.39 52.22 4.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.529 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.947 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.237 0 CA-C-O 120.81 0.254 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.3 87.48 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.207 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 21.6 p-80 -135.04 -164.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.68 -52.02 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.762 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 18.2 mt-10 -58.12 -49.07 78.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -58.98 -36.57 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.98 -31.43 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.43 -52.72 43.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 t -59.53 -43.71 93.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.6 t80 -52.87 -52.7 56.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.73 -37.27 85.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 46' ' ' ILE . 6.5 t70 -66.23 -32.59 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.005 0.431 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.68 -31.31 36.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.767 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 33.0 t -78.72 -24.31 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.125 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 16.6 tptt -81.5 -46.76 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 42' ' ' ASP . 19.7 mt -65.09 -47.83 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -29.41 70.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 54' ' ' THR . 25.8 m-85 -116.12 39.34 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.36 -28.75 73.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 m -101.4 18.14 20.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.595 0.236 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.27 86.99 12.37 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.8 -26.33 32.48 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.83 -38.29 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.3 m -76.16 -37.81 57.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 33.9 t80 -71.9 -52.85 15.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.01 -37.65 80.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.78 -42.43 95.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 61' ' ' ILE . 28.0 t80 -59.2 -53.2 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' HB1' ' B' ' 53' ' ' ALA . 3.0 mt -59.8 -35.34 74.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -39.88 92.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -64.55 -54.34 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 28.8 mmt -62.05 -40.25 95.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.869 ' HG3' HD21 ' B' ' 54' ' ' LEU . 14.2 tttt -68.12 -31.1 70.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.03 -37.57 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD1' HG21 ' A' ' 75' ' ' VAL . 48.3 t80 -67.84 -38.9 83.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -57.97 -32.12 67.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.793 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -68.25 -12.04 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 65.65 39.54 4.85 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.56 -47.87 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.888 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.7 tt -87.09 158.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -89.69 -177.68 5.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.546 HG21 ' CE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -72.74 -51.38 6.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.1 Cg_exo -49.75 -33.59 32.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.78 -30.72 67.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.411 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 65' ' ' PHE . 21.5 t -72.94 -35.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.9 mm -67.72 -46.29 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -36.45 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -63.26 -53.85 46.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.9 t -66.56 -47.92 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.191 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.637 ' HB2' HG22 ' A' ' 105' ' ' ILE . 78.4 p -58.24 -23.24 55.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -87.11 -41.57 13.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 54' ' ' THR . 2.2 tp -62.75 -31.1 71.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.893 ' CD1' HD13 ' A' ' 89' ' ' LEU . 15.3 m-85 -116.31 58.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -71.7 -32.2 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.201 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.6 33.7 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.159 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.8 ' CB ' HD12 ' A' ' 89' ' ' LEU . 59.7 m-70 -140.06 86.16 13.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.054 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.723 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.9 Cg_exo -57.02 -50.53 11.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.25 . . . . 0.0 112.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -19.12 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.446 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.893 HD13 ' CD1' ' A' ' 83' ' ' PHE . 7.0 mt -87.64 -57.7 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 87' ' ' PRO . 11.7 tt -59.59 -31.9 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.177 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.7 t -77.47 -44.75 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.79 -38.49 96.04 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 79' ' ' VAL . 71.2 t80 -72.96 -34.09 66.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.073 0.464 . . . . 0.0 110.788 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -69.14 -23.9 64.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.963 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.37 -11.19 57.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.734 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -99.7 -30.21 12.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.71 143.9 63.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 162.91 41.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.42 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -28.55 67.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.57 -27.65 61.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CE2' HG21 ' A' ' 72' ' ' THR . 24.2 m-85 -111.2 102.09 10.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.75 0.31 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 141.54 39.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 103' ' ' ILE . 0.7 OUTLIER -87.62 111.53 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -110.52 167.45 10.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.637 HG22 ' HB2' ' A' ' 80' ' ' SER . 1.7 pt -127.82 128.61 23.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.26 135.24 22.31 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.433 2.088 . . . . 0.0 112.29 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.1 mttt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.984 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' B' ' 44' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' B' ' 43' ' ' ALA . 55.6 Cg_endo -70.06 -26.33 26.27 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.642 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.5 OUTLIER -77.04 -22.97 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' B' ' 46' ' ' LEU . 15.4 mt -76.9 -35.7 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 mt -72.71 -38.81 59.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.426 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.697 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.89 -27.02 61.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.812 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.642 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.7 OUTLIER -70.65 -45.21 65.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.52 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 62' ' ' MET . . . -67.0 -34.49 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -64.44 -47.58 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.697 HG23 ' O ' ' B' ' 48' ' ' MET . 37.2 t -66.18 -28.26 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.88 -36.11 42.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.276 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.869 HD21 ' HG3' ' A' ' 63' ' ' LYS . 7.1 mp -84.16 -21.24 31.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.953 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.4 93.82 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.64 44.71 2.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.954 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.897 0.291 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.3 m -65.71 77.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.237 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.47 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.42 -28.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.27 -39.23 71.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.712 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.89 77.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.22 63.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.52 -49.72 57.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -59.44 -44.92 92.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.7 t80 -54.54 -51.26 65.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.98 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.51 -31.07 71.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -33.04 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.731 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -79.28 -31.35 43.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.671 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.4 t -78.38 -29.83 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.751 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 1.2 tttm -72.84 -48.98 33.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.22 -41.64 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -28.33 65.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -117.61 40.11 3.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.93 50.99 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.552 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.7 17.08 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.661 0.267 . . . . 0.0 111.181 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.3 t0 -140.25 62.74 21.1 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 110.941 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 51' ' ' ASP . 50.2 Cg_exo -53.4 -23.26 23.59 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.533 2.155 . . . . 0.0 112.462 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.47 72.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG23 ' HG ' ' A' ' 82' ' ' LEU . 2.0 m -60.36 -47.42 86.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 13.6 t80 -63.04 -43.34 98.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -44.38 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -43.81 98.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.548 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HA ' HD12 ' A' ' 61' ' ' ILE . 67.3 t80 -58.78 -43.29 90.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 mt -61.7 -37.1 82.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.78 -43.63 97.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.7 mt -59.93 -59.5 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.3 91.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HD3' HD21 ' B' ' 54' ' ' LEU . 1.3 ttpp -64.46 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.02 -32.82 59.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 75' ' ' VAL . 66.9 t80 -66.27 -35.9 81.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -59.21 -32.15 69.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.1 -16.89 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.28 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.46 40.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 p -113.11 -48.77 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 65' ' ' PHE . 13.0 tt -78.69 156.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.1 t0 -87.08 173.56 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -72.06 -51.95 7.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.1 Cg_exo -49.62 -35.33 37.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.536 2.157 . . . . 0.0 112.358 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.83 -30.08 70.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.413 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 79' ' ' VAL . 32.4 t -71.03 -47.01 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 0.0 111.038 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 103' ' ' ILE . 6.7 mt -66.06 -32.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -49.78 56.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -45.91 90.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 75' ' ' VAL . 40.2 t -59.47 -46.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -62.12 -24.96 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -78.03 -47.26 18.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 mp -60.18 -29.0 68.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 89' ' ' LEU . 4.4 m-85 -111.78 54.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.56 -43.34 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.57 26.89 10.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.822 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.9 m170 -128.9 93.66 36.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.799 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 37.3 Cg_endo -66.74 -51.95 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.453 2.102 . . . . 0.0 112.557 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.84 -18.83 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.822 HD12 ' CB ' ' A' ' 86' ' ' HIS . 37.9 mt -84.1 -55.49 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.207 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.75 -28.64 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.081 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' PRO . 58.8 t -73.71 -46.27 47.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.426 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.47 -35.3 84.81 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.8 t80 -72.59 -35.14 67.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.0 110.775 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -66.95 -27.26 67.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -16.76 55.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.75 -30.07 12.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -68.94 147.64 97.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.26 173.48 11.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.557 2.172 . . . . 0.0 112.349 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -30.88 69.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -68.55 -64.63 2.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.53 84.82 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.55 147.51 27.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 76' ' ' ILE . 8.7 tt -89.03 129.86 39.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.3 OUTLIER -134.31 -173.32 3.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 104' ' ' ASP . 1.8 pt -156.91 96.38 2.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.061 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.5 122.82 9.35 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.55 2.167 . . . . 0.0 112.389 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.927 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.12 -19.84 22.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.457 2.104 . . . . 0.0 112.453 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.99 -24.69 47.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 110.788 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 46' ' ' LEU . 17.5 mt -76.19 -38.83 56.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.476 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.8 mt -70.49 -39.64 76.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.665 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.5 -27.09 62.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.749 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' HE3' ' B' ' 48' ' ' MET . 4.6 mt -68.7 -46.54 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.59 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.462 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -65.27 -36.35 83.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.051 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -61.89 -45.97 91.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 48' ' ' MET . 41.7 t -67.15 -27.87 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.88 -35.19 51.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.25 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 63' ' ' LYS . 9.5 mp -86.25 -22.63 26.76 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.826 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.423 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -167.65 71.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.14 -35.66 2.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.933 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.487 1.131 0 CA-C-O 120.88 0.283 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.891 HG11 ' HG2' ' B' ' 45' ' ' GLN . 25.6 t -70.0 86.45 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 -169.38 2.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.577 ' HA ' HG21 ' B' ' 52' ' ' VAL . 21.4 t -48.0 -29.11 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.37 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.92 76.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -38.49 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.46 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.99 -54.06 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.4 t -60.5 -44.83 95.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.3 t80 -55.42 -49.9 71.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.053 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.2 mt -65.19 -34.96 79.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 46' ' ' ILE . 24.4 m-20 -70.91 -27.76 64.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -31.06 34.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 40' ' ' TYR . 30.0 t -81.75 -31.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.861 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -73.36 -49.25 28.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 42' ' ' ASP . 27.6 mt -66.02 -45.31 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -62.39 -32.89 73.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 54' ' ' THR . 41.4 m-85 -119.14 39.87 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.34 -44.07 52.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.5 m -66.33 -16.39 64.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.661 0.267 . . . . 0.0 111.223 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -132.58 92.68 26.67 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.7 -12.33 35.15 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.516 2.144 . . . . 0.0 112.492 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.8 77.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 64.5 m -69.0 -36.86 78.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 59' ' ' LEU . 32.5 t80 -65.74 -49.98 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -60.54 -32.74 71.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.69 -51.65 52.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.778 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.2 t80 -59.24 -42.98 92.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 55' ' ' TYR . 73.1 mt -59.83 -40.61 89.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -42.75 99.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.3 mt -65.45 -37.95 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.5 mmt -68.95 -55.69 10.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.68 ' HG3' HD21 ' B' ' 54' ' ' LEU . 18.9 tttt -60.35 -31.28 70.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.792 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.22 -40.91 86.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 75' ' ' VAL . 42.1 t80 -66.78 -44.48 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -58.46 -42.43 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.652 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -63.15 -16.63 60.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.26 43.84 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.819 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.94 14.76 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.331 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 65' ' ' PHE . 19.1 tt -155.09 145.81 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.042 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 t70 -84.36 178.37 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.53 -53.2 17.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 73.3 Cg_exo -48.99 -38.09 38.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.562 2.175 . . . . 0.0 112.405 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.72 -29.64 71.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.5 t -75.03 -34.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.9 mt -71.4 -44.31 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.148 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -43.53 94.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -48.06 81.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 75' ' ' VAL . 34.9 t -72.76 -34.17 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.512 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.8 t -62.44 -25.43 67.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -32.35 11.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.528 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -61.71 -32.66 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.562 ' CD1' HD13 ' A' ' 89' ' ' LEU . 26.4 m-85 -124.38 47.68 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -9.49 58.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.54 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -103.5 -29.65 11.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.821 0.343 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -100.01 108.25 50.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.67 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.25 -42.85 3.52 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.41 2.073 . . . . 0.0 112.229 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.56 -17.64 34.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.288 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 83' ' ' PHE . 18.1 mt -88.2 -56.63 3.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.261 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.584 HD11 HG12 ' A' ' 103' ' ' ILE . 11.3 tt -60.92 -33.17 54.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.232 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.3 t -77.11 -43.64 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.453 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.27 86.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 97' ' ' LEU . 70.8 t80 -73.92 -38.88 64.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.609 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.3 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.767 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.74 -9.53 51.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.824 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CE2' HG13 ' A' ' 32' ' ' VAL . 10.5 m-85 -99.72 -29.37 12.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 93' ' ' PHE . 3.4 mt -86.05 151.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.87 159.24 53.74 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -27.29 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -52.69 47.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.621 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -104.34 68.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -63.99 173.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.976 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -96.67 130.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -77.27 176.04 9.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.68 84.28 3.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.91 126.08 18.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.617 2.211 . . . . 0.0 112.252 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.808 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.67 0.271 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.36 -9.72 26.5 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 112.606 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.891 ' HG2' HG11 ' A' ' 32' ' ' VAL . 1.1 mt-30 -77.55 -27.33 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.65 -33.66 60.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.367 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mm -73.37 -38.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.67 -27.46 62.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.34 -53.44 19.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.12 67.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.107 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.852 ' O ' HG22 ' B' ' 55' ' ' THR . 37.5 t-20 -67.52 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 34' ' ' VAL . 38.1 t -59.06 -24.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.91 63.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.17 0.509 . . . . 0.0 109.699 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.68 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.9 mp -98.71 10.14 41.8 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.008 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.852 HG22 ' O ' ' B' ' 51' ' ' ASN . 9.0 t -170.85 70.04 0.05 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.68 -31.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.93 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.488 1.18 0 CA-C-O 120.979 0.324 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG12 ' CE2' ' A' ' 96' ' ' PHE . 3.7 m -63.2 91.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.26 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.84 -168.47 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.11 -31.04 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -37.59 65.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -67.05 -43.84 81.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.44 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -62.27 -55.7 25.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -59.02 -44.63 91.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 44' ' ' VAL . 63.3 t80 -53.29 -38.18 62.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.081 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.55 -47.26 49.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -31.62 69.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 110.963 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.2 -46.52 50.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.0 t -65.95 -16.72 21.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.314 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -85.03 -44.06 13.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -66.14 -56.4 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -56.52 -28.38 59.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 54' ' ' THR . 33.3 m-85 -117.26 39.77 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.0 70.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -101.96 19.44 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.664 0.269 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.24 74.7 29.53 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.905 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.46 -28.8 65.83 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.384 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.27 89.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' HD21 ' A' ' 82' ' ' LEU . 2.9 m -59.8 -51.58 69.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -63.16 -50.44 70.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.69 -42.23 92.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.48 -43.92 98.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.0 t80 -58.93 -49.97 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.075 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.23 76.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.59 -42.89 99.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -61.64 -50.12 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 31.3 mmt -60.15 -49.2 78.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.644 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.7 ttpt -63.88 -31.61 72.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.74 -46.02 80.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' CE2' HD13 ' B' ' 46' ' ' LEU . 34.4 t80 -63.48 -44.0 95.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 t -62.89 -17.25 61.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 70.04 39.82 1.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 -43.09 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.3 tt -97.19 158.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -85.34 176.08 8.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.14 -53.04 27.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' ILE . 74.4 Cg_exo -49.2 -28.2 14.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.581 2.187 . . . . 0.0 112.438 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.23 -32.09 60.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 61' ' ' ILE . 32.6 t -72.8 -44.05 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 97' ' ' LEU . 3.7 mt -64.31 -47.7 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -39.25 92.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -57.02 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.0 t -64.19 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 t -61.62 -22.61 65.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -94.72 -34.29 12.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 54' ' ' THR . 7.2 tp -61.19 -36.57 80.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.909 ' CD1' HD13 ' A' ' 89' ' ' LEU . 24.7 m-85 -112.67 52.67 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -61.86 -25.43 67.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.223 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 25.4 11.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.3 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.809 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.14 86.73 12.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.911 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.702 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 Cg_exo -58.25 -48.73 14.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.703 2.268 . . . . 0.0 112.422 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.07 -20.91 7.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.598 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.909 HD13 ' CD1' ' A' ' 83' ' ' PHE . 44.2 mt -86.84 -59.24 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.436 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.4 tt -58.31 -30.48 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.38 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 87' ' ' PRO . 88.9 t -76.28 -47.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.96 -37.49 85.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.096 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' HE1' HD11 ' A' ' 97' ' ' LEU . 41.8 t80 -74.24 -33.43 63.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.097 0.475 . . . . 0.0 110.673 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.35 -25.17 66.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.8 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.11 26.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.931 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' CE2' HG12 ' A' ' 32' ' ' VAL . 87.3 m-85 -99.76 -35.05 9.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.831 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.542 HD13 HG12 ' A' ' 76' ' ' ILE . 2.4 mt -76.08 146.76 79.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.42 176.42 8.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tp -73.47 -24.91 60.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 -26.48 30.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.618 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.93 114.43 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -85.76 139.34 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 tt -78.58 143.9 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.14 137.41 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.538 ' O ' HD12 ' A' ' 105' ' ' ILE . 1.2 pp -141.23 89.22 9.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.11 122.1 8.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.58 2.187 . . . . 0.0 112.323 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.591 0.234 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.06 -26.56 14.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.523 2.149 . . . . 0.0 112.366 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.448 ' O ' HD12 ' B' ' 49' ' ' LEU . 3.2 mm-40 -75.95 -23.3 55.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.611 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 65' ' ' PHE . 1.8 mt -77.03 -33.79 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.342 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -72.9 -39.38 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.442 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.44 -29.57 65.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.73 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.448 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.4 mt -68.32 -49.21 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -30.5 71.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -62.45 -49.88 73.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 48' ' ' MET . 39.4 t -65.64 -29.17 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.836 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.54 -34.24 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.203 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.8 mp -86.76 -19.32 29.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.917 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.561 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.4 OUTLIER -167.89 84.69 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.5 41.72 2.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.467 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.943 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.487 1.14 0 CA-C-O 120.774 0.239 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 96' ' ' PHE . 87.8 t -60.22 -81.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.88 146.46 3.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 38' ' ' LEU . 33.8 t -57.7 -38.99 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.69 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.07 -38.49 88.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.431 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -71.37 -39.68 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.529 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.77 72.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.52 HD12 HG12 ' A' ' 34' ' ' VAL . 3.2 mt -64.76 -52.77 55.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 36' ' ' ASP . 3.2 t -54.64 -42.32 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.1 t80 -54.97 -54.93 36.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.6 mt -63.48 -30.29 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.27 -41.08 94.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.53 -27.16 51.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 35.9 t -79.59 -30.97 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.746 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -71.92 -49.64 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.687 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -64.35 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -59.89 -30.99 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -119.68 40.29 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.26 -38.17 81.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.398 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -81.45 -18.05 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.14 89.9 51.31 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.012 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.32 -8.94 24.8 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.583 2.189 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.61 -39.07 67.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.249 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.474 HG23 ' HG ' ' A' ' 82' ' ' LEU . 1.2 m -75.48 -43.04 51.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -61.27 -48.83 79.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -61.38 -43.41 98.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.97 83.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.375 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.822 ' HA ' HD12 ' A' ' 61' ' ' ILE . 19.3 t80 -61.13 -35.39 76.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mt -65.1 -46.48 80.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.51 75.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 58' ' ' PHE . 9.4 mt -69.34 -32.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.8 mmt -75.43 -44.48 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.842 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.8 OUTLIER -69.25 -33.51 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.32 -41.15 81.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.809 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CD1' HG21 ' A' ' 75' ' ' VAL . 78.8 t80 -61.99 -46.02 91.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.6 -39.32 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -15.87 60.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 73.87 41.05 0.44 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.25 -42.37 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.804 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.34 147.95 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.8 t0 -84.12 171.24 13.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.7 -53.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.7 Cg_exo -50.36 -37.86 51.48 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.91 82.42 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.452 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.2 t -62.33 -49.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.21 -43.64 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -44.65 96.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -59.66 -50.99 71.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 75' ' ' VAL . 46.9 t -62.34 -42.95 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.96 -23.3 66.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -46.3 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 tp -60.61 -34.99 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.87 53.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -61.97 -57.45 11.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.42 27.08 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.604 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.2 m170 -126.59 89.55 51.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.781 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.755 ' O ' HG23 ' A' ' 91' ' ' VAL . 34.7 Cg_endo -65.05 -51.17 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.605 2.203 . . . . 0.0 112.598 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.9 -21.99 4.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.501 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 86' ' ' HIS . 73.0 mt -85.17 -58.35 2.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.346 . . . . 0.0 110.446 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.5 tt -59.08 -27.85 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.0 t -76.17 -48.87 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.517 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.89 93.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.129 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -72.39 -33.35 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -62.5 -34.54 77.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 -22.4 49.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 32' ' ' VAL . 47.5 m-85 -100.0 30.32 3.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.823 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.5 126.46 22.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.38 176.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.492 2.128 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -29.05 28.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.75 -27.18 58.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -126.14 95.81 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 139.29 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 90' ' ' ILE . 3.9 tt -65.18 128.4 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.91 115.61 21.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 pt -101.92 145.54 30.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.28 148.45 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.5 2.133 . . . . 0.0 112.318 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.831 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.749 0.309 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.38 -21.22 20.06 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.514 2.143 . . . . 0.0 112.586 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.542 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.5 mp0 -79.93 -27.33 39.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.45 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -79.77 -34.65 39.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.349 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.03 -32.98 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.504 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.593 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -77.33 -30.35 53.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.542 HD12 ' O ' ' B' ' 45' ' ' GLN . 15.3 mt -71.36 -43.32 67.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.42 72.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -63.97 -49.21 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.744 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -66.74 -28.76 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.19 -35.41 41.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.842 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.4 mp -86.08 -20.17 29.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.887 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.51 70.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG13 ' B' ' 52' ' ' VAL . . . -120.61 27.54 6.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.955 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.866 0.278 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG12 ' HE2' ' B' ' 48' ' ' MET . 25.4 t -77.15 81.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 29.9 p-80 -125.98 -161.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.725 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.25 -31.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -64.84 -44.55 89.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -65.37 -44.16 88.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.934 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.74 66.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 mt -64.86 -53.99 37.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 2.9 t -59.51 -45.55 91.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.813 ' O ' HG23 ' A' ' 44' ' ' VAL . 53.8 t80 -55.69 -47.2 77.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.067 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.36 -31.42 72.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -69.79 -32.68 71.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.81 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -26.39 38.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.835 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.8 t -80.45 -29.16 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -46.2 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.0 mt -66.62 -41.6 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -30.91 68.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' A' ' 54' ' ' THR . 56.0 m-85 -124.82 43.75 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.1 -35.58 84.68 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.469 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 p -107.9 42.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -140.13 92.38 9.63 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.94 -38.84 12.23 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.472 2.114 . . . . 0.0 112.24 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.47 77.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.604 HG21 ' CD2' ' A' ' 48' ' ' PHE . 6.2 m -71.57 -48.21 49.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.735 ' O ' HD12 ' A' ' 59' ' ' LEU . 15.4 t80 -65.35 -58.53 5.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.32 -32.11 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.68 -50.57 41.6 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' HD12 ' A' ' 61' ' ' ILE . 31.6 t80 -57.66 -44.58 85.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 55' ' ' TYR . 0.5 OUTLIER -64.65 -35.27 80.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.696 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.7 -35.8 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.874 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 58' ' ' PHE . 21.8 mt -69.48 -50.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -32.39 73.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HE2' HD21 ' B' ' 54' ' ' LEU . 7.0 tttm -71.87 -31.63 66.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 -30.13 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HA ' HG12 ' A' ' 70' ' ' ILE . 40.4 t80 -70.44 -40.35 73.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -56.97 -32.54 66.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -64.94 -16.15 62.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.05 42.5 1.25 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.743 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -113.86 -51.5 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 65' ' ' PHE . 11.2 pt -74.58 178.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -116.62 -177.47 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.42 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.35 -52.76 20.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.6 Cg_exo -47.94 -27.75 9.19 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.642 2.228 . . . . 0.0 112.428 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.8 -29.35 57.57 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 79' ' ' VAL . 18.5 t -76.67 -33.89 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 103' ' ' ILE . 39.4 mt -73.59 -45.43 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -46.41 76.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -45.65 87.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 75' ' ' VAL . 38.8 t -76.11 -41.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.066 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.2 t -58.28 -22.51 52.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.09 -38.77 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.07 -31.57 72.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 89' ' ' LEU . 17.7 m-85 -119.92 50.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -67.44 -41.09 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -100.74 30.0 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.646 ' CB ' HD12 ' A' ' 89' ' ' LEU . 83.8 m-70 -139.96 85.77 13.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.7 Cg_exo -56.93 -59.31 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.61 2.207 . . . . 0.0 112.225 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -51.33 -22.77 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.556 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 86' ' ' HIS . 14.9 mt -81.79 -55.72 4.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 110.224 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 103' ' ' ILE . 12.3 tt -63.28 -26.21 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 87' ' ' PRO . 95.6 t -72.94 -47.92 46.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.33 -43.56 93.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.31 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.45 -29.53 66.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.921 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.499 ' HB2' HD12 ' A' ' 103' ' ' ILE . 1.4 t30 -72.24 -22.49 61.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 -3.32 28.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.413 ' CE2' ' CG1' ' A' ' 32' ' ' VAL . 79.5 m-85 -99.76 -28.98 12.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.3 mt -89.03 140.07 29.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.63 177.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.443 2.095 . . . . 0.0 112.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.9 -31.69 71.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.32 -34.64 81.34 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.55 75.13 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.89 127.51 33.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 90' ' ' ILE . 33.2 mt -84.66 122.64 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.77 137.82 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -128.16 89.86 48.9 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.75 139.16 87.22 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.244 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.454 ' CB ' HD12 ' B' ' 46' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.716 0.294 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.66 -22.19 38.08 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.521 2.147 . . . . 0.0 112.385 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.437 ' O ' HD12 ' B' ' 49' ' ' LEU . 5.8 mt-30 -78.61 -21.0 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.386 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.454 HD12 ' CB ' ' B' ' 43' ' ' ALA . 18.3 mt -79.38 -38.74 34.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.35 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.02 -35.2 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.789 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -75.98 -27.8 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.75 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.437 HD12 ' O ' ' B' ' 45' ' ' GLN . 5.2 mt -71.14 -43.46 67.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.425 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -36.46 79.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.997 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.54 -39.98 94.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 48' ' ' MET . 35.4 t -72.52 -28.03 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.748 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.49 52.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.514 HD21 ' HE2' ' A' ' 63' ' ' LYS . 7.2 mp -90.67 -23.24 20.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.36 79.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.55 -40.13 6.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.5 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.843 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 120.774 0.239 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 32' ' ' VAL . 3.0 m -62.8 82.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.81 -164.51 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.759 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.8 t -53.52 -27.67 14.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.261 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.87 -39.47 69.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -36.28 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.43 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.83 -49.87 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 t -59.5 -44.66 93.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 62.8 t80 -53.08 -49.75 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.042 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.77 -32.63 73.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.409 ' OD1' HD11 ' A' ' 46' ' ' ILE . 7.7 t0 -66.21 -33.22 75.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -26.03 36.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.3 t -76.94 -28.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.932 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -80.34 -49.72 11.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' OD1' ' A' ' 42' ' ' ASP . 47.5 mt -60.82 -38.98 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -67.88 -27.4 66.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.643 ' CE2' HG21 ' A' ' 54' ' ' THR . 31.8 m-85 -114.99 39.21 2.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.09 -28.35 53.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.78 21.68 16.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -140.2 81.85 17.71 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 -28.1 23.82 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.597 2.198 . . . . 0.0 112.327 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.05 93.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.643 HG21 ' CE2' ' A' ' 48' ' ' PHE . 9.8 m -60.38 -38.64 84.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -69.89 -47.02 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -59.91 -42.62 94.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.95 94.54 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.551 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.53 -50.45 73.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.28 -36.57 78.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.97 -45.61 92.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 78' ' ' ARG . 28.5 mt -59.57 -45.58 93.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -49.9 55.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.765 ' HG3' HD21 ' B' ' 54' ' ' LEU . 7.8 ttmt -59.49 -36.62 76.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.97 -30.74 67.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 70' ' ' ILE . 50.2 t80 -74.19 -35.33 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -57.72 -40.89 80.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.762 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -15.84 61.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 71.93 53.76 0.19 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.985 0.421 . . . . 0.0 110.836 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.59 -39.02 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 65' ' ' PHE . 13.5 pt -92.34 156.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.215 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -90.79 170.09 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.4 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -62.16 -54.22 51.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.791 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.9 Cg_exo -48.38 -41.16 36.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.167 . . . . 0.0 112.233 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.73 99.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 71' ' ' ASP . 18.8 t -58.5 -40.0 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.98 -43.26 98.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -67.86 -36.06 79.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.569 ' HB3' HD13 ' A' ' 61' ' ' ILE . 26.6 mmt180 -57.27 -65.82 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.9 t -63.44 -31.31 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -64.85 -23.82 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.66 -37.73 11.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.49 -30.26 70.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.023 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' HD13 ' A' ' 89' ' ' LEU . 11.8 m-85 -114.62 55.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -66.78 -33.09 74.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.56 26.35 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.408 ' CB ' HD12 ' A' ' 89' ' ' LEU . 94.9 m-70 -140.05 88.21 11.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.971 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.878 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.3 Cg_endo -67.96 -44.46 3.93 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.591 2.194 . . . . 0.0 112.282 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -50.15 -25.35 3.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 83' ' ' PHE . 92.9 mt -82.72 -51.0 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.86 HD12 HD13 ' A' ' 105' ' ' ILE . 57.0 mt -62.52 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.956 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.4 t -73.01 -50.41 32.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.465 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.35 80.52 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.323 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 97' ' ' LEU . 64.5 t80 -74.76 -30.74 61.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.92 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 97' ' ' LEU . 47.2 t30 -74.89 -27.28 60.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.878 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.25 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.519 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -99.66 -38.38 8.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.06 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 93' ' ' PHE . 7.1 mt -66.24 148.32 98.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 172.32 12.49 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.53 -22.21 57.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.77 -44.2 70.1 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.693 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -102.9 99.44 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.829 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -77.97 116.26 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.405 HG22 ' ND2' ' A' ' 94' ' ' ASN . 3.6 tt -76.53 145.86 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -96.59 173.3 7.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.0 111.143 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 90' ' ' ILE . 5.0 tp -162.07 80.11 1.91 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.4 112.78 1.03 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.519 2.146 . . . . 0.0 112.227 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.627 0.251 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HD12 ' B' ' 47' ' ' ILE . 42.6 Cg_endo -67.64 -11.97 33.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.438 2.092 . . . . 0.0 112.52 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -79.49 -26.48 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.658 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 46' ' ' LEU . 20.5 mt -78.92 -36.08 42.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' B' ' 44' ' ' PRO . 7.4 mt -73.47 -34.7 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.508 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.5 OUTLIER -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.35 -43.35 67.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.67 72.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -50.32 69.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 48' ' ' MET . 38.7 t -65.46 -29.16 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.68 -34.44 58.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.111 0.481 . . . . 0.0 110.091 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.765 HD21 ' HG3' ' A' ' 63' ' ' LYS . 6.6 mp -83.99 -20.74 32.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.728 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.464 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -171.06 84.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.775 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.2 46.45 2.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.536 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.883 -179.935 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.926 0.303 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG12 ' HE2' ' B' ' 48' ' ' MET . 21.4 t -90.04 82.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.169 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' CD2' ' HB2' ' A' ' 35' ' ' GLU . 5.6 p-80 -110.28 -170.58 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -41.99 -32.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.886 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 5.7 mm-40 -63.46 -47.21 82.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.707 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -64.36 -37.74 88.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.95 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.44 -48.78 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -60.21 -45.67 92.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 69.2 t80 -55.47 -47.89 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.69 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.438 ' O ' HD12 ' A' ' 46' ' ' ILE . 60.6 m-20 -63.11 -30.2 71.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.59 -28.29 30.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 12.9 t -81.02 -20.29 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.11 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.33 -46.43 9.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.724 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.9 mt -67.04 -50.07 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -59.41 -30.66 68.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.65 ' HE1' HD11 ' A' ' 89' ' ' LEU . 69.3 m-85 -119.62 40.75 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.02 -29.26 64.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.578 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -107.72 30.35 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.17 88.58 11.5 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.62 -28.53 31.2 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.513 2.142 . . . . 0.0 112.329 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.68 69.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -74.04 -56.64 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -59.19 -52.03 67.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -61.27 -34.85 75.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.2 -50.16 23.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.902 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.7 t80 -60.23 -27.41 67.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -53.48 15.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.8 -38.23 69.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.016 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -60.87 -56.85 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.852 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.09 86.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.777 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' B' ' 54' ' ' LEU . 12.5 ttpt -64.59 -52.09 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.82 -30.35 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 61.8 t80 -66.48 -47.49 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -57.31 -27.37 62.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 m -66.97 -13.03 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.86 47.78 2.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.956 0.407 . . . . 0.0 110.823 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 m -121.82 -39.28 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 65' ' ' PHE . 9.5 pt -91.26 178.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -108.85 172.69 6.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.424 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.17 -51.98 32.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.014 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.3 Cg_exo -50.38 -34.1 39.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.27 90.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 79' ' ' VAL . 19.0 t -61.95 -39.36 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 103' ' ' ILE . 40.5 mt -69.03 -35.9 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.173 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -70.31 -47.3 61.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 61' ' ' ILE . 18.8 mtp85 -58.45 -37.94 76.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -73.22 -45.54 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 t -58.61 -23.83 59.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -84.02 -40.14 18.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.806 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.88 -31.5 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 89' ' ' LEU . 6.0 m-85 -121.58 62.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -69.71 -44.12 71.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.654 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -99.94 26.63 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.8 m170 -130.83 104.31 15.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 91' ' ' VAL . 62.5 Cg_endo -74.6 -47.51 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.091 . . . . 0.0 112.712 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.25 -17.65 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.58 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.65 HD11 ' HE1' ' A' ' 48' ' ' PHE . 11.2 mt -87.68 -55.86 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.208 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.658 HG13 HD13 ' A' ' 103' ' ' ILE . 11.5 tt -56.72 -30.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.06 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.7 t -77.17 -45.57 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.289 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 -34.55 82.49 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.998 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.741 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 62.8 t80 -74.15 -37.79 63.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.659 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -61.45 -29.89 70.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -17.94 57.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.496 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.85 29.7 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.333 . . . . 0.0 110.954 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.2 145.32 23.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 158.88 54.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -26.81 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.34 -27.46 53.23 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.615 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 109.03 10.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.658 HD13 HG13 ' A' ' 90' ' ' ILE . 4.4 tt -95.31 124.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.21 169.69 14.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.013 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 13.5 pt -152.04 146.41 18.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.88 126.87 11.68 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.59 2.194 . . . . 0.0 112.271 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.908 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 -22.28 26.89 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.586 2.191 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.545 ' O ' HD12 ' B' ' 49' ' ' LEU . 15.1 mp0 -77.28 -19.02 57.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -78.99 -38.29 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 110.37 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.49 -37.25 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.448 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.419 ' HE2' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.8 -28.46 61.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.545 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.6 mt -72.18 -41.29 67.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.39 75.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.867 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.04 -53.48 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.693 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 48' ' ' MET . 43.7 t -63.06 -28.0 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.003 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.1 48.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.096 0.474 . . . . 0.0 110.214 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.4 mp -84.01 -20.41 32.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.888 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.41 78.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.23 28.54 15.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.517 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.02 -179.969 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.092 0 CA-C-O 120.861 0.276 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.93 75.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -165.7 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.27 -36.81 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.26 -39.71 95.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.66 75.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 -30.78 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mt -66.53 -53.14 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.58 -44.31 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 44' ' ' VAL . 60.5 t80 -52.87 -55.74 20.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.06 -33.13 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -69.6 -28.87 66.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.53 -26.84 37.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 40' ' ' TYR . 19.0 t -78.77 -29.7 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.973 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -78.23 -47.2 18.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 42' ' ' ASP . 20.7 mt -63.01 -45.53 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.13 -28.44 68.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 54' ' ' THR . 63.8 m-85 -123.79 43.1 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -39.53 85.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.448 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -79.25 -19.49 50.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.224 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -111.0 92.86 15.89 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.01 -23.75 40.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.02 77.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.76 HG21 ' CD2' ' A' ' 48' ' ' PHE . 18.9 m -65.14 -48.41 73.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.612 ' CE2' HD11 ' A' ' 59' ' ' LEU . 9.2 t80 -62.76 -46.96 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -60.27 -34.93 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.22 -49.54 56.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 61' ' ' ILE . 50.7 t80 -58.78 -53.06 62.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 55' ' ' TYR . 33.2 mt -57.3 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -37.86 73.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.4 mt -73.08 -29.07 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.052 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -41.45 61.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.822 ' CG ' HD11 ' B' ' 54' ' ' LEU . 12.8 mttt -71.82 -44.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -58.6 -58.55 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 20.2 t80 -60.24 -44.14 95.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.138 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HD2' HD22 ' B' ' 54' ' ' LEU . 33.2 tttm -52.57 -37.17 57.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -13.86 61.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.032 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 71.02 49.38 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.0 m -112.44 -33.36 6.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 65' ' ' PHE . 11.0 pt -104.96 173.37 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -96.21 168.94 10.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.01 -52.32 75.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.8 Cg_exo -48.23 -35.43 26.91 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.288 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.08 81.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.338 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 65' ' ' PHE . 24.9 t -74.97 -33.38 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.9 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.607 HG23 HG12 ' A' ' 103' ' ' ILE . 39.6 mt -71.8 -47.38 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -64.23 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -55.01 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.506 HG13 ' CE2' ' A' ' 83' ' ' PHE . 37.7 t -69.84 -35.32 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -62.54 -26.99 68.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.92 -32.5 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.81 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 16.9 tp -61.08 -40.14 92.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.676 ' CD1' HD13 ' A' ' 89' ' ' LEU . 16.9 m-85 -107.26 61.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -92.39 22.47 4.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.403 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -128.37 -44.94 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.541 ' HB2' HD12 ' A' ' 89' ' ' LEU . 11.7 m80 -103.09 118.25 58.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 91' ' ' VAL . 56.3 Cg_endo -70.19 -33.54 14.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.525 2.15 . . . . 0.0 112.326 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.23 -13.95 33.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.527 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 83' ' ' PHE . 5.0 mt -87.19 -56.74 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.32 -31.28 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.0 t -75.75 -47.67 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.529 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.2 82.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.092 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -73.24 -35.02 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.47 . . . . 0.0 110.717 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -33.27 73.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -18.5 58.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.322 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -99.79 30.03 3.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -144.3 147.12 35.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.88 159.77 51.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.545 2.163 . . . . 0.0 112.212 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.622 HD11 ' NH2' ' A' ' 102' ' ' ARG . 1.6 tp -59.99 -29.76 68.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.49 69.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.8 88.52 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.622 ' NH2' HD11 ' A' ' 99' ' ' LEU . 3.5 mtt180 -85.74 -174.58 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.607 HG12 HG23 ' A' ' 76' ' ' ILE . 27.8 mt -122.26 140.13 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.151 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.95 132.82 34.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.49 125.47 59.61 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.22 157.69 49.84 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.478 2.119 . . . . 0.0 112.217 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 tptm . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.904 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.69 0.281 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -12.47 31.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.593 2.195 . . . . 0.0 112.613 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.52 -25.67 41.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 65' ' ' PHE . 55.4 mt -79.4 -36.01 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.43 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.6 mm -74.26 -33.62 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.544 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.737 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -77.1 -29.44 54.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.696 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.06 -46.0 65.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -33.46 73.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.965 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -64.26 -42.55 96.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.82 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 48' ' ' MET . 35.2 t -70.97 -30.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.726 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.99 43.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.307 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.2 mp -88.78 -18.39 27.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.91 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.408 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER -170.47 76.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.781 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.15 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.911 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.488 1.159 0 CA-C-O 120.823 0.26 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 96' ' ' PHE . 3.5 m -62.62 83.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -165.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.47 -30.71 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.206 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -38.8 78.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -39.47 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.37 69.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.66 -54.35 43.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 t -59.83 -44.53 94.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.1 t80 -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.077 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.65 -34.23 73.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -65.69 -29.49 70.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -81.37 -26.55 35.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.92 HG22 HD21 ' A' ' 89' ' ' LEU . 15.8 t -80.25 -29.93 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.043 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 2.8 tptt -78.15 -47.61 17.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 42' ' ' ASP . 24.2 mt -64.91 -48.39 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -62.09 -31.55 72.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.81 ' CD2' HG21 ' A' ' 54' ' ' THR . 64.4 m-85 -122.14 42.35 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 -35.03 91.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.566 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -97.63 20.83 11.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.288 . . . . 0.0 111.223 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.21 89.15 11.07 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.994 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.15 -26.91 42.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.417 2.078 . . . . 0.0 112.25 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -45.15 93.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CD2' ' A' ' 48' ' ' PHE . 28.2 m -61.23 -55.84 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 t80 -60.3 -46.87 88.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.26 -38.15 82.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.45 -46.15 91.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.489 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.7 t80 -60.76 -46.31 90.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HG ' ' HB1' ' B' ' 53' ' ' ALA . 0.9 OUTLIER -60.49 -37.71 81.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.22 -41.97 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.0 mt -63.97 -46.79 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.566 ' HB3' ' HB2' ' B' ' 50' ' ' ALA . 27.2 mmt -69.37 -43.43 73.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.4 ttmt -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -66.01 -32.75 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.1 t80 -65.54 -47.39 76.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.21 -41.66 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.693 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -64.45 -15.1 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 74.02 40.93 0.43 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.939 0.399 . . . . 0.0 110.798 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.7 t -117.55 14.3 14.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 tt -159.01 146.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 t70 -90.52 177.19 6.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.37 -53.85 42.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 76' ' ' ILE . 77.0 Cg_exo -48.01 -39.14 32.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.572 2.182 . . . . 0.0 112.467 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 -29.21 72.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 61' ' ' ILE . 38.4 t -72.41 -43.86 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 73' ' ' PRO . 5.1 mt -61.83 -43.83 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -41.3 84.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -44.16 78.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 75' ' ' VAL . 29.5 t -76.13 -32.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -62.46 -25.37 67.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -31.17 13.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.41 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 12.5 tp -62.23 -63.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.699 ' CD1' HD13 ' A' ' 89' ' ' LEU . 11.3 m-85 -89.19 53.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.19 -39.4 93.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.02 25.8 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.157 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 1.2 m-70 -140.17 97.15 7.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.839 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.4 Cg_endo -72.94 -46.65 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.59 2.194 . . . . 0.0 112.891 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -55.83 -20.75 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.92 HD21 HG22 ' A' ' 44' ' ' VAL . 1.8 mt -85.67 -57.77 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -53.84 -26.43 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.193 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.6 t -77.2 -50.56 20.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.188 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 -32.59 53.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.979 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' CE2' HD11 ' A' ' 97' ' ' LEU . 39.9 t80 -78.32 -34.88 48.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.18 0.514 . . . . 0.0 110.494 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -59.96 -29.19 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.633 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.59 -4.5 27.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.881 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.641 ' HA ' HG11 ' A' ' 32' ' ' VAL . 69.3 m-85 -99.7 -50.1 4.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.71 0.291 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD13 HG12 ' A' ' 76' ' ' ILE . 7.6 mt -66.24 142.6 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 176.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.134 . . . . 0.0 112.311 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.15 -28.98 60.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.75 -51.21 58.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.624 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.79 88.79 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -86.36 122.37 30.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.577 HG12 HD11 ' A' ' 90' ' ' ILE . 8.0 tt -65.19 121.44 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.49 157.26 16.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.52 103.01 54.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.982 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.72 108.8 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.358 2.039 . . . . 0.0 112.286 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.69 0.281 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.72 -23.69 41.89 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.499 2.132 . . . . 0.0 112.36 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.648 ' O ' HD12 ' B' ' 49' ' ' LEU . 20.3 mp0 -76.12 -26.56 56.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.514 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 75' ' ' VAL . 6.0 mt -76.61 -32.56 58.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.237 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -72.74 -37.98 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.646 ' O ' HG23 ' B' ' 52' ' ' VAL . 2.7 ptt? -71.05 -32.16 68.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.648 HD12 ' O ' ' B' ' 45' ' ' GLN . 1.1 mt -67.97 -43.18 79.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.62 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' MET . . . -66.88 -34.02 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -65.54 -44.83 85.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.646 HG23 ' O ' ' B' ' 48' ' ' MET . 25.4 t -67.62 -29.1 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -77.68 -35.26 52.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 110.256 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.55 ' O ' HG23 ' B' ' 55' ' ' THR . 9.0 mp -86.81 -19.53 28.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.915 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.55 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.5 OUTLIER -167.37 87.4 0.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.33 47.2 2.61 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.938 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 120.79 0.246 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG12 ' CE2' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -90.1 77.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 35' ' ' GLU . 29.2 p-80 -129.23 -160.39 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.714 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -44.63 -30.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.813 0.339 . . . . 0.0 111.532 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 33' ' ' HIS . 29.6 tt0 -62.22 -59.41 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -31.15 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.12 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mt -61.94 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -62.02 -44.51 96.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 44' ' ' VAL . 61.9 t80 -54.13 -48.31 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.088 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -63.05 -37.66 88.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.48 -32.14 70.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -30.62 62.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.6 t -82.87 -37.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.807 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -48.11 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.702 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -70.6 -47.97 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -60.73 -36.05 77.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 54' ' ' THR . 19.1 m-85 -115.68 39.06 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.19 -27.83 65.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -97.38 15.21 23.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.693 0.282 . . . . 0.0 111.29 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -140.18 77.49 25.06 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 -24.26 19.86 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.51 -55.28 36.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.228 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.743 HG23 ' HG ' ' A' ' 82' ' ' LEU . 3.3 m -59.85 -38.34 81.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.13 -56.23 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -31.97 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 -49.41 12.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.469 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 61' ' ' ILE . 61.1 t80 -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.042 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -39.64 83.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -62.24 -40.31 95.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 58' ' ' PHE . 7.5 mt -64.47 -51.74 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -41.83 98.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.787 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.0 OUTLIER -64.61 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -69.12 -42.52 75.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 75' ' ' VAL . 23.3 t80 -62.81 -44.72 95.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -31.63 67.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -66.49 -13.33 60.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.245 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 63.43 42.16 6.96 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.962 0.411 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -116.65 -39.04 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.0 tt -96.16 157.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -84.51 -177.69 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -74.36 -53.29 3.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 71.3 Cg_exo -48.75 -27.95 11.95 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.584 2.189 . . . . 0.0 112.364 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.38 -37.03 48.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.429 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.57 HG21 ' CD1' ' A' ' 65' ' ' PHE . 16.8 t -68.29 -40.16 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.765 0.316 . . . . 0.0 111.029 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 103' ' ' ILE . 16.3 mt -68.81 -42.51 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -58.76 -44.67 90.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.9 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' CZ ' ' A' ' 93' ' ' PHE . 45.5 t -64.51 -41.97 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -23.36 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.01 -39.33 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HG ' HG23 ' A' ' 54' ' ' THR . 9.2 tp -61.38 -34.15 74.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.736 ' CD1' HD13 ' A' ' 89' ' ' LEU . 18.5 m-85 -109.08 42.42 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -60.11 -29.52 68.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 28.15 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.697 ' CB ' HD12 ' A' ' 89' ' ' LEU . 29.3 m80 -140.13 96.13 8.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.6 Cg_endo -68.07 -48.39 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.348 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.62 -18.26 28.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' A' ' 83' ' ' PHE . 40.9 mt -87.41 -56.11 3.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.328 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.529 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -59.22 -28.49 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.278 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 87' ' ' PRO . 66.1 t -78.34 -48.04 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.21 85.67 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.934 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 40.9 t80 -72.51 -40.3 66.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.508 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -67.05 -21.18 65.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.004 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.66 -7.26 43.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.87 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CE2' HG12 ' A' ' 32' ' ' VAL . 81.8 m-85 -99.72 -30.24 12.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.331 . . . . 0.0 110.951 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -77.85 153.81 80.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 163.95 29.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.283 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.09 -31.1 68.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.0 -43.82 92.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.403 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -93.91 76.02 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.01 162.9 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.529 HG12 HD11 ' A' ' 90' ' ' ILE . 0.8 OUTLIER -97.53 138.08 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.63 144.14 39.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 105' ' ' ILE . 2.4 tp -159.01 122.28 2.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 154.87 65.59 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.405 2.07 . . . . 0.0 112.369 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.71 0.29 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 -21.76 20.23 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.33 -25.84 51.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.706 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . 57.8 mt -77.16 -33.13 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.297 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.2 mm -74.06 -37.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.491 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.51 -28.96 62.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.687 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.18 -47.4 61.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.436 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.547 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -66.19 -30.75 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.943 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -63.52 -50.73 68.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -64.15 -30.61 50.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.82 53.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.787 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.7 mp -83.47 -9.72 58.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.993 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.459 HG22 ' O ' ' B' ' 54' ' ' LEU . 13.5 t 45.37 43.88 8.87 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.932 0.396 . . . . 0.0 111.324 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.89 -27.55 66.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.423 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.934 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 CA-C-O 120.744 0.227 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 3.1 m -68.98 82.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.25 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 35' ' ' GLU . 27.1 p-80 -122.53 -162.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -44.78 -46.66 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.718 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . 21.7 tt0 -58.2 -41.35 83.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.974 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -65.88 -36.42 83.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.85 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -61.96 -54.89 35.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.6 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 81.4 t80 -55.21 -51.63 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' B' ' 53' ' ' ALA . 24.0 mt -65.39 -32.0 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.3 m-20 -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.96 -27.39 33.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 27.1 t -80.67 -29.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.53 -48.19 15.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.711 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 42' ' ' ASP . 26.5 mt -64.77 -49.08 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -59.41 -30.25 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CE2' HG21 ' A' ' 54' ' ' THR . 34.2 m-85 -115.81 39.29 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.03 93.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.24 25.07 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.663 0.268 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -140.19 87.01 12.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.63 -28.34 37.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.574 2.183 . . . . 0.0 112.258 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.01 88.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 48' ' ' PHE . 8.7 m -66.9 -50.89 60.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 45' ' ' LYS . 12.5 t80 -60.06 -51.68 68.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.793 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.61 -54.01 31.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.437 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 61' ' ' ILE . 9.4 t80 -60.02 -36.65 77.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.431 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.3 mt -66.27 -41.17 90.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -59.82 -39.13 83.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.3 mt -72.34 -31.82 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -69.17 -43.73 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.866 ' HG3' HD11 ' B' ' 54' ' ' LEU . 5.0 mttm -70.81 -31.08 67.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -55.28 32.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.8 t80 -59.66 -42.26 92.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -36.47 74.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.42 -15.7 61.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 72.27 51.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 t -130.77 -54.29 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 65' ' ' PHE . 4.3 tt -73.96 148.52 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t70 -89.96 175.34 7.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.03 -53.26 56.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' A' ' 76' ' ' ILE . 76.2 Cg_exo -49.87 -36.53 43.37 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.615 2.21 . . . . 0.0 112.305 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.92 77.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 71' ' ' ASP . 21.6 t -65.99 -46.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.0 mt -59.49 -48.85 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 mtt85 -59.83 -40.09 87.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -49.82 76.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -75.1 -36.09 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.186 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 90' ' ' ILE . 8.6 t -60.57 -25.12 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.91 -33.51 11.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.7 tp -62.98 -46.79 86.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 89' ' ' LEU . 23.7 m-85 -104.63 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 -4.85 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.609 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -102.49 -35.31 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.629 ' HB2' HD12 ' A' ' 89' ' ' LEU . 71.3 m-70 -105.83 119.76 51.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 91' ' ' VAL . 73.2 Cg_endo -76.18 -42.44 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.447 2.098 . . . . 0.0 112.287 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.61 -18.01 17.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.629 HD12 ' HB2' ' A' ' 86' ' ' HIS . 12.9 mt -85.23 -55.79 3.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.303 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.55 HG13 HD11 ' A' ' 103' ' ' ILE . 17.7 tt -61.4 -27.51 42.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 87' ' ' PRO . 65.1 t -76.43 -48.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.16 -35.68 65.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.098 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.76 -36.14 62.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.685 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -63.02 -25.86 68.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.714 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.3 -1.66 21.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.444 ' CD2' ' HB ' ' A' ' 32' ' ' VAL . 76.2 m-85 -99.75 -30.89 11.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.88 153.58 70.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.38 173.8 9.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.45 -13.89 61.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.266 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.05 -29.99 45.22 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.687 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -131.63 137.56 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -108.52 139.92 42.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.667 HG23 HD11 ' A' ' 105' ' ' ILE . 0.9 OUTLIER -80.1 141.27 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -98.61 140.09 33.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.799 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.667 HD11 HG23 ' A' ' 103' ' ' ILE . 3.7 mp -140.97 103.59 6.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.47 142.47 59.55 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.762 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.692 0.282 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.95 -21.51 37.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 112.425 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -79.65 -22.29 43.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 21.9 mt -81.31 -35.66 30.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.96 -33.61 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.351 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.655 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -76.68 -31.29 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.607 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.55 -49.94 60.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.62 74.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.818 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.655 HG23 ' O ' ' B' ' 48' ' ' MET . 39.0 t -71.25 -31.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 41' ' ' LEU . . . -78.11 -34.59 49.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.49 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.866 HD11 ' HG3' ' A' ' 63' ' ' LYS . 9.8 mp -86.78 -20.13 28.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.796 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.49 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER -167.54 73.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.777 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.87 42.5 1.92 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.487 1.116 0 CA-C-O 120.89 0.288 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -90.04 12.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.713 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 38' ' ' LEU . 21.7 t -47.01 -28.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.536 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.9 -49.3 78.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.767 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.58 -30.88 64.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.86 -39.57 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 34' ' ' VAL . 23.3 mt -63.47 -51.99 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -58.15 -42.68 86.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.3 t80 -53.65 -50.01 66.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.17 -34.82 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -66.54 -33.59 76.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -27.12 38.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 23.6 t -79.27 -28.52 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.938 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.5 -47.23 17.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.3 mt -63.54 -48.53 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -63.93 -29.97 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.843 ' CD2' HG21 ' A' ' 54' ' ' THR . 4.8 m-85 -117.91 40.07 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.02 -28.62 72.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 p -104.89 25.55 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.11 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -140.18 68.11 33.48 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.28 -28.12 33.22 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.568 2.179 . . . . 0.0 112.307 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.64 89.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 48' ' ' PHE . 57.1 m -65.6 -45.03 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 12.4 t80 -59.52 -51.3 70.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -33.52 73.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.46 -50.85 40.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 61' ' ' ILE . 39.5 t80 -57.77 -46.07 85.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 110.779 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -44.24 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -54.01 -40.19 66.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 58' ' ' PHE . 12.7 mt -69.49 -32.1 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 32.8 mmt -69.59 -47.9 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HG2' HD11 ' B' ' 54' ' ' LEU . 5.4 mttt -65.45 -38.4 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.716 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.99 -44.59 94.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CD1' HG21 ' A' ' 75' ' ' VAL . 16.3 t80 -59.19 -54.7 43.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -59.48 -35.18 73.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -64.0 -16.92 62.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.254 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.81 44.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.13 -41.73 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.68 147.84 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t0 -87.04 172.61 9.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.416 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -61.8 -52.78 66.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.997 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.4 Cg_exo -49.73 -47.57 22.6 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.487 2.125 . . . . 0.0 112.463 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.33 -29.88 66.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.2 t -68.76 -47.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 mt -64.19 -36.34 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -61.85 -50.23 73.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -57.25 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.1 t -57.74 -47.56 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -59.12 -22.78 61.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.066 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -94.28 -36.46 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.58 -35.33 79.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 89' ' ' LEU . 13.8 m-85 -113.1 56.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.962 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -69.55 -29.91 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.153 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.15 26.21 10.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CB ' HD12 ' A' ' 89' ' ' LEU . 34.7 m-70 -140.14 94.62 8.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.835 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.54 -45.78 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.85 -18.87 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 48' ' ' PHE . 8.1 mt -85.17 -56.91 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 103' ' ' ILE . 13.1 tt -57.62 -26.75 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.259 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 87' ' ' PRO . 63.0 t -76.12 -51.63 19.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.39 87.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.126 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.63 -31.99 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 97' ' ' LEU . 34.4 t30 -62.87 -32.3 73.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.632 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.22 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.379 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.554 ' CE2' HG22 ' A' ' 32' ' ' VAL . 29.8 m-85 -99.82 29.94 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 103' ' ' ILE . 20.9 mt -134.76 141.21 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.949 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.85 164.15 35.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.466 2.111 . . . . 0.0 112.295 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -26.69 68.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.014 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.7 -36.32 71.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.575 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -120.9 96.79 5.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.644 HD11 ' CD1' ' A' ' 97' ' ' LEU . 25.5 mt -75.17 153.25 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 105' ' ' ILE . 5.9 p-10 -89.67 171.43 9.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 104' ' ' ASP . 1.8 pt -155.51 137.13 9.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.61 145.6 47.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.072 . . . . 0.0 112.173 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.527 0.203 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.69 -11.94 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.508 2.138 . . . . 0.0 112.603 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -79.84 -27.28 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.7 mt -78.98 -37.1 40.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.385 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.85 -34.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.719 ' O ' HG23 ' B' ' 52' ' ' VAL . 5.1 ptt? -75.5 -30.69 59.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 96' ' ' PHE . 11.8 mt -66.39 -49.9 65.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.86 79.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.921 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.12 -40.37 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.704 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.719 HG23 ' O ' ' B' ' 48' ' ' MET . 42.9 t -70.37 -34.07 56.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.802 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.6 -32.93 47.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.352 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.58 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.6 mp -88.41 -9.14 53.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.291 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.511 HG22 ' O ' ' B' ' 54' ' ' LEU . 14.7 t 45.97 37.84 4.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.958 0.408 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.87 -26.16 54.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.391 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.926 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 5.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 CA-C-O 120.844 0.269 . . . . 0.0 111.768 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.34 80.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.346 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.589 ' CD2' ' HB2' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -121.07 -171.48 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -45.59 -35.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.444 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.44 -33.31 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -43.71 59.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.36 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.971 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.93 -55.68 15.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.1 t -58.59 -45.07 89.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 44' ' ' VAL . 58.9 t80 -55.19 -48.06 74.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.07 -39.79 93.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.97 -29.07 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.801 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -79.45 -26.87 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 40' ' ' TYR . 21.6 t -78.94 -25.45 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -82.14 -45.99 14.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.24 -51.91 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.207 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -58.13 -30.22 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 54' ' ' THR . 32.0 m-85 -116.99 39.82 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 -40.32 92.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.575 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -97.75 24.0 7.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.038 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.17 63.96 24.94 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -51.3 -25.35 17.79 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.548 2.166 . . . . 0.0 112.436 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.51 82.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.869 HG21 ' CE2' ' A' ' 48' ' ' PHE . 4.9 m -68.32 -48.91 63.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CE2' HD11 ' A' ' 59' ' ' LEU . 16.9 t80 -60.66 -48.49 81.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.21 -40.53 90.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -48.19 80.36 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.22 -44.3 88.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.454 HD11 ' CE2' ' A' ' 55' ' ' TYR . 17.6 mt -61.07 -40.41 93.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.09 -38.49 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.43 HD13 ' HB3' ' A' ' 78' ' ' ARG . 27.8 mt -69.7 -33.59 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.412 ' O ' ' HB1' ' B' ' 50' ' ' ALA . 0.1 OUTLIER -69.64 -35.77 75.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HG2' HD11 ' B' ' 54' ' ' LEU . 4.4 mttt -76.62 -33.54 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.761 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -38.47 89.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.0 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 75' ' ' VAL . 37.7 t80 -76.26 -45.98 30.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.2 OUTLIER -57.76 -34.59 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 p -67.46 -13.09 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.324 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 43.93 0.29 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.911 0.386 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 m -115.36 -65.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.97 144.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.3 m-20 -82.5 -178.14 6.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.31 -52.9 50.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.4 Cg_exo -48.46 -43.03 33.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.556 2.171 . . . . 0.0 112.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.41 -29.92 76.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.394 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -74.55 -45.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 73' ' ' PRO . 3.6 mt -61.37 -50.6 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -58.55 -45.72 88.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HB3' HD13 ' A' ' 61' ' ' ILE . 33.7 mtt-85 -59.44 -31.38 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.001 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 75' ' ' VAL . 37.5 t -80.75 -47.32 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.165 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -22.19 48.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -92.58 -36.58 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.27 -30.57 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.39 40.63 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -68.04 -13.41 62.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.445 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -100.05 -30.29 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 111.072 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.637 ' CB ' HD12 ' A' ' 89' ' ' LEU . 8.3 m-70 -100.14 114.44 65.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.855 ' O ' HG23 ' A' ' 91' ' ' VAL . 68.8 Cg_endo -74.2 -43.55 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.45 2.1 . . . . 0.0 112.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -16.08 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.7 HD21 HG22 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -86.27 -53.46 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 0.0 110.055 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.676 HD11 ' O ' ' A' ' 104' ' ' ASP . 7.4 tt -61.25 -28.69 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.192 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 87' ' ' PRO . 54.7 t -75.56 -51.07 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.26 -35.37 55.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -75.81 -34.33 60.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -62.53 -27.63 69.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.62 -1.63 22.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.012 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -99.88 -30.28 12.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.91 138.43 20.98 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.07 177.02 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.452 2.102 . . . . 0.0 112.227 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp -65.65 -29.94 70.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.57 -72.33 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.566 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.95 65.32 6.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.93 157.89 29.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.4 tt -89.63 136.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.154 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.676 ' O ' HD11 ' A' ' 90' ' ' ILE . 2.0 m-20 -61.25 -177.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pp -146.58 129.96 8.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.05 162.29 37.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.461 2.107 . . . . 0.0 112.415 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.756 0.312 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.65 -30.33 34.94 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.47 2.113 . . . . 0.0 112.326 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.547 ' O ' HD12 ' B' ' 49' ' ' LEU . 17.8 mt-30 -79.81 -21.12 44.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 22.6 mt -81.08 -39.07 26.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.367 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 mt -72.59 -34.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.379 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.451 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -74.85 -32.35 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.435 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.547 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.8 OUTLIER -68.42 -44.65 74.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.403 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 62' ' ' MET . . . -66.43 -34.33 77.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.44 -46.32 90.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 48' ' ' MET . 43.5 t -68.93 -27.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.686 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.44 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -79.71 -36.26 37.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.069 0.461 . . . . 0.0 110.381 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.881 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.0 mp -87.91 -17.4 31.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.044 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.493 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -169.79 70.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.97 49.48 0.85 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.488 1.147 0 CA-C-O 120.813 0.255 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -86.18 -31.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.9 100.09 0.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.971 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.57 -30.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -50.19 18.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' THR . 3.4 t0 -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.89 -39.16 64.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.53 -50.99 67.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.2 t -59.1 -42.78 91.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.851 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.9 t80 -52.56 -51.32 60.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.998 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.22 -33.27 75.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.586 ' OD1' HD11 ' A' ' 46' ' ' ILE . 14.6 t0 -67.77 -30.73 70.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -80.85 -26.02 37.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.2 t -78.74 -28.4 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 55' ' ' TYR . 1.5 tppp? -80.13 -49.29 11.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.586 HD11 ' OD1' ' A' ' 42' ' ' ASP . 34.0 mt -63.39 -41.12 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -60.05 -28.07 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 54' ' ' THR . 31.4 m-85 -131.97 47.63 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.84 77.81 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 19.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.21 87.27 12.28 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.855 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.97 -24.54 39.37 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.595 2.196 . . . . 0.0 112.418 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.34 80.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 48' ' ' PHE . 16.3 m -67.32 -57.98 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.758 ' CE2' HD11 ' A' ' 59' ' ' LEU . 15.9 t80 -59.97 -43.9 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -60.48 -38.28 83.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.77 56.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.664 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.0 t80 -57.97 -48.52 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.758 HD11 ' CE2' ' A' ' 55' ' ' TYR . 96.5 mt -57.92 -49.51 76.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -42.47 61.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 58' ' ' PHE . 11.4 mt -65.02 -31.91 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -43.84 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -74.14 -38.2 63.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 110.806 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB2' HD11 ' A' ' 70' ' ' ILE . 77.9 t80 -66.84 -45.98 76.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -55.14 -29.69 58.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -15.32 62.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.305 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 69.33 42.03 1.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.921 0.391 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 p -117.5 -36.52 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 65' ' ' PHE . 1.2 pt -93.32 178.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -114.86 170.16 8.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.443 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.69 -60.72 9.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.228 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 93.3 Cg_exo -42.99 -30.46 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.602 2.201 . . . . 0.0 112.58 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.74 -34.93 66.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.314 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 79' ' ' VAL . 25.0 t -70.67 -48.64 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.358 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.478 HG23 HG12 ' A' ' 103' ' ' ILE . 48.9 mt -60.17 -34.74 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -76.0 -39.68 55.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -61.31 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.4 t -60.42 -49.47 84.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.074 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.777 ' HA ' HD12 ' A' ' 90' ' ' ILE . 28.3 t -56.96 -25.5 58.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.104 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.78 -42.88 26.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 54' ' ' THR . 3.2 tp -64.23 -31.37 72.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE1' HD23 ' A' ' 82' ' ' LEU . 4.7 m-85 -118.22 61.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -73.59 -31.12 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.566 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.85 24.15 12.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.51 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CB ' HD12 ' A' ' 89' ' ' LEU . 1.9 m170 -129.65 90.81 42.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.79 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.811 ' O ' HG23 ' A' ' 91' ' ' VAL . 29.5 Cg_endo -64.11 -55.5 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.513 2.142 . . . . 0.0 112.393 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -50.75 -23.7 2.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.476 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD12 ' CB ' ' A' ' 86' ' ' HIS . 9.1 mt -81.53 -57.9 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.24 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 103' ' ' ILE . 1.6 tt -61.94 -25.4 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.466 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 87' ' ' PRO . 98.3 t -72.98 -50.5 31.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.19 -37.51 80.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.219 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -72.85 -30.71 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.047 0.451 . . . . 0.0 110.837 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 103' ' ' ILE . 65.2 t30 -69.02 -27.42 65.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.16 -13.59 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -99.75 -29.18 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.7 149.7 78.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.721 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.98 172.07 12.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.612 2.208 . . . . 0.0 112.301 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -67.67 -42.78 81.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.68 -49.22 79.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.406 ' HB3' HD11 ' A' ' 76' ' ' ILE . 6.8 m-85 -94.19 54.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.849 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -174.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 90' ' ' ILE . 22.5 mt -117.87 156.95 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 103' ' ' ILE . 5.8 m-20 -126.5 130.47 50.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.675 ' CG2' HD13 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -143.66 89.83 7.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.61 108.75 2.31 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.498 2.132 . . . . 0.0 112.276 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.673 0.273 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.72 -25.59 46.3 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.59 2.193 . . . . 0.0 112.435 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.38 -24.62 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 46' ' ' LEU . 11.8 mt -78.02 -40.23 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.447 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 65' ' ' PHE . 32.1 mm -70.0 -37.52 72.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.47 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.731 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.22 -29.06 62.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.628 179.685 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.43 -43.45 81.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.514 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' HG3' ' A' ' 66' ' ' LYS . . . -67.19 -39.84 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.77 -46.35 89.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.628 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 48' ' ' MET . 40.6 t -68.2 -30.22 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.12 43.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.416 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.686 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.4 mp -91.08 -4.2 56.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.327 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' B' ' 54' ' ' LEU . 11.6 t 44.97 47.0 9.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.61 65.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.373 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.959 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.115 0 CA-C-O 120.87 0.279 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.72 81.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.59 -171.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.24 -32.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.198 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.71 -34.34 75.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.96 -41.44 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.89 -51.19 60.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.7 t -60.12 -44.93 94.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.802 ' O ' HG23 ' A' ' 44' ' ' VAL . 70.0 t80 -52.79 -51.28 61.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.916 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -60.7 -40.23 91.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.454 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m-20 -71.39 -25.29 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.18 -28.21 38.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.3 t -79.68 -30.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.977 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 55' ' ' TYR . 1.2 ttpm? -76.92 -47.89 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 42' ' ' ASP . 22.6 mt -64.02 -44.61 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.12 -29.01 63.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.9 42.8 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -42.39 85.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.83 9.57 26.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.613 0.244 . . . . 0.0 111.296 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -140.32 79.51 21.02 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 -15.6 48.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.54 2.16 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.67 68.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.233 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.544 ' O ' HD21 ' A' ' 82' ' ' LEU . 53.8 m -63.85 -47.54 80.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 59' ' ' LEU . 17.7 t80 -58.8 -46.9 86.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.996 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.67 -46.66 45.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.615 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 61' ' ' ILE . 79.2 t80 -61.81 -49.68 75.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.6 mt -56.9 -43.61 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.064 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -55.89 -47.1 78.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.163 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -61.3 -38.56 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.108 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.3 mmt -66.83 -47.84 70.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -64.56 -45.02 88.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.684 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -33.63 76.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 75' ' ' VAL . 38.5 t80 -60.1 -55.02 39.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.85 -30.27 70.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.0 p -71.37 -8.33 53.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.262 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 65.81 43.3 3.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.815 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -119.84 1.92 11.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.323 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.1 tt -145.04 137.82 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -80.16 172.21 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.997 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -58.5 -58.32 19.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.6 Cg_endo -47.33 -42.36 27.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.549 2.166 . . . . 0.0 112.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 -29.02 67.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.202 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 79' ' ' VAL . 23.8 t -74.86 -43.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.849 0.357 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 103' ' ' ILE . 41.3 mt -69.02 -41.72 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -60.13 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -55.77 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 75' ' ' VAL . 42.3 t -58.66 -45.28 90.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.9 p -61.48 -23.42 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.044 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -94.77 -31.36 13.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 54' ' ' THR . 4.1 tp -60.56 -36.54 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.762 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.3 m-85 -113.71 47.19 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -62.39 -22.58 66.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.182 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -99.9 -32.14 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.581 ' CB ' HD12 ' A' ' 89' ' ' LEU . 81.7 m-70 -102.48 95.13 5.65 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.59 -30.94 22.27 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.41 2.073 . . . . 0.0 112.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.85 -19.7 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -85.27 -49.82 7.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.014 0.435 . . . . 0.0 109.87 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.524 HG23 HG21 ' A' ' 103' ' ' ILE . 53.5 mt -61.57 -27.66 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.915 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 87' ' ' PRO . 47.7 t -74.2 -51.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.28 81.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.071 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CD2' HG11 ' A' ' 79' ' ' VAL . 18.1 t80 -70.26 -35.57 73.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.95 -26.68 66.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.668 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 -11.41 53.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.747 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.6 -37.25 9.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.613 HD13 HD11 ' A' ' 103' ' ' ILE . 3.9 mp -72.32 116.86 53.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.47 177.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.418 2.078 . . . . 0.0 112.275 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.97 -27.29 65.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -31.14 58.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.519 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -133.03 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -111.95 134.94 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 97' ' ' LEU . 24.5 mt -92.38 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 103' ' ' ILE . 2.3 p30 -73.58 128.9 36.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -136.71 153.0 75.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.96 142.53 57.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.586 2.191 . . . . 0.0 112.299 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 tttt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.895 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' B' ' 46' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.91 -22.52 36.01 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.577 2.184 . . . . 0.0 112.435 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.3 mp0 -77.86 -23.24 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.72 HD12 ' CB ' ' B' ' 43' ' ' ALA . 52.1 mt -77.92 -37.31 48.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.381 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -71.35 -38.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.453 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.659 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.99 -29.59 64.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.434 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.9 mt -68.82 -43.05 76.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.86 83.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.947 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -61.85 -42.74 99.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.658 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.659 HG23 ' O ' ' B' ' 48' ' ' MET . 38.3 t -69.12 -29.69 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.02 -36.85 40.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.31 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.547 HD11 ' CG ' ' A' ' 63' ' ' LYS . 7.4 mp -83.44 -25.11 31.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.835 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.67 71.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.628 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.53 -48.34 3.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.54 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.846 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 CA-C-O 120.83 0.262 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 95' ' ' ALA . 3.2 m -65.04 79.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -131.26 -175.95 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.2 -29.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.52 -41.62 72.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.5 -33.56 69.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.16 -36.94 64.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.037 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -52.22 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -60.08 -42.92 95.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.901 ' O ' HG23 ' A' ' 44' ' ' VAL . 55.0 t80 -52.08 -47.69 65.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.16 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.13 -40.42 94.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -68.06 -29.88 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -76.62 -30.19 56.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.797 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.2 t -78.06 -30.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.46 -45.59 58.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.65 -39.62 84.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -29.9 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.7 m-85 -118.46 40.19 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.99 -21.5 79.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.3 p -92.01 -9.16 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -140.03 100.57 7.17 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.575 0.226 . . . . 0.0 111.041 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.46 -14.93 37.84 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.491 2.128 . . . . 0.0 112.598 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.84 -40.36 69.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CE2' ' A' ' 48' ' ' PHE . 22.8 m -68.37 -50.0 56.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -61.75 -49.11 77.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.47 -34.46 74.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -48.55 49.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.5 t80 -56.69 -46.63 81.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.944 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.55 -39.33 87.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -62.03 -38.61 89.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.8 mt -68.53 -48.81 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.6 mmt -64.23 -37.57 87.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -70.84 -47.77 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.85 -29.88 69.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 54.3 t80 -76.44 -42.11 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm -54.26 -33.8 59.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.006 0.431 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -15.86 60.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.03 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 63.66 43.4 5.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 110.763 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -116.53 -35.63 4.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.6 pt -86.6 178.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.23 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.36 161.44 13.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -58.47 -59.26 14.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.0 Cg_endo -45.46 -41.28 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.812 2.341 . . . . 0.0 112.179 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.31 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.613 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.5 t -79.27 -46.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 mt -65.68 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -45.63 68.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.756 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -48.01 82.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -67.03 -41.15 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -61.39 -23.44 65.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -36.38 11.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.793 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 54' ' ' THR . 5.0 tp -61.66 -38.91 89.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.8 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.9 m-85 -104.61 60.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.07 31.25 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -46.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.677 ' HB2' HD12 ' A' ' 89' ' ' LEU . 50.6 m-70 -105.2 103.52 42.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.854 ' O ' HG23 ' A' ' 91' ' ' VAL . 36.8 Cg_exo -57.73 -34.24 97.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.536 2.157 . . . . 0.0 112.292 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.63 -17.79 16.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.606 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.8 HD13 ' CD1' ' A' ' 83' ' ' PHE . 4.3 mt -83.06 -55.91 4.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.179 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 103' ' ' ILE . 18.0 tt -60.25 -27.08 38.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.22 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 87' ' ' PRO . 67.7 t -73.75 -48.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.524 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -38.56 90.78 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -71.68 -32.26 67.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.967 0.413 . . . . 0.0 110.715 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 97' ' ' LEU . 50.2 t30 -66.51 -29.38 69.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.784 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.42 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -61.41 -17.72 55.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.496 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.74 30.07 3.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 94' ' ' ASN . 6.1 mt -142.06 143.58 28.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.13 169.44 22.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.286 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.02 -32.53 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.16 89.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.45 93.16 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -103.55 148.9 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 90' ' ' ILE . 5.8 tt -79.09 138.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -72.8 129.08 37.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.2 mt -110.17 78.38 1.35 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 140.5 38.9 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.58 2.186 . . . . 0.0 112.253 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.852 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.719 0.295 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 -25.51 22.08 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.545 2.163 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 48' ' ' MET . 14.5 mt-30 -79.09 -22.08 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.1 mt -79.13 -37.85 37.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.35 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -72.68 -36.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' MET . . . . . 0.698 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.1 OUTLIER -73.9 -29.19 61.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.67 -47.25 67.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.34 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.25 80.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.7 -42.79 99.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.59 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.698 HG23 ' O ' ' B' ' 48' ' ' MET . 39.3 t -67.32 -32.97 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.873 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.28 -33.48 49.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.443 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.485 ' O ' HG22 ' B' ' 55' ' ' THR . 6.1 mp -91.75 -3.91 55.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.293 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' THR . . . . . 0.485 HG22 ' O ' ' B' ' 54' ' ' LEU . 15.2 t 45.5 42.17 7.59 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.368 . . . . 0.0 111.504 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.76 28.52 5.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.398 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.944 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.764 0.316 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 t -52.58 -28.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.267 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.02 -41.53 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -38.37 83.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.87 -34.19 66.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -63.48 -53.49 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 t -59.47 -42.37 91.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.905 ' O ' HG23 ' A' ' 44' ' ' VAL . 39.6 t80 -52.64 -46.87 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.66 -43.39 96.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -29.5 69.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -31.42 56.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 40' ' ' TYR . 32.9 t -79.45 -24.76 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 tttm -77.83 -44.27 27.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -68.73 -51.11 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.34 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -29.21 63.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.137 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 54' ' ' THR . 11.5 m-85 -115.69 39.18 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.21 -28.0 71.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.6 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 p -97.32 6.79 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.453 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.17 86.68 12.79 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.672 0.273 . . . . 0.0 110.916 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.83 -25.07 28.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.593 2.195 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.28 86.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.763 HG21 ' CE2' ' A' ' 48' ' ' PHE . 19.6 m -61.1 -45.06 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.452 ' CE2' HD11 ' A' ' 59' ' ' LEU . 28.6 t80 -60.83 -50.86 71.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -31.12 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.79 -43.4 84.07 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.842 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.9 t80 -61.05 -44.35 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.828 HD23 ' HB1' ' B' ' 53' ' ' ALA . 6.6 mt -62.45 -37.03 84.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.78 -44.66 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 58' ' ' PHE . 4.9 mt -59.37 -53.2 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -50.19 70.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HG3' HD21 ' B' ' 54' ' ' LEU . 21.6 tttm -59.34 -39.79 84.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.27 -31.24 71.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CZ ' HD13 ' B' ' 46' ' ' LEU . 41.0 t80 -69.98 -40.35 75.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -59.41 -34.74 72.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.6 -16.07 62.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.272 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.38 39.51 0.92 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.833 0.349 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.51 -51.4 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.63 131.09 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.16 172.75 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -60.08 -58.41 19.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 83.1 Cg_exo -45.06 -31.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.442 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.44 64.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.461 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 61' ' ' ILE . 33.5 t -71.07 -48.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 72' ' ' THR . 3.1 mp -67.73 -32.18 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -63.91 -52.49 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -57.09 -47.99 79.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 75' ' ' VAL . 44.0 t -61.47 -42.06 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.967 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -62.51 -24.84 67.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -96.53 -35.5 11.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' CE1' ' A' ' 83' ' ' PHE . 1.9 tp -62.83 -44.38 96.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.3 m-85 -107.03 51.11 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.74 -30.83 71.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.26 26.64 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.785 ' HB3' HD12 ' A' ' 89' ' ' LEU . 19.2 m-70 -140.11 95.11 8.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.1 Cg_endo -67.7 -48.92 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.428 2.085 . . . . 0.0 112.359 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -55.25 -20.62 11.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.4 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -85.68 -56.59 3.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 110.415 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 87' ' ' PRO . 16.2 tt -61.01 -28.99 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.8 t -75.76 -47.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.88 -39.47 68.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.161 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -74.84 -32.59 61.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 -30.06 70.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -8.85 49.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.783 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -99.76 -38.83 8.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 76' ' ' ILE . 68.9 mt -70.52 138.01 86.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.75 177.04 9.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.537 2.158 . . . . 0.0 112.383 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.15 -29.86 68.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.96 -63.48 5.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.593 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -104.2 88.25 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -87.27 178.77 6.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 76' ' ' ILE . 17.6 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.771 0.238 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.612 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.4 mm-40 -76.86 -25.51 53.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 110.562 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.68 HD21 HG11 ' A' ' 75' ' ' VAL . 2.3 mt -77.49 -33.73 54.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.273 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -73.22 -36.38 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.747 ' O ' HG23 ' B' ' 52' ' ' VAL . 10.0 ptt? -74.45 -29.96 61.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.703 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.612 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.3 mt -67.56 -48.36 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.675 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.24 -33.0 74.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -64.58 -46.09 84.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.747 HG23 ' O ' ' B' ' 48' ' ' MET . 26.1 t -67.79 -28.8 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.828 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.62 -35.5 45.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.326 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.639 HD21 ' HG3' ' A' ' 63' ' ' LYS . 4.2 mp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.909 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.697 0.284 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 38' ' ' LEU . 21.8 t -47.56 -28.48 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.455 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.25 -52.38 65.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -30.57 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.941 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB2' ' HE3' ' B' ' 48' ' ' MET . . . -74.39 -39.23 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 34' ' ' VAL . 4.9 mt -63.34 -51.08 67.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.53 -44.75 93.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 44' ' ' VAL . 56.6 t80 -54.68 -42.34 71.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.03 -30.21 64.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HD12 ' A' ' 46' ' ' ILE . 34.4 t70 -70.46 -31.79 69.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.991 0.424 . . . . 0.0 111.096 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -82.02 -30.98 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 40' ' ' TYR . 41.7 t -77.02 -22.8 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.071 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -85.05 -47.18 10.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.983 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 42' ' ' ASP . 23.0 mt -62.9 -53.45 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -29.64 67.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 54' ' ' THR . 24.2 m-85 -118.36 40.24 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.92 -28.22 63.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -114.92 38.47 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.11 87.72 12.15 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.53 -29.5 24.86 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.557 2.171 . . . . 0.0 112.324 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.77 -49.9 75.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.799 ' HA ' HD11 ' A' ' 82' ' ' LEU . 1.7 m -64.75 -52.51 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.432 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 5.6 t80 -59.71 -49.07 79.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -60.37 -30.65 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.28 -57.11 7.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.712 ' HA ' HD12 ' A' ' 61' ' ' ILE . 8.4 t80 -57.01 -41.21 78.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -45.86 91.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -44.37 87.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.7 mt -63.27 -31.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -47.41 31.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.859 ' HG2' HD11 ' B' ' 54' ' ' LEU . 2.1 mttp -66.74 -41.39 87.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.816 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -41.76 98.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CE2' HD13 ' B' ' 47' ' ' ILE . 26.8 t80 -59.36 -48.14 82.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HZ3' ' HB3' ' B' ' 50' ' ' ALA . 0.0 OUTLIER -59.4 -36.58 76.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -16.69 61.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.9 40.57 0.92 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 p -111.98 -38.23 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.7 tt -98.47 133.28 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 18.0 m-20 -75.99 178.99 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -64.85 -52.82 47.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.2 Cg_exo -48.43 -38.99 35.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 -29.34 74.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.5 t -73.9 -47.86 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.078 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.9 mt -59.69 -37.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -41.31 60.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -49.06 78.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 83' ' ' PHE . 49.9 t -65.92 -39.13 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -61.66 -25.82 67.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -45.05 13.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.784 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 54' ' ' THR . 12.8 tp -60.68 -38.76 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.64 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.55 61.05 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -58.39 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 28.44 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 2.7 m170 -125.11 90.64 50.63 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.788 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.6 Cg_endo -65.02 -51.94 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.519 2.146 . . . . 0.0 112.43 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -55.83 -20.37 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.64 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.0 mt -86.9 -56.65 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.249 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 103' ' ' ILE . 16.5 tt -59.73 -31.93 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 87' ' ' PRO . 70.2 t -75.16 -44.93 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.32 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.36 -32.83 68.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.054 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -73.43 -42.3 62.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 110.707 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 103' ' ' ILE . 1.1 t30 -61.57 -24.78 66.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.778 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.83 -9.96 48.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -99.58 -30.7 11.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 94' ' ' ASN . 3.4 mt -82.88 146.52 52.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 171.07 13.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.509 2.139 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.04 -27.87 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.07 -45.83 92.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.573 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -108.19 126.34 52.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -127.36 136.55 52.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 HG13 ' A' ' 90' ' ' ILE . 20.8 tt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 CA-C-O 120.827 0.261 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -20.38 54.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 7.6 mt -77.55 -39.99 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.338 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.483 HD13 ' CE2' ' A' ' 65' ' ' PHE . 27.9 mm -70.44 -38.95 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.885 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.02 -26.74 61.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.809 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -68.28 -50.12 55.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' HZ3' ' A' ' 66' ' ' LYS . . . -64.1 -35.58 81.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -63.25 -39.25 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.739 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.885 HG23 ' O ' ' B' ' 48' ' ' MET . 36.2 t -70.9 -30.39 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.93 -35.43 43.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 110.416 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.4 mp . . . . . 0 N--CA 1.451 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.091 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.26 -33.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.53 -43.71 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 39' ' ' THR . 6.5 m-20 -66.19 -39.13 89.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.61 -33.51 69.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -54.38 34.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.1 t -58.02 -42.67 85.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.894 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.7 t80 -52.63 -49.14 65.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.008 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -72.03 -30.0 64.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 110.994 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -76.8 -30.02 56.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.5 t -78.49 -30.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.802 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 55' ' ' TYR . 1.6 tppp? -71.77 -47.75 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.05 -48.02 89.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -30.47 69.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.3 m-85 -121.79 42.19 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.33 -45.54 92.72 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.533 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -98.18 28.1 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.23 65.98 29.6 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.98 -23.21 20.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.598 2.198 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.55 -39.61 67.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.514 HG21 ' CE2' ' A' ' 48' ' ' PHE . 3.1 m -76.87 -46.43 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 30.4 t80 -62.28 -51.91 65.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.35 -43.32 92.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.21 -48.53 85.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 61' ' ' ILE . 13.2 t80 -59.48 -31.35 69.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' B' ' 53' ' ' ALA . 14.8 mt -70.2 -46.72 63.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -38.32 83.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 58' ' ' PHE . 13.1 mt -65.59 -51.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 18.2 mmt -67.05 -41.33 86.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.2 ttmm -68.67 -31.46 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.92 -34.76 62.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' HG21 ' A' ' 75' ' ' VAL . 25.9 t80 -64.66 -56.56 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.019 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.0 OUTLIER -57.94 -36.41 72.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.895 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t -67.41 -12.91 61.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.224 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 74.83 45.06 0.17 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -114.46 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.1 tt -81.5 150.1 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 t0 -88.34 -175.3 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -54.61 4.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.2 -32.15 18.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 -38.27 60.23 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 79' ' ' VAL . 26.3 t -65.53 -33.56 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 103' ' ' ILE . 20.6 mt -75.28 -35.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -75.62 -42.74 50.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -62.24 -56.97 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 93' ' ' PHE . 47.1 t -58.09 -48.06 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -60.57 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -91.37 -42.68 10.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.755 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HG ' HG23 ' A' ' 54' ' ' THR . 2.6 tp -60.41 -30.79 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.868 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.0 m-85 -110.16 46.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.57 -34.61 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.065 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -108.03 26.12 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.689 ' CB ' HD12 ' A' ' 89' ' ' LEU . 29.8 m-70 -140.12 94.4 8.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.819 ' O ' HG23 ' A' ' 91' ' ' VAL . 44.7 Cg_endo -68.41 -44.99 2.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -64.26 -13.78 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.35 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.3 mt -86.72 -54.57 4.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.37 -29.25 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.151 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.6 t -75.66 -49.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.469 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.74 -38.39 87.96 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.065 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 79' ' ' VAL . 85.1 t80 -71.36 -34.29 70.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.591 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.55 -33.46 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.9 57.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CB ' HD11 ' B' ' 49' ' ' LEU . 75.8 m-85 -99.8 29.9 3.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.54 143.81 48.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.489 2.126 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -19.3 61.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.12 49.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.819 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -128.76 145.57 51.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.63 137.01 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.767 HG12 HG23 ' A' ' 76' ' ' ILE . 17.3 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.761 0.234 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.48 -25.48 50.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 110.69 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 65' ' ' PHE . 6.9 mt -76.99 -33.97 57.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.374 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -72.43 -39.99 63.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.427 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.548 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -70.47 -29.92 66.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.621 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' A' ' 96' ' ' PHE . 3.9 mt -66.58 -50.29 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.419 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.03 -33.45 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -61.62 -44.48 96.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.629 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 48' ' ' MET . 39.8 t -67.95 -29.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.903 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -77.72 -35.19 52.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.067 0.46 . . . . 0.0 110.204 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 66' ' ' LYS . 8.3 mp . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.872 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 21.6 p-80 . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.694 0.283 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.68 -52.02 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.762 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 18.2 mt-10 -58.12 -49.07 78.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -58.98 -36.57 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.98 -31.43 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.43 -52.72 43.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 t -59.53 -43.71 93.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.6 t80 -52.87 -52.7 56.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.73 -37.27 85.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 46' ' ' ILE . 6.5 t70 -66.23 -32.59 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.005 0.431 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.68 -31.31 36.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.767 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 33.0 t -78.72 -24.31 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.125 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 16.6 tptt -81.5 -46.76 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 42' ' ' ASP . 19.7 mt -65.09 -47.83 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -29.41 70.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 54' ' ' THR . 25.8 m-85 -116.12 39.34 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.36 -28.75 73.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 m -101.4 18.14 20.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.595 0.236 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.27 86.99 12.37 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.8 -26.33 32.48 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.83 -38.29 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.3 m -76.16 -37.81 57.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 33.9 t80 -71.9 -52.85 15.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.01 -37.65 80.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.78 -42.43 95.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 61' ' ' ILE . 28.0 t80 -59.2 -53.2 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' HB1' ' B' ' 53' ' ' ALA . 3.0 mt -59.8 -35.34 74.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -39.88 92.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -64.55 -54.34 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 28.8 mmt -62.05 -40.25 95.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.869 ' HG3' HD21 ' B' ' 54' ' ' LEU . 14.2 tttt -68.12 -31.1 70.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.03 -37.57 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD1' HG21 ' A' ' 75' ' ' VAL . 48.3 t80 -67.84 -38.9 83.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -57.97 -32.12 67.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.793 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -68.25 -12.04 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 65.65 39.54 4.85 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.56 -47.87 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.888 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.7 tt -87.09 158.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -89.69 -177.68 5.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.546 HG21 ' CE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -72.74 -51.38 6.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.1 Cg_exo -49.75 -33.59 32.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.78 -30.72 67.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.411 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 65' ' ' PHE . 21.5 t -72.94 -35.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.9 mm -67.72 -46.29 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -36.45 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -63.26 -53.85 46.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.9 t -66.56 -47.92 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.191 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.4 p -58.24 -23.24 55.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -87.11 -41.57 13.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 54' ' ' THR . 2.2 tp -62.75 -31.1 71.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.893 ' CD1' HD13 ' A' ' 89' ' ' LEU . 15.3 m-85 -116.31 58.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -71.7 -32.2 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.201 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.6 33.7 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.159 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.8 ' CB ' HD12 ' A' ' 89' ' ' LEU . 59.7 m-70 -140.06 86.16 13.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.054 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.723 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.9 Cg_exo -57.02 -50.53 11.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.25 . . . . 0.0 112.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -19.12 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.446 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.893 HD13 ' CD1' ' A' ' 83' ' ' PHE . 7.0 mt -87.64 -57.7 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 87' ' ' PRO . 11.7 tt -59.59 -31.9 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.177 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.7 t -77.47 -44.75 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.79 -38.49 96.04 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 79' ' ' VAL . 71.2 t80 -72.96 -34.09 66.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.073 0.464 . . . . 0.0 110.788 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -69.14 -23.9 64.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.963 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.37 -11.19 57.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.734 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -99.7 -30.21 12.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.71 143.9 63.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 162.91 41.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.42 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -28.55 67.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.57 -27.65 61.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CE2' HG21 ' A' ' 72' ' ' THR . 24.2 m-85 -111.2 102.09 10.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.75 0.31 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 141.54 39.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 103' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.862 0.276 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.642 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.5 mp0 -77.04 -22.97 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' B' ' 46' ' ' LEU . 15.4 mt -76.9 -35.7 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 mt -72.71 -38.81 59.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.426 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.697 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.89 -27.02 61.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.812 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.642 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.7 OUTLIER -70.65 -45.21 65.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.52 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 62' ' ' MET . . . -67.0 -34.49 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -64.44 -47.58 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.697 HG23 ' O ' ' B' ' 48' ' ' MET . 37.2 t -66.18 -28.26 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.88 -36.11 42.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.276 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.869 HD21 ' HG3' ' A' ' 63' ' ' LYS . 7.1 mp . . . . . 0 N--CA 1.451 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.953 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.42 -28.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.27 -39.23 71.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.712 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.89 77.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.22 63.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.52 -49.72 57.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -59.44 -44.92 92.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.7 t80 -54.54 -51.26 65.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.98 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.51 -31.07 71.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -33.04 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.731 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -79.28 -31.35 43.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.671 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.4 t -78.38 -29.83 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.751 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 1.2 tttm -72.84 -48.98 33.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.22 -41.64 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -28.33 65.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -117.61 40.11 3.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.93 50.99 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.552 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.7 17.08 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.661 0.267 . . . . 0.0 111.181 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.3 t0 -140.25 62.74 21.1 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 110.941 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 51' ' ' ASP . 50.2 Cg_exo -53.4 -23.26 23.59 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.533 2.155 . . . . 0.0 112.462 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.47 72.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG23 ' HG ' ' A' ' 82' ' ' LEU . 2.0 m -60.36 -47.42 86.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 13.6 t80 -63.04 -43.34 98.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -44.38 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -43.81 98.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.548 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HA ' HD12 ' A' ' 61' ' ' ILE . 67.3 t80 -58.78 -43.29 90.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 mt -61.7 -37.1 82.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.78 -43.63 97.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.7 mt -59.93 -59.5 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.3 91.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HD3' HD21 ' B' ' 54' ' ' LEU . 1.3 ttpp -64.46 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.02 -32.82 59.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 75' ' ' VAL . 66.9 t80 -66.27 -35.9 81.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -59.21 -32.15 69.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.1 -16.89 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.28 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.46 40.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 p -113.11 -48.77 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 65' ' ' PHE . 13.0 tt -78.69 156.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.1 t0 -87.08 173.56 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -72.06 -51.95 7.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.1 Cg_exo -49.62 -35.33 37.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.536 2.157 . . . . 0.0 112.358 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.83 -30.08 70.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.413 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 79' ' ' VAL . 32.4 t -71.03 -47.01 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 0.0 111.038 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 103' ' ' ILE . 6.7 mt -66.06 -32.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -49.78 56.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -45.91 90.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 75' ' ' VAL . 40.2 t -59.47 -46.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -62.12 -24.96 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -78.03 -47.26 18.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 mp -60.18 -29.0 68.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 89' ' ' LEU . 4.4 m-85 -111.78 54.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.56 -43.34 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.57 26.89 10.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.822 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.9 m170 -128.9 93.66 36.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.799 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 37.3 Cg_endo -66.74 -51.95 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.453 2.102 . . . . 0.0 112.557 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.84 -18.83 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.822 HD12 ' CB ' ' A' ' 86' ' ' HIS . 37.9 mt -84.1 -55.49 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.207 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.75 -28.64 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.081 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' PRO . 58.8 t -73.71 -46.27 47.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.426 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.47 -35.3 84.81 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.8 t80 -72.59 -35.14 67.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.0 110.775 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -66.95 -27.26 67.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -16.76 55.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.75 -30.07 12.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -68.94 147.64 97.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.26 173.48 11.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.557 2.172 . . . . 0.0 112.349 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -30.88 69.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -68.55 -64.63 2.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.53 84.82 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.55 147.51 27.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 76' ' ' ILE . 8.7 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.723 0.218 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.99 -24.69 47.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 110.788 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 46' ' ' LEU . 17.5 mt -76.19 -38.83 56.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.476 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.8 mt -70.49 -39.64 76.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.665 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.5 -27.09 62.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.749 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' HE3' ' B' ' 48' ' ' MET . 4.6 mt -68.7 -46.54 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.59 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.462 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -65.27 -36.35 83.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.051 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -61.89 -45.97 91.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 48' ' ' MET . 41.7 t -67.15 -27.87 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.88 -35.19 51.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.25 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 63' ' ' LYS . 9.5 mp . . . . . 0 N--CA 1.45 -0.465 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.826 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.718 0.294 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.577 ' HA ' HG21 ' B' ' 52' ' ' VAL . 21.4 t -48.0 -29.11 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.37 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.92 76.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -38.49 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.46 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.99 -54.06 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.4 t -60.5 -44.83 95.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.3 t80 -55.42 -49.9 71.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.053 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.2 mt -65.19 -34.96 79.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 46' ' ' ILE . 24.4 m-20 -70.91 -27.76 64.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -31.06 34.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 40' ' ' TYR . 30.0 t -81.75 -31.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.861 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -73.36 -49.25 28.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 42' ' ' ASP . 27.6 mt -66.02 -45.31 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -62.39 -32.89 73.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 54' ' ' THR . 41.4 m-85 -119.14 39.87 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.34 -44.07 52.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.5 m -66.33 -16.39 64.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.661 0.267 . . . . 0.0 111.223 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -132.58 92.68 26.67 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.7 -12.33 35.15 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.516 2.144 . . . . 0.0 112.492 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.8 77.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 64.5 m -69.0 -36.86 78.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 59' ' ' LEU . 32.5 t80 -65.74 -49.98 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -60.54 -32.74 71.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.69 -51.65 52.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.778 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.2 t80 -59.24 -42.98 92.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 55' ' ' TYR . 73.1 mt -59.83 -40.61 89.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -42.75 99.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.3 mt -65.45 -37.95 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.5 mmt -68.95 -55.69 10.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.68 ' HG3' HD21 ' B' ' 54' ' ' LEU . 18.9 tttt -60.35 -31.28 70.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.792 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.22 -40.91 86.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 75' ' ' VAL . 42.1 t80 -66.78 -44.48 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -58.46 -42.43 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.652 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -63.15 -16.63 60.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.26 43.84 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.819 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.94 14.76 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.331 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 65' ' ' PHE . 19.1 tt -155.09 145.81 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.042 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 t70 -84.36 178.37 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.53 -53.2 17.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 73.3 Cg_exo -48.99 -38.09 38.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.562 2.175 . . . . 0.0 112.405 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.72 -29.64 71.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.5 t -75.03 -34.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.9 mt -71.4 -44.31 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.148 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -43.53 94.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -48.06 81.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 75' ' ' VAL . 34.9 t -72.76 -34.17 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.512 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.8 t -62.44 -25.43 67.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -32.35 11.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.528 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -61.71 -32.66 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.562 ' CD1' HD13 ' A' ' 89' ' ' LEU . 26.4 m-85 -124.38 47.68 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -9.49 58.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.54 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -103.5 -29.65 11.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.821 0.343 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -100.01 108.25 50.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.67 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.25 -42.85 3.52 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.41 2.073 . . . . 0.0 112.229 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.56 -17.64 34.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.288 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 83' ' ' PHE . 18.1 mt -88.2 -56.63 3.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.261 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.584 HD11 HG12 ' A' ' 103' ' ' ILE . 11.3 tt -60.92 -33.17 54.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.232 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.3 t -77.11 -43.64 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.453 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.27 86.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 97' ' ' LEU . 70.8 t80 -73.92 -38.88 64.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.609 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.3 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.767 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.74 -9.53 51.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.824 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -99.72 -29.37 12.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 93' ' ' PHE . 3.4 mt -86.05 151.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.87 159.24 53.74 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -27.29 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -52.69 47.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.621 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -104.34 68.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -63.99 173.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.976 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 90' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 C--O 1.232 0.213 0 N-CA-C 112.606 0.195 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -77.55 -27.33 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.648 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.65 -33.66 60.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.367 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mm -73.37 -38.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.67 -27.46 62.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.34 -53.44 19.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.12 67.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.107 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -67.52 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 34' ' ' VAL . 38.1 t -59.06 -24.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.91 63.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.17 0.509 . . . . 0.0 109.699 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.68 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.9 mp . . . . . 0 N--CA 1.447 -0.582 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.008 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.11 -31.04 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -37.59 65.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -67.05 -43.84 81.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.44 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -62.27 -55.7 25.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -59.02 -44.63 91.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 44' ' ' VAL . 63.3 t80 -53.29 -38.18 62.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.081 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.55 -47.26 49.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -31.62 69.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 110.963 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.2 -46.52 50.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.0 t -65.95 -16.72 21.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.314 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -85.03 -44.06 13.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -66.14 -56.4 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -56.52 -28.38 59.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 54' ' ' THR . 33.3 m-85 -117.26 39.77 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.0 70.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -101.96 19.44 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.664 0.269 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.24 74.7 29.53 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.905 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.46 -28.8 65.83 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.384 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.27 89.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' HD21 ' A' ' 82' ' ' LEU . 2.9 m -59.8 -51.58 69.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -63.16 -50.44 70.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.69 -42.23 92.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.48 -43.92 98.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.0 t80 -58.93 -49.97 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.075 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.23 76.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.59 -42.89 99.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -61.64 -50.12 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 31.3 mmt -60.15 -49.2 78.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.644 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.7 ttpt -63.88 -31.61 72.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.74 -46.02 80.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' CE2' HD13 ' B' ' 46' ' ' LEU . 34.4 t80 -63.48 -44.0 95.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 t -62.89 -17.25 61.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 70.04 39.82 1.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 -43.09 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.3 tt -97.19 158.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -85.34 176.08 8.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.14 -53.04 27.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' ILE . 74.4 Cg_exo -49.2 -28.2 14.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.581 2.187 . . . . 0.0 112.438 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.23 -32.09 60.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 61' ' ' ILE . 32.6 t -72.8 -44.05 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 97' ' ' LEU . 3.7 mt -64.31 -47.7 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -39.25 92.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -57.02 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.0 t -64.19 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 t -61.62 -22.61 65.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -94.72 -34.29 12.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 54' ' ' THR . 7.2 tp -61.19 -36.57 80.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.909 ' CD1' HD13 ' A' ' 89' ' ' LEU . 24.7 m-85 -112.67 52.67 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.86 -25.43 67.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.223 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 25.4 11.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.3 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.809 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -140.14 86.73 12.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.911 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.702 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 Cg_exo -58.25 -48.73 14.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.703 2.268 . . . . 0.0 112.422 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.07 -20.91 7.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.598 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.909 HD13 ' CD1' ' A' ' 83' ' ' PHE . 44.2 mt -86.84 -59.24 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.436 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.4 tt -58.31 -30.48 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.38 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 87' ' ' PRO . 88.9 t -76.28 -47.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.96 -37.49 85.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.096 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' HE1' HD11 ' A' ' 97' ' ' LEU . 41.8 t80 -74.24 -33.43 63.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.097 0.475 . . . . 0.0 110.673 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.35 -25.17 66.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.8 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.11 26.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.931 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.76 -35.05 9.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.831 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 HD13 HG12 ' A' ' 76' ' ' ILE . 2.4 mt -76.08 146.76 79.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.42 176.42 8.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tp -73.47 -24.91 60.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 -26.48 30.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.618 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.93 114.43 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -85.76 139.34 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.157 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.743 0.226 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.448 ' O ' HD12 ' B' ' 49' ' ' LEU . 3.2 mm-40 -75.95 -23.3 55.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.611 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 65' ' ' PHE . 1.8 mt -77.03 -33.79 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.342 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -72.9 -39.38 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.442 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.44 -29.57 65.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.73 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.448 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.4 mt -68.32 -49.21 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -30.5 71.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -62.45 -49.88 73.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 48' ' ' MET . 39.4 t -65.64 -29.17 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.836 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.54 -34.24 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.203 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.8 mp . . . . . 0 N--CA 1.45 -0.432 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.917 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.907 0.384 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 38' ' ' LEU . 33.8 t -57.7 -38.99 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.69 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.07 -38.49 88.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.431 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -71.37 -39.68 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.529 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.77 72.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.52 HD12 HG12 ' A' ' 34' ' ' VAL . 3.2 mt -64.76 -52.77 55.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 36' ' ' ASP . 3.2 t -54.64 -42.32 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.1 t80 -54.97 -54.93 36.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.6 mt -63.48 -30.29 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.27 -41.08 94.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.53 -27.16 51.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 35.9 t -79.59 -30.97 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.746 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -71.92 -49.64 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.687 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -64.35 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -59.89 -30.99 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -119.68 40.29 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.26 -38.17 81.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.398 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -81.45 -18.05 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.14 89.9 51.31 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.012 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.32 -8.94 24.8 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.583 2.189 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.61 -39.07 67.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.249 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.474 HG23 ' HG ' ' A' ' 82' ' ' LEU . 1.2 m -75.48 -43.04 51.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -61.27 -48.83 79.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -61.38 -43.41 98.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.97 83.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.375 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.822 ' HA ' HD12 ' A' ' 61' ' ' ILE . 19.3 t80 -61.13 -35.39 76.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mt -65.1 -46.48 80.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.51 75.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 58' ' ' PHE . 9.4 mt -69.34 -32.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.8 mmt -75.43 -44.48 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.842 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.8 OUTLIER -69.25 -33.51 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.32 -41.15 81.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.809 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CD1' HG21 ' A' ' 75' ' ' VAL . 78.8 t80 -61.99 -46.02 91.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.6 -39.32 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -15.87 60.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 73.87 41.05 0.44 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.25 -42.37 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.804 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.34 147.95 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.8 t0 -84.12 171.24 13.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.7 -53.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.7 Cg_exo -50.36 -37.86 51.48 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.91 82.42 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.452 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.2 t -62.33 -49.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.21 -43.64 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -44.65 96.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -59.66 -50.99 71.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 75' ' ' VAL . 46.9 t -62.34 -42.95 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.96 -23.3 66.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -46.3 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 tp -60.61 -34.99 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.87 53.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -61.97 -57.45 11.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.42 27.08 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.604 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.2 m170 -126.59 89.55 51.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.781 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.755 ' O ' HG23 ' A' ' 91' ' ' VAL . 34.7 Cg_endo -65.05 -51.17 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.605 2.203 . . . . 0.0 112.598 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.9 -21.99 4.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.501 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 86' ' ' HIS . 73.0 mt -85.17 -58.35 2.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.346 . . . . 0.0 110.446 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.5 tt -59.08 -27.85 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.0 t -76.17 -48.87 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.517 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.89 93.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.129 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -72.39 -33.35 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -62.5 -34.54 77.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 -22.4 49.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -100.0 30.32 3.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.823 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.5 126.46 22.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.38 176.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.492 2.128 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -29.05 28.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.75 -27.18 58.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -126.14 95.81 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 139.29 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 90' ' ' ILE . 3.9 tt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.692 0.205 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.542 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.5 mp0 -79.93 -27.33 39.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.45 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -79.77 -34.65 39.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.349 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.03 -32.98 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.504 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.593 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -77.33 -30.35 53.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.542 HD12 ' O ' ' B' ' 45' ' ' GLN . 15.3 mt -71.36 -43.32 67.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.42 72.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -63.97 -49.21 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.744 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -66.74 -28.76 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.19 -35.41 41.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.842 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.4 mp . . . . . 0 N--CA 1.451 -0.412 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.887 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 29.9 p-80 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.501 0.191 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.25 -31.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -64.84 -44.55 89.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -65.37 -44.16 88.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.934 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.74 66.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 mt -64.86 -53.99 37.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 2.9 t -59.51 -45.55 91.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.813 ' O ' HG23 ' A' ' 44' ' ' VAL . 53.8 t80 -55.69 -47.2 77.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.067 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.36 -31.42 72.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -69.79 -32.68 71.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.81 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -26.39 38.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.835 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.8 t -80.45 -29.16 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -46.2 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.0 mt -66.62 -41.6 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -30.91 68.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' A' ' 54' ' ' THR . 56.0 m-85 -124.82 43.75 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.1 -35.58 84.68 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.469 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 p -107.9 42.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -140.13 92.38 9.63 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.94 -38.84 12.23 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.472 2.114 . . . . 0.0 112.24 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.47 77.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.604 HG21 ' CD2' ' A' ' 48' ' ' PHE . 6.2 m -71.57 -48.21 49.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.735 ' O ' HD12 ' A' ' 59' ' ' LEU . 15.4 t80 -65.35 -58.53 5.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.32 -32.11 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.68 -50.57 41.6 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' HD12 ' A' ' 61' ' ' ILE . 31.6 t80 -57.66 -44.58 85.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 55' ' ' TYR . 0.5 OUTLIER -64.65 -35.27 80.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.696 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.7 -35.8 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.874 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 58' ' ' PHE . 21.8 mt -69.48 -50.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -32.39 73.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HE2' HD21 ' B' ' 54' ' ' LEU . 7.0 tttm -71.87 -31.63 66.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 -30.13 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HA ' HG12 ' A' ' 70' ' ' ILE . 40.4 t80 -70.44 -40.35 73.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -56.97 -32.54 66.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -64.94 -16.15 62.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.05 42.5 1.25 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.743 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -113.86 -51.5 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 65' ' ' PHE . 11.2 pt -74.58 178.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -116.62 -177.47 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.42 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.35 -52.76 20.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.6 Cg_exo -47.94 -27.75 9.19 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.642 2.228 . . . . 0.0 112.428 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.8 -29.35 57.57 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 79' ' ' VAL . 18.5 t -76.67 -33.89 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 103' ' ' ILE . 39.4 mt -73.59 -45.43 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -46.41 76.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -45.65 87.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 75' ' ' VAL . 38.8 t -76.11 -41.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.066 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.2 t -58.28 -22.51 52.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.09 -38.77 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.07 -31.57 72.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 89' ' ' LEU . 17.7 m-85 -119.92 50.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -67.44 -41.09 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -100.74 30.0 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.646 ' CB ' HD12 ' A' ' 89' ' ' LEU . 83.8 m-70 -139.96 85.77 13.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.7 Cg_exo -56.93 -59.31 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.61 2.207 . . . . 0.0 112.225 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -51.33 -22.77 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.556 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 86' ' ' HIS . 14.9 mt -81.79 -55.72 4.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 110.224 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 103' ' ' ILE . 12.3 tt -63.28 -26.21 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 87' ' ' PRO . 95.6 t -72.94 -47.92 46.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.33 -43.56 93.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.31 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.45 -29.53 66.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.921 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.499 ' HB2' HD12 ' A' ' 103' ' ' ILE . 1.4 t30 -72.24 -22.49 61.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 -3.32 28.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.4 ' CZ ' ' OD2' ' A' ' 36' ' ' ASP . 79.5 m-85 -99.76 -28.98 12.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.3 mt -89.03 140.07 29.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.63 177.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.443 2.095 . . . . 0.0 112.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.9 -31.69 71.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.32 -34.64 81.34 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.55 75.13 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.89 127.51 33.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 90' ' ' ILE . 33.2 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.697 0.207 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.437 ' O ' HD12 ' B' ' 49' ' ' LEU . 5.8 mt-30 -78.61 -21.0 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.386 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 18.3 mt -79.38 -38.74 34.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.35 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.02 -35.2 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.789 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -75.98 -27.8 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.75 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.437 HD12 ' O ' ' B' ' 45' ' ' GLN . 5.2 mt -71.14 -43.46 67.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.425 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -36.46 79.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.997 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.54 -39.98 94.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 48' ' ' MET . 35.4 t -72.52 -28.03 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.748 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.49 52.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.514 HD21 ' HE2' ' A' ' 63' ' ' LYS . 7.2 mp . . . . . 0 N--CA 1.449 -0.51 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.796 0.331 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.8 t -53.52 -27.67 14.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.261 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.87 -39.47 69.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -36.28 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.43 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.83 -49.87 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 t -59.5 -44.66 93.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 62.8 t80 -53.08 -49.75 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.042 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.77 -32.63 73.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.409 ' OD1' HD11 ' A' ' 46' ' ' ILE . 7.7 t0 -66.21 -33.22 75.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -26.03 36.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.3 t -76.94 -28.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.932 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -80.34 -49.72 11.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' OD1' ' A' ' 42' ' ' ASP . 47.5 mt -60.82 -38.98 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -67.88 -27.4 66.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.643 ' CE2' HG21 ' A' ' 54' ' ' THR . 31.8 m-85 -114.99 39.21 2.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.09 -28.35 53.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.78 21.68 16.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -140.2 81.85 17.71 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 -28.1 23.82 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.597 2.198 . . . . 0.0 112.327 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.05 93.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.643 HG21 ' CE2' ' A' ' 48' ' ' PHE . 9.8 m -60.38 -38.64 84.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -69.89 -47.02 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -59.91 -42.62 94.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.95 94.54 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.551 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.53 -50.45 73.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.28 -36.57 78.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.97 -45.61 92.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 78' ' ' ARG . 28.5 mt -59.57 -45.58 93.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -49.9 55.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.765 ' HG3' HD21 ' B' ' 54' ' ' LEU . 7.8 ttmt -59.49 -36.62 76.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.97 -30.74 67.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 70' ' ' ILE . 50.2 t80 -74.19 -35.33 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -57.72 -40.89 80.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.762 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -15.84 61.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 71.93 53.76 0.19 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.985 0.421 . . . . 0.0 110.836 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.59 -39.02 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 65' ' ' PHE . 13.5 pt -92.34 156.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.215 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -90.79 170.09 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.4 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -62.16 -54.22 51.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.791 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.9 Cg_exo -48.38 -41.16 36.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.167 . . . . 0.0 112.233 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.73 99.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 71' ' ' ASP . 18.8 t -58.5 -40.0 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.98 -43.26 98.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -67.86 -36.06 79.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.569 ' HB3' HD13 ' A' ' 61' ' ' ILE . 26.6 mmt180 -57.27 -65.82 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.9 t -63.44 -31.31 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -64.85 -23.82 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.66 -37.73 11.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.49 -30.26 70.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.023 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' HD13 ' A' ' 89' ' ' LEU . 11.8 m-85 -114.62 55.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -66.78 -33.09 74.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.56 26.35 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.408 ' CB ' HD12 ' A' ' 89' ' ' LEU . 94.9 m-70 -140.05 88.21 11.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.971 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.878 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.3 Cg_endo -67.96 -44.46 3.93 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.591 2.194 . . . . 0.0 112.282 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -50.15 -25.35 3.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 83' ' ' PHE . 92.9 mt -82.72 -51.0 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 83' ' ' PHE . 57.0 mt -62.52 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.956 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.4 t -73.01 -50.41 32.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.465 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.35 80.52 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.323 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 97' ' ' LEU . 64.5 t80 -74.76 -30.74 61.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.92 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 97' ' ' LEU . 47.2 t30 -74.89 -27.28 60.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.878 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.25 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.519 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -99.66 -38.38 8.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.06 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 93' ' ' PHE . 7.1 mt -66.24 148.32 98.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 172.32 12.49 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.53 -22.21 57.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.77 -44.2 70.1 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.693 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -102.9 99.44 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.829 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -77.97 116.26 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.405 HG22 ' ND2' ' A' ' 94' ' ' ASN . 3.6 tt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.024 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HD12 ' B' ' 47' ' ' ILE . 42.6 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.708 0.212 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -79.49 -26.48 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.658 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 46' ' ' LEU . 20.5 mt -78.92 -36.08 42.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' B' ' 44' ' ' PRO . 7.4 mt -73.47 -34.7 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.508 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.5 OUTLIER -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.35 -43.35 67.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.67 72.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -50.32 69.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 48' ' ' MET . 38.7 t -65.46 -29.16 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.68 -34.44 58.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.111 0.481 . . . . 0.0 110.091 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.765 HD21 ' HG3' ' A' ' 63' ' ' LYS . 6.6 mp . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.728 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.454 ' CD2' ' HB2' ' A' ' 35' ' ' GLU . 5.6 p-80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -41.99 -32.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.886 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 5.7 mm-40 -63.46 -47.21 82.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.707 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -64.36 -37.74 88.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.95 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.44 -48.78 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -60.21 -45.67 92.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 69.2 t80 -55.47 -47.89 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.69 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.438 ' O ' HD12 ' A' ' 46' ' ' ILE . 60.6 m-20 -63.11 -30.2 71.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.59 -28.29 30.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 12.9 t -81.02 -20.29 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.11 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.33 -46.43 9.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.724 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.9 mt -67.04 -50.07 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -59.41 -30.66 68.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.65 ' HE1' HD11 ' A' ' 89' ' ' LEU . 69.3 m-85 -119.62 40.75 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.02 -29.26 64.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.578 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -107.72 30.35 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.17 88.58 11.5 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.62 -28.53 31.2 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.513 2.142 . . . . 0.0 112.329 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.68 69.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -74.04 -56.64 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -59.19 -52.03 67.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -61.27 -34.85 75.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.2 -50.16 23.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.902 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.7 t80 -60.23 -27.41 67.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -53.48 15.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.8 -38.23 69.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.016 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -60.87 -56.85 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.852 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.09 86.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.777 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' B' ' 54' ' ' LEU . 12.5 ttpt -64.59 -52.09 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.82 -30.35 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 61.8 t80 -66.48 -47.49 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -57.31 -27.37 62.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 m -66.97 -13.03 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.86 47.78 2.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.956 0.407 . . . . 0.0 110.823 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 m -121.82 -39.28 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 65' ' ' PHE . 9.5 pt -91.26 178.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -108.85 172.69 6.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.424 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.17 -51.98 32.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.014 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.3 Cg_exo -50.38 -34.1 39.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.27 90.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 79' ' ' VAL . 19.0 t -61.95 -39.36 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 103' ' ' ILE . 40.5 mt -69.03 -35.9 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.173 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -70.31 -47.3 61.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 61' ' ' ILE . 18.8 mtp85 -58.45 -37.94 76.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -73.22 -45.54 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 t -58.61 -23.83 59.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -84.02 -40.14 18.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.806 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.88 -31.5 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 89' ' ' LEU . 6.0 m-85 -121.58 62.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -69.71 -44.12 71.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.654 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -99.94 26.63 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.8 m170 -130.83 104.31 15.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 91' ' ' VAL . 62.5 Cg_endo -74.6 -47.51 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.091 . . . . 0.0 112.712 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.25 -17.65 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.58 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.65 HD11 ' HE1' ' A' ' 48' ' ' PHE . 11.2 mt -87.68 -55.86 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.208 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.658 HG13 HD13 ' A' ' 103' ' ' ILE . 11.5 tt -56.72 -30.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.06 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.7 t -77.17 -45.57 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.289 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 -34.55 82.49 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.998 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.741 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 62.8 t80 -74.15 -37.79 63.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.659 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -61.45 -29.89 70.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -17.94 57.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.496 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.85 29.7 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.333 . . . . 0.0 110.954 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.2 145.32 23.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 158.88 54.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -26.81 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.34 -27.46 53.23 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.615 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 109.03 10.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.658 HD13 HG13 ' A' ' 90' ' ' ILE . 4.4 tt . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.746 0.228 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.545 ' O ' HD12 ' B' ' 49' ' ' LEU . 15.1 mp0 -77.28 -19.02 57.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -78.99 -38.29 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 110.37 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.49 -37.25 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.448 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.415 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.8 -28.46 61.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.545 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.6 mt -72.18 -41.29 67.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.39 75.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.867 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.04 -53.48 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.693 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 48' ' ' MET . 43.7 t -63.06 -28.0 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.003 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.1 48.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.096 0.474 . . . . 0.0 110.214 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.4 mp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.888 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.821 0.343 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.27 -36.81 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.26 -39.71 95.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.66 75.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 -30.78 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mt -66.53 -53.14 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.58 -44.31 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 44' ' ' VAL . 60.5 t80 -52.87 -55.74 20.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.06 -33.13 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -69.6 -28.87 66.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.53 -26.84 37.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 40' ' ' TYR . 19.0 t -78.77 -29.7 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.973 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -78.23 -47.2 18.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 42' ' ' ASP . 20.7 mt -63.01 -45.53 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.13 -28.44 68.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 54' ' ' THR . 63.8 m-85 -123.79 43.1 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -39.53 85.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.448 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -79.25 -19.49 50.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.224 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -111.0 92.86 15.89 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.01 -23.75 40.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.02 77.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.76 HG21 ' CD2' ' A' ' 48' ' ' PHE . 18.9 m -65.14 -48.41 73.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.612 ' CE2' HD11 ' A' ' 59' ' ' LEU . 9.2 t80 -62.76 -46.96 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -60.27 -34.93 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.22 -49.54 56.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 61' ' ' ILE . 50.7 t80 -58.78 -53.06 62.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 55' ' ' TYR . 33.2 mt -57.3 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -37.86 73.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.4 mt -73.08 -29.07 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.052 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -41.45 61.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.822 ' CG ' HD11 ' B' ' 54' ' ' LEU . 12.8 mttt -71.82 -44.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -58.6 -58.55 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 20.2 t80 -60.24 -44.14 95.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.138 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HD2' HD22 ' B' ' 54' ' ' LEU . 33.2 tttm -52.57 -37.17 57.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -13.86 61.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.032 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 71.02 49.38 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.0 m -112.44 -33.36 6.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 65' ' ' PHE . 11.0 pt -104.96 173.37 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -96.21 168.94 10.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.01 -52.32 75.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.8 Cg_exo -48.23 -35.43 26.91 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.288 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.08 81.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.338 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 65' ' ' PHE . 24.9 t -74.97 -33.38 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.9 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.607 HG23 HG12 ' A' ' 103' ' ' ILE . 39.6 mt -71.8 -47.38 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -64.23 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -55.01 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.506 HG13 ' CE2' ' A' ' 83' ' ' PHE . 37.7 t -69.84 -35.32 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -62.54 -26.99 68.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.92 -32.5 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.81 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 16.9 tp -61.08 -40.14 92.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.676 ' CD1' HD13 ' A' ' 89' ' ' LEU . 16.9 m-85 -107.26 61.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -92.39 22.47 4.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.403 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -128.37 -44.94 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.541 ' HB2' HD12 ' A' ' 89' ' ' LEU . 14.0 m-70 -103.09 118.25 58.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 91' ' ' VAL . 56.3 Cg_endo -70.19 -33.54 14.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.525 2.15 . . . . 0.0 112.326 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.23 -13.95 33.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.527 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 83' ' ' PHE . 5.0 mt -87.19 -56.74 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.32 -31.28 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.0 t -75.75 -47.67 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.529 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.2 82.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.092 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -73.24 -35.02 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.47 . . . . 0.0 110.717 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -33.27 73.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -18.5 58.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.322 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -99.79 30.03 3.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -144.3 147.12 35.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.88 159.77 51.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.545 2.163 . . . . 0.0 112.212 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.622 HD11 ' NH2' ' A' ' 102' ' ' ARG . 1.6 tp -59.99 -29.76 68.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.49 69.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.8 88.52 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.622 ' NH2' HD11 ' A' ' 99' ' ' LEU . 3.5 mtt180 -85.74 -174.58 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.607 HG12 HG23 ' A' ' 76' ' ' ILE . 27.8 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.151 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.231 0.174 0 N-CA-C 112.613 0.197 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.52 -25.67 41.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 65' ' ' PHE . 55.4 mt -79.4 -36.01 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.43 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.6 mm -74.26 -33.62 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.544 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.737 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -77.1 -29.44 54.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.696 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.06 -46.0 65.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -33.46 73.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.965 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.26 -42.55 96.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.82 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 48' ' ' MET . 35.2 t -70.97 -30.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.726 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.99 43.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.307 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.2 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.91 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.741 0.305 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.47 -30.71 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.206 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -38.8 78.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -39.47 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.37 69.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.66 -54.35 43.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 t -59.83 -44.53 94.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.1 t80 -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.077 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.65 -34.23 73.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -65.69 -29.49 70.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -81.37 -26.55 35.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.92 HG22 HD21 ' A' ' 89' ' ' LEU . 15.8 t -80.25 -29.93 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.043 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 2.8 tptt -78.15 -47.61 17.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 42' ' ' ASP . 24.2 mt -64.91 -48.39 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -62.09 -31.55 72.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.81 ' CD2' HG21 ' A' ' 54' ' ' THR . 64.4 m-85 -122.14 42.35 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 -35.03 91.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.566 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -97.63 20.83 11.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.288 . . . . 0.0 111.223 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.21 89.15 11.07 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.994 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.15 -26.91 42.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.417 2.078 . . . . 0.0 112.25 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -45.15 93.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CD2' ' A' ' 48' ' ' PHE . 28.2 m -61.23 -55.84 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 t80 -60.3 -46.87 88.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.26 -38.15 82.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.45 -46.15 91.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.489 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.7 t80 -60.76 -46.31 90.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HG ' ' HB1' ' B' ' 53' ' ' ALA . 0.9 OUTLIER -60.49 -37.71 81.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.22 -41.97 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.0 mt -63.97 -46.79 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.566 ' HB3' ' HB2' ' B' ' 50' ' ' ALA . 27.2 mmt -69.37 -43.43 73.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.4 ttmt -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -66.01 -32.75 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.1 t80 -65.54 -47.39 76.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.21 -41.66 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.693 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -64.45 -15.1 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 74.02 40.93 0.43 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.939 0.399 . . . . 0.0 110.798 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.7 t -117.55 14.3 14.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 tt -159.01 146.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 t70 -90.52 177.19 6.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.37 -53.85 42.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 76' ' ' ILE . 77.0 Cg_exo -48.01 -39.14 32.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.572 2.182 . . . . 0.0 112.467 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 -29.21 72.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 61' ' ' ILE . 38.4 t -72.41 -43.86 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 73' ' ' PRO . 5.1 mt -61.83 -43.83 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -41.3 84.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -44.16 78.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 75' ' ' VAL . 29.5 t -76.13 -32.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -62.46 -25.37 67.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -31.17 13.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.41 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 12.5 tp -62.23 -63.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.699 ' CD1' HD13 ' A' ' 89' ' ' LEU . 11.3 m-85 -89.19 53.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.19 -39.4 93.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.02 25.8 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.157 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 1.2 m-70 -140.17 97.15 7.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.839 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.4 Cg_endo -72.94 -46.65 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.59 2.194 . . . . 0.0 112.891 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -55.83 -20.75 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.92 HD21 HG22 ' A' ' 44' ' ' VAL . 1.8 mt -85.67 -57.77 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -53.84 -26.43 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.193 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.6 t -77.2 -50.56 20.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.188 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 -32.59 53.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.979 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' CE2' HD11 ' A' ' 97' ' ' LEU . 39.9 t80 -78.32 -34.88 48.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.18 0.514 . . . . 0.0 110.494 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -59.96 -29.19 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.633 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.59 -4.5 27.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.881 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -99.7 -50.1 4.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.71 0.291 . . . . 0.0 110.886 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD13 HG12 ' A' ' 76' ' ' ILE . 7.6 mt -66.24 142.6 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 176.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.134 . . . . 0.0 112.311 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.15 -28.98 60.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.75 -51.21 58.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.624 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.79 88.79 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -86.36 122.37 30.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.577 HG12 HD11 ' A' ' 90' ' ' ILE . 8.0 tt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.794 0.247 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.648 ' O ' HD12 ' B' ' 49' ' ' LEU . 20.3 mp0 -76.12 -26.56 56.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.514 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 75' ' ' VAL . 6.0 mt -76.61 -32.56 58.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.237 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -72.74 -37.98 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.646 ' O ' HG23 ' B' ' 52' ' ' VAL . 2.7 ptt? -71.05 -32.16 68.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.648 HD12 ' O ' ' B' ' 45' ' ' GLN . 1.1 mt -67.97 -43.18 79.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.62 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' MET . . . -66.88 -34.02 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.54 -44.83 85.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.646 HG23 ' O ' ' B' ' 48' ' ' MET . 25.4 t -67.62 -29.1 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -77.68 -35.26 52.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 110.256 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.506 HD21 ' HG3' ' A' ' 63' ' ' LYS . 9.0 mp . . . . . 0 N--CA 1.45 -0.442 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.915 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 35' ' ' GLU . 29.2 p-80 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.529 0.204 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -44.63 -30.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.813 0.339 . . . . 0.0 111.532 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 33' ' ' HIS . 29.6 tt0 -62.22 -59.41 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -31.15 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.12 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mt -61.94 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -62.02 -44.51 96.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 44' ' ' VAL . 61.9 t80 -54.13 -48.31 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.088 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -63.05 -37.66 88.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.48 -32.14 70.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -30.62 62.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.6 t -82.87 -37.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.807 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -48.11 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.702 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -70.6 -47.97 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -60.73 -36.05 77.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 54' ' ' THR . 19.1 m-85 -115.68 39.06 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.19 -27.83 65.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -97.38 15.21 23.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.693 0.282 . . . . 0.0 111.29 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -140.18 77.49 25.06 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 -24.26 19.86 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.51 -55.28 36.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.228 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.743 HG23 ' HG ' ' A' ' 82' ' ' LEU . 3.3 m -59.85 -38.34 81.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.13 -56.23 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -31.97 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 -49.41 12.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.469 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 61' ' ' ILE . 61.1 t80 -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.042 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -39.64 83.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -62.24 -40.31 95.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 58' ' ' PHE . 7.5 mt -64.47 -51.74 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -41.83 98.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.787 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.0 OUTLIER -64.61 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -69.12 -42.52 75.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 75' ' ' VAL . 23.3 t80 -62.81 -44.72 95.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -31.63 67.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -66.49 -13.33 60.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.245 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 63.43 42.16 6.96 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.962 0.411 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -116.65 -39.04 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.0 tt -96.16 157.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -84.51 -177.69 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -74.36 -53.29 3.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 71.3 Cg_exo -48.75 -27.95 11.95 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.584 2.189 . . . . 0.0 112.364 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.38 -37.03 48.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.429 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.57 HG21 ' CD1' ' A' ' 65' ' ' PHE . 16.8 t -68.29 -40.16 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.765 0.316 . . . . 0.0 111.029 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 103' ' ' ILE . 16.3 mt -68.81 -42.51 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -58.76 -44.67 90.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.9 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' CZ ' ' A' ' 93' ' ' PHE . 45.5 t -64.51 -41.97 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -23.36 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.01 -39.33 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HG ' HG23 ' A' ' 54' ' ' THR . 9.2 tp -61.38 -34.15 74.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.736 ' CD1' HD13 ' A' ' 89' ' ' LEU . 18.5 m-85 -109.08 42.42 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -29.52 68.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 28.15 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.697 ' CB ' HD12 ' A' ' 89' ' ' LEU . 50.3 m-70 -140.13 96.13 8.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.6 Cg_endo -68.07 -48.39 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.348 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.62 -18.26 28.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' A' ' 83' ' ' PHE . 40.9 mt -87.41 -56.11 3.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.328 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.529 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -59.22 -28.49 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.278 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 87' ' ' PRO . 66.1 t -78.34 -48.04 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.21 85.67 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.934 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 40.9 t80 -72.51 -40.3 66.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.508 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -67.05 -21.18 65.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.004 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.66 -7.26 43.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.87 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -99.72 -30.24 12.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.331 . . . . 0.0 110.951 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -77.85 153.81 80.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 163.95 29.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.283 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.09 -31.1 68.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.0 -43.82 92.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.403 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -93.91 76.02 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.01 162.9 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.529 HG12 HD11 ' A' ' 90' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.735 0.223 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.33 -25.84 51.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.706 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . 57.8 mt -77.16 -33.13 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.297 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.2 mm -74.06 -37.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.491 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.51 -28.96 62.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.687 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.18 -47.4 61.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.436 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.547 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -66.19 -30.75 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.943 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -63.52 -50.73 68.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -64.15 -30.61 50.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.82 53.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.787 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.7 mp . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.993 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 35' ' ' GLU . 27.1 p-80 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.602 0.239 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -44.78 -46.66 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.718 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . 21.7 tt0 -58.2 -41.35 83.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.974 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -65.88 -36.42 83.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.85 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -61.96 -54.89 35.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.6 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 81.4 t80 -55.21 -51.63 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' B' ' 53' ' ' ALA . 24.0 mt -65.39 -32.0 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.3 m-20 -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.96 -27.39 33.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 27.1 t -80.67 -29.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.53 -48.19 15.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.711 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 42' ' ' ASP . 26.5 mt -64.77 -49.08 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -59.41 -30.25 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CE2' HG21 ' A' ' 54' ' ' THR . 34.2 m-85 -115.81 39.29 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.03 93.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.24 25.07 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.663 0.268 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -140.19 87.01 12.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.63 -28.34 37.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.574 2.183 . . . . 0.0 112.258 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.01 88.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 48' ' ' PHE . 8.7 m -66.9 -50.89 60.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 45' ' ' LYS . 12.5 t80 -60.06 -51.68 68.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.793 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.61 -54.01 31.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.437 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 61' ' ' ILE . 9.4 t80 -60.02 -36.65 77.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.431 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.3 mt -66.27 -41.17 90.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -59.82 -39.13 83.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.3 mt -72.34 -31.82 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -69.17 -43.73 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.866 ' HG3' HD11 ' B' ' 54' ' ' LEU . 5.0 mttm -70.81 -31.08 67.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -55.28 32.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.8 t80 -59.66 -42.26 92.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -36.47 74.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.42 -15.7 61.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 72.27 51.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 t -130.77 -54.29 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 65' ' ' PHE . 4.3 tt -73.96 148.52 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t70 -89.96 175.34 7.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.03 -53.26 56.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' A' ' 76' ' ' ILE . 76.2 Cg_exo -49.87 -36.53 43.37 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.615 2.21 . . . . 0.0 112.305 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.92 77.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 71' ' ' ASP . 21.6 t -65.99 -46.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.0 mt -59.49 -48.85 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 mtt85 -59.83 -40.09 87.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -49.82 76.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -75.1 -36.09 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.186 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 90' ' ' ILE . 8.6 t -60.57 -25.12 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.91 -33.51 11.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.7 tp -62.98 -46.79 86.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 89' ' ' LEU . 23.7 m-85 -104.63 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.68 -4.85 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.609 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -102.49 -35.31 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.629 ' HB2' HD12 ' A' ' 89' ' ' LEU . 71.3 m-70 -105.83 119.76 51.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 91' ' ' VAL . 73.2 Cg_endo -76.18 -42.44 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.447 2.098 . . . . 0.0 112.287 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.61 -18.01 17.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.629 HD12 ' HB2' ' A' ' 86' ' ' HIS . 12.9 mt -85.23 -55.79 3.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.303 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.55 HG13 HD11 ' A' ' 103' ' ' ILE . 17.7 tt -61.4 -27.51 42.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 87' ' ' PRO . 65.1 t -76.43 -48.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.16 -35.68 65.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.098 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.76 -36.14 62.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.685 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -63.02 -25.86 68.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.714 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.3 -1.66 21.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -99.75 -30.89 11.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.88 153.58 70.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.38 173.8 9.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.45 -13.89 61.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.266 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.05 -29.99 45.22 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.687 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -131.63 137.56 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -108.52 139.92 42.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.55 HD11 HG13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.733 0.222 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -79.65 -22.29 43.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 21.9 mt -81.31 -35.66 30.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.96 -33.61 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.351 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.655 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -76.68 -31.29 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.607 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.55 -49.94 60.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.62 74.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.818 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.655 HG23 ' O ' ' B' ' 48' ' ' MET . 39.0 t -71.25 -31.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 41' ' ' LEU . . . -78.11 -34.59 49.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.49 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.866 HD11 ' HG3' ' A' ' 63' ' ' LYS . 9.8 mp . . . . . 0 N--CA 1.45 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.796 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 38' ' ' LEU . 21.7 t -47.01 -28.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.536 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.9 -49.3 78.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.767 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.58 -30.88 64.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.86 -39.57 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 34' ' ' VAL . 23.3 mt -63.47 -51.99 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -58.15 -42.68 86.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.3 t80 -53.65 -50.01 66.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.17 -34.82 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -66.54 -33.59 76.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -27.12 38.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 23.6 t -79.27 -28.52 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.938 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.5 -47.23 17.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.3 mt -63.54 -48.53 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -63.93 -29.97 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.843 ' CD2' HG21 ' A' ' 54' ' ' THR . 4.8 m-85 -117.91 40.07 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.02 -28.62 72.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 p -104.89 25.55 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.11 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -140.18 68.11 33.48 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.28 -28.12 33.22 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.568 2.179 . . . . 0.0 112.307 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.64 89.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 48' ' ' PHE . 57.1 m -65.6 -45.03 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 12.4 t80 -59.52 -51.3 70.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -33.52 73.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.46 -50.85 40.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 61' ' ' ILE . 39.5 t80 -57.77 -46.07 85.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 110.779 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -44.24 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -54.01 -40.19 66.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 58' ' ' PHE . 12.7 mt -69.49 -32.1 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 32.8 mmt -69.59 -47.9 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HG2' HD11 ' B' ' 54' ' ' LEU . 5.4 mttt -65.45 -38.4 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.716 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.99 -44.59 94.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CD1' HG21 ' A' ' 75' ' ' VAL . 16.3 t80 -59.19 -54.7 43.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -59.48 -35.18 73.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -64.0 -16.92 62.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.254 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.81 44.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.13 -41.73 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.68 147.84 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t0 -87.04 172.61 9.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.416 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -61.8 -52.78 66.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.997 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.4 Cg_exo -49.73 -47.57 22.6 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.487 2.125 . . . . 0.0 112.463 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.33 -29.88 66.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.2 t -68.76 -47.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 mt -64.19 -36.34 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -61.85 -50.23 73.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -57.25 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.1 t -57.74 -47.56 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -59.12 -22.78 61.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.066 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -94.28 -36.46 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.58 -35.33 79.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 89' ' ' LEU . 13.8 m-85 -113.1 56.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.962 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -69.55 -29.91 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.153 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.15 26.21 10.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CB ' HD12 ' A' ' 89' ' ' LEU . 34.7 m-70 -140.14 94.62 8.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.835 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.54 -45.78 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.85 -18.87 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 48' ' ' PHE . 8.1 mt -85.17 -56.91 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 103' ' ' ILE . 13.1 tt -57.62 -26.75 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.259 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 87' ' ' PRO . 63.0 t -76.12 -51.63 19.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.39 87.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.126 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.63 -31.99 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 97' ' ' LEU . 34.4 t30 -62.87 -32.3 73.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.632 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.22 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.379 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CB ' HD11 ' B' ' 49' ' ' LEU . 29.8 m-85 -99.82 29.94 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 103' ' ' ILE . 20.9 mt -134.76 141.21 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.949 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.85 164.15 35.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.466 2.111 . . . . 0.0 112.295 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -26.69 68.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.014 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.7 -36.32 71.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.575 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -120.9 96.79 5.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.644 HD11 ' CD1' ' A' ' 97' ' ' LEU . 25.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 CA-C-O 120.692 0.205 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -79.84 -27.28 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.7 mt -78.98 -37.1 40.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.385 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.85 -34.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.719 ' O ' HG23 ' B' ' 52' ' ' VAL . 5.1 ptt? -75.5 -30.69 59.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 96' ' ' PHE . 11.8 mt -66.39 -49.9 65.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.86 79.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.921 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.12 -40.37 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.704 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.719 HG23 ' O ' ' B' ' 48' ' ' MET . 42.9 t -70.37 -34.07 56.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.802 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.6 -32.93 47.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.352 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.58 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.6 mp . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.291 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.619 0.247 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -45.59 -35.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.444 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.44 -33.31 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -43.71 59.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.36 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.971 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.93 -55.68 15.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.1 t -58.59 -45.07 89.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 44' ' ' VAL . 58.9 t80 -55.19 -48.06 74.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.07 -39.79 93.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.97 -29.07 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.801 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -79.45 -26.87 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 40' ' ' TYR . 21.6 t -78.94 -25.45 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -82.14 -45.99 14.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.24 -51.91 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.207 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -58.13 -30.22 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 54' ' ' THR . 32.0 m-85 -116.99 39.82 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 -40.32 92.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.575 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -97.75 24.0 7.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.038 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.17 63.96 24.94 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -51.3 -25.35 17.79 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.548 2.166 . . . . 0.0 112.436 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.51 82.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.869 HG21 ' CE2' ' A' ' 48' ' ' PHE . 4.9 m -68.32 -48.91 63.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CE2' HD11 ' A' ' 59' ' ' LEU . 16.9 t80 -60.66 -48.49 81.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.21 -40.53 90.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -48.19 80.36 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.22 -44.3 88.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.454 HD11 ' CE2' ' A' ' 55' ' ' TYR . 17.6 mt -61.07 -40.41 93.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.09 -38.49 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.43 HD13 ' HB3' ' A' ' 78' ' ' ARG . 27.8 mt -69.7 -33.59 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.412 ' O ' ' HB1' ' B' ' 50' ' ' ALA . 0.1 OUTLIER -69.64 -35.77 75.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HG2' HD11 ' B' ' 54' ' ' LEU . 4.4 mttt -76.62 -33.54 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.761 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -38.47 89.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.0 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 75' ' ' VAL . 37.7 t80 -76.26 -45.98 30.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.2 OUTLIER -57.76 -34.59 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 p -67.46 -13.09 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.324 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 43.93 0.29 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.911 0.386 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 m -115.36 -65.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.97 144.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.3 m-20 -82.5 -178.14 6.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.31 -52.9 50.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.4 Cg_exo -48.46 -43.03 33.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.556 2.171 . . . . 0.0 112.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.41 -29.92 76.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.394 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -74.55 -45.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 73' ' ' PRO . 3.6 mt -61.37 -50.6 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -58.55 -45.72 88.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HB3' HD13 ' A' ' 61' ' ' ILE . 33.7 mtt-85 -59.44 -31.38 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.001 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 75' ' ' VAL . 37.5 t -80.75 -47.32 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.165 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -22.19 48.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -92.58 -36.58 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.27 -30.57 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.39 40.63 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -68.04 -13.41 62.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.445 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -100.05 -30.29 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 111.072 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.637 ' CB ' HD12 ' A' ' 89' ' ' LEU . 8.3 m-70 -100.14 114.44 65.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.855 ' O ' HG23 ' A' ' 91' ' ' VAL . 68.8 Cg_endo -74.2 -43.55 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.45 2.1 . . . . 0.0 112.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -16.08 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.7 HD21 HG22 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -86.27 -53.46 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 0.0 110.055 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 tt -61.25 -28.69 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.192 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 87' ' ' PRO . 54.7 t -75.56 -51.07 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.26 -35.37 55.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -75.81 -34.33 60.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -62.53 -27.63 69.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.62 -1.63 22.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.012 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -99.88 -30.28 12.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.91 138.43 20.98 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.07 177.02 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.452 2.102 . . . . 0.0 112.227 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp -65.65 -29.94 70.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.57 -72.33 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.566 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.95 65.32 6.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.93 157.89 29.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.154 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.854 0.273 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.547 ' O ' HD12 ' B' ' 49' ' ' LEU . 17.8 mt-30 -79.81 -21.12 44.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 22.6 mt -81.08 -39.07 26.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.367 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 mt -72.59 -34.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.379 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.451 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -74.85 -32.35 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.435 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.547 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.8 OUTLIER -68.42 -44.65 74.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.403 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 62' ' ' MET . . . -66.43 -34.33 77.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.44 -46.32 90.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 48' ' ' MET . 43.5 t -68.93 -27.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.686 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.44 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -79.71 -36.26 37.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.069 0.461 . . . . 0.0 110.381 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.881 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.0 mp . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.044 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.57 -30.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -50.19 18.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' THR . 3.4 t0 -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.89 -39.16 64.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.53 -50.99 67.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.2 t -59.1 -42.78 91.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.851 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.9 t80 -52.56 -51.32 60.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.998 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.22 -33.27 75.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.586 ' OD1' HD11 ' A' ' 46' ' ' ILE . 14.6 t0 -67.77 -30.73 70.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -80.85 -26.02 37.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.2 t -78.74 -28.4 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 55' ' ' TYR . 1.5 tppp? -80.13 -49.29 11.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.586 HD11 ' OD1' ' A' ' 42' ' ' ASP . 34.0 mt -63.39 -41.12 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -60.05 -28.07 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 54' ' ' THR . 31.4 m-85 -131.97 47.63 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.84 77.81 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 19.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.21 87.27 12.28 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.855 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.97 -24.54 39.37 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.595 2.196 . . . . 0.0 112.418 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.34 80.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 48' ' ' PHE . 16.3 m -67.32 -57.98 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.758 ' CE2' HD11 ' A' ' 59' ' ' LEU . 15.9 t80 -59.97 -43.9 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -60.48 -38.28 83.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.77 56.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.664 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.0 t80 -57.97 -48.52 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.758 HD11 ' CE2' ' A' ' 55' ' ' TYR . 96.5 mt -57.92 -49.51 76.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -42.47 61.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 58' ' ' PHE . 11.4 mt -65.02 -31.91 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -43.84 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -74.14 -38.2 63.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 110.806 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB2' HD11 ' A' ' 70' ' ' ILE . 77.9 t80 -66.84 -45.98 76.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -55.14 -29.69 58.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -15.32 62.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.305 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 69.33 42.03 1.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.921 0.391 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 p -117.5 -36.52 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 65' ' ' PHE . 1.2 pt -93.32 178.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -114.86 170.16 8.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.443 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.69 -60.72 9.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.228 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 93.3 Cg_exo -42.99 -30.46 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.602 2.201 . . . . 0.0 112.58 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.74 -34.93 66.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.314 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 79' ' ' VAL . 25.0 t -70.67 -48.64 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.358 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.478 HG23 HG12 ' A' ' 103' ' ' ILE . 48.9 mt -60.17 -34.74 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -76.0 -39.68 55.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -61.31 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.4 t -60.42 -49.47 84.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.074 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.777 ' HA ' HD12 ' A' ' 90' ' ' ILE . 28.3 t -56.96 -25.5 58.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.104 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.78 -42.88 26.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 54' ' ' THR . 3.2 tp -64.23 -31.37 72.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE1' HD23 ' A' ' 82' ' ' LEU . 4.7 m-85 -118.22 61.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -73.59 -31.12 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.566 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.85 24.15 12.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.51 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CB ' HD12 ' A' ' 89' ' ' LEU . 1.9 m170 -129.65 90.81 42.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.79 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.811 ' O ' HG23 ' A' ' 91' ' ' VAL . 29.5 Cg_endo -64.11 -55.5 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.513 2.142 . . . . 0.0 112.393 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -50.75 -23.7 2.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.476 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD12 ' CB ' ' A' ' 86' ' ' HIS . 9.1 mt -81.53 -57.9 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.24 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 103' ' ' ILE . 1.6 tt -61.94 -25.4 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.466 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 87' ' ' PRO . 98.3 t -72.98 -50.5 31.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.19 -37.51 80.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.219 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -72.85 -30.71 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.047 0.451 . . . . 0.0 110.837 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 103' ' ' ILE . 65.2 t30 -69.02 -27.42 65.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.16 -13.59 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -99.75 -29.18 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.7 149.7 78.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.721 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.98 172.07 12.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.612 2.208 . . . . 0.0 112.301 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -67.67 -42.78 81.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.68 -49.22 79.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.406 ' HB3' HD11 ' A' ' 76' ' ' ILE . 6.8 m-85 -94.19 54.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.849 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -174.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 90' ' ' ILE . 22.5 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.767 0.236 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.38 -24.62 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 46' ' ' LEU . 11.8 mt -78.02 -40.23 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.447 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 65' ' ' PHE . 32.1 mm -70.0 -37.52 72.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.47 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.731 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.22 -29.06 62.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.628 179.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.43 -43.45 81.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.514 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' HG3' ' A' ' 66' ' ' LYS . . . -67.19 -39.84 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.77 -46.35 89.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.628 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 48' ' ' MET . 40.6 t -68.2 -30.22 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.12 43.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.416 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.686 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.4 mp . . . . . 0 N--CA 1.449 -0.49 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.327 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.812 0.339 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.24 -32.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.198 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.71 -34.34 75.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.96 -41.44 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.89 -51.19 60.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.7 t -60.12 -44.93 94.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.802 ' O ' HG23 ' A' ' 44' ' ' VAL . 70.0 t80 -52.79 -51.28 61.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.916 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -60.7 -40.23 91.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.454 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m-20 -71.39 -25.29 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.18 -28.21 38.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.3 t -79.68 -30.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.977 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 55' ' ' TYR . 1.2 ttpm? -76.92 -47.89 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 42' ' ' ASP . 22.6 mt -64.02 -44.61 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.12 -29.01 63.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.9 42.8 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -42.39 85.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.83 9.57 26.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.613 0.244 . . . . 0.0 111.296 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -140.32 79.51 21.02 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 -15.6 48.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.54 2.16 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.67 68.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.233 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.544 ' O ' HD21 ' A' ' 82' ' ' LEU . 53.8 m -63.85 -47.54 80.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 59' ' ' LEU . 17.7 t80 -58.8 -46.9 86.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.996 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.67 -46.66 45.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.615 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 61' ' ' ILE . 79.2 t80 -61.81 -49.68 75.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.6 mt -56.9 -43.61 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.064 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -55.89 -47.1 78.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.163 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -61.3 -38.56 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.108 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.3 mmt -66.83 -47.84 70.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -64.56 -45.02 88.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.684 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -33.63 76.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 75' ' ' VAL . 38.5 t80 -60.1 -55.02 39.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.85 -30.27 70.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.0 p -71.37 -8.33 53.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.262 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 65.81 43.3 3.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.815 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -119.84 1.92 11.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.323 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.1 tt -145.04 137.82 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -80.16 172.21 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.997 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -58.5 -58.32 19.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.6 Cg_endo -47.33 -42.36 27.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.549 2.166 . . . . 0.0 112.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 -29.02 67.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.202 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 79' ' ' VAL . 23.8 t -74.86 -43.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.849 0.357 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 103' ' ' ILE . 41.3 mt -69.02 -41.72 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -60.13 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -55.77 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 75' ' ' VAL . 42.3 t -58.66 -45.28 90.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.9 p -61.48 -23.42 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.044 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -94.77 -31.36 13.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 54' ' ' THR . 4.1 tp -60.56 -36.54 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.762 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.3 m-85 -113.71 47.19 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -62.39 -22.58 66.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.182 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -99.9 -32.14 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.581 ' CB ' HD12 ' A' ' 89' ' ' LEU . 81.7 m-70 -102.48 95.13 5.65 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.59 -30.94 22.27 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.41 2.073 . . . . 0.0 112.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.85 -19.7 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -85.27 -49.82 7.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.014 0.435 . . . . 0.0 109.87 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.524 HG23 HG21 ' A' ' 103' ' ' ILE . 53.5 mt -61.57 -27.66 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.915 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 87' ' ' PRO . 47.7 t -74.2 -51.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.28 81.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.071 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CD2' HG11 ' A' ' 79' ' ' VAL . 18.1 t80 -70.26 -35.57 73.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.95 -26.68 66.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.668 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 -11.41 53.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.747 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.6 -37.25 9.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.613 HD13 HD11 ' A' ' 103' ' ' ILE . 3.9 mp -72.32 116.86 53.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.47 177.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.418 2.078 . . . . 0.0 112.275 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.97 -27.29 65.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -31.14 58.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.519 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -133.03 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -111.95 134.94 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 97' ' ' LEU . 24.5 mt . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 CA--C 1.527 0.13 0 CA-C-O 120.807 0.253 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.3 mp0 -77.86 -23.24 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.1 mt -77.92 -37.31 48.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.381 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -71.35 -38.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.453 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.659 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.99 -29.59 64.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.434 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.9 mt -68.82 -43.05 76.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.86 83.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.947 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -61.85 -42.74 99.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.658 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.659 HG23 ' O ' ' B' ' 48' ' ' MET . 38.3 t -69.12 -29.69 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.02 -36.85 40.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.31 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.547 HD11 ' CG ' ' A' ' 63' ' ' LYS . 7.4 mp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.857 0.36 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.2 -29.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.52 -41.62 72.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.5 -33.56 69.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.16 -36.94 64.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.037 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -52.22 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -60.08 -42.92 95.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.901 ' O ' HG23 ' A' ' 44' ' ' VAL . 55.0 t80 -52.08 -47.69 65.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.16 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.13 -40.42 94.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -68.06 -29.88 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -76.62 -30.19 56.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.797 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.2 t -78.06 -30.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.46 -45.59 58.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.65 -39.62 84.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -29.9 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.7 m-85 -118.46 40.19 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.99 -21.5 79.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.3 p -92.01 -9.16 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -140.03 100.57 7.17 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.575 0.226 . . . . 0.0 111.041 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.46 -14.93 37.84 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.491 2.128 . . . . 0.0 112.598 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.84 -40.36 69.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CE2' ' A' ' 48' ' ' PHE . 22.8 m -68.37 -50.0 56.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -61.75 -49.11 77.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.47 -34.46 74.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -48.55 49.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.5 t80 -56.69 -46.63 81.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.944 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.55 -39.33 87.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -62.03 -38.61 89.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.8 mt -68.53 -48.81 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.6 mmt -64.23 -37.57 87.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -70.84 -47.77 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.85 -29.88 69.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 54.3 t80 -76.44 -42.11 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm -54.26 -33.8 59.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.006 0.431 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -15.86 60.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.03 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 63.66 43.4 5.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 110.763 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -116.53 -35.63 4.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.6 pt -86.6 178.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.23 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.36 161.44 13.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -58.47 -59.26 14.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.0 Cg_endo -45.46 -41.28 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.812 2.341 . . . . 0.0 112.179 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.31 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.613 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.5 t -79.27 -46.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 mt -65.68 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -45.63 68.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.756 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -48.01 82.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -67.03 -41.15 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -61.39 -23.44 65.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -36.38 11.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.793 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 54' ' ' THR . 5.0 tp -61.66 -38.91 89.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.8 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.9 m-85 -104.61 60.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.07 31.25 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -46.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.677 ' HB2' HD12 ' A' ' 89' ' ' LEU . 50.6 m-70 -105.2 103.52 42.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.854 ' O ' HG23 ' A' ' 91' ' ' VAL . 36.8 Cg_exo -57.73 -34.24 97.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.536 2.157 . . . . 0.0 112.292 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.63 -17.79 16.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.606 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.8 HD13 ' CD1' ' A' ' 83' ' ' PHE . 4.3 mt -83.06 -55.91 4.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.179 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 103' ' ' ILE . 18.0 tt -60.25 -27.08 38.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.22 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 87' ' ' PRO . 67.7 t -73.75 -48.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.524 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -38.56 90.78 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -71.68 -32.26 67.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.967 0.413 . . . . 0.0 110.715 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 97' ' ' LEU . 50.2 t30 -66.51 -29.38 69.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.784 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.41 -17.72 55.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.496 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.74 30.07 3.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 94' ' ' ASN . 6.1 mt -142.06 143.58 28.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.13 169.44 22.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.286 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.02 -32.53 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.16 89.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.45 93.16 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -103.55 148.9 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 90' ' ' ILE . 5.8 tt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.788 0.245 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 48' ' ' MET . 14.5 mt-30 -79.09 -22.08 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.1 mt -79.13 -37.85 37.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.35 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -72.68 -36.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' MET . . . . . 0.698 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.1 OUTLIER -73.9 -29.19 61.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.67 -47.25 67.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.34 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.25 80.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.7 -42.79 99.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.59 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.698 HG23 ' O ' ' B' ' 48' ' ' MET . 39.3 t -67.32 -32.97 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.873 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.28 -33.48 49.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.443 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.451 -0.419 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.293 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 CA-C-O 120.729 0.221 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 m -67.62 83.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.27 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -125.12 -176.69 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.8 t -52.58 -28.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.267 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.02 -41.53 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -38.37 83.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.811 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.87 -34.19 66.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -63.48 -53.49 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.946 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 t -59.47 -42.37 91.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.905 ' O ' HG23 ' A' ' 44' ' ' VAL . 39.6 t80 -52.64 -46.87 67.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.8 mt -63.66 -43.39 96.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -29.5 69.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -31.42 56.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.798 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 40' ' ' TYR . 32.9 t -79.45 -24.76 12.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.981 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 4.4 tttm -77.83 -44.27 27.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -68.73 -51.11 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.34 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -29.21 63.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.137 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 54' ' ' THR . 11.5 m-85 -115.69 39.18 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.21 -28.0 71.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.6 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 p -97.32 6.79 47.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.453 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.17 86.68 12.79 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.672 0.273 . . . . 0.0 110.916 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.83 -25.07 28.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.593 2.195 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.28 86.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.763 HG21 ' CE2' ' A' ' 48' ' ' PHE . 19.6 m -61.1 -45.06 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.452 ' CE2' HD11 ' A' ' 59' ' ' LEU . 28.6 t80 -60.83 -50.86 71.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -31.12 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.79 -43.4 84.07 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.842 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.9 t80 -61.05 -44.35 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.828 HD23 ' HB1' ' B' ' 53' ' ' ALA . 6.6 mt -62.45 -37.03 84.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.78 -44.66 96.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 58' ' ' PHE . 4.9 mt -59.37 -53.2 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -50.19 70.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.639 ' HG3' HD21 ' B' ' 54' ' ' LEU . 21.6 tttm -59.34 -39.79 84.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.27 -31.24 71.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CZ ' HD13 ' B' ' 46' ' ' LEU . 41.0 t80 -69.98 -40.35 75.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -59.41 -34.74 72.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.6 -16.07 62.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.272 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 71.38 39.51 0.92 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.833 0.349 . . . . 0.0 110.821 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.51 -51.4 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.5 tt -79.63 131.09 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.16 172.75 10.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -60.08 -58.41 19.59 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 83.1 Cg_exo -45.06 -31.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.578 2.185 . . . . 0.0 112.442 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 -32.44 64.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.461 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 61' ' ' ILE . 33.5 t -71.07 -48.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 72' ' ' THR . 3.1 mp -67.73 -32.18 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.223 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -63.91 -52.49 59.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -57.09 -47.99 79.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 75' ' ' VAL . 44.0 t -61.47 -42.06 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.967 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -62.51 -24.84 67.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.181 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -96.53 -35.5 11.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD23 ' CE1' ' A' ' 83' ' ' PHE . 1.9 tp -62.83 -44.38 96.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.3 m-85 -107.03 51.11 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.74 -30.83 71.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.26 26.64 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.785 ' HB3' HD12 ' A' ' 89' ' ' LEU . 19.2 m-70 -140.11 95.11 8.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.962 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.76 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.1 Cg_endo -67.7 -48.92 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.428 2.085 . . . . 0.0 112.359 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -55.25 -20.62 11.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.4 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 86' ' ' HIS . 5.0 mt -85.68 -56.59 3.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 110.415 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 87' ' ' PRO . 16.2 tt -61.01 -28.99 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.8 t -75.76 -47.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.88 -39.47 68.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.161 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -74.84 -32.59 61.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.42 -30.06 70.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.762 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.14 -8.85 49.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.783 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -99.76 -38.83 8.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.787 0.327 . . . . 0.0 111.017 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.463 HD13 HG12 ' A' ' 76' ' ' ILE . 68.9 mt -70.52 138.01 86.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.75 177.04 9.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.537 2.158 . . . . 0.0 112.383 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.15 -29.86 68.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.96 -63.48 5.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.593 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -104.2 88.25 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -87.27 178.77 6.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 76' ' ' ILE . 17.6 mt -109.2 140.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.26 154.44 23.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.51 78.68 28.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.87 115.27 2.3 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.552 2.168 . . . . 0.0 112.254 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.857 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.622 0.249 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.75 -22.92 49.17 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.516 2.144 . . . . 0.0 112.418 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.612 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.4 mm-40 -76.86 -25.51 53.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.963 0.411 . . . . 0.0 110.562 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.68 HD21 HG11 ' A' ' 75' ' ' VAL . 2.3 mt -77.49 -33.73 54.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.273 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -73.22 -36.38 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.747 ' O ' HG23 ' B' ' 52' ' ' VAL . 10.0 ptt? -74.45 -29.96 61.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.703 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.612 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.3 mt -67.56 -48.36 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.675 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.24 -33.0 74.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -64.58 -46.09 84.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.747 HG23 ' O ' ' B' ' 48' ' ' MET . 26.1 t -67.79 -28.8 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.828 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.62 -35.5 45.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.326 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.639 HD21 ' HG3' ' A' ' 63' ' ' LYS . 4.2 mp -86.71 -19.4 29.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.909 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.98 78.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.799 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.19 50.74 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.929 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.488 1.16 0 CA-C-O 120.795 0.248 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG11 ' CD2' ' A' ' 96' ' ' PHE . 25.2 t -81.91 78.37 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -106.34 -161.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 38' ' ' LEU . 21.8 t -47.56 -28.48 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.455 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -59.25 -52.38 65.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -30.57 66.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.941 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.39 -39.23 62.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 34' ' ' VAL . 4.9 mt -63.34 -51.08 67.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.53 -44.75 93.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.887 ' O ' HG23 ' A' ' 44' ' ' VAL . 56.6 t80 -54.68 -42.34 71.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.079 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.03 -30.21 64.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' HD12 ' A' ' 46' ' ' ILE . 34.4 t70 -70.46 -31.79 69.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.991 0.424 . . . . 0.0 111.096 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -82.02 -30.98 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 40' ' ' TYR . 41.7 t -77.02 -22.8 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.071 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG2' ' CE1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -85.05 -47.18 10.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.983 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 42' ' ' ASP . 23.0 mt -62.9 -53.45 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -29.64 67.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.984 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 54' ' ' THR . 24.2 m-85 -118.36 40.24 3.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.92 -28.22 63.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.537 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -114.92 38.47 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.11 87.72 12.15 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.53 -29.5 24.86 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.557 2.171 . . . . 0.0 112.324 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.77 -49.9 75.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.077 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.799 ' HA ' HD11 ' A' ' 82' ' ' LEU . 1.7 m -64.75 -52.51 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.432 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 5.6 t80 -59.71 -49.07 79.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -60.37 -30.65 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.28 -57.11 7.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.514 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.712 ' HA ' HD12 ' A' ' 61' ' ' ILE . 8.4 t80 -57.01 -41.21 78.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -45.86 91.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -44.37 87.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.7 mt -63.27 -31.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -47.41 31.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.859 ' HG2' HD11 ' B' ' 54' ' ' LEU . 2.1 mttp -66.74 -41.39 87.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.816 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -41.76 98.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CE2' HD13 ' B' ' 47' ' ' ILE . 26.8 t80 -59.36 -48.14 82.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HZ3' ' HB3' ' B' ' 50' ' ' ALA . 0.0 OUTLIER -59.4 -36.58 76.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -16.69 61.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.134 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.9 40.57 0.92 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 p -111.98 -38.23 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.7 tt -98.47 133.28 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.004 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 75' ' ' VAL . 18.0 m-20 -75.99 178.99 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -64.85 -52.82 47.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.2 Cg_exo -48.43 -38.99 35.89 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.94 -29.34 74.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.5 t -73.9 -47.86 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 111.078 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.9 mt -59.69 -37.05 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -41.31 60.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -49.06 78.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 83' ' ' PHE . 49.9 t -65.92 -39.13 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.0 p -61.66 -25.82 67.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -45.05 13.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.784 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 54' ' ' THR . 12.8 tp -60.68 -38.76 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.64 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.55 61.05 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -58.39 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.379 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 28.44 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.332 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 2.7 m170 -125.11 90.64 50.63 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.788 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.6 Cg_endo -65.02 -51.94 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.519 2.146 . . . . 0.0 112.43 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -55.83 -20.37 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.64 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.0 mt -86.9 -56.65 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.249 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 103' ' ' ILE . 16.5 tt -59.73 -31.93 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 87' ' ' PRO . 70.2 t -75.16 -44.93 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.32 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.36 -32.83 68.89 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.054 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -73.43 -42.3 62.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.118 0.485 . . . . 0.0 110.707 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 103' ' ' ILE . 1.1 t30 -61.57 -24.78 66.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.778 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.83 -9.96 48.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.484 ' CD2' HG11 ' A' ' 32' ' ' VAL . 10.9 m-85 -99.58 -30.7 11.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 110.931 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 94' ' ' ASN . 3.4 mt -82.88 146.52 52.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 171.07 13.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.509 2.139 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.04 -27.87 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.07 -45.83 92.07 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.573 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -108.19 126.34 52.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -127.36 136.55 52.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 HG13 ' A' ' 90' ' ' ILE . 20.8 tt -90.79 118.92 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.58 177.34 4.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.025 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.41 ' CG1' HD13 ' A' ' 90' ' ' ILE . 1.4 mp -127.79 94.97 35.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.45 164.19 33.7 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.79 -31.38 10.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.589 2.192 . . . . 0.0 112.368 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -20.38 54.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 7.6 mt -77.55 -39.99 44.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.338 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.483 HD13 ' CE2' ' A' ' 65' ' ' PHE . 27.9 mm -70.44 -38.95 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.885 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.02 -26.74 61.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.809 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.468 ' HG ' ' HE3' ' B' ' 48' ' ' MET . 10.0 mt -68.28 -50.12 55.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' HZ3' ' A' ' 66' ' ' LYS . . . -64.1 -35.58 81.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -63.25 -39.25 94.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.739 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.885 HG23 ' O ' ' B' ' 48' ' ' MET . 36.2 t -70.9 -30.39 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.93 -35.43 43.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.054 0.454 . . . . 0.0 110.416 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.4 mp -87.39 -19.93 27.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.091 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.9 93.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.03 30.82 7.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.947 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.487 1.134 0 CA-C-O 120.864 0.276 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 3.7 m -63.1 83.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -107.58 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.26 -33.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.53 -43.71 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 39' ' ' THR . 6.5 m-20 -66.19 -39.13 89.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.786 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.61 -33.51 69.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -54.38 34.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.1 t -58.02 -42.67 85.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.894 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.7 t80 -52.63 -49.14 65.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.008 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -72.03 -30.0 64.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 110.994 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -76.8 -30.02 56.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.5 t -78.49 -30.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.802 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HE2' ' CZ ' ' A' ' 55' ' ' TYR . 1.6 tppp? -71.77 -47.75 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.05 -48.02 89.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -30.47 69.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.3 m-85 -121.79 42.19 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.33 -45.54 92.72 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.533 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 p -98.18 28.1 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 111.0 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.23 65.98 29.6 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.98 -23.21 20.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.598 2.198 . . . . 0.0 112.481 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.55 -39.61 67.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.514 HG21 ' CE2' ' A' ' 48' ' ' PHE . 3.1 m -76.87 -46.43 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 30.4 t80 -62.28 -51.91 65.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.35 -43.32 92.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.21 -48.53 85.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' HA ' HD12 ' A' ' 61' ' ' ILE . 13.2 t80 -59.48 -31.35 69.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.33 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD23 ' HB1' ' B' ' 53' ' ' ALA . 14.8 mt -70.2 -46.72 63.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.38 -38.32 83.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 58' ' ' PHE . 13.1 mt -65.59 -51.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.086 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 18.2 mmt -67.05 -41.33 86.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.55 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.2 ttmm -68.67 -31.46 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.92 -34.76 62.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' HG21 ' A' ' 75' ' ' VAL . 25.9 t80 -64.66 -56.56 13.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.019 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.597 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.0 OUTLIER -57.94 -36.41 72.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.895 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t -67.41 -12.91 61.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.224 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 74.83 45.06 0.17 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -114.46 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.1 tt -81.5 150.1 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 t0 -88.34 -175.3 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -54.61 4.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.2 -32.15 18.5 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 -38.27 60.23 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.493 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 79' ' ' VAL . 26.3 t -65.53 -33.56 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 103' ' ' ILE . 20.6 mt -75.28 -35.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -75.62 -42.74 50.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -62.24 -56.97 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' CE2' ' A' ' 93' ' ' PHE . 47.1 t -58.09 -48.06 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.3 p -60.57 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -91.37 -42.68 10.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.755 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HG ' HG23 ' A' ' 54' ' ' THR . 2.6 tp -60.41 -30.79 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.868 ' CD1' HD13 ' A' ' 89' ' ' LEU . 19.0 m-85 -110.16 46.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.57 -34.61 78.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.065 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -108.03 26.12 10.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.689 ' CB ' HD12 ' A' ' 89' ' ' LEU . 29.8 m-70 -140.12 94.4 8.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.819 ' O ' HG23 ' A' ' 91' ' ' VAL . 44.7 Cg_endo -68.41 -44.99 2.88 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.414 2.076 . . . . 0.0 112.371 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -64.26 -13.78 51.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.35 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.868 HD13 ' CD1' ' A' ' 83' ' ' PHE . 13.3 mt -86.72 -54.57 4.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.176 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.37 -29.25 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.151 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.6 t -75.66 -49.89 25.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.469 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.74 -38.39 87.96 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.065 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.647 ' CE2' HG21 ' A' ' 79' ' ' VAL . 85.1 t80 -71.36 -34.29 70.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.591 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.55 -33.46 73.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -17.9 57.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CB ' HD11 ' B' ' 49' ' ' LEU . 75.8 m-85 -99.8 29.9 3.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.54 143.81 48.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.24 176.1 9.04 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.489 2.126 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -19.3 61.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.12 49.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.819 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -128.76 145.57 51.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.63 137.01 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.767 HG12 HG23 ' A' ' 76' ' ' ILE . 17.3 mt -91.25 150.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.86 156.85 22.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.53 79.22 67.56 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 136.89 67.85 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.605 2.203 . . . . 0.0 112.253 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.687 0.28 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 -18.89 22.32 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.595 2.197 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.48 -25.48 50.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.01 0.433 . . . . 0.0 110.69 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 65' ' ' PHE . 6.9 mt -76.99 -33.97 57.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.374 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.3 mt -72.43 -39.99 63.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.427 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.548 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -70.47 -29.92 66.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.621 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' A' ' 96' ' ' PHE . 3.9 mt -66.58 -50.29 63.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.419 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.45 ' HB1' ' HG2' ' A' ' 66' ' ' LYS . . . -62.03 -33.45 74.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.758 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -61.62 -44.48 96.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.629 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 48' ' ' MET . 39.8 t -67.95 -29.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.903 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.515 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -77.72 -35.19 52.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.067 0.46 . . . . 0.0 110.204 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 66' ' ' LYS . 8.3 mp -84.43 -21.09 30.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.872 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.83 93.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.804 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.39 52.22 4.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.529 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.947 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.237 0 CA-C-O 120.81 0.254 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.3 87.48 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.207 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 21.6 p-80 -135.04 -164.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.68 -52.02 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.762 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 18.2 mt-10 -58.12 -49.07 78.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -58.98 -36.57 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.98 -31.43 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.43 -52.72 43.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.8 t -59.53 -43.71 93.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.956 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 42.6 t80 -52.87 -52.7 56.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.73 -37.27 85.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 46' ' ' ILE . 6.5 t70 -66.23 -32.59 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.005 0.431 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.68 -31.31 36.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.767 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 33.0 t -78.72 -24.31 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.125 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 16.6 tptt -81.5 -46.76 14.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 42' ' ' ASP . 19.7 mt -65.09 -47.83 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -29.41 70.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 54' ' ' THR . 25.8 m-85 -116.12 39.34 3.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 0.0 110.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.36 -28.75 73.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 m -101.4 18.14 20.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.595 0.236 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.27 86.99 12.37 Favored Pre-proline 0 N--CA 1.453 -0.309 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.8 -26.33 32.48 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.489 2.126 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.83 -38.29 78.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.3 m -76.16 -37.81 57.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.438 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 33.9 t80 -71.9 -52.85 15.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -60.01 -37.65 80.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.78 -42.43 95.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 61' ' ' ILE . 28.0 t80 -59.2 -53.2 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.878 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' HB1' ' B' ' 53' ' ' ALA . 3.0 mt -59.8 -35.34 74.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -39.88 92.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.837 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -64.55 -54.34 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' B' ' 50' ' ' ALA . 28.8 mmt -62.05 -40.25 95.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.869 ' HG3' HD21 ' B' ' 54' ' ' LEU . 14.2 tttt -68.12 -31.1 70.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.03 -37.57 58.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.539 ' CD1' HG21 ' A' ' 75' ' ' VAL . 48.3 t80 -67.84 -38.9 83.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -57.97 -32.12 67.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.793 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -68.25 -12.04 60.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 65.65 39.54 4.85 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.977 0.418 . . . . 0.0 110.829 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.56 -47.87 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.888 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.7 tt -87.09 158.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -89.69 -177.68 5.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.546 HG21 ' CE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -72.74 -51.38 6.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.1 Cg_exo -49.75 -33.59 32.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.78 -30.72 67.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.411 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 65' ' ' PHE . 21.5 t -72.94 -35.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.9 mm -67.72 -46.29 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -36.45 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -63.26 -53.85 46.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 93' ' ' PHE . 42.9 t -66.56 -47.92 82.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.191 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.637 ' HB2' HG22 ' A' ' 105' ' ' ILE . 78.4 p -58.24 -23.24 55.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -87.11 -41.57 13.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 54' ' ' THR . 2.2 tp -62.75 -31.1 71.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.893 ' CD1' HD13 ' A' ' 89' ' ' LEU . 15.3 m-85 -116.31 58.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -71.7 -32.2 67.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.201 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.6 33.7 5.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.159 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.8 ' CB ' HD12 ' A' ' 89' ' ' LEU . 59.7 m-70 -140.06 86.16 13.42 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.054 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.723 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.9 Cg_exo -57.02 -50.53 11.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.25 . . . . 0.0 112.323 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -19.12 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.446 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.893 HD13 ' CD1' ' A' ' 83' ' ' PHE . 7.0 mt -87.64 -57.7 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 87' ' ' PRO . 11.7 tt -59.59 -31.9 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.177 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.7 t -77.47 -44.75 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.79 -38.49 96.04 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 79' ' ' VAL . 71.2 t80 -72.96 -34.09 66.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.073 0.464 . . . . 0.0 110.788 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -69.14 -23.9 64.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.963 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.37 -11.19 57.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.734 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -99.7 -30.21 12.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.71 143.9 63.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 162.91 41.08 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.42 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -28.55 67.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.57 -27.65 61.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.546 ' CE2' HG21 ' A' ' 72' ' ' THR . 24.2 m-85 -111.2 102.09 10.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.75 0.31 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 141.54 39.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 103' ' ' ILE . 0.7 OUTLIER -87.62 111.53 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -110.52 167.45 10.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.637 HG22 ' HB2' ' A' ' 80' ' ' SER . 1.7 pt -127.82 128.61 23.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.18 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.26 135.24 22.31 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.433 2.088 . . . . 0.0 112.29 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.1 mttt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.984 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' B' ' 44' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.735 0.302 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' B' ' 43' ' ' ALA . 55.6 Cg_endo -70.06 -26.33 26.27 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.642 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.5 mp0 -77.04 -22.97 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' B' ' 46' ' ' LEU . 15.4 mt -76.9 -35.7 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.335 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.0 mt -72.71 -38.81 59.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.426 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.697 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.89 -27.02 61.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.812 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.642 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.7 OUTLIER -70.65 -45.21 65.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.52 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 62' ' ' MET . . . -67.0 -34.49 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.943 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -64.44 -47.58 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.697 HG23 ' O ' ' B' ' 48' ' ' MET . 37.2 t -66.18 -28.26 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.003 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.447 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -78.88 -36.11 42.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.276 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.869 HD21 ' HG3' ' A' ' 63' ' ' LYS . 7.1 mp -84.16 -21.24 31.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.953 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.4 93.82 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.64 44.71 2.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.954 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.897 0.291 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.3 m -65.71 77.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.237 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.47 -169.76 2.0 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.802 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -48.42 -28.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.27 -39.23 71.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.712 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -37.89 77.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.789 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.22 63.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.52 -49.72 57.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -59.44 -44.92 92.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.7 t80 -54.54 -51.26 65.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.98 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.51 -31.07 71.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -33.04 69.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.731 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -79.28 -31.35 43.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.671 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.4 t -78.38 -29.83 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.751 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 1.2 tttm -72.84 -48.98 33.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.22 -41.64 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.46 -28.33 65.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -117.61 40.11 3.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.93 50.99 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.552 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.7 17.08 19.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.661 0.267 . . . . 0.0 111.181 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 4.3 t0 -140.25 62.74 21.1 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 110.941 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 51' ' ' ASP . 50.2 Cg_exo -53.4 -23.26 23.59 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.533 2.155 . . . . 0.0 112.462 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.47 72.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.356 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG23 ' HG ' ' A' ' 82' ' ' LEU . 2.0 m -60.36 -47.42 86.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CE2' ' HD2' ' A' ' 45' ' ' LYS . 13.6 t80 -63.04 -43.34 98.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -44.38 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -43.81 98.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.548 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HA ' HD12 ' A' ' 61' ' ' ILE . 67.3 t80 -58.78 -43.29 90.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 mt -61.7 -37.1 82.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.78 -43.63 97.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.7 mt -59.93 -59.5 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.3 91.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HD3' HD21 ' B' ' 54' ' ' LEU . 1.3 ttpp -64.46 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.02 -32.82 59.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 75' ' ' VAL . 66.9 t80 -66.27 -35.9 81.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -59.21 -32.15 69.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.1 -16.89 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.28 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.46 40.91 1.37 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 p -113.11 -48.77 2.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 65' ' ' PHE . 13.0 tt -78.69 156.31 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.1 t0 -87.08 173.56 9.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.427 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -72.06 -51.95 7.89 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 72' ' ' THR . 76.1 Cg_exo -49.62 -35.33 37.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.536 2.157 . . . . 0.0 112.358 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.83 -30.08 70.61 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.413 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 79' ' ' VAL . 32.4 t -71.03 -47.01 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.796 0.331 . . . . 0.0 111.038 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 103' ' ' ILE . 6.7 mt -66.06 -32.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -49.78 56.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -45.91 90.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 75' ' ' VAL . 40.2 t -59.47 -46.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.1 p -62.12 -24.96 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -78.03 -47.26 18.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 mp -60.18 -29.0 68.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.816 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.421 ' CD1' HD13 ' A' ' 89' ' ' LEU . 4.4 m-85 -111.78 54.02 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.56 -43.34 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.078 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -110.57 26.89 10.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.822 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.9 m170 -128.9 93.66 36.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.799 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 37.3 Cg_endo -66.74 -51.95 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.453 2.102 . . . . 0.0 112.557 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.84 -18.83 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.822 HD12 ' CB ' ' A' ' 86' ' ' HIS . 37.9 mt -84.1 -55.49 4.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.207 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.75 -28.64 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.081 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' PRO . 58.8 t -73.71 -46.27 47.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.426 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.47 -35.3 84.81 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.059 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.8 t80 -72.59 -35.14 67.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.089 0.471 . . . . 0.0 110.775 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -66.95 -27.26 67.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -16.76 55.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.75 -30.07 12.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -68.94 147.64 97.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.26 173.48 11.35 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.557 2.172 . . . . 0.0 112.349 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.21 -30.88 69.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -68.55 -64.63 2.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -78.53 84.82 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.55 147.51 27.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 76' ' ' ILE . 8.7 tt -89.03 129.86 39.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.036 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.3 OUTLIER -134.31 -173.32 3.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.949 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 104' ' ' ASP . 1.8 pt -156.91 96.38 2.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.061 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.5 122.82 9.35 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.55 2.167 . . . . 0.0 112.389 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.927 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.12 -19.84 22.32 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.457 2.104 . . . . 0.0 112.453 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.99 -24.69 47.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.959 0.409 . . . . 0.0 110.788 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 46' ' ' LEU . 17.5 mt -76.19 -38.83 56.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.476 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 42.8 mt -70.49 -39.64 76.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.426 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.665 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.5 -27.09 62.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.749 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.446 ' HG ' ' HE3' ' B' ' 48' ' ' MET . 4.6 mt -68.7 -46.54 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.59 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.462 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -65.27 -36.35 83.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.051 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -61.89 -45.97 91.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.703 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 48' ' ' MET . 41.7 t -67.15 -27.87 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.88 -35.19 51.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.25 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 63' ' ' LYS . 9.5 mp -86.25 -22.63 26.76 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.826 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.423 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -167.65 71.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.14 -35.66 2.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.933 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.487 1.131 0 CA-C-O 120.88 0.283 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.891 HG11 ' HG2' ' B' ' 45' ' ' GLN . 25.6 t -70.0 86.45 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 -169.38 2.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.577 ' HA ' HG21 ' B' ' 52' ' ' VAL . 21.4 t -48.0 -29.11 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.37 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.92 76.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -38.49 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.46 64.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.99 -54.06 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.4 t -60.5 -44.83 95.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.3 t80 -55.42 -49.9 71.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.053 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.2 mt -65.19 -34.96 79.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.47 ' O ' HD12 ' A' ' 46' ' ' ILE . 24.4 m-20 -70.91 -27.76 64.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -31.06 34.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 40' ' ' TYR . 30.0 t -81.75 -31.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.861 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -73.36 -49.25 28.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 42' ' ' ASP . 27.6 mt -66.02 -45.31 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -62.39 -32.89 73.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 54' ' ' THR . 41.4 m-85 -119.14 39.87 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.34 -44.07 52.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.438 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.5 m -66.33 -16.39 64.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.661 0.267 . . . . 0.0 111.223 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -132.58 92.68 26.67 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.7 -12.33 35.15 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.516 2.144 . . . . 0.0 112.492 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.8 77.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 48' ' ' PHE . 64.5 m -69.0 -36.86 78.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 59' ' ' LEU . 32.5 t80 -65.74 -49.98 66.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -60.54 -32.74 71.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.69 -51.65 52.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.778 ' HA ' HD12 ' A' ' 61' ' ' ILE . 23.2 t80 -59.24 -42.98 92.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.884 0.373 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 55' ' ' TYR . 73.1 mt -59.83 -40.61 89.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -42.75 99.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.3 mt -65.45 -37.95 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.5 mmt -68.95 -55.69 10.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.68 ' HG3' HD21 ' B' ' 54' ' ' LEU . 18.9 tttt -60.35 -31.28 70.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.792 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.22 -40.91 86.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 75' ' ' VAL . 42.1 t80 -66.78 -44.48 81.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -58.46 -42.43 87.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.652 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.3 p -63.15 -16.63 60.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.26 43.84 0.19 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.819 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.94 14.76 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.331 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 65' ' ' PHE . 19.1 tt -155.09 145.81 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.042 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.71 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.7 t70 -84.36 178.37 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.53 -53.2 17.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 73.3 Cg_exo -48.99 -38.09 38.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.562 2.175 . . . . 0.0 112.405 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.72 -29.64 71.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.5 t -75.03 -34.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 110.985 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.9 mt -71.4 -44.31 72.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.148 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -43.53 94.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -48.06 81.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 75' ' ' VAL . 34.9 t -72.76 -34.17 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.512 ' HA ' HD12 ' A' ' 90' ' ' ILE . 10.8 t -62.44 -25.43 67.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -32.35 11.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.528 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 5.7 tp -61.71 -32.66 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.992 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.562 ' CD1' HD13 ' A' ' 89' ' ' LEU . 26.4 m-85 -124.38 47.68 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -9.49 58.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.54 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -103.5 -29.65 11.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.821 0.343 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -100.01 108.25 50.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.907 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.67 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.25 -42.85 3.52 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.41 2.073 . . . . 0.0 112.229 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -59.56 -17.64 34.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.288 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 83' ' ' PHE . 18.1 mt -88.2 -56.63 3.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.261 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.584 HD11 HG12 ' A' ' 103' ' ' ILE . 11.3 tt -60.92 -33.17 54.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.232 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 87' ' ' PRO . 61.3 t -77.11 -43.64 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.453 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.95 -35.27 86.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.013 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 97' ' ' LEU . 70.8 t80 -73.92 -38.88 64.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.488 . . . . 0.0 110.609 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -64.3 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.767 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.74 -9.53 51.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.824 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.456 ' CE2' HG13 ' A' ' 32' ' ' VAL . 10.5 m-85 -99.72 -29.37 12.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 93' ' ' PHE . 3.4 mt -86.05 151.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.87 159.24 53.74 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -27.29 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -52.69 47.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.621 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -104.34 68.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.381 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -63.99 173.31 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.976 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -96.67 130.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.13 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -77.27 176.04 9.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.68 84.28 3.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.91 126.08 18.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.617 2.211 . . . . 0.0 112.252 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.808 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.67 0.271 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.36 -9.72 26.5 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.597 2.198 . . . . 0.0 112.606 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.891 ' HG2' HG11 ' A' ' 32' ' ' VAL . 1.1 mt-30 -77.55 -27.33 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.65 -33.66 60.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.367 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mm -73.37 -38.28 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -72.67 -27.46 62.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.773 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.34 -53.44 19.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.12 67.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.107 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.852 ' O ' HG22 ' B' ' 55' ' ' THR . 37.5 t-20 -67.52 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.621 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 34' ' ' VAL . 38.1 t -59.06 -24.97 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -31.91 63.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.17 0.509 . . . . 0.0 109.699 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.68 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.9 mp -98.71 10.14 41.8 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.008 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.852 HG22 ' O ' ' B' ' 51' ' ' ASN . 9.0 t -170.85 70.04 0.05 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.68 -31.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.93 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.488 1.18 0 CA-C-O 120.979 0.324 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG12 ' CE2' ' A' ' 96' ' ' PHE . 3.7 m -63.2 91.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.26 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.84 -168.47 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.11 -31.04 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -37.59 65.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -67.05 -43.84 81.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.44 75.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -62.27 -55.7 25.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -59.02 -44.63 91.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 44' ' ' VAL . 63.3 t80 -53.29 -38.18 62.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.081 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.55 -47.26 49.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -31.62 69.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 110.963 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.2 -46.52 50.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.0 t -65.95 -16.72 21.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.314 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -85.03 -44.06 13.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.3 mt -66.14 -56.4 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.391 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -56.52 -28.38 59.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.273 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 54' ' ' THR . 33.3 m-85 -117.26 39.77 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.41 -27.0 70.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -101.96 19.44 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.664 0.269 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.24 74.7 29.53 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.905 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.46 -28.8 65.83 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.604 2.203 . . . . 0.0 112.384 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.27 89.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.477 ' O ' HD21 ' A' ' 82' ' ' LEU . 2.9 m -59.8 -51.58 69.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -63.16 -50.44 70.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -59.69 -42.23 92.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.48 -43.92 98.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.0 t80 -58.93 -49.97 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.075 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -37.23 76.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.59 -42.89 99.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.1 mt -61.64 -50.12 81.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 31.3 mmt -60.15 -49.2 78.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.644 ' HB2' HD11 ' B' ' 54' ' ' LEU . 4.7 ttpt -63.88 -31.61 72.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -65.74 -46.02 80.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' CE2' HD13 ' B' ' 46' ' ' LEU . 34.4 t80 -63.48 -44.0 95.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -58.83 -36.01 73.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.78 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 t -62.89 -17.25 61.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 70.04 39.82 1.32 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 -43.09 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.3 tt -97.19 158.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -85.34 176.08 8.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.14 -53.04 27.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 76' ' ' ILE . 74.4 Cg_exo -49.2 -28.2 14.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.581 2.187 . . . . 0.0 112.438 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.23 -32.09 60.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.671 HG13 HG22 ' A' ' 61' ' ' ILE . 32.6 t -72.8 -44.05 59.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 97' ' ' LEU . 3.7 mt -64.31 -47.7 88.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -39.25 92.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -57.02 14.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.0 t -64.19 -40.24 88.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 t -61.62 -22.61 65.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -94.72 -34.29 12.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 54' ' ' THR . 7.2 tp -61.19 -36.57 80.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.909 ' CD1' HD13 ' A' ' 89' ' ' LEU . 24.7 m-85 -112.67 52.67 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.86 -25.43 67.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.223 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 25.4 11.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.3 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.809 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -140.14 86.73 12.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.911 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.702 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 Cg_exo -58.25 -48.73 14.61 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.703 2.268 . . . . 0.0 112.422 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -54.07 -20.91 7.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.598 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.909 HD13 ' CD1' ' A' ' 83' ' ' PHE . 44.2 mt -86.84 -59.24 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.436 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.4 tt -58.31 -30.48 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.38 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 87' ' ' PRO . 88.9 t -76.28 -47.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.96 -37.49 85.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.096 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' HE1' HD11 ' A' ' 97' ' ' LEU . 41.8 t80 -74.24 -33.43 63.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.097 0.475 . . . . 0.0 110.673 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.35 -25.17 66.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.8 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.11 26.76 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.931 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' CE2' HG12 ' A' ' 32' ' ' VAL . 87.3 m-85 -99.76 -35.05 9.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.778 0.323 . . . . 0.0 110.831 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 HD13 HG12 ' A' ' 76' ' ' ILE . 2.4 mt -76.08 146.76 79.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.42 176.42 8.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tp -73.47 -24.91 60.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.46 -26.48 30.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.618 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.93 114.43 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -85.76 139.34 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.9 tt -78.58 143.9 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.14 137.41 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.538 ' O ' HD12 ' A' ' 105' ' ' ILE . 1.2 pp -141.23 89.22 9.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.11 122.1 8.94 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.58 2.187 . . . . 0.0 112.323 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.591 0.234 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.06 -26.56 14.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.523 2.149 . . . . 0.0 112.366 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.448 ' O ' HD12 ' B' ' 49' ' ' LEU . 3.2 mm-40 -75.95 -23.3 55.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.611 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.659 HD13 ' CE2' ' A' ' 65' ' ' PHE . 1.8 mt -77.03 -33.79 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.342 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -72.9 -39.38 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.376 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.442 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.44 -29.57 65.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.73 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.448 HD12 ' O ' ' B' ' 45' ' ' GLN . 3.4 mt -68.32 -49.21 61.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.65 -30.5 71.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -62.45 -49.88 73.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 48' ' ' MET . 39.4 t -65.64 -29.17 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.836 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.54 -34.24 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.203 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.8 mp -86.76 -19.32 29.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.917 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.561 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.4 OUTLIER -167.89 84.69 0.2 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.5 41.72 2.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.467 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.943 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.487 1.14 0 CA-C-O 120.774 0.239 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 96' ' ' PHE . 87.8 t -60.22 -81.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.88 146.46 3.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 HD12 ' A' ' 38' ' ' LEU . 33.8 t -57.7 -38.99 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.69 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -66.07 -38.49 88.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.431 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -71.37 -39.68 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.529 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.77 72.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.52 HD12 HG12 ' A' ' 34' ' ' VAL . 3.2 mt -64.76 -52.77 55.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.077 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 36' ' ' ASP . 3.2 t -54.64 -42.32 71.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.998 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 17.1 t80 -54.97 -54.93 36.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.747 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.6 mt -63.48 -30.29 71.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.27 -41.08 94.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.085 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.53 -27.16 51.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 35.9 t -79.59 -30.97 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.746 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -71.92 -49.64 35.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.687 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -64.35 -41.65 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.036 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -59.89 -30.99 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -119.68 40.29 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.26 -38.17 81.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.398 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -81.45 -18.05 46.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.693 0.282 . . . . 0.0 111.208 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.14 89.9 51.31 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.012 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.32 -8.94 24.8 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.583 2.189 . . . . 0.0 112.64 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.61 -39.07 67.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 111.249 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.474 HG23 ' HG ' ' A' ' 82' ' ' LEU . 1.2 m -75.48 -43.04 51.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -61.27 -48.83 79.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -61.38 -43.41 98.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.77 -48.97 83.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.375 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.822 ' HA ' HD12 ' A' ' 61' ' ' ILE . 19.3 t80 -61.13 -35.39 76.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mt -65.1 -46.48 80.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.51 75.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.822 HD12 ' HA ' ' A' ' 58' ' ' PHE . 9.4 mt -69.34 -32.5 53.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.8 mmt -75.43 -44.48 44.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.842 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.8 OUTLIER -69.25 -33.51 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.32 -41.15 81.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.809 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CD1' HG21 ' A' ' 75' ' ' VAL . 78.8 t80 -61.99 -46.02 91.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -58.6 -39.32 80.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.26 -15.87 60.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.117 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 73.87 41.05 0.44 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.25 -42.37 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.804 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -99.34 147.95 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.8 t0 -84.12 171.24 13.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.415 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.7 -53.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.7 Cg_exo -50.36 -37.86 51.48 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.488 2.125 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.91 82.42 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.452 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASP . 28.2 t -62.33 -49.78 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 mt -60.21 -43.64 93.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -44.65 96.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -59.66 -50.99 71.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 75' ' ' VAL . 46.9 t -62.34 -42.95 97.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.96 -23.3 66.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -46.3 12.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' HG ' HG23 ' A' ' 54' ' ' THR . 1.4 tp -60.61 -34.99 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.8 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 89' ' ' LEU . 9.0 m-85 -106.87 53.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -61.97 -57.45 11.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.42 27.08 6.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.604 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.2 m170 -126.59 89.55 51.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.781 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.755 ' O ' HG23 ' A' ' 91' ' ' VAL . 34.7 Cg_endo -65.05 -51.17 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.605 2.203 . . . . 0.0 112.598 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -52.9 -21.99 4.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.501 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 86' ' ' HIS . 73.0 mt -85.17 -58.35 2.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.346 . . . . 0.0 110.446 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 87' ' ' PRO . 17.5 tt -59.08 -27.85 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 87' ' ' PRO . 92.0 t -76.17 -48.87 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.517 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.89 93.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.129 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -72.39 -33.35 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -62.5 -34.54 77.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 -22.4 49.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 32' ' ' VAL . 47.5 m-85 -100.0 30.32 3.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.823 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.5 126.46 22.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.38 176.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.492 2.128 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.55 -29.05 28.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.75 -27.18 58.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -126.14 95.81 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 139.29 42.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 90' ' ' ILE . 3.9 tt -65.18 128.4 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.91 115.61 21.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.8 pt -101.92 145.54 30.67 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.28 148.45 32.48 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.5 2.133 . . . . 0.0 112.318 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.831 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.749 0.309 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.38 -21.22 20.06 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.514 2.143 . . . . 0.0 112.586 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.542 ' O ' HD12 ' B' ' 49' ' ' LEU . 12.5 mp0 -79.93 -27.33 39.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.45 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -79.77 -34.65 39.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.349 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -75.03 -32.98 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.504 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.593 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -77.33 -30.35 53.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.786 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.542 HD12 ' O ' ' B' ' 45' ' ' GLN . 15.3 mt -71.36 -43.32 67.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.463 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -33.42 72.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -63.97 -49.21 73.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.744 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -66.74 -28.76 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.19 -35.41 41.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.36 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.842 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.4 mp -86.08 -20.17 29.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.887 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.51 70.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.444 ' HA3' HG13 ' B' ' 52' ' ' VAL . . . -120.61 27.54 6.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.955 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.866 0.278 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG12 ' HE2' ' B' ' 48' ' ' MET . 25.4 t -77.15 81.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 35' ' ' GLU . 29.9 p-80 -125.98 -161.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.725 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.25 -31.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -64.84 -44.55 89.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -65.37 -44.16 88.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.934 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.74 66.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 mt -64.86 -53.99 37.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 2.9 t -59.51 -45.55 91.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.005 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.813 ' O ' HG23 ' A' ' 44' ' ' VAL . 53.8 t80 -55.69 -47.2 77.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.067 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.36 -31.42 72.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -69.79 -32.68 71.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.81 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -26.39 38.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.835 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 40' ' ' TYR . 24.8 t -80.45 -29.16 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.939 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -46.2 22.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.0 mt -66.62 -41.6 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -30.91 68.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.604 ' CD2' HG21 ' A' ' 54' ' ' THR . 56.0 m-85 -124.82 43.75 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.1 -35.58 84.68 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.469 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 p -107.9 42.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -140.13 92.38 9.63 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.94 -38.84 12.23 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.472 2.114 . . . . 0.0 112.24 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.47 77.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.604 HG21 ' CD2' ' A' ' 48' ' ' PHE . 6.2 m -71.57 -48.21 49.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.735 ' O ' HD12 ' A' ' 59' ' ' LEU . 15.4 t80 -65.35 -58.53 5.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.32 -32.11 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.68 -50.57 41.6 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HA ' HD12 ' A' ' 61' ' ' ILE . 31.6 t80 -57.66 -44.58 85.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 55' ' ' TYR . 0.5 OUTLIER -64.65 -35.27 80.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.696 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.7 -35.8 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.874 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 58' ' ' PHE . 21.8 mt -69.48 -50.41 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -32.39 73.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HE2' HD21 ' B' ' 54' ' ' LEU . 7.0 tttm -71.87 -31.63 66.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 -30.13 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HA ' HG12 ' A' ' 70' ' ' ILE . 40.4 t80 -70.44 -40.35 73.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -56.97 -32.54 66.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m -64.94 -16.15 62.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.05 42.5 1.25 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.0 0.429 . . . . 0.0 110.743 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -113.86 -51.5 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 65' ' ' PHE . 11.2 pt -74.58 178.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.169 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -116.62 -177.47 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.42 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -68.35 -52.76 20.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.6 Cg_exo -47.94 -27.75 9.19 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.642 2.228 . . . . 0.0 112.428 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.8 -29.35 57.57 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 79' ' ' VAL . 18.5 t -76.67 -33.89 22.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 103' ' ' ILE . 39.4 mt -73.59 -45.43 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -46.41 76.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -45.65 87.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 75' ' ' VAL . 38.8 t -76.11 -41.26 37.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.066 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.2 t -58.28 -22.51 52.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.09 -38.77 11.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.07 -31.57 72.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CD1' HD13 ' A' ' 89' ' ' LEU . 17.7 m-85 -119.92 50.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -67.44 -41.09 85.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -100.74 30.0 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.028 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.646 ' CB ' HD12 ' A' ' 89' ' ' LEU . 83.8 m-70 -139.96 85.77 13.91 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.7 Cg_exo -56.93 -59.31 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.61 2.207 . . . . 0.0 112.225 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -51.33 -22.77 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.556 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 86' ' ' HIS . 14.9 mt -81.79 -55.72 4.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 110.224 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 103' ' ' ILE . 12.3 tt -63.28 -26.21 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 87' ' ' PRO . 95.6 t -72.94 -47.92 46.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.33 -43.56 93.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.31 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -70.45 -29.53 66.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 110.921 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.499 ' HB2' HD12 ' A' ' 103' ' ' ILE . 1.4 t30 -72.24 -22.49 61.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 -3.32 28.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.413 ' CE2' ' CG1' ' A' ' 32' ' ' VAL . 79.5 m-85 -99.76 -28.98 12.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.94 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.3 mt -89.03 140.07 29.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.63 177.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.443 2.095 . . . . 0.0 112.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.9 -31.69 71.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.32 -34.64 81.34 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.448 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -102.55 75.13 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.89 127.51 33.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 90' ' ' ILE . 33.2 mt -84.66 122.64 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.77 137.82 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -128.16 89.86 48.9 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.995 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.75 139.16 87.22 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.667 2.245 . . . . 0.0 112.244 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.454 ' CB ' HD12 ' B' ' 46' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.716 0.294 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.66 -22.19 38.08 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.521 2.147 . . . . 0.0 112.385 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.437 ' O ' HD12 ' B' ' 49' ' ' LEU . 5.8 mt-30 -78.61 -21.0 49.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.386 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.454 HD12 ' CB ' ' B' ' 43' ' ' ALA . 18.3 mt -79.38 -38.74 34.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.35 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 20.3 mt -73.02 -35.2 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.393 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.789 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -75.98 -27.8 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.75 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.437 HD12 ' O ' ' B' ' 45' ' ' GLN . 5.2 mt -71.14 -43.46 67.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.425 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.42 -36.46 79.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.997 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.54 -39.98 94.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 48' ' ' MET . 35.4 t -72.52 -28.03 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.748 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.85 -33.49 52.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.514 HD21 ' HE2' ' A' ' 63' ' ' LYS . 7.2 mp -90.67 -23.24 20.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.843 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.36 79.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.55 -40.13 6.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.5 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.843 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 120.774 0.239 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 32' ' ' VAL . 3.0 m -62.8 82.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.81 -164.51 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.759 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.8 t -53.52 -27.67 14.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.261 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.87 -39.47 69.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.64 -36.28 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.43 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.83 -49.87 66.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 t -59.5 -44.66 93.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.889 ' O ' HG23 ' A' ' 44' ' ' VAL . 62.8 t80 -53.08 -49.75 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.042 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mt -62.77 -32.63 73.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.409 ' OD1' HD11 ' A' ' 46' ' ' ILE . 7.7 t0 -66.21 -33.22 75.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -26.03 36.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.3 t -76.94 -28.95 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.932 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -80.34 -49.72 11.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' OD1' ' A' ' 42' ' ' ASP . 47.5 mt -60.82 -38.98 80.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.943 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -67.88 -27.4 66.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.643 ' CE2' HG21 ' A' ' 54' ' ' THR . 31.8 m-85 -114.99 39.21 2.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -56.09 -28.35 53.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.567 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.78 21.68 16.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.642 0.258 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -140.2 81.85 17.71 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 -28.1 23.82 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.597 2.198 . . . . 0.0 112.327 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.05 93.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.643 HG21 ' CE2' ' A' ' 48' ' ' PHE . 9.8 m -60.38 -38.64 84.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -69.89 -47.02 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -59.91 -42.62 94.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.95 94.54 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.551 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -59.53 -50.45 73.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.28 -36.57 78.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.97 -45.61 92.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 78' ' ' ARG . 28.5 mt -59.57 -45.58 93.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -49.9 55.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.765 ' HG3' HD21 ' B' ' 54' ' ' LEU . 7.8 ttmt -59.49 -36.62 76.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.016 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.97 -30.74 67.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' HB2' HD11 ' A' ' 70' ' ' ILE . 50.2 t80 -74.19 -35.33 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -57.72 -40.89 80.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.762 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -15.84 61.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 71.93 53.76 0.19 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.985 0.421 . . . . 0.0 110.836 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.59 -39.02 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.845 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 65' ' ' PHE . 13.5 pt -92.34 156.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.215 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -90.79 170.09 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.4 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -62.16 -54.22 51.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.791 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 72' ' ' THR . 72.9 Cg_exo -48.38 -41.16 36.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.167 . . . . 0.0 112.233 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.73 99.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.362 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 71' ' ' ASP . 18.8 t -58.5 -40.0 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.98 -43.26 98.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -67.86 -36.06 79.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.569 ' HB3' HD13 ' A' ' 61' ' ' ILE . 26.6 mmt180 -57.27 -65.82 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.9 t -63.44 -31.31 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -64.85 -23.82 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.163 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.66 -37.73 11.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.49 -30.26 70.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.023 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' HD13 ' A' ' 89' ' ' LEU . 11.8 m-85 -114.62 55.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -66.78 -33.09 74.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.56 26.35 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.408 ' CB ' HD12 ' A' ' 89' ' ' LEU . 94.9 m-70 -140.05 88.21 11.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.971 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.878 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.3 Cg_endo -67.96 -44.46 3.93 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.591 2.194 . . . . 0.0 112.282 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -50.15 -25.35 3.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.198 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 83' ' ' PHE . 92.9 mt -82.72 -51.0 8.11 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.86 HD12 HD13 ' A' ' 105' ' ' ILE . 57.0 mt -62.52 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.956 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.4 t -73.01 -50.41 32.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.465 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.98 -31.35 80.52 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.323 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.75 ' CE2' HD11 ' A' ' 97' ' ' LEU . 64.5 t80 -74.76 -30.74 61.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 110.92 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 97' ' ' LEU . 47.2 t30 -74.89 -27.28 60.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.878 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.66 -19.25 48.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.519 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -99.66 -38.38 8.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.06 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.75 HD11 ' CE2' ' A' ' 93' ' ' PHE . 7.1 mt -66.24 148.32 98.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 172.32 12.49 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.512 2.141 . . . . 0.0 112.316 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.53 -22.21 57.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -53.77 -44.2 70.1 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.693 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -102.9 99.44 9.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 0.0 110.829 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -77.97 116.26 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.405 HG22 ' ND2' ' A' ' 94' ' ' ASN . 3.6 tt -76.53 145.86 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -96.59 173.3 7.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.0 111.143 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 90' ' ' ILE . 5.0 tp -162.07 80.11 1.91 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.4 112.78 1.03 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.519 2.146 . . . . 0.0 112.227 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.627 0.251 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.556 ' HA ' HD12 ' B' ' 47' ' ' ILE . 42.6 Cg_endo -67.64 -11.97 33.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.438 2.092 . . . . 0.0 112.52 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -79.49 -26.48 41.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 110.658 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 46' ' ' LEU . 20.5 mt -78.92 -36.08 42.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' B' ' 44' ' ' PRO . 7.4 mt -73.47 -34.7 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.508 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.5 OUTLIER -75.69 -30.06 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.35 -43.35 67.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.395 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.67 72.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -50.32 69.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 48' ' ' MET . 38.7 t -65.46 -29.16 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.818 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.68 -34.44 58.22 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.111 0.481 . . . . 0.0 110.091 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.765 HD21 ' HG3' ' A' ' 63' ' ' LYS . 6.6 mp -83.99 -20.74 32.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.728 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.464 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -171.06 84.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.775 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.2 46.45 2.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.536 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.883 -179.935 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.926 0.303 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG12 ' HE2' ' B' ' 48' ' ' MET . 21.4 t -90.04 82.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.169 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' CD2' ' HB2' ' A' ' 35' ' ' GLU . 5.6 p-80 -110.28 -170.58 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -41.99 -32.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.886 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 33' ' ' HIS . 5.7 mm-40 -63.46 -47.21 82.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.707 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -64.36 -37.74 88.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.08 -32.95 63.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.44 -48.78 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -60.21 -45.67 92.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 44' ' ' VAL . 69.2 t80 -55.47 -47.89 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.69 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.438 ' O ' HD12 ' A' ' 46' ' ' ILE . 60.6 m-20 -63.11 -30.2 71.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.849 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -82.59 -28.29 30.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.673 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 40' ' ' TYR . 12.9 t -81.02 -20.29 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.11 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.33 -46.43 9.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.724 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.9 mt -67.04 -50.07 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -59.41 -30.66 68.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.65 ' HE1' HD11 ' A' ' 89' ' ' LEU . 69.3 m-85 -119.62 40.75 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.02 -29.26 64.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.578 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -107.72 30.35 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -140.17 88.58 11.5 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.62 -28.53 31.2 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.513 2.142 . . . . 0.0 112.329 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.76 -30.68 69.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -74.04 -56.64 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -59.19 -52.03 67.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.788 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -61.27 -34.85 75.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.2 -50.16 23.45 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.902 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.7 t80 -60.23 -27.41 67.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.85 -53.48 15.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.144 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.8 -38.23 69.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.016 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.902 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -60.87 -56.85 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.852 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -38.09 86.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.777 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' B' ' 54' ' ' LEU . 12.5 ttpt -64.59 -52.09 59.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -58.82 -30.35 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 61.8 t80 -66.48 -47.49 72.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -57.31 -27.37 62.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 m -66.97 -13.03 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.86 47.78 2.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.956 0.407 . . . . 0.0 110.823 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 m -121.82 -39.28 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 65' ' ' PHE . 9.5 pt -91.26 178.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -108.85 172.69 6.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.424 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.17 -51.98 32.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.014 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 72' ' ' THR . 78.3 Cg_exo -50.38 -34.1 39.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -42.27 90.62 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 79' ' ' VAL . 19.0 t -61.95 -39.36 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 103' ' ' ILE . 40.5 mt -69.03 -35.9 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.173 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -70.31 -47.3 61.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 61' ' ' ILE . 18.8 mtp85 -58.45 -37.94 76.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.05 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -73.22 -45.54 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 t -58.61 -23.83 59.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.044 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -84.02 -40.14 18.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.806 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.88 -31.5 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 89' ' ' LEU . 6.0 m-85 -121.58 62.16 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.784 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.451 ' CE1' ' HG3' ' A' ' 106' ' ' PRO . 6.7 t60 -69.71 -44.12 71.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.654 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -99.94 26.63 6.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 83' ' ' PHE . 1.8 m170 -130.83 104.31 15.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 91' ' ' VAL . 62.5 Cg_endo -74.6 -47.51 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.436 2.091 . . . . 0.0 112.712 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -60.25 -17.65 43.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.58 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.65 HD11 ' HE1' ' A' ' 48' ' ' PHE . 11.2 mt -87.68 -55.86 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.208 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.658 HG13 HD13 ' A' ' 103' ' ' ILE . 11.5 tt -56.72 -30.44 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.06 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.7 t -77.17 -45.57 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.289 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 -34.55 82.49 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.998 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.741 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 62.8 t80 -74.15 -37.79 63.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.659 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -61.45 -29.89 70.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.657 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -17.94 57.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.496 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.85 29.7 4.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.798 0.333 . . . . 0.0 110.954 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.2 145.32 23.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 158.88 54.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -26.81 65.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.34 -27.46 53.23 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.615 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 109.03 10.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.19 166.74 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.658 HD13 HG13 ' A' ' 90' ' ' ILE . 4.4 tt -95.31 124.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.21 169.69 14.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.013 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 13.5 pt -152.04 146.41 18.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 60.7 Cg_endo -72.88 126.87 11.68 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.59 2.194 . . . . 0.0 112.271 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.908 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.7 0.286 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.94 -22.28 26.89 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.586 2.191 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.545 ' O ' HD12 ' B' ' 49' ' ' LEU . 15.1 mp0 -77.28 -19.02 57.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 26.4 mt -78.99 -38.29 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 110.37 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.49 -37.25 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.448 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.419 ' HE2' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.8 -28.46 61.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.726 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.545 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.6 mt -72.18 -41.29 67.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.39 75.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.867 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.04 -53.48 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.693 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 48' ' ' MET . 43.7 t -63.06 -28.0 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.003 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.1 48.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.096 0.474 . . . . 0.0 110.214 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 63' ' ' LYS . 7.4 mp -84.01 -20.41 32.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.888 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.41 78.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.23 28.54 15.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.517 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.02 -179.969 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.092 0 CA-C-O 120.861 0.276 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.93 75.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.26 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -165.7 1.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.27 -36.81 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.26 -39.71 95.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -41.66 75.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 -30.78 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mt -66.53 -53.14 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.004 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -59.58 -44.31 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 44' ' ' VAL . 60.5 t80 -52.87 -55.74 20.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.06 -33.13 72.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -69.6 -28.87 66.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.53 -26.84 37.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 40' ' ' TYR . 19.0 t -78.77 -29.7 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.973 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -78.23 -47.2 18.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 42' ' ' ASP . 20.7 mt -63.01 -45.53 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.13 -28.44 68.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 54' ' ' THR . 63.8 m-85 -123.79 43.1 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.82 -39.53 85.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.448 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -79.25 -19.49 50.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.224 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -111.0 92.86 15.89 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.01 -23.75 40.04 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.524 2.149 . . . . 0.0 112.291 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.02 77.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.76 HG21 ' CD2' ' A' ' 48' ' ' PHE . 18.9 m -65.14 -48.41 73.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.612 ' CE2' HD11 ' A' ' 59' ' ' LEU . 9.2 t80 -62.76 -46.96 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -60.27 -34.93 74.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.22 -49.54 56.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.416 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 61' ' ' ILE . 50.7 t80 -58.78 -53.06 62.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.757 0.313 . . . . 0.0 110.851 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 55' ' ' TYR . 33.2 mt -57.3 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -37.86 73.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.4 mt -73.08 -29.07 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.052 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -41.45 61.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.822 ' CG ' HD11 ' B' ' 54' ' ' LEU . 12.8 mttt -71.82 -44.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -58.6 -58.55 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 20.2 t80 -60.24 -44.14 95.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.138 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HD2' HD22 ' B' ' 54' ' ' LEU . 33.2 tttm -52.57 -37.17 57.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -13.86 61.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.032 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 71.02 49.38 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 110.74 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.0 m -112.44 -33.36 6.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 65' ' ' PHE . 11.0 pt -104.96 173.37 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.181 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -96.21 168.94 10.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.01 -52.32 75.65 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 72' ' ' THR . 74.8 Cg_exo -48.23 -35.43 26.91 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.288 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.93 -32.08 81.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.338 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 65' ' ' PHE . 24.9 t -74.97 -33.38 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.9 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.607 HG23 HG12 ' A' ' 103' ' ' ILE . 39.6 mt -71.8 -47.38 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -64.23 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -55.01 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.506 HG13 ' CE2' ' A' ' 83' ' ' PHE . 37.7 t -69.84 -35.32 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.095 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.1 t -62.54 -26.99 68.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.92 -32.5 11.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.81 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 16.9 tp -61.08 -40.14 92.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.676 ' CD1' HD13 ' A' ' 89' ' ' LEU . 16.9 m-85 -107.26 61.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -92.39 22.47 4.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.403 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -128.37 -44.94 1.38 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.541 ' HB2' HD12 ' A' ' 89' ' ' LEU . 14.0 m-70 -103.09 118.25 58.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 91' ' ' VAL . 56.3 Cg_endo -70.19 -33.54 14.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.525 2.15 . . . . 0.0 112.326 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.23 -13.95 33.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.527 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.676 HD13 ' CD1' ' A' ' 83' ' ' PHE . 5.0 mt -87.19 -56.74 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.32 -31.28 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 87' ' ' PRO . 59.0 t -75.75 -47.67 32.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.529 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.2 82.32 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.092 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -73.24 -35.02 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.47 . . . . 0.0 110.717 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -33.27 73.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.513 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -18.5 58.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.322 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -99.79 30.03 3.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.0 mt -144.3 147.12 35.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.88 159.77 51.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.545 2.163 . . . . 0.0 112.212 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.622 HD11 ' NH2' ' A' ' 102' ' ' ARG . 1.6 tp -59.99 -29.76 68.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.49 69.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.8 88.52 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.622 ' NH2' HD11 ' A' ' 99' ' ' LEU . 3.5 mtt180 -85.74 -174.58 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.607 HG12 HG23 ' A' ' 76' ' ' ILE . 27.8 mt -122.26 140.13 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.151 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -83.95 132.82 34.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.829 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.49 125.47 59.61 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.22 157.69 49.84 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.478 2.119 . . . . 0.0 112.217 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.9 tptm . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.904 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.69 0.281 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -12.47 31.43 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.593 2.195 . . . . 0.0 112.613 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -79.52 -25.67 41.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 65' ' ' PHE . 55.4 mt -79.4 -36.01 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.43 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.6 mm -74.26 -33.62 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.544 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.737 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.4 OUTLIER -77.1 -29.44 54.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.696 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.06 -46.0 65.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -33.46 73.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.965 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -64.26 -42.55 96.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.82 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 48' ' ' MET . 35.2 t -70.97 -30.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.726 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.08 -33.99 43.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.307 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' A' ' 63' ' ' LYS . 9.2 mp -88.78 -18.39 27.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.91 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.408 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER -170.47 76.19 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.781 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.15 2.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.46 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.911 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.488 1.159 0 CA-C-O 120.823 0.26 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 96' ' ' PHE . 3.5 m -62.62 83.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.193 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -165.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.47 -30.71 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.206 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.24 -38.8 78.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -39.47 72.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.37 69.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.66 -54.35 43.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 t -59.83 -44.53 94.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.659 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.1 t80 -54.04 -50.4 66.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.077 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.8 mt -60.65 -34.23 73.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -65.69 -29.49 70.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -81.37 -26.55 35.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.874 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.92 HG22 HD21 ' A' ' 89' ' ' LEU . 15.8 t -80.25 -29.93 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.043 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 2.8 tptt -78.15 -47.61 17.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 42' ' ' ASP . 24.2 mt -64.91 -48.39 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -62.09 -31.55 72.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.81 ' CD2' HG21 ' A' ' 54' ' ' THR . 64.4 m-85 -122.14 42.35 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.47 -35.03 91.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.566 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -97.63 20.83 11.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.706 0.288 . . . . 0.0 111.223 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.21 89.15 11.07 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.994 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.15 -26.91 42.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.417 2.078 . . . . 0.0 112.25 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -45.15 93.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CD2' ' A' ' 48' ' ' PHE . 28.2 m -61.23 -55.84 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.445 ' CZ ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 t80 -60.3 -46.87 88.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.26 -38.15 82.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.45 -46.15 91.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.489 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.7 t80 -60.76 -46.31 90.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.351 . . . . 0.0 110.86 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HG ' ' HB1' ' B' ' 53' ' ' ALA . 0.9 OUTLIER -60.49 -37.71 81.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.22 -41.97 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.0 mt -63.97 -46.79 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.566 ' HB3' ' HB2' ' B' ' 50' ' ' ALA . 27.2 mmt -69.37 -43.43 73.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.765 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.4 ttmt -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -66.01 -32.75 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.1 t80 -65.54 -47.39 76.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.21 -41.66 89.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.693 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -64.45 -15.1 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.992 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 74.02 40.93 0.43 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.939 0.399 . . . . 0.0 110.798 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.7 t -117.55 14.3 14.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.4 tt -159.01 146.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.792 0.329 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 75' ' ' VAL . 4.1 t70 -90.52 177.19 6.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.37 -53.85 42.82 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 76' ' ' ILE . 77.0 Cg_exo -48.01 -39.14 32.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.572 2.182 . . . . 0.0 112.467 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 -29.21 72.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 61' ' ' ILE . 38.4 t -72.41 -43.86 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 73' ' ' PRO . 5.1 mt -61.83 -43.83 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.121 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -41.3 84.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -44.16 78.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 75' ' ' VAL . 29.5 t -76.13 -32.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m -62.46 -25.37 67.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -31.17 13.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.41 HD23 ' CZ ' ' A' ' 83' ' ' PHE . 12.5 tp -62.23 -63.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.009 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.699 ' CD1' HD13 ' A' ' 89' ' ' LEU . 11.3 m-85 -89.19 53.86 2.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -64.19 -39.4 93.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -100.02 25.8 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.157 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 1.2 m-70 -140.17 97.15 7.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.839 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.4 Cg_endo -72.94 -46.65 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.59 2.194 . . . . 0.0 112.891 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -55.83 -20.75 16.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.92 HD21 HG22 ' A' ' 44' ' ' VAL . 1.8 mt -85.67 -57.77 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.24 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -53.84 -26.43 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.193 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 87' ' ' PRO . 60.6 t -77.2 -50.56 20.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.188 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 -32.59 53.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.979 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' CE2' HD11 ' A' ' 97' ' ' LEU . 39.9 t80 -78.32 -34.88 48.38 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.18 0.514 . . . . 0.0 110.494 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -59.96 -29.19 68.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.633 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.59 -4.5 27.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.881 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.641 ' HA ' HG11 ' A' ' 32' ' ' VAL . 69.3 m-85 -99.7 -50.1 4.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.71 0.291 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD13 HG12 ' A' ' 76' ' ' ILE . 7.6 mt -66.24 142.6 97.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.01 176.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.134 . . . . 0.0 112.311 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.15 -28.98 60.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.75 -51.21 58.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.624 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -96.79 88.79 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -86.36 122.37 30.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.577 HG12 HD11 ' A' ' 90' ' ' ILE . 8.0 tt -65.19 121.44 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.49 157.26 16.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.52 103.01 54.38 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.982 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.72 108.8 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.358 2.039 . . . . 0.0 112.286 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.69 0.281 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.72 -23.69 41.89 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.499 2.132 . . . . 0.0 112.36 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.648 ' O ' HD12 ' B' ' 49' ' ' LEU . 20.3 mp0 -76.12 -26.56 56.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.049 0.452 . . . . 0.0 110.514 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 75' ' ' VAL . 6.0 mt -76.61 -32.56 58.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.237 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 41.7 mt -72.74 -37.98 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.646 ' O ' HG23 ' B' ' 52' ' ' VAL . 2.7 ptt? -71.05 -32.16 68.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.621 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.648 HD12 ' O ' ' B' ' 45' ' ' GLN . 1.1 mt -67.97 -43.18 79.58 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.62 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' MET . . . -66.88 -34.02 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.54 -44.83 85.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.646 HG23 ' O ' ' B' ' 48' ' ' MET . 25.4 t -67.62 -29.1 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.508 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -77.68 -35.26 52.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.126 0.489 . . . . 0.0 110.256 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.55 ' O ' HG23 ' B' ' 55' ' ' THR . 9.0 mp -86.81 -19.53 28.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.915 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.55 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.5 OUTLIER -167.37 87.4 0.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.33 47.2 2.61 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.448 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.938 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 120.79 0.246 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG12 ' CE2' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -90.1 77.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 35' ' ' GLU . 29.2 p-80 -129.23 -160.39 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.714 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.4 t -44.63 -30.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.813 0.339 . . . . 0.0 111.532 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 33' ' ' HIS . 29.6 tt0 -62.22 -59.41 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -31.15 72.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.12 71.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.014 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mt -61.94 -52.82 62.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.9 t -62.02 -44.51 96.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 44' ' ' VAL . 61.9 t80 -54.13 -48.31 70.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.088 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 mt -63.05 -37.66 88.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.48 -32.14 70.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -30.62 62.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.725 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 40' ' ' TYR . 29.6 t -82.87 -37.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.807 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -48.11 83.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.702 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -70.6 -47.97 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -60.73 -36.05 77.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 54' ' ' THR . 19.1 m-85 -115.68 39.06 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.19 -27.83 65.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.537 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -97.38 15.21 23.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.693 0.282 . . . . 0.0 111.29 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -140.18 77.49 25.06 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 -24.26 19.86 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.619 2.213 . . . . 0.0 112.358 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.51 -55.28 36.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.228 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.743 HG23 ' HG ' ' A' ' 82' ' ' LEU . 3.3 m -59.85 -38.34 81.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -67.13 -56.23 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -31.97 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 -49.41 12.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.469 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 61' ' ' ILE . 61.1 t80 -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.042 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -39.64 83.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -62.24 -40.31 95.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 58' ' ' PHE . 7.5 mt -64.47 -51.74 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -41.83 98.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.787 ' HG3' HD21 ' B' ' 54' ' ' LEU . 1.0 OUTLIER -64.61 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -69.12 -42.52 75.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 75' ' ' VAL . 23.3 t80 -62.81 -44.72 95.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -31.63 67.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -66.49 -13.33 60.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.245 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 63.43 42.16 6.96 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.962 0.411 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.5 p -116.65 -39.04 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.0 tt -96.16 157.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -84.51 -177.69 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.405 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -74.36 -53.29 3.66 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 72' ' ' THR . 71.3 Cg_exo -48.75 -27.95 11.95 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.584 2.189 . . . . 0.0 112.364 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.38 -37.03 48.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.429 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.57 HG21 ' CD1' ' A' ' 65' ' ' PHE . 16.8 t -68.29 -40.16 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.765 0.316 . . . . 0.0 111.029 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 103' ' ' ILE . 16.3 mt -68.81 -42.51 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 mtt85 -58.76 -44.67 90.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.9 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 ' CZ ' ' A' ' 93' ' ' PHE . 45.5 t -64.51 -41.97 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.035 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -23.36 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.01 -39.33 10.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HG ' HG23 ' A' ' 54' ' ' THR . 9.2 tp -61.38 -34.15 74.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.736 ' CD1' HD13 ' A' ' 89' ' ' LEU . 18.5 m-85 -109.08 42.42 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -29.52 68.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.15 28.15 9.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.697 ' CB ' HD12 ' A' ' 89' ' ' LEU . 50.3 m-70 -140.13 96.13 8.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.996 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.75 ' O ' HG23 ' A' ' 91' ' ' VAL . 43.6 Cg_endo -68.07 -48.39 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.447 2.098 . . . . 0.0 112.348 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.62 -18.26 28.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' A' ' 83' ' ' PHE . 40.9 mt -87.41 -56.11 3.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.328 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.529 HD11 HG12 ' A' ' 103' ' ' ILE . 17.8 tt -59.22 -28.49 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.278 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 87' ' ' PRO . 66.1 t -78.34 -48.04 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.21 85.67 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.934 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 40.9 t80 -72.51 -40.3 66.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.508 . . . . 0.0 110.773 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -67.05 -21.18 65.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.004 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.66 -7.26 43.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.87 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' CE2' HG12 ' A' ' 32' ' ' VAL . 81.8 m-85 -99.72 -30.24 12.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.331 . . . . 0.0 110.951 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.6 mt -77.85 153.81 80.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 163.95 29.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.283 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.09 -31.1 68.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.0 -43.82 92.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.403 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -93.91 76.02 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.01 162.9 27.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.529 HG12 HD11 ' A' ' 90' ' ' ILE . 0.8 OUTLIER -97.53 138.08 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.63 144.14 39.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 105' ' ' ILE . 2.4 tp -159.01 122.28 2.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 154.87 65.59 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.405 2.07 . . . . 0.0 112.369 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.71 0.29 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 -21.76 20.23 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.33 -25.84 51.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.706 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . 57.8 mt -77.16 -33.13 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.297 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 26.2 mm -74.06 -37.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.491 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.51 -28.96 62.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.687 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -70.18 -47.4 61.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.436 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.547 ' O ' HD13 ' B' ' 54' ' ' LEU . . . -66.19 -30.75 71.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.943 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -63.52 -50.73 68.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.682 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 48' ' ' MET . 38.5 t -64.15 -30.61 50.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.63 -34.82 53.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.248 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.787 HD21 ' HG3' ' A' ' 63' ' ' LYS . 8.7 mp -83.47 -9.72 58.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.993 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.459 HG22 ' O ' ' B' ' 54' ' ' LEU . 13.5 t 45.37 43.88 8.87 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.932 0.396 . . . . 0.0 111.324 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.89 -27.55 66.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.423 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.934 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 CA-C-O 120.744 0.227 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 3.1 m -68.98 82.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.25 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 35' ' ' GLU . 27.1 p-80 -122.53 -162.85 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -44.78 -46.66 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.818 0.342 . . . . 0.0 111.718 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . 21.7 tt0 -58.2 -41.35 83.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.974 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -65.88 -36.42 83.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.85 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -61.96 -54.89 35.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.6 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.94 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 81.4 t80 -55.21 -51.63 65.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' B' ' 53' ' ' ALA . 24.0 mt -65.39 -32.0 73.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.907 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.3 m-20 -71.11 -30.31 66.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.96 -27.39 33.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 27.1 t -80.67 -29.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.53 -48.19 15.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.711 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 42' ' ' ASP . 26.5 mt -64.77 -49.08 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -59.41 -30.25 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CE2' HG21 ' A' ' 54' ' ' THR . 34.2 m-85 -115.81 39.29 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.03 93.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.496 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.24 25.07 5.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.663 0.268 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -140.19 87.01 12.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.63 -28.34 37.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.574 2.183 . . . . 0.0 112.258 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.01 88.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.519 HG21 ' CE2' ' A' ' 48' ' ' PHE . 8.7 m -66.9 -50.89 60.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.441 ' CZ ' ' HG3' ' A' ' 45' ' ' LYS . 12.5 t80 -60.06 -51.68 68.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.793 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.61 -54.01 31.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.437 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 61' ' ' ILE . 9.4 t80 -60.02 -36.65 77.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.431 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.3 mt -66.27 -41.17 90.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.798 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -59.82 -39.13 83.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 58' ' ' PHE . 6.3 mt -72.34 -31.82 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.8 mmt -69.17 -43.73 73.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.866 ' HG3' HD11 ' B' ' 54' ' ' LEU . 5.0 mttm -70.81 -31.08 67.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.59 -55.28 32.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' CD2' ' HB3' ' B' ' 46' ' ' LEU . 25.8 t80 -59.66 -42.26 92.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -36.47 74.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.799 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.42 -15.7 61.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 72.27 51.88 0.19 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 t -130.77 -54.29 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 65' ' ' PHE . 4.3 tt -73.96 148.52 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t70 -89.96 175.34 7.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.03 -53.26 56.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' A' ' 76' ' ' ILE . 76.2 Cg_exo -49.87 -36.53 43.37 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.615 2.21 . . . . 0.0 112.305 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.92 77.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 71' ' ' ASP . 21.6 t -65.99 -46.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 73' ' ' PRO . 4.0 mt -59.49 -48.85 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 mtt85 -59.83 -40.09 87.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -49.82 76.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.6 t -75.1 -36.09 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.186 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.454 ' HA ' HD12 ' A' ' 90' ' ' ILE . 8.6 t -60.57 -25.12 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.91 -33.51 11.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.7 tp -62.98 -46.79 86.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 89' ' ' LEU . 23.7 m-85 -104.63 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.68 -4.85 45.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.609 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -102.49 -35.31 8.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.629 ' HB2' HD12 ' A' ' 89' ' ' LEU . 71.3 m-70 -105.83 119.76 51.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.031 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 91' ' ' VAL . 73.2 Cg_endo -76.18 -42.44 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.447 2.098 . . . . 0.0 112.287 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.61 -18.01 17.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.629 HD12 ' HB2' ' A' ' 86' ' ' HIS . 12.9 mt -85.23 -55.79 3.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.303 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.55 HG13 HD11 ' A' ' 103' ' ' ILE . 17.7 tt -61.4 -27.51 42.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 87' ' ' PRO . 65.1 t -76.43 -48.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.432 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.16 -35.68 65.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.098 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.76 -36.14 62.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.149 0.499 . . . . 0.0 110.685 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -63.02 -25.86 68.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.714 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.3 -1.66 21.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.444 ' CD2' ' HB ' ' A' ' 32' ' ' VAL . 76.2 m-85 -99.75 -30.89 11.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.88 153.58 70.0 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.38 173.8 9.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.45 -13.89 61.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.266 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.05 -29.99 45.22 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.687 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -131.63 137.56 48.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.983 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -108.52 139.92 42.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.667 HG23 HD11 ' A' ' 105' ' ' ILE . 0.9 OUTLIER -80.1 141.27 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -98.61 140.09 33.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.799 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.667 HD11 HG23 ' A' ' 103' ' ' ILE . 3.7 mp -140.97 103.59 6.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.47 142.47 59.55 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.419 2.079 . . . . 0.0 112.178 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.762 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.692 0.282 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.95 -21.51 37.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.545 2.163 . . . . 0.0 112.425 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -79.65 -22.29 43.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.873 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 21.9 mt -81.31 -35.66 30.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 7.6 mt -74.96 -33.61 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.351 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.655 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -76.68 -31.29 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.607 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -67.55 -49.94 60.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.62 74.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.818 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.655 HG23 ' O ' ' B' ' 48' ' ' MET . 39.0 t -71.25 -31.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 41' ' ' LEU . . . -78.11 -34.59 49.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.13 0.49 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.866 HD11 ' HG3' ' A' ' 63' ' ' LYS . 9.8 mp -86.78 -20.13 28.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.796 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.49 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER -167.54 73.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.777 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.87 42.5 1.92 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.498 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.487 1.116 0 CA-C-O 120.89 0.288 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -90.04 12.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.713 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.85 0.357 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 38' ' ' LEU . 21.7 t -47.01 -28.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.536 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.9 -49.3 78.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.767 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -72.58 -30.88 64.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.86 -39.57 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 34' ' ' VAL . 23.3 mt -63.47 -51.99 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -58.15 -42.68 86.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.862 ' O ' HG23 ' A' ' 44' ' ' VAL . 57.3 t80 -53.65 -50.01 66.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.106 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.17 -34.82 75.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -66.54 -33.59 76.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -27.12 38.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 40' ' ' TYR . 23.6 t -79.27 -28.52 13.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.938 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -78.5 -47.23 17.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 42' ' ' ASP . 17.3 mt -63.54 -48.53 86.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 -63.93 -29.97 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.843 ' CD2' HG21 ' A' ' 54' ' ' THR . 4.8 m-85 -117.91 40.07 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.02 -28.62 72.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 p -104.89 25.55 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.11 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -140.18 68.11 33.48 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.28 -28.12 33.22 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.568 2.179 . . . . 0.0 112.307 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.64 89.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.843 HG21 ' CD2' ' A' ' 48' ' ' PHE . 57.1 m -65.6 -45.03 84.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 12.4 t80 -59.52 -51.3 70.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -33.52 73.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.46 -50.85 40.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 61' ' ' ILE . 39.5 t80 -57.77 -46.07 85.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 110.779 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -44.24 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.766 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -54.01 -40.19 66.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 58' ' ' PHE . 12.7 mt -69.49 -32.1 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 32.8 mmt -69.59 -47.9 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HG2' HD11 ' B' ' 54' ' ' LEU . 5.4 mttt -65.45 -38.4 89.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.716 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.99 -44.59 94.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CD1' HG21 ' A' ' 75' ' ' VAL . 16.3 t80 -59.19 -54.7 43.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -59.48 -35.18 73.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -64.0 -16.92 62.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.254 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.81 44.62 0.61 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.13 -41.73 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.0 tt -95.68 147.84 5.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.707 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.7 t0 -87.04 172.61 9.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.416 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -61.8 -52.78 66.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.997 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 72' ' ' THR . 75.4 Cg_exo -49.73 -47.57 22.6 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.487 2.125 . . . . 0.0 112.463 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.33 -29.88 66.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.435 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 71' ' ' ASP . 23.2 t -68.76 -47.95 73.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.9 mt -64.19 -36.34 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -61.85 -50.23 73.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -57.25 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.1 t -57.74 -47.56 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -59.12 -22.78 61.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.066 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -94.28 -36.46 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.768 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 tp -62.58 -35.33 79.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 89' ' ' LEU . 13.8 m-85 -113.1 56.29 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.962 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -69.55 -29.91 67.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.153 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.15 26.21 10.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CB ' HD12 ' A' ' 89' ' ' LEU . 34.7 m-70 -140.14 94.62 8.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.931 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.835 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.54 -45.78 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.465 2.11 . . . . 0.0 112.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.85 -18.87 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 48' ' ' PHE . 8.1 mt -85.17 -56.91 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.207 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 103' ' ' ILE . 13.1 tt -57.62 -26.75 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.259 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 87' ' ' PRO . 63.0 t -76.12 -51.63 19.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.535 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -39.39 87.5 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.126 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.63 -31.99 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.58 ' HA ' HD12 ' A' ' 97' ' ' LEU . 34.4 t30 -62.87 -32.3 73.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.632 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.22 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.379 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.554 ' CE2' HG22 ' A' ' 32' ' ' VAL . 29.8 m-85 -99.82 29.94 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 103' ' ' ILE . 20.9 mt -134.76 141.21 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.949 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.85 164.15 35.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.466 2.111 . . . . 0.0 112.295 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -26.69 68.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.014 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.7 -36.32 71.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.575 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -120.9 96.79 5.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -93.44 133.5 36.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.644 HD11 ' CD1' ' A' ' 97' ' ' LEU . 25.5 mt -75.17 153.25 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 105' ' ' ILE . 5.9 p-10 -89.67 171.43 9.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 104' ' ' ASP . 1.8 pt -155.51 137.13 9.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.61 145.6 47.43 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.072 . . . . 0.0 112.173 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.527 0.203 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.69 -11.94 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.508 2.138 . . . . 0.0 112.603 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -79.84 -27.28 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.972 0.415 . . . . 0.0 110.789 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.7 mt -78.98 -37.1 40.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.385 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.85 -34.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.517 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.719 ' O ' HG23 ' B' ' 52' ' ' VAL . 5.1 ptt? -75.5 -30.69 59.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 96' ' ' PHE . 11.8 mt -66.39 -49.9 65.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.442 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.86 79.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.921 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.12 -40.37 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.704 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.719 HG23 ' O ' ' B' ' 48' ' ' MET . 42.9 t -70.37 -34.07 56.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.802 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.6 -32.93 47.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.352 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.58 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.6 mp -88.41 -9.14 53.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.291 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.511 HG22 ' O ' ' B' ' 54' ' ' LEU . 14.7 t 45.97 37.84 4.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.958 0.408 . . . . 0.0 111.357 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.87 -26.16 54.19 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.391 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.926 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.418 ' HB2' ' CE1' ' A' ' 33' ' ' HIS . 5.2 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 CA-C-O 120.844 0.269 . . . . 0.0 111.768 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.34 80.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.346 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -121.07 -171.48 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -45.59 -35.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.444 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.44 -33.31 75.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -43.71 59.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.36 68.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.971 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.93 -55.68 15.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.1 t -58.59 -45.07 89.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 44' ' ' VAL . 58.9 t80 -55.19 -48.06 74.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.02 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.07 -39.79 93.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -64.97 -29.07 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.801 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -79.45 -26.87 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.901 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 40' ' ' TYR . 21.6 t -78.94 -25.45 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.038 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -82.14 -45.99 14.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.24 -51.91 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.207 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -58.13 -30.22 66.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.113 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 54' ' ' THR . 32.0 m-85 -116.99 39.82 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.58 -40.32 92.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.575 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -97.75 24.0 7.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 111.038 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.17 63.96 24.94 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.915 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -51.3 -25.35 17.79 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.548 2.166 . . . . 0.0 112.436 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.51 82.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.869 HG21 ' CE2' ' A' ' 48' ' ' PHE . 4.9 m -68.32 -48.91 63.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' CE2' HD11 ' A' ' 59' ' ' LEU . 16.9 t80 -60.66 -48.49 81.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.21 -40.53 90.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -48.19 80.36 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.22 -44.3 88.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.454 HD11 ' CE2' ' A' ' 55' ' ' TYR . 17.6 mt -61.07 -40.41 93.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.09 -38.49 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.43 HD13 ' HB3' ' A' ' 78' ' ' ARG . 27.8 mt -69.7 -33.59 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.412 ' O ' ' HB1' ' B' ' 50' ' ' ALA . 0.1 OUTLIER -69.64 -35.77 75.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.881 ' HG2' HD11 ' B' ' 54' ' ' LEU . 4.4 mttt -76.62 -33.54 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.761 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -38.47 89.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.0 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 75' ' ' VAL . 37.7 t80 -76.26 -45.98 30.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HD3' HD22 ' B' ' 54' ' ' LEU . 0.2 OUTLIER -57.76 -34.59 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 p -67.46 -13.09 61.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.324 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 43.93 0.29 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.911 0.386 . . . . 0.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.3 m -115.36 -65.3 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -74.97 144.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.72 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.3 m-20 -82.5 -178.14 6.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.977 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.414 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -64.31 -52.9 50.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HA ' HD12 ' A' ' 76' ' ' ILE . 72.4 Cg_exo -48.46 -43.03 33.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.556 2.171 . . . . 0.0 112.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.41 -29.92 76.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.394 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.876 ' O ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -74.55 -45.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 73' ' ' PRO . 3.6 mt -61.37 -50.6 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -58.55 -45.72 88.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.012 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HB3' HD13 ' A' ' 61' ' ' ILE . 33.7 mtt-85 -59.44 -31.38 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.001 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 75' ' ' VAL . 37.5 t -80.75 -47.32 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.165 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -22.19 48.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -92.58 -36.58 12.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.27 -30.57 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.39 40.63 3.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -68.04 -13.41 62.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.445 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -100.05 -30.29 12.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.766 0.317 . . . . 0.0 111.072 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.637 ' CB ' HD12 ' A' ' 89' ' ' LEU . 8.3 m-70 -100.14 114.44 65.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.049 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.855 ' O ' HG23 ' A' ' 91' ' ' VAL . 68.8 Cg_endo -74.2 -43.55 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.45 2.1 . . . . 0.0 112.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -16.08 22.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.469 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.7 HD21 HG22 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -86.27 -53.46 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 0.0 110.055 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.676 HD11 ' O ' ' A' ' 104' ' ' ASP . 7.4 tt -61.25 -28.69 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.192 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 87' ' ' PRO . 54.7 t -75.56 -51.07 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.26 -35.37 55.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.125 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -75.81 -34.33 60.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -62.53 -27.63 69.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.62 -1.63 22.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.012 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -99.88 -30.28 12.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.3 mt -97.91 138.43 20.98 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.07 177.02 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.452 2.102 . . . . 0.0 112.227 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 tp -65.65 -29.94 70.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -57.57 -72.33 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.566 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.95 65.32 6.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.93 157.89 29.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.4 tt -89.63 136.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.154 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.676 ' O ' HD11 ' A' ' 90' ' ' ILE . 2.0 m-20 -61.25 -177.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pp -146.58 129.96 8.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.1 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.05 162.29 37.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.461 2.107 . . . . 0.0 112.415 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.937 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.756 0.312 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.65 -30.33 34.94 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.47 2.113 . . . . 0.0 112.326 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.547 ' O ' HD12 ' B' ' 49' ' ' LEU . 17.8 mt-30 -79.81 -21.12 44.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 65' ' ' PHE . 22.6 mt -81.08 -39.07 26.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.367 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 25.4 mt -72.59 -34.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.379 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.451 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -74.85 -32.35 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.435 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.547 HD12 ' O ' ' B' ' 45' ' ' GLN . 0.8 OUTLIER -68.42 -44.65 74.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.403 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 62' ' ' MET . . . -66.43 -34.33 77.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -61.44 -46.32 90.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 48' ' ' MET . 43.5 t -68.93 -27.43 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.686 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.44 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -79.71 -36.26 37.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.069 0.461 . . . . 0.0 110.381 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.881 HD11 ' HG2' ' A' ' 63' ' ' LYS . 9.0 mp -87.91 -17.4 31.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.044 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.493 HG23 ' O ' ' B' ' 54' ' ' LEU . 0.1 OUTLIER -169.79 70.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.97 49.48 0.85 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.488 1.147 0 CA-C-O 120.813 0.255 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -86.18 -31.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.9 100.09 0.38 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.971 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.57 -30.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -50.19 18.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' THR . 3.4 t0 -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.754 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.89 -39.16 64.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.53 -50.99 67.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 36' ' ' ASP . 4.2 t -59.1 -42.78 91.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.851 ' O ' HG23 ' A' ' 44' ' ' VAL . 75.9 t80 -52.56 -51.32 60.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.998 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.22 -33.27 75.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.586 ' OD1' HD11 ' A' ' 46' ' ' ILE . 14.6 t0 -67.77 -30.73 70.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.974 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -80.85 -26.02 37.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 40' ' ' TYR . 17.2 t -78.74 -28.4 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 55' ' ' TYR . 1.5 tppp? -80.13 -49.29 11.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.586 HD11 ' OD1' ' A' ' 42' ' ' ASP . 34.0 mt -63.39 -41.12 91.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -60.05 -28.07 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 54' ' ' THR . 31.4 m-85 -131.97 47.63 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.57 -34.84 77.81 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.74 19.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.7 0.286 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.21 87.27 12.28 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.855 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.97 -24.54 39.37 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.595 2.196 . . . . 0.0 112.418 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.34 80.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.874 HG21 ' CD2' ' A' ' 48' ' ' PHE . 16.3 m -67.32 -57.98 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.758 ' CE2' HD11 ' A' ' 59' ' ' LEU . 15.9 t80 -59.97 -43.9 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -60.48 -38.28 83.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.77 56.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.664 ' HA ' HD12 ' A' ' 61' ' ' ILE . 20.0 t80 -57.97 -48.52 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.758 HD11 ' CE2' ' A' ' 55' ' ' TYR . 96.5 mt -57.92 -49.51 76.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -42.47 61.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.966 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 58' ' ' PHE . 11.4 mt -65.02 -31.91 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -43.84 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.285 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -74.14 -38.2 63.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.839 0.352 . . . . 0.0 110.806 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.67 84.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB2' HD11 ' A' ' 70' ' ' ILE . 77.9 t80 -66.84 -45.98 76.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -55.14 -29.69 58.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -65.83 -15.32 62.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.305 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 69.33 42.03 1.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.921 0.391 . . . . 0.0 110.85 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 p -117.5 -36.52 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 65' ' ' PHE . 1.2 pt -93.32 178.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -114.86 170.16 8.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.443 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.69 -60.72 9.02 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.228 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 72' ' ' THR . 93.3 Cg_exo -42.99 -30.46 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.602 2.201 . . . . 0.0 112.58 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.74 -34.93 66.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.314 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 79' ' ' VAL . 25.0 t -70.67 -48.64 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.358 . . . . 0.0 110.877 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.478 HG23 HG12 ' A' ' 103' ' ' ILE . 48.9 mt -60.17 -34.74 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -76.0 -39.68 55.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -61.31 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 75' ' ' VAL . 22.4 t -60.42 -49.47 84.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.074 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.777 ' HA ' HD12 ' A' ' 90' ' ' ILE . 28.3 t -56.96 -25.5 58.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.104 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.78 -42.88 26.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 54' ' ' THR . 3.2 tp -64.23 -31.37 72.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE1' HD23 ' A' ' 82' ' ' LEU . 4.7 m-85 -118.22 61.87 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -73.59 -31.12 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.566 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.85 24.15 12.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.51 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.578 ' CB ' HD12 ' A' ' 89' ' ' LEU . 1.9 m170 -129.65 90.81 42.49 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.79 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.811 ' O ' HG23 ' A' ' 91' ' ' VAL . 29.5 Cg_endo -64.11 -55.5 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.513 2.142 . . . . 0.0 112.393 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -50.75 -23.7 2.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.476 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD12 ' CB ' ' A' ' 86' ' ' HIS . 9.1 mt -81.53 -57.9 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.24 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 103' ' ' ILE . 1.6 tt -61.94 -25.4 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.466 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 87' ' ' PRO . 98.3 t -72.98 -50.5 31.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.19 -37.51 80.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.219 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -72.85 -30.71 64.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.047 0.451 . . . . 0.0 110.837 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 103' ' ' ILE . 65.2 t30 -69.02 -27.42 65.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.835 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.16 -13.59 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -99.75 -29.18 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.7 149.7 78.02 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.721 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.98 172.07 12.52 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.612 2.208 . . . . 0.0 112.301 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -67.67 -42.78 81.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.68 -49.22 79.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.406 ' HB3' HD11 ' A' ' 76' ' ' ILE . 6.8 m-85 -94.19 54.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.849 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -174.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 90' ' ' ILE . 22.5 mt -117.87 156.95 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 103' ' ' ILE . 5.8 m-20 -126.5 130.47 50.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.675 ' CG2' HD13 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -143.66 89.83 7.28 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.61 108.75 2.31 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.498 2.132 . . . . 0.0 112.276 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.673 0.273 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.72 -25.59 46.3 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.59 2.193 . . . . 0.0 112.435 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.38 -24.62 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 46' ' ' LEU . 11.8 mt -78.02 -40.23 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.447 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 65' ' ' PHE . 32.1 mm -70.0 -37.52 72.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.47 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.731 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -73.22 -29.06 62.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.628 179.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -67.43 -43.45 81.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.514 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' HG3' ' A' ' 66' ' ' LYS . . . -67.19 -39.84 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -61.77 -46.35 89.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.628 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 48' ' ' MET . 40.6 t -68.2 -30.22 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.12 43.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.416 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.686 HD11 ' HG2' ' A' ' 63' ' ' LYS . 8.4 mp -91.08 -4.2 56.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.327 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' B' ' 54' ' ' LEU . 11.6 t 44.97 47.0 9.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.61 65.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.373 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.959 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.115 0 CA-C-O 120.87 0.279 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 m -63.72 81.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.221 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.59 -171.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.24 -32.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.198 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.71 -34.34 75.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -73.96 -41.44 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.89 -51.19 60.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 40' ' ' TYR . 3.7 t -60.12 -44.93 94.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.802 ' O ' HG23 ' A' ' 44' ' ' VAL . 70.0 t80 -52.79 -51.28 61.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.916 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.8 mt -60.7 -40.23 91.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.454 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m-20 -71.39 -25.29 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.18 -28.21 38.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.3 t -79.68 -30.17 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.977 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 55' ' ' TYR . 1.2 ttpm? -76.92 -47.89 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 42' ' ' ASP . 22.6 mt -64.02 -44.61 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.12 -29.01 63.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.9 42.8 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -42.39 85.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.83 9.57 26.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.613 0.244 . . . . 0.0 111.296 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -140.32 79.51 21.02 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.884 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 -15.6 48.75 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.54 2.16 . . . . 0.0 112.546 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.67 68.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.233 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.544 ' O ' HD21 ' A' ' 82' ' ' LEU . 53.8 m -63.85 -47.54 80.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' A' ' 59' ' ' LEU . 17.7 t80 -58.8 -46.9 86.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.996 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.82 -30.05 69.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.67 -46.66 45.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.615 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 61' ' ' ILE . 79.2 t80 -61.81 -49.68 75.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD11 ' CZ ' ' A' ' 55' ' ' TYR . 5.6 mt -56.9 -43.61 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.064 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -55.89 -47.1 78.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.163 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 58' ' ' PHE . 14.7 mt -61.3 -38.56 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.108 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.3 mmt -66.83 -47.84 70.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.547 ' CG ' HD11 ' B' ' 54' ' ' LEU . 0.1 OUTLIER -64.56 -45.02 88.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.684 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -33.63 76.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 75' ' ' VAL . 38.5 t80 -60.1 -55.02 39.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.85 -30.27 70.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.807 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.0 p -71.37 -8.33 53.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.262 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 65.81 43.3 3.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 110.815 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -119.84 1.92 11.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.323 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.1 tt -145.04 137.82 21.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -80.16 172.21 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.997 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -58.5 -58.32 19.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.153 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.6 Cg_endo -47.33 -42.36 27.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.549 2.166 . . . . 0.0 112.245 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 -29.02 67.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.202 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 79' ' ' VAL . 23.8 t -74.86 -43.28 46.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.849 0.357 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.525 HG23 HG12 ' A' ' 103' ' ' ILE . 41.3 mt -69.02 -41.72 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.054 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -60.13 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -55.77 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 75' ' ' VAL . 42.3 t -58.66 -45.28 90.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 97.9 p -61.48 -23.42 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.044 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -94.77 -31.36 13.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 54' ' ' THR . 4.1 tp -60.56 -36.54 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.762 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.3 m-85 -113.71 47.19 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -62.39 -22.58 66.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.182 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -99.9 -32.14 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 111.103 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.581 ' CB ' HD12 ' A' ' 89' ' ' LEU . 81.7 m-70 -102.48 95.13 5.65 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 91' ' ' VAL . 52.6 Cg_endo -69.59 -30.94 22.27 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.41 2.073 . . . . 0.0 112.263 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.85 -19.7 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -85.27 -49.82 7.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.014 0.435 . . . . 0.0 109.87 179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.524 HG23 HG21 ' A' ' 103' ' ' ILE . 53.5 mt -61.57 -27.66 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.915 178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 87' ' ' PRO . 47.7 t -74.2 -51.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.28 81.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.071 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CD2' HG11 ' A' ' 79' ' ' VAL . 18.1 t80 -70.26 -35.57 73.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.674 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.95 -26.68 66.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.668 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 -11.41 53.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.747 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.6 -37.25 9.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.613 HD13 HD11 ' A' ' 103' ' ' ILE . 3.9 mp -72.32 116.86 53.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.47 177.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.418 2.078 . . . . 0.0 112.275 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.97 -27.29 65.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -56.07 -31.14 58.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.519 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -133.03 113.41 12.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -111.95 134.94 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.613 HD11 HD13 ' A' ' 97' ' ' LEU . 24.5 mt -92.38 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 103' ' ' ILE . 2.3 p30 -73.58 128.9 36.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -136.71 153.0 75.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.96 142.53 57.13 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.586 2.191 . . . . 0.0 112.299 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.3 tttt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.895 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.72 ' CB ' HD12 ' B' ' 46' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.91 -22.52 36.01 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.577 2.184 . . . . 0.0 112.435 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.3 mp0 -77.86 -23.24 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.72 HD12 ' CB ' ' B' ' 43' ' ' ALA . 52.1 mt -77.92 -37.31 48.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.381 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 29.7 mt -71.35 -38.63 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.453 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.659 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.0 OUTLIER -71.99 -29.59 64.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.434 HD12 ' O ' ' B' ' 45' ' ' GLN . 4.9 mt -68.82 -43.05 76.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.86 83.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.947 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -61.85 -42.74 99.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.658 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.659 HG23 ' O ' ' B' ' 48' ' ' MET . 38.3 t -69.12 -29.69 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.741 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.02 -36.85 40.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.31 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.547 HD11 ' CG ' ' A' ' 63' ' ' LYS . 7.4 mp -83.44 -25.11 31.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.835 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.67 71.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.628 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.53 -48.34 3.5 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.54 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.846 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.488 1.163 0 CA-C-O 120.83 0.262 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 95' ' ' ALA . 3.2 m -65.04 79.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -131.26 -175.95 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.2 -29.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.52 -41.62 72.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.5 -33.56 69.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.16 -36.94 64.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.037 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -52.22 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -60.08 -42.92 95.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.901 ' O ' HG23 ' A' ' 44' ' ' VAL . 55.0 t80 -52.08 -47.69 65.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.16 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.13 -40.42 94.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -68.06 -29.88 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -76.62 -30.19 56.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.797 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 40' ' ' TYR . 25.2 t -78.06 -30.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.46 -45.59 58.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.6 mt -66.65 -39.62 84.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -29.9 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 54' ' ' THR . 68.7 m-85 -118.46 40.19 3.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.99 -21.5 79.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.3 p -92.01 -9.16 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.509 0.195 . . . . 0.0 111.362 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -140.03 100.57 7.17 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.575 0.226 . . . . 0.0 111.041 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.46 -14.93 37.84 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.491 2.128 . . . . 0.0 112.598 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.84 -40.36 69.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.86 HG21 ' CE2' ' A' ' 48' ' ' PHE . 22.8 m -68.37 -50.0 56.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -61.75 -49.11 77.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -60.47 -34.46 74.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -48.55 49.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.478 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.5 t80 -56.69 -46.63 81.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.944 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.55 -39.33 87.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -62.03 -38.61 89.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 58' ' ' PHE . 5.8 mt -68.53 -48.81 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.6 mmt -64.23 -37.57 87.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -70.84 -47.77 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.85 -29.88 69.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' HG21 ' A' ' 75' ' ' VAL . 54.3 t80 -76.44 -42.11 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 ttmm -54.26 -33.8 59.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.006 0.431 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -15.86 60.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.03 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 63.66 43.4 5.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 110.763 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -116.53 -35.63 4.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.6 pt -86.6 178.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.23 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.36 161.44 13.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -58.47 -59.26 14.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.0 Cg_endo -45.46 -41.28 18.08 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.812 2.341 . . . . 0.0 112.179 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.31 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.613 HG21 ' CD1' ' A' ' 65' ' ' PHE . 12.5 t -79.27 -46.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.952 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 mt -65.68 -36.48 77.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -45.63 68.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.756 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -48.01 82.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 75' ' ' VAL . 39.9 t -67.03 -41.15 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.4 t -61.39 -23.44 65.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -36.38 11.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.793 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 54' ' ' THR . 5.0 tp -61.66 -38.91 89.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.8 ' CD1' HD13 ' A' ' 89' ' ' LEU . 21.9 m-85 -104.61 60.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.07 31.25 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.01 -46.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.677 ' HB2' HD12 ' A' ' 89' ' ' LEU . 50.6 m-70 -105.2 103.52 42.53 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.93 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.854 ' O ' HG23 ' A' ' 91' ' ' VAL . 36.8 Cg_exo -57.73 -34.24 97.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.536 2.157 . . . . 0.0 112.292 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.63 -17.79 16.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.606 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.8 HD13 ' CD1' ' A' ' 83' ' ' PHE . 4.3 mt -83.06 -55.91 4.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.179 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 103' ' ' ILE . 18.0 tt -60.25 -27.08 38.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.22 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 87' ' ' PRO . 67.7 t -73.75 -48.7 38.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.524 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.33 -38.56 90.78 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -71.68 -32.26 67.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.967 0.413 . . . . 0.0 110.715 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 97' ' ' LEU . 50.2 t30 -66.51 -29.38 69.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.784 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.42 ' O ' HG11 ' A' ' 32' ' ' VAL . . . -61.41 -17.72 55.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.496 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -99.74 30.07 3.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 94' ' ' ASN . 6.1 mt -142.06 143.58 28.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.13 169.44 22.22 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.544 2.163 . . . . 0.0 112.286 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.02 -32.53 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.783 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.16 89.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.458 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.45 93.16 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -103.55 148.9 25.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 90' ' ' ILE . 5.8 tt -79.09 138.47 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -72.8 129.08 37.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.2 mt -110.17 78.38 1.35 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 140.5 38.9 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.58 2.186 . . . . 0.0 112.253 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.852 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.719 0.295 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 -25.51 22.08 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.545 2.163 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 48' ' ' MET . 14.5 mt-30 -79.09 -22.08 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.921 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.1 mt -79.13 -37.85 37.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.35 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 mm -72.68 -36.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' MET . . . . . 0.698 ' O ' HG23 ' B' ' 52' ' ' VAL . 0.1 OUTLIER -73.9 -29.19 61.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.67 -47.25 67.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.34 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.25 80.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.845 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.7 -42.79 99.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.59 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.698 HG23 ' O ' ' B' ' 48' ' ' MET . 39.3 t -67.32 -32.97 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.873 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.28 -33.48 49.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.443 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.485 ' O ' HG22 ' B' ' 55' ' ' THR . 6.1 mp -91.75 -3.91 55.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.293 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' THR . . . . . 0.485 HG22 ' O ' ' B' ' 54' ' ' LEU . 15.2 t 45.5 42.17 7.59 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.368 . . . . 0.0 111.504 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.76 28.52 5.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.398 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.944 179.997 . . . . . . . . 1 1 . 1 stop_ save_